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41. Background
5The Ethical Framework for End-of-life Care is part of a national programme, 
the Hospice Friendly Hospitals Programme (HfH) of the Irish Hospice 
Foundation, which is intended to improve the culture of care and 
organization regarding dying, death and bereavement in Irish hospitals. 
The Framework is an educational resource that consists of eight Modules of 
Learning for health professionals, patients, families and the general public. 
The Framework is the outcome of a unique collaboration between University College Cork, 
the Royal College of Surgeons in Ireland and the Irish Hospice Foundation, with contributions 
from ethicists, legal experts, theologians, sociologists and clinicians. It draws on a range 
of values and principles that have been identified as important considerations in end-of-
life decision making by international experts in bioethics and by professional codes of 
conduct, policy documents and laws. It is also informed by extensive international research 
on patients’ and families’ experiences of death and dying and the contribution of health 
professionals and organizations to quality end-of-life care. 
In order to ensure that the Framework addresses the concerns of the Irish public and that it 
is relevant and useful to the work of health professionals involved in end-of-life care in Irish 
hospitals, the Framework is informed by reviews and studies involving hospice, palliative 
and acute care services especially commissioned by the Irish Hospice Foundation in the 
last decade. It also draws on a significant body of research, undertaken in 2007/2008, which 
specifically addresses ethical issues in relation to end-of-life care in Irish hospitals. 
62. National Research
7Reports of the national research undertaken in 2007/2008 are provided in 
the Appendix to the Framework and they include:
•	 Focus group interviews with members of the general public to identify issues of concern 
at the end of life (Weafer, 2009a). 
•	 A national survey of the public’s understanding of, and concerns about dying, death and 
bereavement (Weafer, McCarthy and Loughrey, 2009). 
•	 Interviews with public representatives in relation to ethical and legislative issues that 
arise at the end of life (Weafer, 2009b). 
•	 A literature review to explore the concept of autonomy in theory and in hospital practice 
and to consider a range of initiatives and interventions to support dying patients’ decision 
making capacity (Quinlan, 2009b). 
•	 An analysis of Irish and UK newspapers, television and radio treatment of issues arising in 
relation to death and dying in Irish society (Quinlan, 2009a). 
•	 Individual and focus group interviews conducted with healthcare practitioners working 
in fifteen Irish hospitals, in order to gain an understanding of their experiences of caring 
for dying patients and their families (Quinlan and O’Neill, 2009).
8Evidence from the national research indicates the following:
•	 The general public and Irish legislators are largely unfamiliar with, or have little 
understanding of, terms associated with end-of-life treatment and care, such as do not 
resuscitate orders, advance directives, artificial nutrition and hydration (Weafer, 2009a, 
2009b; Weafer, McCarthy and Loughrey 2009). 
•	 Most people want to be informed if they have a terminal condition (Weafer 2009a; 
Weafer, McCarthy and Loughrey, 2009).
•	 Information about diagnoses and prognoses is often shared with families instead of 
patients (particularly older patients) at the end of life (Quinlan and O’Neill, 2009).
•	 If they are unable to make decisions for themselves, most people prefer their families 
and/or loved ones (often, in conjunction with doctors) to make decisions about starting 
or stopping treatment for them (Weafer, 2009a; Weafer, McCarthy and Loughrey, 2009).
•	 One in five people have told someone how they would like to be treated if they were 
terminally ill and dying. One in twenty people have written a Living Will (Weafer, 
McCarthy and Loughrey, 2009).
Most people believe that 
•	 If they were severely ill with no hope of recovery, the quality of their life would be 
more important than how long it lasted. 
•	 Spiritual or religious support is important to them. 
•	 Every competent person has the right to refuse medical treatment even if such refusal 
could lead to their death (Weafer, McCarthy and Loughrey, 2009).
•	 Patients who are dying have medical concerns; but they are also concerned about other 
things such as family relationships (Quinlan, 2009b).
•	 Patients who are dying value their autonomy but they also value other things such as the 
wellbeing of others (Quinlan, 2009b, Quinlan and O’Neill, 2009).
•	 The notion of patient autonomy is not well understood by many health professionals 
working in Irish hospitals (Quinlan and O’Neill, 2009).
 
 
9•	 Health professionals face communication challenges in sharing decision-making with 
patients and families in end-of-life situations (Quinlan and O’Neill, 2009).
The eight modules of The Ethical Framework for End-of-Life Care address the concerns 
that have been highlighted in the research outlined above and consider a number 
of the narratives that have emerged from interviews and focus groups with health 
professionals. 
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3. Aim and Objectives of the Ethical 
Framework for End-of-Life Care
11
Aim: The Ethical Framework for End-of-Life Care is an educational 
resource that aims to foster and support ethically and legally 
sound clinical practice in end-of-life treatment and care in  
Irish hospitals. 
Objectives
1. A key objective of the Ethical Framework is to enhance the reflective, critical and 
communicative skills of health professionals, hospital staff and hospital administrators so 
that they become more informed, confident and collaborative in addressing ethical and legal 
challenges that arise in the treatment and care of dying patients and their families. 
2. A second objective is to provide patients, families and the general public with easily 
accessible information and opportunities for learning which will deepen their ethical and 
legal understanding of the issues that arise in relation to death and dying and enhance their 
decision-making capacity in relation to their own deaths and those of their loved ones. 
3. A third objective is to increase the capacity of Irish healthcare organisations 
•	 to support health professionals to do their work and patients to receive their care in an 
ethically healthy climate
•	 to create safe spaces where individuals feel free to raise ethical, professional and legal 
concerns and to express nagging doubts and fears
•	 to encourage open, inclusive and respectful dialogue about ethical, professional and 
legal concerns.
12
4. Educational Philosophy
13
Research evidence clearly indicates that health professionals, 
patients and families must often make difficult decisions in tense, 
demanding, emotionally fraught and constrained circumstances. 
The Ethical Framework for End-of-life Care offers an opportunity 
to readers to take a reflective step back from their intuitive 
responses to ethically challenging situations and to examine 
received values, assumptions and emotional responses in light of 
general norms, professional codes and laws. 
The philosophy underpinning the development of the Ethical Framework is one that 
views ethical work as a critically engaged process whose object is to negotiate, rather than 
eliminate, ethical uncertainty. The assumption is that it is precisely the experience of moral 
uncertainty, disagreement and diversity that forces us to critically reflect on our moral 
viewpoints: difference creates the need for moralizing to begin with. 
The educational aim of the Ethical Framework, therefore, is not to tell people what to do, but 
to offer tools for thinking about difficult problems. The educational task is to foster a range 
of ethical skills and competencies to ensure that ethical decisions are arrived at in the most 
reasonable, sensitive and collaborative way possible. These include skills of reflection and 
analysis as well as the critical ability to evaluate the adequacy of reasons and arguments 
that support different positions and courses of action. To this end, the Framework Modules 
employ different moral perspectives – traditional and contemporary – to draw out different 
ethical features of each of the situations considered (See Module 1 for an account of different 
moral perspectives). In addition, Modules 3 and 4 have a particularly legal focus, which 
serves to illustrate the way in which very deeply-held moral values have been enshrined and 
expressed in laws and court decisions. 
14
Readers are also introduced to the process of ethical reasoning and resolution through 
interactive learning and reflection on case studies drawn from practice. These bring into 
sharper focus the need for sensitivity to the unique stories and circumstances of individual 
patients and families. This is all the more important given the multicultural and socially 
diverse world that health professionals, healthcare staff, patients and families belong to. 
15
5. Ethical Framework
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The Framework is divided into 8 distinct Modules of Learning which:
(1) Identify relevant considerations in situations at the end of life that  
may be ethically and/or legally challenging; 
(2) Explore and explain the ethical and legal issues at stake, and; 
(3) Offer reasonable and well-supported approaches to addressing  
these issues. 
 
Discusses one key notion that is linked with death and dying; the meaning of a ‘good 
death’. Describes a range of different approaches to moral problems and distinguishes 
ethics from other perspectives such as religion and the law. 
 
 
Explains why telling patients the truth about their condition is important and reflects 
on the challenges that diverse cultural perspectives on patient and family relationships 
present to health professionals when they are considering breaking bad news. Presents 
arguments for and arguments against, breaking bad news.
Considers the way in which deeply-held moral values in relation to dying and death have 
been enshrined and expressed in laws and court decisions. Explains the relationship 
between moral and legal rights and discusses the advantages and the limits of taking a 
rights based approach to the decision making process at end of life.
 
Explains the legal right of patients to refuse treatment as well as the positive right of 
patients to control and direct how their treatment and care proceeds. Evaluates the 
contribution of an autonomy-based model of decision-making and the limits of patient 
autonomy. Outlines the legal test of capacity, and the health professional’s obligation to 
facilitate the participation of patients who lack capacity.
17
Describes the different kinds of pain and suffering that patients may endure and 
considers reasons why adequate pain relief may not be provided to different patient 
groups. Explains the challenge of determining adequate and proportionate responses to 
patients’ pain and ethically evaluates palliative measures that are sometimes provided to 
alleviate extreme and intractable suffering. 
 
 
Explains the ethical and legal concerns that arise in relation to decisions not to start or 
to discontinue the use of life prolonging treatments. Presents and considers different 
positions on the ethical and legal status of euthanasia and assisted suicide.
Describes the onus on health professionals to protect the confidentiality and privacy 
of patients who are dying and deceased. Discusses exceptions to the ethical and legal 
requirement of confidentiality and the relevant interests of others such as patients’ 
families.
 
Outlines and considers the role of Clinical Ethics Committees and the process of ethics 
consultation in clinical practice. Charts the emergence of Research Ethics Committees 
and their contribution to the regulation of research and the protection of research 
participants.
18
6. Module Format
19
Each of the modules is formatted in a similar way; it is divided 
into distinct sections that offer Key Points, Definitions, 
Background, Main Topics, Cases and Suggested Professional 
Responsibilities, 1 Further Discussion, Summary Learning Guides, 
Activities, References and Further Reading.
The uniform presentation of the Modules enables readers to take or leave parts or all of any 
module. In addition, individual Case Studies are linked to specific Activities and Learning 
Guides so that these can be considered independently of the rest of the Module.
1. Key points  
Offers a brief summary of each of the main points that arise in the Module. These 
points are discussed more extensively in the main body of the Module. 
2. Definitions 
Explains the meaning of key terms used in the Module. Readers may find it useful to 
return to it when, in the course of their reading, they come across terms that they are 
unfamiliar with. 
3. Background 
Introduces the reader to the main topic of the Module and indicates the key ethical 
and legal challenges that it presents. 
 
 
1  Module 1 provides an overview of the task of ethical reasoning and does not consider individual cases.
20
4/5. Key Topics 
Explains and explores the main ethical and legal issues that the Module is  
concerned with.  
6. Cases  
Describe situations from practice which give rise to ethical challenges for health 
professionals, patients and their families, e.g., decisions about pain relief and starting 
or stopping medical treatments. Many of the cases are concrete narratives drawn 
from the everyday experiences of patients, families, health and allied professionals in 
Irish hospital wards, operating theatres, clinics and other healthcare settings. Where 
relevant, cases are drawn from other countries. The narratives highlight a number of 
ethical and legal questions and issues that are then explained and discussed in the 
text. This section suggests some of the Professional Responsibilities that might arise 
in relation to each case for readers to consider. 
7. Further Discussion 
This material discusses in more detail the ethical and legal issues that are addressed in 
the Module.  
8. Summary Learning Guides 
Provide brief synopses of the key points that are made in the Module. These are 
presented in boxed format in order to facilitate a revision of concepts, definitions and 
arguments.  
9. Activities
Questions for reflection or comments are offered to readers at the end of the 
Module to encourage them to tease out the ethical and legal questions raised in the 
discussion, the cases and the analyses that follow.  
10. References and Further Reading
Includes a list of texts referred to in the body of the Module as well as additional 
reading relevant to the topic. Where possible; web sources and links are provided.
21
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1.1 Ethics, or moral philosophy: considers theories about what human beings are capable of 
doing, alongside accounts of what they ought to do if they are to live an ethically good life. 
Ethics may share common ground with the law, religious belief, popular opinion, professional 
codes, hospital policies and the dictates of authority figures, but it is also broader than  
all of these and offers a set of tools and values against which their appropriateness can  
be evaluated.
1.2 Healthcare ethics: is a domain of inquiry which focuses on the moral, or ethical, problems 
and challenges that arise in healthcare settings. While healthcare professionals may differ in 
relation to these issues because of their different roles and responsibilities, they nevertheless 
share much common ground. For example, in end-of-life situations, different professionals 
have different functions: consultants and doctors are, generally, the lead decision-makers 
in relation to treatment or nontreatment decisions, while nurses and allied professionals 
have much of the responsibility for caring for patients and their families through the dying 
process. However, these functions may also overlap in both directions; nurses and other 
professionals contribute to decision-making, consultants and doctors contribute to care. 
1.3 A Good Death and Dying: The diversity of individual values and cultural differences tells 
us that an agreed consensus on what makes for a ‘good death’ may not be within our easy 
reach. But, although there may be no universal agreement about what a ‘good death’ consists 
of, there is some consensus as to the core features of the care that needs to be provided 
to those who are dying and their families and loved ones. For example, drawing on long-
established ethical principles, the UK General Medical Council (GMC) describes good end-of-
life care as that which ‘helps patients with life-limiting conditions to live as well as possible 
until they die, and to die with dignity’ (GMC, 2009, p.3).
27
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2.1 Values: things that matter to us; that we care about; goals or ideals we aspire to, e.g., 
health and happiness. Ethical or moral values express ideals of conduct and character that we 
expect of ourselves and each other, e.g., honesty, loyalty and justice.
2.2 Family: may include the immediate biological family and/or other relatives, spouses, 
partners (including same sex and de facto partners) or friends. They may have a close, 
ongoing, personal relationship with the patient, be chosen by the patient to be involved in  
treatment decisions, and have themselves indicated that they are ready to be involved in 
such decisions.
2.3 Harm Principle: stipulates that individual freedom can only be limited on the basis of 
harm to others, i.e., when an individual, in exercising their autonomy, limits the autonomy or 
threatens the welfare and safety of others. 
2.4 Objective perspective: a view that is independent of any particular person’s or 
group’s perspective.
2.5 Subjective perspective: a personal point of view.
28
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3.1 What Ethics Is
Ethics is a branch of philosophy that attempts to understand people’s moral beliefs 
and actions (these modules use the terms, ‘ethics’ and ‘morality’; ‘ethical’ and ‘moral’ 
interchangeably, although traditionally ‘ethics’ described the process of thinking about 
people’s morality). Ethics, or moral philosophy, considers theories about what human 
beings are capable of doing, alongside accounts of what they ought to do if they are to live 
an ethically good life. Ethics also explores the meaning and the ranking of different ethical 
values, such as honesty, autonomy, equality and justice, and it considers ethical quandaries 
that human beings face in the course of living their own independent but, also, socially 
interdependent lives. 
One of the key tasks of ethical reasoning, generally, is to analyse and critically consider the 
values we hold and the claims we make in relation to the perceived obligations that we 
might have towards one another. Applied to the processes of death and dying and the care 
provided at end of life, key values that arise include sanctity of life (the fact of being alive 
is itself deeply valued), quality of life (the fact of having positive experiences and avoiding 
negative experiences is considered deeply morally significant), autonomy (respecting 
someone’s preferences in relation to where, how and when they die is, increasingly, 
considered to be deeply morally significant and challenging). 
A second key task of ethics is to evaluate the adequacy of reasons that we give for our 
actions: it considers, for example, whether the reasons offered to support a particular course 
of action are based on sound evidence and/or logical argument. Applied to the processes of 
death and dying, reasons that are evaluated might be the arguments a health professional 
offers in support of resuscitating an incompetent terminally-ill patient or a parent’s reasons 
for refusing medical treatment for a severely disabled neonate.
 
The tasks of weighing ethical values and evaluating different ethical arguments are unlike 
many other kinds of human tasks. Ethical values are usually not as easy to understand as 
other kinds of values, e.g., it is probably easier to explain the (mainly) practical value of 
energy than it is to explain the ethical value of courage. In turn, it is easier to test a person’s 
blood pressure than it is to determine whether or not they are virtuous. 
Moreover, ethical problems are often not as clear as other kinds of problems and resolving 
ethical problems as definitively is not always possible. The aim of ethics then, is not, despite 
popular opinion, to take the high moral ground and tell people what to do, but, rather, to 
offer tools for thinking about difficult problems. Good ethical thinking purposefully seeks out 
29
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the grey in questions and concerns in order to acknowledge the diversity and complexity of 
roles, situations and circumstances that arise in human life and relationships. 
As complex as ethical situations may be, however, there is still an onus on everyone involved 
in ethically-challenging situations to resolve any problems that arise in the most sincere, 
reasonable and collaborative way possible. This means that they must be prepared to review 
and revise their position in the light of reflection, discussion and changing circumstances. 
(See Further Discussion for more detail on traditional and contemporary ethical theories).
3.2 Healthcare Ethics
Healthcare ethics is a domain of inquiry which focuses on the moral, or ethical, problems 
and challenges that arise in healthcare settings. Healthcare ethics addresses these concerns, 
largely from the perspective of different professional groups, including doctors and nurses, 
as well as occupational therapists and dentists. It can be further subdivided into medical 
ethics, nursing ethics, dentistry ethics, etc., but, for the purposes of these modules, the 
broader term ‘healthcare ethics’ is used. This is because all health professionals and some 
allied professionals share common ethical concerns about how best to care for patients at the 
end of life. These concerns arise in all patient/professional relationships, and include worries 
about breaking bad news, obtaining informed consent and respecting confidentiality. All 
health professionals also have similar experiences of dealing with challenges in relation to 
distributing scarce resources, addressing social injustice and dealing with incompetent or 
immoral colleagues (Holm, 1997).
While healthcare professionals may differ in relation to these issues as a result of their 
different roles and responsibilities, they nevertheless share much common ground. For 
example, in end-of-life situations, different professionals have different functions: consultants 
and doctors are, generally, the lead decision-makers in relation to treatment or nontreatment 
decisions, while nurses and allied professionals have much of the responsibility for caring for 
patients and their families through the dying process. However, these functions may also  
overlap in both directions; nurses and other professionals contribute to decision-making, 
consultants and doctors contribute to care.
In the past twenty years, the field of healthcare ethics in general has rapidly expanded in an 
effort to address the seismic moral and metaphysical shifts that have occurred as a result of 
technological advances at the beginning and end of life. Today, human beings can create 
life, modify life and prolong life in ways that make the wildest of science fiction stories sound 
tame. Clinical Ethics Committees, Research Ethics Committees and Commissions are being 
instituted to attend to the moral uncertainty and moral challenges that accompany such 
rapid changes. Similarly, the evolution of healthcare ethics can be seen as part of a process of 
development that involves confronting and addressing these challenges. 
30
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which health professionals face during the course of their work, the focus, in recent years, 
has been on good judgement, collaborative decision-making and professional and personal 
accountability. In addition, because of the particular nature of this work, human relationships, 
and the ethical bonds and obligations that they give rise to, are at the heart of the moral 
realm of healthcare provision. Storch captures this in the following quotation, in which she 
claims that the ethical life is one that is most deeply lived in relationship with others:
‘[Healthcare] ethics is about being in relationship to persons in care. The enactment of healthcare 
ethics is a constant readiness to engage one’s moral agency. Almost every [healthcare] action and 
situation involves ethics. To raise questions about ethics is to ask about the good in our practice. 
Are we doing the right thing for this patient? Are we listening to this person’s need for pain relief? 
Are we respecting a family’s grief over their dying child as they struggle to squeeze out a few 
extra days or hours for the child through alternative therapies? Are we ready to stand up for what 
we know to be right when we face a situation requiring us to perform a procedure that we are 
confident is not appropriate and that violates the dignity of another human being? Are we willing 
to find time to debrief after complex situations to determine how we could have done better, with 
a commitment to doing everything in our power to prevent similar situations from occurring in 
the future?’ (Storch, 2004, p.7)
Echoing Storch’s emphasis on human relationships, Arthur Frank, author of the 
internationally-acclaimed book, The Wounded Storyteller, has posed the question of how 
health professionals can remain generous in the middle of expanding needs and demands on 
them and the pressure to deliver treatments as commodities. Frank describes fundamental 
medicine as:
 
‘[F]ace-to-face encounters between people who are suffering bodily ills and other people who 
need both the skills to relieve the suffering and the grace to welcome those who suffer […] 
Before and after fundamental medicine offers diagnoses, drugs, and surgery to those who suffer, 
it should offer consolation. Consolation is a gift. Consolation comforts when loss occurs or is 
inevitable. This comfort may be one person’s promise not to abandon another.[ … ][T]hose who 
make medicine their work are to find their consolation in being the kind of people who offer such 
hospitality.’  
(Frank, 2004, p.1-3)
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4.1 Defining ‘Death’
When the question is posed, ‘what is death’?, it seems a straightforward question with a 
simple answer – the cessation of all life functions. But that’s simply a biological definition 
and it is disputed, i.e., does death occur when the heart stops? When the brain partially 
or wholly stops functioning? when the question is posed, ‘what is the meaning of 
death’?, it becomes even more apparent that death cannot be directly apprehended in 
straightforward scientific terms. 
Death is a fact of life, but how one thinks about mortality and the limits of earthly life 
reflects social, not biological realities (Kliever, 2004). This means that beliefs about death 
and its significance and value are ‘socially constructed’. Depending on the society in which 
we grow up, we learn much about dying. We acquire emotions about death and dying and, 
along with our memories of others who have died, we accumulate anxieties, or develop 
a sense of acceptance, dread or detachment about dying. Our ‘society’ is the sum of our 
unique environmental space, our geography, our culture, our religious traditions and 
family influences. Because the beliefs and attitudes towards dying are ‘socially constructed’ 
in the sense just explained, a culturally diverse society, such as Ireland is now, reveals a 
similar diversity of ‘death perceptions and values’. 
4.2 Cultural Differences
Culture provides the key medium for comprehending the final boundary between our 
existence as living beings and the eventual end of that existence. If one is a religious 
person, he or she might believe that death means the end of existence ‘at least in this 
mortal sphere’. For example, the beliefs of Muslims hold a promise that death is not 
the end. ‘They believe that dying is part of living and an entrance to the next life, a 
transformation from one life to another, a part of a journey, and a contract and part of their 
faith in God’ (Our Lady of Lourdes Hospital, 2005, p.11). 
Similarly, belief in the Catholic religion frames the way in which death is negotiated 
for many Irish people. As Quinlan (2009a) observes in relation to her research of media 
representations of death and dying in Ireland: 
‘The Catholic nature of much of Irish spirituality was evident. It was evident in the response of 
one mother to the prognostication of terminal cancer in her young daughter Rachel (Tubridy: 
04.02.2008). She spoke of trips to Lourdes, to Medjugorje, to Rome for a meeting with the Pope, 
in search of a miracle that would save her daughter’s life. She said that they had not discussed 
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death with Rachel. Rachel was five years old when she died. Her mother said that when Rachel’s 
siblings asked if Rachel was going to die, her response was: “we hope not. She is very sick but we 
are praying to holy God. We are praying to him to make her well again”.’
(Quinlan, 2009a, p.7-8, See Appendix)
The reality of cultural diversity is a recurring theme of the Ethical Framework for End-of-Life 
Care precisely because recognition of this diversity means recognition of, and respect for, 
the differing values of patients in the illness and dying processes. Some illustrative examples 
show what this may mean in practice. In Middle-Eastern societies, it is common to support 
a border-line existence for patients suffering from persistent vegetative state, maintaining 
their biological lives in specialised ventilatory-care units. It is as if death must be resisted 
at all costs. But the Wari people, native inhabitants of the Amazon, do not shrink from the 
reality of dying, but employ customs that might be shocking to many Western value-systems. 
Wari people show respect for their dead and salve their grief by engaging in ritual mortuary 
cannibalism. Western onlookers might be aghast at such behaviour that looks like profound 
disrespect for the deceased loved ones. However, the value of ‘respect’ is pronounced among 
the Wari people. 
Cultural differences may also challenge some basic assumptions in hospice philosophy, 
making it more difficult for hospice carers to respect these differences. For example, home 
death is often considered an ideal in hospice philosophy, and a ‘good death’ is characterised 
as taking place at home, surrounded by family and/or friends with symptoms and pain under 
control and spiritual needs identified and met following appropriate good-byes. At variance 
with this hospice goal, home death (or ‘Hogan’ death to use the Navajo term for ‘home’) may 
not always be valued in diverse ethnic groups, for whom it is deemed dangerous or polluting 
to be around the dead. Among traditional Navajo, dying persons were removed from the 
Hogan dwelling to a separate shed-like room through a special door to avoid the travesty of a 
death happening in the Hogan, because the Hogan would then have to be destroyed.  
To ensure that ghosts could not find their way back to the Hogan, family members did not 
touch the body (Koenig and Marshall, 2004). This task was assigned to outsiders. The Navajo 
Indian likewise considers advance care planning a violation of their traditional values  
(Carrese and Rhodes, 1995).
Quinlan’s account of the views of some Irish Travellers indicate that there are culturally 
different attitudes to death and dying among Irish people also – some Irish Travellers, for 
example, find common ground with the US Navajo Indians in their view of the place dying: 
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discussion of Irish Travellers and their experience of hospice. Professor McQuillan said that 
Irish Travellers, unlike Irish people generally, did not like to die at home. She talked about how 
Travellers would traditionally leave a place where one of their community died. She detailed 
how they would burn all of the person’s belongings, even burn the dead person’s trailer. She said 
that in the history of The Irish Hospice only two Travellers had died in a hospice, both in 1999 
and none since. She quoted one Traveller as saying: “Now that we know what kind of place it is, 
we wouldn’t want anyone to go there. It’s a place without hope, and Travellers can’t live without 
hope”.’ (Quinlan, 2009a, p.8)
4.3 Individual Differences
In addition to cultural differences, there are also individual differences in the way in which 
dying is negotiated. For some, ‘a good death’ may seem a contradiction, especially if one 
does not have the possible comfort and solace of religious belief in an afterlife. Death may 
signal the end of all that is loved, all that is experienced and all that is possible.  
The sentiments that reject the very notion of a ‘good death’ are voiced by Dylan Thomas 
(1945/2003). Expressing a sense of frustration that his father might not resist the illness 
that beset him, Thomas wrote these words to his father as a moving plea not to give in to 
‘the dying of the light’.
 Do not go gentle into that good night, 
 Old age should burn and rave at close of day;
 Rage, rage against the dying of the light. (p. 239)
Dylan Thomas stressed the importance of affirming life, of fighting the ‘dying of the light’ 
up until the last breath, and refusing the call to accept death quietly. An opposed view is 
that of Elizabeth Kubler-Ross (1975), who urges us to move through a number of stages: 
denial, anger, bargaining, depression and a final detachment which is an ‘acceptance’ 
facilitating a peaceful demise. On Kubler-Ross’s view, health professionals would be 
facilitators helping the dying person with the journey through these stages. ‘Since the 
dawn of human-kind, the human mind has pondered death, searching for the answer to its 
mysteries. The key to the question of death unlocks the door of life’ (1975, p.1).
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Recent research on dying and death in Ireland also gives us some indication of the variety 
of responses of people living in Ireland when queried about their understanding of a ‘good 
death’. The following features were highlighted by members of the focus groups convened in 
the course of Weafer’s qualitative research for the Irish Hospice Foundation  
(Weafer, 2009a):
•	 Fast and peaceful/ to die in your sleep.
•	 To have your family with you when you die.
•	 To have control over the time and circumstances of your death.
•	 To be cared for at home, with adequate medical support.
•	 No pain or suffering involved.
•	 To die with dignity and all that entails.
•	 Your children to be reared and independent.
•	 When you are old; in accordance with the natural life-cycle.
•	 With enough time to get your affairs in order.
•	 With a pint of Guinness in one hand and a model in the other!
In addition, the top three concerns of the respondents in a national survey (n = 667) on the 
public’s reported concerns at the end of life related to family/friends, pain/violent death, and 
actually dying (Weafer, McCarthy and Loughrey, 2009). This echoes an earlier study on the 
same theme, in which the three most important aspects of care cited by respondents if they 
were dying or in the last stages of a terminal illness were: to be surrounded by loved ones, to 
be free from pain, to be conscious and able to communicate (Weafer, 2004).
Quinlan claims that there is evidence of a culturally-specific Irish attitude to death in 
Professor McQuillan’s observation that ‘there is a frankness about death in the UK and 
the US that is absent in Ireland’. ‘We are not’, she said, ‘so open about death here’. (Quinlan 
2009a, p.7). Indicating that this Irish reluctance to talk about death may be changing, Emma 
Doyle’s recent research describes the now famous interview by Marion Finucane with Irish 
author and broadcaster, Nuala O’Faoláin, during which O’Faoláin shared her experience 
and subsequent struggle, on learning of her diagnosis of terminal cancer. Doyle terms the 
interview a ‘critical event’ which sparked a ‘national conversation about death’:
‘On a Saturday morning in April, many Irish people stopped what they were doing and listened 
to the voice of a person who was talking about dying. People who missed the interview heard 
about it from others and listened to it later on the internet or read the transcript in the next day’s 
papers. This voice moved many to reflect on their own feelings about dying or the deaths of their 
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loved ones and started a national conversation about death. The emotional response of so 
many people to the narrative of a dying woman serves to highlight how unusual it has become 
to speak out publicly about death, and the belief of over half the population that death is not 
discussed enough shows that Irish people were ready to have this conversation. By drawing 
attention to the lived experience of dying, O’Faoláin began a discussion where previously there 
had been silence. (Doyle, 2008, p.25)
Doyle refers to one participant in this ‘national conversation’, Terence Cosgrave, whose 
editorial in the Irish Medical Times points out:
‘[I]f Nuala O’Faoláin has taught us anything, it is that we should put the person who is 
experiencing the trauma of terminal illness at the forefront […] Their interests should be 
paramount and we should not let ideology blind us to their wishes - and their rights […] 
Doctors know if they treat any patient long enough, it will […] end in failure. But the failure to 
keep a patient alive forever is acceptable – that is the nature of life. An undignified death – and 
needless suffering – is a much more catastrophic failure, and one that should be consigned to 
history.’ (Cosgrave, 2008)
Cosgrave’s editorial is of interest, not just because it underlines the inescapability of death, 
but also because it focuses on the obligations of health professionals to accompany the 
dying well. Murray and Jennings (2005) support this commitment to addressing the issue, 
not of death, but of dying badly. They suggest that in the past, end-of-life-care reform in 
the US has been excessively driven by the law and that it is time to turn the lens on the 
need for culture to catch up. 
‘The next decades should be, we believe, a time of education and soul-searching discussions in 
communities and at kitchen tables, as well as in health care settings. […] We must talk about 
what we dare not name, and look at what we dare not see. We shall never get end  of life care 
‘right’ because death is not a puzzle to be solved. Death is an inevitable aspect of the human 
condition. But let us never forget: while death is inevitable, dying badly is not.’ (Murray and 
Jennings, 2005, p. S57) 
Speaking of death and dying, commentators such as Murray and Jennings agree that we 
have witnessed a basic change in the way we die. With this change has come a rethinking 
of the goals of medicine and the roles of health professionals. If one accepts that dying and 
practices surrounding death vary within Irish culture and across many other cultures, then 
engagement in and awareness of these cultural realities need to be encouraged. Persons 
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who are not members of a society’s dominant cultural group cannot simply be seen as a 
challenging ‘other’. Ethnic, social and cultural differences that reveal meaning through end of 
life rituals generally deserve professionals’ respect, in the form of efforts to become informed 
and through efforts to avoid harmful stereotyping. The caveat on giving this respect would 
be if a certain practice sought was clearly limiting another individual’s autonomy or putting 
another’s welfare at risk (see discussion on Autonomy in Module 4).
Finally, recent years has witnessed intense public debates in many Western societies in 
relation to the moral and/or legal permissibility of euthanasia and assisted suicide.  
In countries such as the Netherlands and Switzerland, the notion of a ‘good death’ is linked 
by some with the notion of a ‘right to die’, i.e., the right to have active steps taken to end a 
person’s life (euthanasia) or to assist a person in ending his or her own life (assisted suicide). 
Some of the ethical and legal challenges to which these issues give rise are discussed in  
more detail in Modules 4 and 7. For present purposes, one important point to note is that 
neither is permissible under Irish law. Under Irish law, any person who deliberately ends  
the life of another person is potentially guilty of murder. It makes no difference that the  
person consented to the ending of his or her life or even that he or she requested that this 
should happen. 
A second point to note is that the focus of the Irish Hospice Foundation, through the 
HfH programme, is to work assiduously to get a ‘right to die’ understood, not as a right 
to euthanasia or assisted suicide, but as a claim or expectation on state and institutional 
provisions to facilitate the most appropriate care and treatment at the end of life. A central 
objective of the HfH programme is to draw attention to the obligation on state institutions 
and the Department of Health and Children to assume the responsibility to make resources, 
policies and physical environments consistent with a ‘good end-of-life care’.
4.4 Elements of Good End-of-Life Care
As illustrated, the diversity of individual values and cultural differences tells us that an agreed 
consensus on what makes for a good dying may not be within our easy reach. 
However, if there is no universal agreement about what a ‘good death’ consists of, there is, 
fortunately, some consensus as to the core features of the care that needs to be provided to 
those who are dying and their families and loved ones. Drawing on long-established  
ethical principles, the UK General Medical Council articulates good end-of-life care as that 
which ‘helps patients with life-limiting conditions to live as well as possible until they die, and 
to die with dignity’ (GMC, 2009, p.3). Many documents have been published that address the 
elements of such end-of-life care (The College & Association of Registered Nurses of Alberta, 
2005; German National Ethics Council, 2006; Medical Council, 2009; National Consensus 
Project for Quality Palliative Care, 2009; NCEPOD 2009; New South Wales Department 
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of Health, 2005; Sisters of Bon Secours, 2000). Ten general features that recur in these 
documents are listed below. They apply equally to those in the end stages of life as well as 
those suffering from chronic, long-term illnesses. 
Elements of Good End-of-Life Care
1. Health professionals with communication skills and sensitivity towards the beliefs and 
practices of diverse cultures and individuals in their understandings of a ‘good dying’
2. Respectful opportunities for the patient’s voice to be heard concerning their dying
3. Provisions for comfort and relief of pain and suffering
4. Due regard for, and provisions made to ensure, patient privacy
5. Respect for the right to refuse treatment or the request for withdrawal of treatment
6. Respect for health professionals’ responsibility not to start, or to discontinue some 
treatments when appropriate, with consideration for both patient and family 
preferences 
7. A collaborative approach to care: families and the healthcare team work together for 
patients who lack capacity, taking into account their previously expressed wishes
8. Non-discriminatory care: decisions are dependent only on factors relevant to the 
patient’s medical condition, values and wishes 
9. Transparency and accountability: decisions are fairly made and the decision-making 
process is clear to all concerned and accurately recorded
10. Hope for the one suffering and loved ones, sustained by reassurances from health 
professionals that all that can be done to achieve a peaceful end of life will be done
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5.1 Ethics is More than the Law
Laws are rules that govern certain human activities which are prescribed by a constitution (in 
Ireland), legislators and courts and the court system. They are binding on everyone and are 
enforced by penalties, such as fines or imprisonment. Law and ethics overlap because many 
illegal actions are, often, also unethical, e.g., killing the innocent or stealing. In turn, many 
ethical actions are also obligatory in law, e.g., paying taxes. 
But there are also important differences between the law and ethics. For example, there are 
many actions, such as infidelity, lying and cheating, which would be considered unethical 
but are not usually enforced by law. Equally, there are many ethically praiseworthy actions 
such as being kind, saving a drowning person and working for charity that we are not legally 
obliged to perform. 
Laws and ethics may also conflict: people might judge laws such as those permitting 
euthanasia to be unethical, while they might view legally-prohibited actions, such as 
abortion, as ethically acceptable. The law can also lag behind the moral standards of a 
society, or it may be used as a tool by a ruling class or dictator, for example, in some societies, 
laws may enshrine racism or discriminate against women. When this happens, social 
reformers usually appeal to more general ethical standards of equality or justice in order to 
have such laws repealed. In short, ethics and law overlap, but ethics offers a set of tools and 
values against which the appropriateness of laws can be evaluated.
5.2 Ethics is More than Religion
Different religions offer moral training, e.g., the Sermon on the Mount or the teachings of 
Confucius. In addition, religious leaders remind their followers of values, such as generosity 
and compassion, and, sometimes, provide good role models, e.g., Gandhi or Christ. Moreover, 
many eminent moral thinkers (such as Immanuel Kant [18th century German philosopher] and 
Charles Taylor [contemporary Canadian philosopher]) are also theists who critically explore 
the faultline between ethical theory and moral theology.
However, the texts and teachings of the various religions are ambiguous and the 
interpretations of their leaders often differ on important issues such as war, family  
planning and the role of women in society. As such, judgements have to be made as to  
what weight to assign them. This is all the more apparent in pluralist societies where 
individuals, not simply Catholics, Protestants, Hindus or Jews, must share more commonly-
held values that appeal to people of different and no religious persuasion. In short, ethics and 
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religion overlap, but ethics appeals to more general rules and values than are expressed 
by religion and does not rely for sanction or legitimacy on the existence of a deity or 
transcendent being.
5.3 Ethics is More than Popular Opinion
Popular opinion is the view that is perceived to be generally held in a society. It is 
determined by the media and/or social analysts on the basis of surveys, polls, and 
interviews or the responses to radio or television programmes. Ethics and popular opinion 
may overlap, in that popular opinion expresses views on moral issues and it may be a 
useful indicator of important social concerns 
But there is also much disagreement. Popular opinion is considered to be unsatisfactory 
as a means of determining what the right thing to do is in any circumstance, for a number 
of reasons. The main one of these is that popular opinion is often volatile, reactionary and 
unreflective, e.g., the majority of people who are polled immediately after a harrowing 
case of child abuse and murder may call for the, arguably unethical, death penalty. A 
second reason why popular opinion is not a satisfactory determination of right action is 
that determining popular opinion is fraught with difficulties – which poll/survey/interview 
counts as truly representative? In short, popular opinion and ethics may overlap, but 
ethics is more reflective and critical and appeals to more general rules and values than are 
expressed by popular opinion.
5.4 Ethics is More than Professional Codes
Professional codes, such as the Medical Council’s (2009) Guide to Professional Conduct 
and Ethics for Registered Medical Practitioners and the An Bord Altranais (2000) Code of 
Professional Conduct for each Nurse and Midwife, express the ethical and professional 
standards of professionals, such as doctors and nurses. They are inherently ethical in that 
they express the aims of these professions and they enumerate the ethical obligations 
that these bodies of health professionals expect of their members. Ideally, codes function 
to help professionals in deciding what is the ethically acceptable course of action to take 
when ethically-worrying challenges arise (e.g., issues concerning patients’ rights or safety). 
In turn, these professional bodies, through their Fitness to Practice Committees, may 
penalize any member who is deemed to have failed in their professional duties. 
However, while codes are themselves ethical in nature, they are inevitably incomplete; they 
cannot provide precise guidance for every single situation that may arise. Moreover, some 
professionals and patients may disagree with the duties imposed in certain circumstances 
(See Module 4 and 6 for a discussion of the views of the Irish Medical Council and An Bord 
Altranais and the Irish Supreme Court in relation to the status of Artificial Nutrition and 
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Hydration). In short, ethics and codes of ethics overlap, but ethics takes a broader view and 
offers tools that enable individuals to critically consider the aims, duties and implications for 
practice of their professional codes. 
5.5 Ethics is More than Hospital Policy
Hospitals and other clinical settings usually have a range of policies on issues such as 
patient confidentiality, informed consent, resuscitation and the allocation of resources. Like 
professional codes, it is reasonable to assume that these policies are ethically sound, but this 
is not always the case. For example, hospitals may have policies which deny access to certain 
procedures, such as heart transplants and infertility treatment, to groups of people on the 
basis of their age or family status, and this might be considered ethically dubious or, at least, 
debatable. In short, while hospital policies may be ethical in general, health professionals 
need to take a critical stance in relation to the obligations and constraints these policies place 
on them as employees. 
5.6 Ethics is More than Authority
Doing what you are told just because you have been told to do it has always been viewed as 
ethically suspect. This is because, while people in authority may often mean well and often 
give ethically sound orders and requests, this is not always the case. That obedience is not 
an excuse for harmful actions was confirmed in law in the Nuremberg trials, when doctors, 
nurses, guards and collaborators were found culpable for their part in Nazi war crimes. 
Similarly, health professionals are ethically, professionally and legally obliged to question 
instructions and requests that put patient safety and/or rights at risk. No matter the source of 
authority, individual health professionals are responsible, and held accountable, for their own 
actions. In short, while figures in authority, such as managers, consultants and Directors of 
Nursing, may mean well and may direct health professionals to do the right thing most of the 
time, individuals are, nevertheless, accountable for what they do themselves.
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An ethical (or moral) theory is an effort to interpret moral life and moral intuitions in a 
more or less formalised way. 
6.1 Traditional Ethical Theories
Traditional ethical theories, such as Utilitarianism, Deontology and Virtue Theory, are 
termed ‘traditional’ because they have been part of the canon of moral philosophy for 
many centuries. 
6.1.1 Utilitarianism: Producing the best consequences 
Utilitarianism – sometimes referred to as ‘consequentialism’ – is a moral theory which 
emphasises the consequences or outcomes of an act rather than the act itself. Good 
outcomes or consequences are those that yield overall benefits, pleasures and happiness 
for the greatest number of persons affected by an action. Good outcomes of actions also 
diminish overall suffering or harm. Any action that produces benefit, pleasure or well-
being is a ‘useful’ action – useful as conducive to the greater good.  
The choices or actions that contribute to maximal happiness or well-being have 
instrumental value. Instrumental values refer to something useful or important for 
achieving some goal or purpose, or, as a means to some end. 
The utilitarian goals of maximising pleasure, happiness, or well-being are contentious. 
There is no consensus about the meanings of these valued goals or human ends. It seems 
clear that different people view pleasure, happiness and well-being with considerable 
disagreement. Diverse cultures might disagree even more profoundly. The nineteenth 
century philosopher, John Stuart Mill, defined in his ‘Happiness theory’ an understanding 
of happiness which he believed would be universally accepted :
‘According to the Greatest Happiness Principle, the ultimate end, with reference to and for the 
sake of which all other things are desirable (whether our own good or that of other people), is 
an existence exempt as far as possible from pain, and as rich as possible in enjoyments, both in 
point of quantity and quality’ (J.S. Mill, [1859], 1991, p.142) 
The ultimate end sought by the utilitarian is a life described by Mill, rich in many pleasures 
of intellect, emotion and sensibility, and spared in terms of suffering and pain. Both 
quantity of rich experiences and quality (range and depth) of experiences mattered in 
Mill’s account of utilitarianism. 
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Utilitarians do not focus on the importance of motives for choosing when locating the moral 
quality of an action. Almost any motive is acceptable for a choice which delivers a positive 
outcome and best overall results. Saving a drowning man is always good, whatever the 
motivation of the rescuer. I might be doing this to get my picture in the paper and maybe get 
some reward from the man I save, yet this doesn’t take away from the good result. Feeding 
starving people who have no subsistence is a good act, and it matters not whether one’s 
motive is primarily to get nominated for the Nobel Peace Prize or whether it arises from a 
deep obligation to suffering humanity. 
Utilitarian theory is a prospective moral theory. It is forward-looking, going beyond the 
choices of the individual to the outcomes of those choices. Utilitarians think that the 
consequences of an action are the effects which the individual could have reasonably 
foreseen, on the basis of information or understandings available to him or her.
Three-Step Action Formula
Utilitarianism might be construed as offering a three-step action formula for action: 
1.  On the basis of what I know, I must project the consequences of each alternative option 
open to me (e.g., taking different kinds of actions or taking no action).
2. Calculate how much happiness, or balance of happiness over unhappiness, is likely to be 
produced by anticipated consequences of each action or none.
3. Select that action which, on balance, will produce the greatest amount of happiness for 
the greatest number of people affected (see Yeo and Moorhouse,1996, p.45).
6.1.2 Deontology: What duty asks of us
What makes a ‘right’ act right? The utilitarian or consequentialist answer to this question is 
that it is the good outcome of an act which makes it right. Moral rightness or wrongness is 
calculated by determining the extent to which the action promotes values such as pleasure, 
well-being, happiness, etc. To this extent, the end justifies the means. In many respects, 
deontological moral theory is diametrically the opposite of utilitarianism. 
The name of the German philosopher, Immanuel Kant (1724-1804) is identified with 
the moral theory known as deontology. Kant was adamantly opposed to the idea that 
the outcome of an action could determine its moral worth. For deontologists, it is not 
consequences which determine the rightness or wrongness of an act, but, rather, the 
intention of the person who carries out the act. The emphasis is on the correctness of the 
action, regardless of the possible benefits or harm it might produce. Deontologists maintain 
that there are some moral obligations which are absolutely binding, no matter what 
consequences are produced. 
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As a ‘rationalist’, Kant believed that we can use our reason to work out a consistent set of 
moral principles which apply in all possible situations and cannot be over-ridden. One way 
of describing these deontological moral principles is to say that they are ‘non-negotiable’ 
and cannot be argued away by persuasion, or counter-reasons.
Unlike utilitarianism, according to which the value of moral actions is determined by 
their instrumentality for achieving the greatest overall benefit, deontology regards good 
choices as intrinsically valuable, that is, valuable in and of themselves. Whether or not 
they bring about good consequences is not essential to their moral quality. Kant aimed to 
establish a fundamental point about morality: that there is such a thing as non-negotiable 
morality; in other words, there is a domain of laws which apply to our conduct and from 
which we cannot exempt ourselves. The laws governing our conduct are derived from 
a supreme or highest principle, which Kant calls the categorical imperative; this is a 
command that admits of no exceptions and must be obeyed by all of us, insofar as we 
consider ourselves rational beings.
One Step Action Formula
Kant formulates the categorical imperative in different ways but it is easiest understood as 
a universal rule which tell us how we ought we to live if we are to live an ethically good life:
1. Act in such a way that I could imagine all other persons doing the same thing in the 
same circumstances. 
The challenging test for us when we choose to do something is that we are required to 
act, not out of self-interest, but because we believe it is the right act to do for anyone in 
the same situation. So, if we are deciding to lie in order to escape a difficult task, then we 
must be ready to allow everyone else to lie for the same reason. If we are stealing rare lilies 
from our neighbour’s garden to bring to a friend in hospital, we need to be ready for our 
neighbour in turn to steal rare roses from our garden for her friend. Kant believed that this 
requirement of universality places necessary constraints on our conduct.
Here, it is clear that Kant does not entirely ignore consequences. We take them into 
account in order to consider our choices. We ask: what would be the consequences if 
everyone acted on the principle I want to follow? So, to answer that, we need to imagine 
the consequences for our world if everyone acted in a manner which is contrary to the 
duties spelled out above. We cannot discount consequences, but good outcomes will 
never make an immoral action moral. Our motives – whether we act with a ‘good will’ 
according to the categorical imperative – determine whether we are persons of moral 
character or not. 
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Deontological morality is grounded in human motivation, and not merely in consequences. 
Even a person with a mean and bitter disposition who has to work hard to be sympathetic 
towards suffering people can, nevertheless, with effort, exercise their will and do the right 
thing in spite of their negative inclinations. They do the right thing, not because they will be 
praised, or rewarded, or gain immortal life, but simply because it is the right thing to do.  
A Kantian deontologist cautions us to be wary of our natural inclinations – whether they are 
negative or positive. Because we are kindly or compassionate by temperament does not give  
us an edge on being moral. It may make it easier to do good for other people, but that is 
not the yardstick Kant uses. People who have negative inclinations by temperament are 
considered much more praiseworthy if they succeed in doing the right thing! 
Kant was a rigorous moralist and a religious believer. However, he argued that religion 
and the possible rewards of immortality could not form part of his argument that morally 
praiseworthy actions must have universal worth. We cannot presuppose that the presence 
of certain religious beliefs will make people moral. Nor can we rely on the presence of good 
inclinations, feelings or sentiments in people to make them moral. We need to look to the 
disciplined will.
 
Before concluding this discussion of deontology, it is important to note that deontologists are 
alive and well today. Religious believers would often consider themselves as deontologists, in 
their acceptance of some actions as categorically right and others wrong. The religious belief 
might, additionally, appeal to revelation for an understanding of which actions are right and 
which are to be avoided. The often uncompromising positions held by religious believes may 
not reflect stubbornness or closed-mindedness, but may instead demonstrate the Kantian 
conviction that consequences – no matter how good – cannot make evil actions good. A 
review of some of the positions presented in Modules 2 and 5 illustrate the contemporary 
deontological perspective most clearly. 
6.1.3 Virtue Theory: Challenging the adequacy of rule-based theories
The ancient Greek philosopher, Aristotle, (384-322 B.C.) first wrote a detailed discussion 
of virtue morality in the Nichomachean Ethics. ‘Virtus’ he understood as strength. 
Correspondingly, specific virtues are seen as strengths of character. But, many years 
after Aristotle’s death, virtue theory came to be over-shadowed by the development of 
utilitarianism and deontology. 
In the past fifty years, however, virtue theory has resurfaced as a major moral theory.  
But why is that so? Virtue ethics has been restated and reinvigorated in the years since 1958 
by philosophers such as Philippa Foot, Alasdair MacIntyre and Elizabeth Anscombe.  
They and many others became disillusioned with the promises of mainstream theories.  
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They argue that how we ought to live could be much more adequately answered by a 
virtue-based theory than in terms of calculating consequences or obeying rules.
Moral Virtue: Centrality of motives
A virtue is a trait of character which is socially valued and a moral virtue is a trait which 
is morally valued. Courage might be a socially-valued trait, but it only becomes moral 
courage if the context is a moral one. Moral virtue is a disposition to act, or a habit of 
acting in accordance with moral ideals, principles or obligations (Pence, 1991). 
Aristotle distinguished between external performance and internal state. This is the 
difference between right action and proper motive. An action can be right without being 
virtuous, he said, but the action can be virtuous only if performed on the basis of the right 
state of mind of the person. 
Virtue, then, is closely aligned with motives. We do care how persons are motivated. 
Someone who gives donations to mental health research and is motivated by personal 
concern or sympathy for suffering people meets with approval, while someone acting the 
same way in order to be able to proclaim generosity as a feature of their character would 
not obtain our endorsement. Persons who are properly motivated – not just in carrying out 
a single action, but by disposition or habit, persons of virtue – don’t simply follow rules, 
but have a morally-relevant motive and desire to act as they do. Virtue theorists think that 
basic instruction and an emphasis on the right motives and desires will guide us, not only 
in terms of what to do but who to be (Frankena, 1998, p.291-296). 
The person of morally good disposition is properly motivated. To be properly motivated, 
says Aristotle, one must experience appropriate feelings. Aristotle explains:
‘We may even go so far as to state that the man [woman] who does not enjoy performing 
noble actions is not a good man [woman] at all. Nobody would call a person just who does not 
enjoy acting justly, nor generous who does not enjoy generous actions, and so on.’  
(Aristotle, 1955, p.42)
Aristotelian virtue theory cautions us away from a negative view of morality that mainly 
requires us to do what we really don’t feel like doing. Anne Thomson speaks of the  
critical role of emotions in developing a moral disposition of fair-mindedness. This focus on 
the centrality of cultivating proper feelings and emotions as ingredients of virtuous action 
stands in stark contrast to the suspiciousness about feelings associated with  
Kantian deontology (see Thomson, 1999, p.143-152).
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Character is More Important than Conformity to Rules
Virtue theorists think that their views supplement deontology and utilitarianism by offering 
a more comprehensive moral theory, which acknowledges our common intuitions that 
motives do make a difference to the quality of our actions and that appropriate feelings 
facilitate virtuous behaviour. 
Writers in the field of health care ethics suggest that efforts to replace the virtuous 
judgements of professionals with rules, codes or procedures will not result in better decisions 
and actions. For example, some believe that, rather than always appealing to government 
regulations or international conventions to protect subjects in research, the most reliable 
protection is a researcher with a character marked by informed conscientiousness, 
responsible sensibility, and compassion. The thesis is that good habits of character are more 
important than conformity to rules, and that such good habits are most likely to lead to 
behaviour consistent with rules. 
The position is that virtues should be inculcated and cultivated over time through 
educational interactions, role modelling, moral mentoring, and the like. Gregory Pence 
contends that the right kinds of desires, feelings and motives are the best protectors of 
patient well-being (Pence, 1991). Almost any healthcare professional can successfully 
evade a system of rules. Pence argues that we should create a climate in which healthcare 
professionals desire by virtue of strong habit not to abuse their subjects. The educational 
process for healthcare professionals provides a context for modelling the virtues of good 
nurses, good doctors and good allied health professionals. Where adequate role models are 
lacking, little progress can be made by further exhortations to become a ‘good (virtuous) 
nurse’, or a ‘good (virtuous) doctor’.
This last point stresses the argument that we do not make moral decisions as isolated 
persons in a social vacuum. It is rather in families, schools or communities that natural 
affection, shared concerns, spontaneous sympathies and expectations for the virtues arise. 
6.1.4 Compatibility of Virtues and Principles
The rule-governed theories of utilitarianism and deontology are not at odds with virtue 
theory; rather, they are compatible and mutually reinforcing. Persons of good moral character 
sometimes have difficulty discerning what is right and recognise that they need principles, 
rules and ideals to help them choose right or good acts. 
‘One often cannot act virtuously unless one makes judgements about the best ways to manifest 
sympathy, desire and the like. The virtues need principles and rules to regulate and supplement 
them. As Aristotle suggests, ethics involves judgements like those in medicine: Principles guide 
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us to actions, but we still need to assess a situation and formulate an appropriate response. 
This assessment and response flows from character and training as much as from principles.’ 
(Beauchamp and Childress, 1994, p.67) 
If we are to progress as moral agents and justify our actions in the eyes of those affected, 
this need to explain and justify requires that we translate our virtuous claims into an 
explanation of the values, duties or principles on which we base those claims. To do this, 
we may need to say why we consider it compassionate behaviour to lie, why we believe 
that it is fair to break the confidence of patients, or why we think it is loyal to keep silent 
when speaking out would correct wrong-doing. This requirement to justify our moral 
decisions reveals the intricate connection between virtue theory and the rule-governed 
theories discussed earlier. 
6.2 Contemporary Ethical Theories
While utilitarianism, deontology, and virtue theory have been in place in the canon of 
moral philosophy for centuries, they have not remained fixed and static as theories. 
Volumes have been written which critique elements of these theories, sharpening them 
for greater clarity and, attuning them more to the fullness of human living. In addition, 
insights into moral living come in fresh forms, breathing new life into the traditional moral 
canon. This is the case with contemporary ethical theories such as principlism, narrative 
ethics and feminist ethics. In these we find new insights that attempt a number of tasks:
1. To offer developments of, and improvements on, essential features of  
traditional theories
2. To fill in the dimensions of human living that were often omitted or understated in 
traditional theorising.
3. To acknowledge that the challenges of moral development require that we move from 
a realm of moral abstractions to concrete situations. This allows us to see whether or 
how much the resources of moral theory help to guide our decision-making.
6.2.1 Principlism
What is known as the principlist approach to ethical decision-making has dominated 
western healthcare ethics for the last twenty years. It emerged with the publication of 
several well-known texts in the 1970s and 80s. One of these was the Belmont Report 
which identified basic principles that would underlie and guide the regulation of research 
involving human subjects (National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral Research, 1979). Three books published around the same time 
outlined and defended a principlist ethical framework, written by Tom Beauchamp and 
James Childress (1979), Robert Veatch (1981) and H. Tristram Engelhardt (1986).
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Of these three, the account developed by Beauchamp and Childress in their book, Principles 
of Biomedical Ethics, is the most well known. This principlist model (hereafter called the 
PBE model) is an ethical decision-making process which negotiates between fundamental 
principles, on the one hand, and the unique nature of specific moral situations on the other.  
 
These principles oblige the healthcare professionals to behave in certain ways in relation to 
patients.
1. The principle of autonomy obliges healthcare professionals to respect the views, choices 
and actions of the individuals in their care. (See Module 4)
2. The principle of nonmaleficence obliges healthcare professionals not to harm patients. 
(See Modules 5 and 6)
3. The principle of beneficence obliges healthcare professionals to act for the benefit of, or 
in the interests of, patients. (See Modules 5 and 6)
4. The principle of justice obliges healthcare professionals to treat people in their care 
equally and to ensure that resources are distributed fairly. 
A good deal of the Principles of Biomedical Ethics text is taken up with an analysis and 
discussion of each of the four principles in terms of their nature and scope. In particular, 
the specific rules which are supported by these principles and which permit, prohibit or 
require particular kinds of action are delineated. These include rules governing truth-telling, 
confidentiality and informed consent (Beauchamp and Childress, 2001, p.57–112).
What is special about the four principles, according to Beauchamp and Childress, is their 
universal or objective nature. These principles, according to Beauchamp and Childress, 
have been drawn from a ‘common morality’, beyond tradition, and beyond the vagaries of 
individual character and culture, the set of norms that ‘all morally serious persons share’  
(2001, p.3). This common morality ‘contains moral norms that bind all persons in all places; 
no norms are more basic in the moral life’, and the notion of international human rights 
is invoked as an example of such universal norms (2001, p.3). Having grounded their four 
principles, they justify their particular choice of principles by pointing out that these four 
have been presupposed by traditional ethical theories and medical codes throughout history.
The most immediate way to decide on the merits of a proposed course of action, on the 
Principles of Biomedical Ethics (PBE) model, is to determine whether or not that course of 
action obeys the moral rules derived from the four principles. For example, on this view, a 
healthcare professional might consider that it is, generally, morally required to provide a 
patient with information about their illness because this action obeys the moral rule ‘Tell the 
truth’ which is, in turn, derived from the principle, ‘Respect patient autonomy’. 
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In morally difficult situations, however, where there is a conflict between principles, or 
between principles and particular judgements, the PBE model stipulates that none of the 
principles is privileged. In any given situation, each principle must be specified and  
weighed relative to the particular context in which it is applied, and informed by generally 
accepted background theories of human nature and moral life. Following John Rawls, 
this weighing and balancing is described as a process of reflective equilibrium and the 
principles are described as prima facie rather than absolute (Beauchamp and Childress, 
2001, p.398). This expresses the idea that any principle is, on first impression, morally 
obligatory, but that it may be modified or overridden in certain situations. 
In the case of Joanna, the patient with Alzheimer’s in Case 4 of Module 2, for example, 
a nurse might initially believe that telling Joanna the truth about the death of her son 
might be the morally correct thing to do. However, on consideration of the concrete 
circumstances of the patient, she might reconsider. In this case, it could be argued that 
it is her particular judgement in relation to what Joanna might find meaningful which 
prompts her to reconsider whether the principle of autonomy, or some other rule, such as 
nonmaleficence, should be the focus here. 
 
On this understanding, the processes of moral deliberation are akin to scientific processes: 
plausible beliefs and possible decisions are considered and accepted, rejected and 
modified on the basis of reflection and experience. Also, analogous to the scientific goal of 
achieving theoretical consistency and unity, the aim of reflective equilibrium is to unify all 
one’s moral beliefs and background commitments.
In positive terms, the PBE model provides a method of supporting ethical decisions 
that has a strong justificatory force. Put simply, on this view, the force of the imperative, 
‘Respect autonomy’, derives from its grounding in universally-accepted norms, and not in 
the subjective viewpoint or intuition of the individual professional. 
Moreover, even in situations of doubt and uncertainty, such as in the case of Joanna in 
Module 2, the deliberative process which comes into play appeals to reasoning strategies 
and goals which are also considered objective, not intuitive or subjective. In addition,  
the course of action that would be considered the most successful, on this view, would  
be one which manages to meet as many of the relevant principles as possible.  
The challenge in Joanna’s case is to respect her autonomy, while at the same time acting in 
her best interests.
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While different shades of principlism have dominated the healthcare landscape in the 
last twenty years, an increasing number of theorists have begun to turn their attention to 
alternative approaches to describing and understanding the various elements of moral life 
(McCarthy, 2003). One such approach deploys narrative concepts and methodologies drawn  
from literary criticism and philosophy as tools of moral understanding and assessment. In 
common with contemporary thinkers in other disciplines (e.g. anthropology, philosophy, 
cognitive psychology and history) who have turned their attention to narratives, narrativists 
in the health care arena argue that the first person narrative, or personal story, is a rich 
medium for qualitative data about the unique lives of individual people. Further, for some 
of these theorists, the narrative is not only an important form of communication, it is also a 
means of making human life, and specifically the moral life, intelligible. While they deploy 
narrative tools in different ways, all of these thinkers are engaged in ‘narrative ethics’. 
Martha Nussbaum (1992), for example, views literature as a vast resource of moral knowledge 
and a means of sensitising people to the responsibilities, obligations and challenges of a full 
moral life. 
Alternatively, the narrative approaches of Albert Jonsen and Stephen Toulmin (1988) and 
John Arras (1991) take a casuistic turn and resolve ethical dilemmas by comparing each new 
situation with others and with paradigm cases. These authors argue that local, contingent 
moral rules and maxims to guide action can be derived from paying attention to the morally 
relevant similarities and differences between cases. 
More recently, Rita Charon (1994) has suggested that our understanding of healthcare 
situations will be greatly enhanced if we pay attention to their narrative elements, e.g., the 
function of the narrator – who tells the story? – the development of plot – how the story 
unfolds – and the relationship with the audience – who hears and interprets the story? In 
addition to supporting Charon’s view, Tod Chambers (1999) has sparked a lively debate in 
the healthcare ethics community by arguing that the task of reporting cases is, itself, not 
a neutral enterprise. This is because, he argues, the process of describing any set of events 
involves making decisions about which pieces of information to include or exclude and 
making choices about the way different facts are presented. For example, take any of the 
modules in this framework and consider how the case scenarios are narrated: from the 
patient’s, professional’s or family’s point of view? Or from an observer point of view?  
Consider the difference that this might make to what is left in and left out of the story that 
is told. Because narrative ethics is in the early stages of development, there is, as yet, no 
ready-to-hand canonical position that best expresses its central tenets. Even so, what follows 
51
Mo
du
le 
1 
Ex
pla
ini
ng
 E
th
ics
is a rough sketch of a plausible and defensible account of narrative ethics. It is also one 
which highlights the tensions between narrative ethics and principlism and exposes the 
congruities and incongruities between these supposedly competing positions. 
On the narrative view, when ethically challenging situations arise, it is the whole journey 
of an individual’s life as he or she conceives it which is privileged (Nelson 1997, p.2001). 
Howard Brody, for example, sees the practice of healthcare as in part ‘a storytelling 
enterprise’ (Brody, 1987, p.xiii). For Brody, actions are made meaningful in the context 
of an individual life story. As such, it is difficult to isolate any given decision or choice, 
to uncouple it from the whole person who acts and evaluate it in terms of abstract and 
general rules. In healthcare settings, this means that the patient’s own account, where 
it is possible to hear it – of their illness, their preferences, their needs – is considered 
profoundly important. However, not any tall tale will do and personal stories are tested 
against various criteria, such as the stories of others and the medical chart. 
This idea of testing personal narratives against various criteria can be likened to the way 
in which the principlist model tests its principles through the application of the process 
of reflective equilibrium. In the case of the PBE model, the four principles are prima facie 
privileged, but may be subsequently modified. On the narrative view, it is first-person 
narratives which are prima facie privileged; however, like principles, they can be challenged 
and modified in the process of a ‘narrative reflective equilibrium’. Recalling the Socratic 
ideal, Paul Ricoeur describes the final story or account of a life that emerges from such 
evaluation as ‘the fruit of an examined life’ (1988, p.246- 247). 
In recent years, a narrative approach of this kind has contributed to discussion and debate 
in relation to surrogate decision-making in end-of-life situations. For example, it informs 
one of the recent recommendations of the US Council on Ethical and Judicial Affairs, which 
suggests that, when it comes to making decisions for incompetent patients, one of the 
tasks of a surrogate decision maker is to consider ‘how the patient constructed his or her 
identity or life story’ in order to enable a decision about a proposed course of treatment 
which continues the story ‘in a manner that is meaningful and consistent with the patient’s 
self-conception’ (Council on Ethical and Judicial Affairs, 2001). In addition, the Council 
argues that it is precisely the fact that a number of different options might be consistent 
with a person’s life story which makes the narrative approach so attractive, because it 
avoids having to predict only a single course of action as compatible and, therefore, 
morally acceptable.
Finally, the task of moral justification for narrative ethics is not, primarily, a unifying one. 
Rather, its focus is on acknowledging and embracing the multiplicity of, often contested, 
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meanings that are available in any given situation. What is key for this narrativist account is 
the idea that many different voices and readings of moral situations and individual lives are 
possible. And, generally, narrativists focus, less on trying to reduce competing perspectives to 
a commonly shared view and, more on involving as many people as possible in the dialogue. 
Anne Hudson Jones summarizes this view as:
‘In ideal form, narrative ethics recognizes the primacy of the patient’s story but encourages 
multiple voices to be heard and multiple stories to be brought forth by all those whose lives will be 
involved in the resolution of a case. Patient, physician, family, healthcare professionals, friend, and 
social worker, for example, may all share their stories in a dialogical chorus that can offer the best 
chance of respecting all the persons involved in a case.’ (Hudson Jones 1998, p.222)
In turn, for narrativists, relational virtues such as empathetic listening and support are 
privileged. In the course of such privileging, these virtues are reworked to acknowledge  
and accommodate the narrative view that, in some senses, difference is irreducible. For 
example, Howard Brody radically reconceives the moral demands of ‘empathy’ in the 
following passage: 
In a culture that prizes autonomy and independence, we may fondly imagine that most people 
are whole and intact, unlike those who suffer from disease[…] Charity tends to assume that I start 
off whole and remain whole while I offer aid to the suffering. Empathy and testimony require a 
full awareness of my own vulnerability and radical incompleteness; to be with the suffering as 
a cohuman presence will require that I change[…] Today I listen to the testimony of someone’s 
suffering; tomorrow that person (or someone else) will be listening to my testimony of my own. 
Today I help to heal the sufferer by listening to and validating her story; tomorrow that sufferer will 
have helped to heal me, as her testimony becomes a model I can use to better make sense of and 
deal with my own suffering (Brody, 1987, pp.21-22)
On Brody’s view, the demand of empathy does not require us to ‘step into another’s shoes’ 
in order to understand their pain. It does not presuppose that it is ever possible to fully 
understand another’s pain. The other person is always ‘other’ to us, their difference persists, 
resisting assimilation under the umbrella of mutual understanding. Instead, empathy 
demands that we bear witness to our own vulnerability and lack so that we stand, not as 
whole to part, or healthy to ill, but as a ‘cohuman presence’. On this view, the healthcare 
professional cannot offer patients the reassurance that they know and understand them,  
only the acknowledgement that they have listened and heard. On this view too, they  
cannot be untouched by a patient’s pain and vulnerability, there is professional engagement, 
not detachment.
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Feminist ethics considers the impact of gender roles and gendered understandings on 
the moral lives of individual human beings and draws attention to the power and power 
differentials inherent in moral relationships at individual, societal and organizational levels. 
Feminist ethics, in short, is the application of feminist theory to understanding the ethical 
realm: it critiques traditional ethical frameworks from a feminist perspective such as those 
already discussed; deontology, utilitarianism and principlism. 
The diversity of theoretical starting points when tackling the subject of ethics makes it 
difficult to identify or talk about a single ‘feminist perspective’ in ethics. However, what 
each of these approaches share is a common concern with the marginalisation and 
disempowerment of women in sexist societies and a transformative concern to change 
those societies for the better (Murphy, 2004). In addition, as Sharon Murphy points out:
‘Given their sensitivity to the oppression of women, feminist perspectives also often share a 
sensitivity to the oppression and marginalisation of other social groupings based on age, 
race, class, sexual orientation, etc. With this sensitivity comes an interest in feminist ethics in 
analysing how moral authority and the status and power that goes with it, has traditionally 
been constructed, aligned and divvied out, moral authority and moral agency having 
traditionally been inequitably distributed among different social groups, with women in 
particular being deemed less morally capable than men.’ (Murphy, 2004)
In general, feminist ethics has widened the scope of health care ethics to include 
consideration of the social, cultural and political dimensions of moral decision-making in 
health care settings. Susan Sherwin makes this point in the following way. 
‘[M]edical and other health care practices should be reviewed not just with regard to their 
effects on the patients who are directly involved but also with respect to the patterns of 
discrimination, exploitation, and dominance that surround them.’ (Sherwin, 1992, p.4-5)
Contemporary moral philosopher, Margaret Urban Walker (1997, 1998), critiques ethical 
frameworks such as deontology and principlism, which, in her view, represent morality as a 
set of compact codes of impersonal statements guiding the actions of individuals.  
She replaces these, with a moral framework that represents morality as a process, rather 
than a set of prescriptions or outcomes. For Walker, morality and politics cannot be pulled 
apart and individuals are not the bounded integrated decision-makers that traditional 
moral approaches seem to presuppose. Rather, who we are and how we decide upon a 
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course of action at any given time must be understood contextually. Morality, for Walker, is 
a socially embedded process which determines what is morally significant, who is assigned 
responsibility for decision making and who is permitted and enabled to participate  
(Walker, 1998).
 
In short, feminist ethics:
•	 recognizes human interdependency and vulnerability
•	 pays attention to the needs of concrete particular individuals in their specific situations
•	 validates traditionally feminine virtues such as nurturance and empathy 
•	 affirms the importance of being actively concerned with the welfare of others
•	 widens the scope of health care ethics to include consideration of the social, cultural and 
political dimensions of moral decision-making in health care settings. (See discussion on 
Relational Autonomy in Module 4)
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7.1 The ethical map
The subject of ethics can be divided into three broad categories:
7.1.1 Meta-ethics: 
•	 Examines the meaning of moral terms and concepts and the relationships between  
these concepts. 
•	 Explores where moral values, such as ‘personhood’ and ‘autonomy’, come from.
•	 Considers the difference between moral values and other kinds of values. 
•	 Examines the way in which moral claims are justified. 
Meta-ethics poses questions of the following kind: What do we mean by the claim, ‘life is 
sacred’? Are moral claims a matter of personal view, religious belief or social standard, or, 
are they objective in some sense? If they are objective, what make them so? Is there a link 
between human psychology and the moral claims that humans make?
7.1.2 Normative Ethics: 
•	 Offers theories or accounts of the best way to live. These theories evaluate actions in a 
systematic way, i.e., they may focus on outcomes or duties or motivation as a means of 
justifying human conduct. 
•	 Includes ethical theories or approaches such as utilitarianism, deontology, virtue ethics, 
principlism, narrative ethics and feminist ethics.
Normative ethics poses questions of the following kind: Are there general principles or 
rules that we could follow which distinguish between right and wrong? Or: are there 
virtues and/or relationships that we can nurture, in order to behave well?
7.1.3 Applied Ethics: 
•	 Applies the insights of ethics to social practices. 
•	 For example, environmental ethics considers issues relevant to the relationship 
between human beings and the natural world, e.g., global warming, animal welfare, 
limited resources.
•	 Healthcare ethics is the branch of applied ethics which applies ethical reasoning and 
standards to the world of healthcare and to the ethical challenges which healthcare 
professionals, allied professionals, patients and families engage with. 
Applied ethics poses questions of the following kind: What should I do in this particular 
situation? How should we organise society? What do healthcare professionals owe patients 
in their care? What do humans owe animals and the environment? 
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of deliberating about ethical challenges. Anyone with an interest in the issues that arise in 
end-of-life care – whether they are professionals working in the area, or patients, or their 
families – may find themselves doing some work in applied ethics. This is because they are 
concerned about specific ethically-challenging situations in healthcare settings and, perhaps, 
the specific duties of their profession or family role. However, in addressing these concerns, 
they may also have worries about how to evaluate their own actions or the actions of others 
(normative ethics). They may need to explore the meaning and the implications of particular 
ethical claims, for example, they may worry about the extent of their obligation to preserve 
life if they hold the view that life is sacred (meta-ethics). 
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8.1 A Good Death and Dying
•	 Death is a fact of life, but beliefs about death and its significance and value are 
socially constructed.
•	 Culture and religion are key mediums for understanding the boundary between life 
and death.
•	 Recognizing cultural diversity implies the need to challenge basic assumptions and 
to recognize and respect the different values of patients in the illness and dying 
processes.
•	 Individuals also differ in the values they hold about dying and death. Research 
indicates that many people are concerned about family and loved ones being 
without pain and being able to communicate.
•	 If there is no universal agreement about what a ‘good death’ consists of, there is some 
consensus on the core features of good end-of-life care. 
8.2 Defining Features of Utilitarian Moral Theory are:
•	 The moral quality of our decisions is determined entirely by the beneficial 
consequences following on these decisions.
•	 Good consequences are understood broadly to mean outcomes such as pleasure, 
health, well-being, justice, happiness, satisfaction of preferences etc.
•	 Moral responsibility is both positive and negative – covering both our actions and 
our failure to act. 
 
Motives as morally neutral
•	 Motives for actions are not relevant for the moral evaluation of that action.
•	 Motives are simply instrumental means for achieving good ends. Ends justify means.
•	 How ought we to live our lives?
•	 We ought always, in our choices, to work to maximise good consequences and 
minimise undesirable outcomes. 
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•	 Actions are intrinsically right or wrong depending on whether right principles  
motivate them.
•	 Consequences must be considered when making a choice, but they can never be 
decisive in measuring the moral quality of an action.
•	 Natural inclinations (positive or negative) might make moral behaviour more or less 
difficult but they are not part of the moral appraisal of a person. 
 
Motives for acting:
•	 The motive one has for acting is morally decisive.
•	 The moral motive for any action is to choose always out of respect for the moral law. 
 
How ought we to live?
•	 We ought to work conscientiously to become persons of good will.
•	 A good will observes the rule of universality. 
8.4 Principlism claims that:
•	 Basic commonly-shared principles – autonomy, nonmaleficence, beneficence and 
justice – and the specific action-guiding rules that are derived from them are central to 
the ethical decision-making process in health care situations.
•	 In any given health care situation, any decision or course of action is morally justified if 
it is consistent with the relevant principles, rules, background theories and judgements 
in particular situations. 
•	 The success of any chosen course of action, on the part of the health professional, 
can be measured by the degree to which it achieves an overall cohesion of all of the 
elements of the decision-making process. 
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•	 Every moral situation is unique and unrepeatable and its meaning cannot be fully 
captured by appealing to law-like universal principles. 
•	 In any given health care situation, any decision or course of action is justified in terms 
of its fit with the individual life story or stories of the patient. The credibility of these, in 
turn, is determined on the basis of narrative reflective equilibrium.
•	 The objective of narrative reflective equilibrium is not necessarily to unify moral beliefs 
and commitments, but to open up dialogue, challenge received views and explore 
tensions between individual and shared meanings.
8.6 Feminist Ethics
•	 is the application of feminist theory to understanding the ethical realm as one in which 
women are treated as moral equals.
•	 considers the impact of gender roles and gendered understandings on the moral lives 
of individual human beings, especially, the moral lives of women.
•	 is sensitive to the power/power differentials and politics inherent in moral relationships. 
•	 highlights the contextual socially embedded nature of moral decision-making.
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9.1 Consider the list of key elements of good end-of-life care. 
Are there other elements of a ‘good dying’ that you think should be included? Explain why.
9.2 Read again the description of what ethics is and ethics is not. 
Consider the examples of statements in the table below and categorise them as one (or 
more) of the following: 
•	 Law
•	 Hospital policy
•	 Professional codes
•	 Public opinion
•	 Authority
•	 Religious belief
State also whether you think the statement is
•	 ethical, i.e., it involves doing the right thing
•	 unethical, i.e., it involves doing the wrong thing
•	 non-ethical, i.e., it does not have ethical content; it does not refer to ethical values  
or reasoning. 
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Statements Law? Policy? Codes? Opinion? Authority? Religious? Ethical? Un- 
ethical?
Non-
ethical?
 
a. Competent over 16s  
can consent to medical 
treatment and care.
 
 
b. Cough mixture A 
is a more effective 
expectorant than cough 
mixture B  
 
 
c. Healthcare professionals 
have a duty to intervene 
in an emergency
   
d. The Patient’s Charter 
informs patients about 
their rights
   
e. Patients ought to be 
informed if they have a 
serious illness 
    
f. Consultants’ orders 
should be followed
   
g. People have a right to 
refuse treatment even if it 
results in their death
    
h. Hospital environments 
should be clean and 
aesthetically pleasing
 
i. 80% of doctors 
agree that cannabis is 
therapeutic, therefore, it 
should be legalized
 
j. all human life is sacred
  
(adapted from Gallagher, 2005)
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For example, a) the issue of consent for over 16s is addressed in Irish law but it might also 
be expressed in hospital policy. You may also consider that it is an ethically good thing to 
respect the treatment choices of over 16s. 
On the other hand, b) the claim that cough mixture A is a more effective expectorant than 
cough mixture B is a factual (non-ethical) claim. Evidence from clinical trials or practice may 
prove this claim true or false. It would only become an ethical (or professional and legal) 
concern if a professional prescribed the least effective expectorant for reasons of personal 
gain, rather than in the best interests of their patient. 
The statement relating to professional duties in emergency situations, c), may be a familiar 
one drawn from your professional code. You may agree or disagree as to whether it is 
reasonable and ethical to expect professionals to always intervene in emergency situations, 
even when they are ‘off-duty’. 
Statement d) concerning the Patients’ Charter is likely to be a matter of hospital policy, but 
it may also reflect Constitutional rights and law and articulate the commitment of a health 
organisation and its employees to deliver ethically appropriate care. 
The obligation to inform most patients if they have a serious condition, e), is usually 
articulated in professional codes, as well as in hospital policies and laws. It is also considered 
to be an ethical obligation because truth-telling is generally viewed as a means of affording 
patients control over information that concerns them, as well as ensuring their participation 
in decisions affecting their treatment and care. 
Statement f ) relates to following orders, obeying the directives of others. The important 
point here is that professionals need to approach such directives critically and ask if they are 
ethically sound and clinically and technically appropriate. 
That a patient has a right to refuse medical treatment even if it leads to their death, g), is a 
widely held belief of the Irish public (it is a matter of public opinion [Weafer, McCarthy and 
Loughrey, 2009]) but it is also viewed as an ethically sound claim that has been underpinned 
by legal decisions, hospital policy documents and professional codes. 
The statement h) may appear, at first sight, to be non-ethical, that is, more a matter of 
aesthetics (concerned with appearance and beauty), than ethics. However, it has been argued 
on the basis of a recent survey of over 2000 nurses in the UK that the physical  
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environment contributed to the promotion and diminution of dignity in care (Royal 
College of Nursing, 2008). The physical environment is, therefore, an ethical issue, as it 
influences whether people feel valued or not valued. 
Statement i) relates to a poll or survey. We do not know exactly which doctors were asked, 
how many doctors were surveyed, or whether the sample was representative. Moreover, 
even if this group of professionals holds this view concerning the therapeutic benefits of 
cannabis, it does not follow that, i, they are correct; ii, that their views should trump the 
views of other individuals or groups, or, iii, that there might not be other practical/ethical/
legal arguments against the legalization of cannabis. 
The final statement j) is a religious claim that links human life with the divine. Some would 
also argue that the claim can be understood in secular terms to mean that human life is 
of supreme value, or at least, that human life has a deeply significant value. Understood in 
these terms, the claim is both religious and ethical (modified from Gallagher, 2005).
9.3 Consider the saying that describes utilitarian morality: 
‘the end justifies the means’. Some commentators think that this policy allows morally 
reprehensible acts to be committed with the aim of achieving good ends.
a. On the basis of your experience, do you think that this habit of carrying out unjust or 
dishonest acts as means to achieve good ends is so unusual? 
b. What about a doctor’s evasion to avoid breaking bad news to a very depressed patient? 
What about prescribing antibiotics for flu symptoms at the request of a patient?
c. What does the fairly common occurrence of such events tell us? That utilitarianism is 
well-suited to human behaviour? 
 
9.4 Review Kant’s rule of universality 
a. Can you give examples where you think this rule should not or could not be observed? 
b. Do you agree with Kant that the consequences of our actions are not fully in our 
control and so should not count in the moral appraisal of our actions?
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open to multiple interpretations and unhelpful for giving practical guidance. 
a. How do you understand the idea of ‘virtue’? Consider someone whom you think is 
‘virtuous’. How would you describe them? What kinds of behaviour or attitudes of the 
person would you offer as moral indicators of virtue? 
b. Does a ‘good’ doctor or nurse have certain characteristic ‘virtues’? If you had to write a 
short essay on ‘The Caring Professional: a Life of Virtue’, what would you have to say? If 
you believe that virtue is not relevant as a focus in healthcare, try and explain why. 
9.6 Consider again the four principles of the PBE approach. 
Taking each principle in turn, can you think of examples from practice which illustrate the 
need for health professionals to respect each principle?
9.7 Read again Brody’s account of empathy on page 35. 
Do you think it is an accurate representation of the patient/professional relationship? 
Consider the strengths and weaknesses of his account.
9.8 Feminist theory highlights the significance of power structures and hierarchies 
in moral situations. These elements of power seem intractable and yet they are found in 
educational settings, in health care contexts and indeed in families. In the context of health 
care, hierarchies of authority seem resistant to change. But are they?
a. Consider a situation where some moral disagreement occurs on in a health care 
setting where power imbalances are at play. These power factors greatly diminish your 
opportunities to speak, to offer suggestions for resolution of a moral disagreement. What 
do you do? What would you suggest be done if asked by a colleague or friend of yours?
b. It seems that power structures and health care hierarchies are culturally relative. Do 
healthcare organisations in some countries suffer more from power imbalances than 
others? If so – how do you explain these cultural differences?
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The Ethics of Breaking Bad News
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1. Module 2 Key points
1.1 Most patients want to know: 
Research in Ireland and abroad indicates that most patients who are terminally ill want to be 
told the truth about their condition but health professionals and families tend to withhold (or 
partially relate) bad news for a variety of reasons.
1.2 The principle of truth-telling: 
obliges health professionals to tell patients the truth about their illness in language they can 
understand, in the presence of those whom the patient has chosen, unless they believe with 
good reason that telling the truth would cause patients serious harm.
1.3 Arguments for and against breaking bad news: 
generally appeal to basic ethical principles such as respect for patient autonomy, doing good 
and avoiding harm. Objections to disclosure also appeal to serious ethical considerations 
such as worries about avoiding harm, ensuring patient well-being and maintaining hope. 
1.4 Health professionals may exercise caution: 
When health professionals believe that telling a patient the truth about their illness risks 
seriously harming them; they may withhold that information. This action is paternalistic. It is 
described as the exercise of therapeutic privilege which should be used with care. 
1.5 Diverse cultural values need to be respected: 
In many cultures, including Irish culture, families may also act paternalistically in withholding 
information from their loved ones. While there is a need to recognise and respect diverse 
cultural values regarding disclosure of bad news it is a matter of debate whether such respect 
is sufficient reason for a health professional to proceed not to tell a patient about their 
diagnosis. Health professionals should not ignore the possibility that the patient may wish to 
have a conversation with them. 
1.6 Patients have a right not to know: 
A patient’s persistent refusal to talk about their illness is an exercise of their autonomy and 
ought to be respected as far as possible. However, the process of not informing a patient is 
an ongoing part of the patient/professional relationship and should be subject to review in 
response to changing circumstances. When a patient is not informed about their condition 
there may be implications for the requirement of informed consent: without knowledge of 
diagnosis and prognosis, this consent process would be profoundly impeded. 
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1.7 Telling the truth is not always appropriate: 
The capacity and the circumstances of every patient are unique. There are some situations 
where it is more important to sensitively communicate with patients in a way that is 
meaningful to them. 
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2. Module 2 Definitions
2.1 Autonomy: 
is the capacity of self-determination; it is a person’s ability to make choices about their own 
life based on their own beliefs and values. 
2.2 Bad News: 
information that seriously and negatively alters an individual’s expectations of his or  
her future.
2.3 Paternalism: 
involves an action that overrides a person’s decision or controls their actions in the interests 
of what is considered to be their own good. Paternalism is described as strong paternalism 
when the person whose decisions and actions are being controlled is autonomous (capable 
of making their own decisions). It is described as weak paternalism when the person whose 
decisions and actions are being controlled is not autonomous.
2.4 Principle of Autonomy: 
requires that, in a healthcare context, health professionals recognize and support the unique 
values, priorities and preferences of patients.
2.5 Principle of Beneficence: 
Requires that health professionals ‘do good’ for patients - that they are actively concerned for 
patient well-being.
2.6 Principle of Nonmaleficence: 
Requires that health professionals ‘do no harm’ - that they avoid or minimize harm to patients.
2.7 Therapeutic Privilege: 
Entitles health professionals to withhold information if they think the information given to 
the patient would run the risk of seriously harming the patient.
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3. Module 2 Background
3.1 Right to Information
As a mark of respect for patient autonomy, Irish healthcare providers – organisations, 
hospitals, clinics, professionals - are increasingly committed to including patients in the 
decisions made about their medical treatment and care. Knowledge of one’s health or 
information about illness seems, in general, a condition for choices about the future. So, 
one way of enhancing patients’ roles in decision making is to provide them with diagnostic 
and prognostic information about their health status. Access to such information is now 
conceived of as a right enshrined in the Irish Patient’s Charter (Irish Patient’s Association, 
2008). These rights are also affirmed in professional codes and laws (An Bord Altranais, 
2000; Medical Council, 2009; Irish Constitution, 1937). However, while all patients might be 
considered to have a right to be reasonably informed about their medical condition; the 
obligations of health professionals, in relation to the information needs of patients who are 
terminally ill, are particularly challenging. 
Breaking bad news to individuals who are seriously ill and have a poor prognosis is a complex 
and contentious issue. Arguments for disclosure of bad news generally appeal to basic ethical 
principles such as respect for patient autonomy, doing good (beneficence) and avoiding 
harm (nonmaleficence). Objections to disclosure also appeal to serious ethical considerations 
such as worries about avoiding harm, ensuring patient well-being and maintaining hope 
(see Arguments For and Against Breaking Bad News). In addition, the situation is made more 
complex because of the number of people who may be involved. These include patients, 
families and health professionals and, while these individuals and groups may be equally 
concerned for the interests of the patient, they may differ as to how those interests might 
best be protected and/or promoted. These concerns deepen for those patients who lack the 
capacity to understand their situation or who are unable to express their own views.
3.2 International Research
International research on health professionals’, patients’ and families’ experiences and 
attitudes in relation to the breaking of bad news is beginning to throw some light on current 
trends (Fujimori and Uchitomi, 2009). A systematic review on the subject of breaking bad 
news broadly found that whilst clinicians believed that patients should be told the truth 
about their illness, many hold back information (Hancock, Clayton and Parker et. al., 2007). 
Reasons for not engaging in truthful disclosure included worries about patient well being, 
the stress incurred by having such conversations, a general discomfort in discussing death, a 
belief that doctors were not well trained in how to conduct such conversations and worries 
that there was no time to engage patients in what might become a lengthy conversation  
(Hancock et. al., 2007). 
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Despite clinicians’ concerns, however, research also indicates that most patients are, at least in 
Western countries such as the United States (US) and the United Kingdom (UK), not seriously 
harmed by such disclosures (Hancock et. al., 2007). To take one example; a recent major study 
conducted in the US demonstrated that patients with advanced cancer who were able to 
have open discussions about their condition with health professionals had better outcomes 
than patients who had no such discussion (Wright et. al., 2008). The latter were subjected to 
more aggressive medical care in their final week of life and were reported as having a poorer 
quality of life near their death. In addition, the caregivers of these patients were found to be 
at an increased risk of developing a depressive illness in the wake of their loved one’s death. 
On the other hand, research also suggests that there is a marked reluctance to disclose 
information directly to patients in many countries where there is much emphasis on the role 
of the family and religious beliefs in the lives of terminally ill patients. Traditionally, in these 
countries, the family, not the patient, takes centre stage. Also central is the deference to the 
decision-making authority of the doctor. This deference combines with a respect for family 
and a belief that family knowledge is essential regarding diagnosis and prognosis in order 
to protect a loved one from emotional suffering. Some Southern European countries – Italy 
and Greece - and many Eastern and African cultures share this view of clinician and family 
participation taking precedence over patient knowledge and autonomy (Johnstone, 2004). 
According to Candib (2002), in cultures such as these, the family, not the individual, is the unit 
of identity and responsibility: ‘The patient knows that family is protecting her and that this is 
what families should do […] non-disclosure is not a matter of lying. Ambiguity may be seen 
as the most suitable strategy to allow the patient to maintain tranquillity.’  
(Candib, 2002, p.214). 
It seems very important then that discussions concerning end-of-life are contextualised. 
This is because the experience and understanding of the death and dying process are clearly 
influenced by social, religious and cultural norms. 
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4. Irish Research
The question arises, is the culture in relation to breaking bad news in Ireland closer to the US/
UK experience, or, to the experience of countries such as Italy, Greece or Pakistan? To answer 
this, it is important, to ascertain and critically consider the extant Irish data pertaining to 
truth-telling/disclosure at end of life. 
In Ireland, a concern for patient well-being as well as a cultural dis-ease around dying and 
death and lack of time also motivates health professionals in their decisions whether to 
communicate bad news or not. Two excerpts from research undertaken in 2009 points to a 
sharp distinction between the communicative practices in many general hospitals and  
those in some long term care facilities. Consider the following account of practices in general 
hospitals: 
‘The practice in general in hospitals in terms of communication around dying and death is 
to follow the patient’s lead, to answer any direct questions. This means that clinicians seldom 
volunteer information, the patient must ask for the information. Frequently communication 
practice among clinicians communicating with patients around dying and death involves 
clinicians responding to patient probes or questions with another question. For instance the 
patient might say something like, ‘I’m not a well as I was’. To this a clinician would respond ‘why 
do you say that?’ A patient might ask ‘how am I doing?’ to this a clinician would typically respond, 
‘how do you think you’re doing?’ In this way, slowing and indirectly, a conversation will unfold 
between a clinician and a patient. 
Given that this research has already established that patients in hospital lose their identities, their 
sense of self, and much of their personal power, given too that the clinicians who participated 
in the research acknowledged the deference that patients pay to clinicians, and the propensity 
of patients in hospital to acquiesce to physician power and inevitability of hospitalised patients 
rapidly becoming part of hospital workflows, and the time needed for such conversations, it seems 
likely that it would be perhaps an exceptional patient who would lead and direct such  
a conversation.
Even in terms of the model of the twelve aspects of daily living that all patients are interviewed 
and assessed on admission to hospital, the one question within the model which is never asked is 
the question on dying. It is never asked.
The participants in the research also highlighted the euphemisms that are used by clinicians when 
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talking to patients about dying and death. Patients might be told that “they are going downhill”, 
that “they are not that well”, that “it’s taking them a bit longer now to pull back this time”, or that” 
it’s going to be a little more difficult than was originally thought”. Consultants were said to be very 
cautious and deliberately oblique with the language they use with patients. Information given to 
patients around end-of-life issues tends to be very guarded, with the information giver constantly 
trying to second-guess how the information is being received. Consultants would typically talk 
to patients about “inflammations” and “shadows” when describing a tumour, even a malignant 
tumour. They would talk to patients about “lumps” and “bumps” and about whether the “lump” or 
“bump” was a malignancy or a non-malignancy. 
There is the difficulty too of patients and families simply not understanding the clinicians. There 
was one case reported in the research of the wife of a man who was dying being told that her 
husband was “deteriorating”, when the woman did not know what the word “deteriorating” 
meant. Patients and their relatives often don’t know what the consultants are talking about, and 
frequently they do not have the courage or capacity to question them. 
Nurses have a substantial role in communication in hospitals, not least in terms of interpreting 
the communications of consultants for patients. Patients seeking information were said to be 
often passed from pillar to post around the hospital as practitioner after practitioner evades 
the question. In practice, direct questions about dying and death from patients at end-of-life in 
hospital are very rare, direct replies from clinicians even rarer.’ 
(Quinlan and O’Neill, 2009, p.90-92)
While Quinlan and O’Neill paint a bleak picture of current practices in relation to professional-
patient communication in many Irish hospitals; the news is more positive in, at least some, 
long term care facilities:
‘The emphasis in the long term care facility for adults with intellectual disabilities was on quality 
of life. Patient autonomy was respected and was constantly the focus of the carers and clinicians 
within the hospital. The willingness of the senior management of the hospital to take risks with 
individual patients in order to enhance their autonomy and support their wishes shaped the 
experience of the facility for those living there. 
One of the clinicians in that facility reported the case of one of the patients who was terminally ill. 
This patient knew her prognosis, she had been given that by the doctor and she decided herself 
that she did not want to go to an acute hospital, she did not want to have surgery. The doctor 
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The woman who had an intellectual disability stayed in the long term care facility in which she 
had lived her life and she died there. That was her choice. 
Another participant said of another patient in this long-term care facility: 
“In my recent experience, while spending some time with a service user who was actually 
diagnosed with a terminal illness I sat with her and asked her if she had any wishes she would like 
us to look after and her wish was to visit Lourdes. She actually had been to Lourdes before but she 
felt herself that she just had the need to go to Lourdes again and she just felt that her condition 
was deteriorating. So while I was talking to her I documented what she was saying and her wish 
was granted. Another concern that this same person actually had was that she would visit her 
parents’ grave and this was a huge wish for her because she herself felt ‘well I want to know where 
I’m going to be buried’ and that was looked after. So they were just two very simple - simple to us, 
we were well able to fulfil that duty - and to her it was a huge issue”.’  
(Quinlan and O’Neill, 2009, p.53-54)
The emphasis in the long-term care facility described by Quinlan and O’Neill is on individual 
people, their unique stories and circumstances. No doubt, the fact that this is a longterm stay 
facility means that attention to individual needs and, significantly, communication about 
what is meaningful to individual patients is prioritized. This focus is missing from the picture 
drawn of general hospitals where the relationships are often impersonal and breaking bad 
news is generally carried out reluctantly, avoided or shrouded in mystery.
From the patient perspective, several recent Irish studies indicate that most patients (over 
80%) who are terminally ill want to be told the truth about their diagnosis and prognosis 
(Keating, Nayeem, Gilmartin et. al., 2005; O’Keeffe et. al. 2000; Weafer 2009a, 2009b, Weafer, 
McCarthy and Loughrey, 2009). However, even though patients may want to be informed, 
Irish research suggests that, in general, relatives are more likely to be informed about 
patients’ illnesses than patients themselves (Keegan, McGee, Hogan et. al., 1999; O’Keeffe et. 
al., 2000). The research also suggests that there is a gap between what relatives think patients 
want to know and what patients actually want to know: patients want to be informed even 
though their relatives believe that they do not (O’Keeffe et. al., 2000). Finally, the research 
indicates that a mutual concern for each others’ wellbeing characterises the relationship 
between patients and their next of kin: both groups want to protect each other from the 
painful news (O’Keeffe et. al., 2000; Quinlan and O’Neill, 2009). 
To return the question posed at the outset of this section, as to whether the culture in 
relation to breaking bad news in Ireland is closer to the US and the UK experience, or, to 
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Many Irish patients want information as do their counterparts in the US and UK. However, 
the Irish patient also shares something in common with patients in Italy and Greece – an 
embeddedness in family relationships. In this context; the family may play a more central role 
in the communicative process and the patient’s voice may be harder for health professionals 
to hear. For some patients and families, this may be welcomed. For others, patients and their 
family members may be confused about the role that family should play. 
Following on this research, it would seem that a major challenge for health professionals 
working in an Irish context is to understand that no single approach to breaking bad 
news will suffice: they must be prepared to respond to the individual and unique set of 
circumstances of each patient and his or her family. A related challenge for healthcare 
organizations is to ensure that patients, families and professionals have a clearer 
understanding of their respective roles in information provision. Some reflection on the  
ethical concerns that arise in relation to truth-telling in healthcare practice in general may be 
a useful start. This is addressed in the following section.
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5. Ethical Concerns
The value of truth-telling as a contributor to patient well-being that is respectful of personal 
autonomy has long been considered by ethicists in all traditions of philosophy. 
5.1 Principle of Truth-telling
The following formulation of the general principle of truth-telling incorporates several 
elements for practice: 
The health professional should tell the patient:
1. the truth about their illness,
2. in a measured manner,
3. in language the patient can understand, 
4. in the presence of those whom the patient has chosen,
5. unless there are good reasons to believe that a degree of harm, 
6. more serious than a temporary emotional depression, would follow as a result of telling 
the truth. 
This general principle can be viewed as respecting several patients’ rights:
•	 The right to information which is accurate and true
•	 The right to decide how much information they feel they need and a right not to receive 
information
•	 The right to decide who should be present during the consultation i.e. family member 
including children and/or significant others.
•	 The right to decide who should be informed about their condition and what information 
that person(s) should receive. (adapted from Irish Hospice Foundation, 2008)
5.2 Arguments For and Against Breaking Bad News
The arguments for and against breaking bad news concern basic ethical principles 
or guidelines for practice: respect autonomy, do good (beneficence) and avoid harm 
(nonmaleficence) and can be clustered under four separate headings: autonomy, clinical 
benefit, psychological benefit and practical reality (Higgs, 1999, p.507-512).  
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5.2.1 Patient Autonomy
For breaking bad news: The patient as a human being has an entitlement to know what 
is discovered about their health and what options are available for treatment and care. 
Respecting autonomy implies respect for a person’s own choices with regard to their own 
lives and precludes anyone else manipulating them in order to achieve ends that are not their 
own. Being kept in ignorance by concealing the reality of illness shows a lack of respect for a 
person’s desire to have some control in the direction of their treatment, care and plans for life. 
Against breaking bad news: The patient does not wish to know and has made this clear. In 
some situations and circumstances, competent individuals choose not to be informed about 
their condition. 
A second argument against breaking bad news is that the patient is not capable of 
understanding the truth. This argument addresses concerns in relation to patients who may 
be cognitively impaired, confused or emotionally distressed. Care must be taken that the 
standard for understanding one’s illness is not set so high that no patient except clinicians 
themselves would qualify for hearing of their diagnosis etc. 
The obligation of the general principle of truth-telling is to explain an illness to the patient in 
language they can understand. This obliges professionals to pay close and creative attention 
to the process of information giving but the circumstances of some patients may not always 
make this possible. 
5.2.2 Clinical Benefit (Beneficence and Nonmaleficence)
For breaking bad news: Treatment is considerably facilitated if the patient knows what
 they are being treated for, what therapeutic options they could choose and why doctors 
or nurses might recommend certain treatments over others. This collaborative approach 
encourages patients to adhere to treatment and care procedures and to provide more 
information about the effects of these on them. It encourages patients to communicate their 
needs and to provide a more complete picture of the whole of their concerns in relation to 
proposed treatments. 
Against breaking bad news: If the patient is informed about their diagnosis, the concern is that 
they will refuse to adhere to treatment and care that would benefit them. In order to ensure 
that professionals are not deceiving competent patients, simply because they disagree with 
what the professional deems is in their best interests, this requires sound judgement that to 
divulge the information would be potentially, and seriously, harmful.
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5.2.3 Psychological Benefit (Beneficence and Nonmaleficence)
For breaking bad news: Disclosure builds trust between patients and health professionals. 
Knowing and understanding diagnoses and prognoses that are communicated with hope 
helps to provide psychological support against isolation in illness. Such conversation with 
hope that everything will be done to help the patient can minimise the worst imaginings 
and fears about the disease process. Knowing that therapies and pain control are available 
for an illness enables the patient to seek help from medical staff, nurses and family members. 
Deception and concealment hinder such positive benefits. Moreover, sustained deception 
can create a climate of secrecy and lies which staff, relatives and friends must endorse and 
which will surround the patient further isolating them from the support that they might need 
in order to prepare for their dying and death.
Against breaking bad news: The truth would harm the patient by causing serious distress 
and taking away hope. Deception is perceived to maintain hope. As with the clinical benefit 
argument; this requires sound medical judgment that to divulge the information would be 
potentially harmful to a depressed, emotionally drained or unstable person.
5.2.4 Practical Reality
For breaking bad news: The patient will find out about their condition whether they are told 
by a health professional or not. The patient finds out by intelligent guessing. A charade of 
pretence is usually unsuccessful in protecting the patient from the truth. Guessing about 
one’s illness rather than being treated with respect as a competent adult affects trust and 
openness with the health professionals and families involved in the deception. 
Against breaking bad news: The patient is not in a position (practically or cognitively) to find 
out the truth.
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6. Cases: Breaking Bad News in Practice
6.1 Case 1: Strong Paternalism – Talking to the Doctors
Consider the following case, recounted by a nurse working in the west of Ireland, which 
represents some of the attitudes and practices in relation to breaking bad news that currently 
prevail in Irish hospitals:
 
Talking to the Doctors
 
And the whole culture lends itself to dealing with the family as opposed to dealing with the 
patient because if somebody’s relative comes and says they want the progress up to date and 
the patient is dying then the consultant will say ‘let the family come and talk to me or when the 
family comes in I’ll talk with the family’ and they may not have discussed the resuscitation status 
with the patient directly but it will be discussed with the families. 
When you talk about prognosis with families, the one thing is they’re very protective of what 
you tell the patient or what you have discussed with the patient. Protecting them in the sense 
that ‘oh I hope you didn’t tell them that their disease has progressed or that they’re not able to 
swallow?’ It’s almost like keeping the person in the dark. I think it’s a real protective thing: ‘don’t 
be telling’. 
Where I work, the layout of the ward makes it difficult so that if you have families coming down 
the ward they’ll almost sort of nearly shield their faces after speaking to the doctor to make sure 
that their mother or father doesn’t see them going out because if they see them going out it is 
always an indication that they are after being told bad news.
Just the other day we had a gentleman, Patrick, who came in because the doctors wanted to 
speak to him because his wife, Mary, was quite ill and death was, you know, soon. So we rang 
the husband to come in and he wanted to know over the phone, ‘was she that ill?’, ‘Had she 
deteriorated that much?’. So we found it very hard to say ‘well actually your wife is dying, you 
need to come quickly’. So when he came in he didn’t want to go in to see Mary because he said, ‘I 
know she’ll know I’m going to talk to the doctors and I don’t want her to know that’. So he spoke 
to the doctors and when he went in to see his wife, she said, ‘I know you’ve been talking to the 
doctors’. Mary just knew by the reaction on his face and she goes ‘I know you’ve been talking 
to the doctors, tell me what they told you?’ And Patrick didn’t tell her at all, it was like they all 
denied what was going on and yet the tears were streaming down their faces. 
(adapted from Quinlan and O’Neill, 2008)
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6.1.1 Discussion
Case 1 involves the collusion of health professionals and a relative in deceiving a patient. 
Taking the arguments for and against breaking bad news and applying them to Case 1 brings 
a number of ethical concerns to the fore.
All four arguments in favour of breaking the truth apply in Mary’s case. In relation to 5.2.1 
Patient Autonomy, Mary is a competent person and there seems to be no doubt about her 
ability to understand the reality of her situation. Yet both her husband and her doctor do 
not respect her autonomy by withholding information that she may need to make choices 
about her treatment and care and life plans in general. In addition, Mary’s right to control 
over that information is also disrespected; her husband is told about her condition before 
she is and he is told by a health professional in the absence of permission from Mary. In 
effect, Mary’s entitlement, both to honesty and confidentiality is breached and the deception 
effectively treats her as a means to others’ ends (See Module 7 for a more detailed discussion 
of confidentiality).
Arguably, Patrick does not actively consciously deceive his wife. He does collude with the 
health professionals in that he asks them to give him information before Mary is told. On the 
other hand, his query is understandable because of the fact that he was telephoned by staff, 
an extraordinary action, that implies that Mary’s situation is bad. In effect, Patrick does not tell 
Mary because he can’t – not because he exercised a choice not to tell her. 
The contrary autonomy argument which favours deception when a patient asks not to be 
told bad news does not apply in this case as Mary has directly asked her husband what the 
doctors have told him about her condition. There is no question of this patient waiving her 
right to know.
Concern for 5.2.2 Clinical Benefit, also applies to Case 1 as it seems that Mary’s treatment and 
care is ongoing. In this case, Mary may benefit therapeutically if she has information about 
her diagnosis, prognosis and the options available to her. 
The contrary argument in favour of appeal to therapeutic privilege does not seem persuasive 
as there is no indication that Mary will refuse treatment that might benefit her.
The 5.2.3 Psychological Benefit that derives from keeping a patient in the information loop 
clearly applies to Mary’s situation; she seems to want to talk openly about her illness. Mary is 
suffering because information directly related to her is being withheld from her. Moreover, 
she is denied emotional support and the opportunity to discuss her fears in relation to her 
deteriorating condition. 
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As Lyckholm (2005) argues: 
‘[I]f we are to take the charge of caring for very ill and vulnerable patients, then truth telling must 
be one on our most precious duties. It is important for patients to know what lies ahead of them 
so they may make final life choices. It is out of respect for their autonomy that we must be honest 
about their prognoses. Patients need to plan financially, psychologically, and emotionally. They 
need the chance to make peace, to say I love you, to say goodbye.’ (p.3037)
The argument justifying deception because it is perceived to maintain hope does not apply 
to Mary; without relevant information about the disease process and pain management, 
Mary is distressed and her situation may well seem hopeless to her. In addition, Patrick also 
struggles in isolation with the news, he wants to avoid Mary because he knows that she will 
know implicitly by the look on his face, and the fact that the doctors had spoken to him, that 
the news was bad.
The 5.2.4 Practical Argument favouring truth-telling also applies to Case 1: Mary knows that 
Patrick has received bad news about her condition. The lack of openness between Mary and 
Patrick and between Mary and the nurses and doctors caring for her seems to be distressing 
to all concerned. There is no doubt that Mary is capable of understanding what is going on; 
the deception, rather than avoiding confusion and emotional upset, adds to it.
In Case 1, both the doctor and, to a lesser degree, the husband, adopt the stance of strong 
paternalism. Strong paternalism refers to actions that obstruct the exercise of choice by 
an autonomous person. The motive for strong paternalism here may well be to benefit 
the patient, Mary, (the obligation of beneficence) but a pertinent question is always: Is this 
decision truly being taken for the well-being of the patient or are other motives dominant 
such as self-interest or self-protection? Thomas Hill links the ideas of a ‘right of autonomy’ and 
the idea of a ‘rational decision-maker’ offering some insight into the case at hand:
‘The right of autonomy is only a right to make one’s choices free from certain interferences by 
others. Among these interferences are illegitimate threats, manipulations, and blocking or 
distorting the perception of options. A rational decision maker wants not only to have a clear 
head and ability to respond wisely to the problems present to him; he wants also to see the 
problems and the important facts that bear on them realistically and in perspective. Thus one 
can also manipulate a person by feeding him information selectively, by covering up pertinent 
evidence, and by planting false clues in order to give a distorted picture of the problem situation.’ 
(Hill, 1991, p.32-33)
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Hill’s worries in relation to the role that others might play in interfering with or limiting 
the autonomy of individuals seem to be at the heart of many experiences that Irish health 
professionals have with terminally ill patients and their families. 
Therapeutic Privilege
The exercise of paternalism by the doctor in Case 1 can also be described as therapeutic 
privilege. Therapeutic privilege assumes that the health professional knows best what is 
in the interests of the patient. If one grants this, then we see a subtle move from medical 
expertise to moral expertise. The ‘privilege’ idea in therapeutic privilege is an entitlement for 
the health care professional to withhold information if they think the information given to 
the patient would run the risk of seriously harming the patient. Notice how this privilege was 
incorporated in the general principle of truth-telling outlined above. 
Beauchamp and Childress think that use of the therapeutic privilege is very controversial 
because it can be over-used in order to avoid difficult challenges in communication with 
patients. What is required is a sound medical judgment that to divulge the information would 
be potentially harmful to a depressed, emotionally drained or unstable person (Beauchamp 
and Childress, 1989, p.91).
Is an appeal to therapeutic privilege in Case 1 a beneficent decision? Mary is not unstable or 
depressed though she is indeed worried. Information about the seriousness of her illness is 
likely to cause considerable distress, tears and fear. But fear and distress is the state that Mary 
is in while not knowing. The application of the therapeutic privilege in this case seems totally 
unjustified. Non-disclosure prevents Mary from beginning the human process of internalising 
the very difficult news of her illness and making plans for her care and her future. One could 
argue that the practice of medicine and nursing precisely involves clinicians in learning the 
art of compassion, listening and creativity in helping patients and families in distress during 
and after receiving bad news. If this process is considered tangential to health care practice, a 
reassessment of the goals of health care provision might be warranted.
The medical doctor and ethics writer, Jay Katz, proposes a new model of trust in the health 
care context, a model that endorses the fundamental importance of communication to 
achievement of good medical practice and respectful patient care.
‘Both parties need to relate to one another as equals and unequals. Their equalities and 
inequalities complement one another. [Health professionals] know more about the disease. 
Patients know more about their own needs. Neither knows at the outset what each can do for the 
other. This trust cannot be earned through deeds alone. It requires words as well. It relies not only 
on [health professionals’] technical competence but also on their willingness to share the burden 
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professionals to trust themselves in order to trust their patients, for to trust patients, [they] first 
must learn to trust themselves to face up to and acknowledge the tragic limitations of their own 
professional knowledge’ (Katz, 2002, p.102).
6.1.2 Suggested Professional Responsibilities
•	 Mary is a competent person and there seems to be no doubt about her ability to 
understand the reality of her situation. Efforts should be made to determine if the 
patient wants to know the truth about her situation. If it is clear that she does, she 
should be informed of her prognosis along the lines of the principle of truth-telling 
and best practice in relation to breaking bad news (See Irish Hospice Foundation 2006; 
Buckman 2005).
•	 The fears and concerns of Mary’s husband, Patrick, need to be addressed in order to 
enable both him and her to come to terms with the fact that Mary is dying.
•	 The practice of disclosing information about a (competent) patient’s illness to family 
members without the patient’s permission breaches patient confidentiality. It is a mark 
of respect for patient autonomy that they control who, and who may not, have access 
to information about them.
•	 The fact that Mary does not know about the seriousness of her situation has 
implications for her capacity to provide informed consent for treatment decisions 
and care. It also means that she is unable to make plans about her dying and death 
including how she might spend her final days. Truth-telling in this case might be 
described as a ‘precious duty’ (Lyckholm, 2002).
6.2 Case 2: Paternalism of Families – Backwards Autonomy
The following case, recounted by a palliative care consultant working in a general hospital 
outside Dublin, tells of his attempts to advocate to protect the autonomy of a vulnerable 
patient. These attempts are thwarted by the paternalism of the patient’s family. As the 
research indicates, this is unfortunately, fairly typical of what can happen when families 
are deeply involved in the care of older and dying relatives. Asked how he might explore 
with patients about how much they understood about their condition, the doctor told the 
following story of ‘backwards autonomy’.
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Backwards Autonomy
 
So I say to the patient ‘you’ve been in hospital a long time, you’ve had a lot of scans and blood 
tests done, do you feel you know what’s going on? Do you feel you know enough or would you 
like to know more?’ and eight or nine times out of ten the patient will say, ‘I want to know’. And 
in a situation where the family are uncomfortable with that we would invite them to be present 
for that conversation, but I would never, ever undertake with the family not to tell the patient. 
Sometimes, the Palliative Care Team become involved when a family will say ‘we’d love you to 
see ...’ it’s typically an older person, so it’s typically a parent rather than a child, they’ll say ‘It’s 
great that you’re coming to see dad but don’t tell him you’re Palliative Care and don’t tell him 
he’s cancer and don’t tell him he’s sick’. We would sort of understand that but again we would 
explain that we will go at the patient’s speed and the patient doesn’t need to know but the 
patient also has the right to know if they choose. And we would always work with that.
Very occasionally, but still probably once a month, we would have patients who we end up not 
seeing because that’s not acceptable to the family. There’s been backwards autonomy in the 
first place: it’s been given to the family to decide whether or not the patient is seen by Palliative 
Care. I mean that should never arise as the issue in the first place but that happens and typically 
it’s somebody who is frail, they can’t come into the clinic to see us without the support of their 
family and the family say ‘well you’ve got to guarantee me you won’t tell them that they have 
cancer otherwise I’m not bringing them in’. It’s very, very rare but we do have it, we had a case 
last week and the family just said ‘well sorry, we’re not bringing Sean in then if that’s what you’re 
going to do’.
In that case, the patient, Sean, is at home and I know from the referring physician, and even 
from talking to the family, that this patient is very unwell, needs the type of support that we can 
offer and our community teams can offer but this patient went home and the doctor whose 
care they were under agreed not to tell them their diagnosis. They are now at home, the family 
aren’t telling the diagnosis and the patient isn’t being allowed access Palliative Care because we 
will not agree to not telling them the diagnosis. We’re not also saying that we have to tell them, 
but we’re saying that if the patient asks us why this has happened over the last two months that 
we will explain that to them in their own speed and in a gentle way. So I think that’s somebody 
whose autonomy isn’t being recognised and it’s someone who is cognitively intact. 
(adapted from Quinlan and O’Neill, 2009. p.63-64)
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6.2.1 Discussion
Case 2 is ethically similar to Case 1 in that both cases involve families who act paternalistically 
towards their relatives. However, there are differences also from an ethical perspective.  
In Case 1, both the family and the health professionals involved collude to keep the patient, 
Mary, in the dark about her condition. In Case 2, however, while Sean’s family adopt the 
stance of strong paternalism, this is being resisted by the palliative care consultant whose 
approach is orientated towards involving Sean in decisions around his treatment and care to 
whatever level that is possible. The family’s motivation may well be to protect Sean but they 
are obstructing his choice to know about his health status and his capacity to make decisions 
in relation to it. Their threat to prevent Sean from seeing the palliative care team because of 
their fears that the team will communicate bad news to Sean directly impacts on the kind 
and quality of treatment he can receive (clinical benefit).
Both cases are also ethically similar in that both Mary’s and Sean’s families are informed 
first about their health status: in effect, they did not seem to have control over who had 
access to information about them and when they would be informed. In both cases, their 
entitlement to confidentiality was not respected. In Case 1, Patrick was informed first by 
the doctor involved; in Case 2, the paternalism of the family was facilitated by the local 
general practitioner who seems to have informed the family first, a gesture the palliative care 
consultant describes as ‘backwards autonomy’. 
No patient likes the tragic news of serious illness. Sadness is painfully normal. Anticipating 
that another will be saddened or distressed at bad news should not be confused with 
evidence that they do not wish to know of their illness. Should health professionals second-
guess a patient’s sincerity in asking the questions to understand? The consultant, in Sean’s 
case, is happy to wait and see after meeting with and talking with Sean, what kind of 
information he might want to have. The consultant states that he will also respect Sean’s right 
not to know. On the contrary, the family are not allowing Sean to exercise either a right to 
know or not to know: they are deciding for him. 
Claiming that the truth will bring harm to a patient requires that one reflects honestly on the 
evidence for anticipated harm. On reflection, evidence may be more difficult than realised.  
Is concern about Mary’s and Sean’s well-being central to the decision made by their families? 
The consciences of the authors of both of these cases are very uneasy. This is, perhaps, 
because they see no evidence for deception. 
The palliative care consultant in Sean’s case, offers strong evidence that the 5.2.4 Practical 
Reality argument in favour of breaking bad news should be taken seriously, especially in 
relation to older people. He observes:
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who is 70 or 80 or 90 their peers, their friends, their family have died, they are more familiar 
with death and that process than the 40 year old son or daughter and we don’t allow for that. 
And we don’t allow for the fact that patients at 70 or 80, even if they have some mild cognitive 
impairment, generally they have a very good awareness of what’s going on and they’re aware 
that they’re a completely different person to who they were 3 or 6 months ago and they know 
there’s something going on. They may well have been sitting in a hospital, a six bedded ward here, 
where the three patients opposite them were all young people with no hair on chemotherapy and 
everyone is assuming that the 82 year old won’t have guessed that cancer could be an issue here.’
(Adapted from Quinlan and O’Neill, 2009)
Sean has had a long and serious illness and he is, most likely, aware that his situation is very 
serious and/or terminal. However, his health status makes him profoundly vulnerable to the 
will of other people. This kind of vulnerability is captured by the philosopher, Sisela Bok:
‘It has always been especially easy to keep knowledge from terminally ill patients. They are 
most vulnerable, least able to take action to learn what they need to know, or to protect their 
autonomy. The very fact of being so ill greatly increases the likelihood of control by others. And the 
fear of being helpless in the face of such control is growing. The sense of possible prolonged pain, 
the uncertainty, increasing weakness, loss of powers, chance of senility, sense of being a burden.’
 (edited from Bok, 1978, p.231-233)
6.2.2 Suggested Professional Responsibilities
•	 Sean’s family’s threat to prevent Sean from seeing the palliative care team is obstructing 
his ability to make a choice to know about his health status and to control who else may 
know about his condition. Efforts should be made to understand the family’s concerns 
in this regard. They also need to be made aware of the health professional’s duty to tell 
the truth (where appropriate) and to protect patient confidentiality.
•	 Preventing Sean from seeing the palliative care team also impacts on the kind and 
quality of treatment he can receive. Efforts need to be made to understand the family 
members’ reluctance to involve Sean, to address their concerns and to explain to them 
the implications of their refusal and the professional’s duty of care to Sean.
•	 Sean’s ability to participate in decision-making around his treatment and care is 
hindered by his lack of knowledge. The family, not the patient, are making the  
decisions in this case. It needs to be established if this is what the patient himself wants 
to happen. 
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6.3 Case 3: Familial, Religious and Medical Authority – Family at the Centre
If we look at a Pakistani perspective on medical decision-making we see the way in which 
family and religion play a significant role in the treatment and care of loved ones who are 
terminally ill. This is markedly different from secular Western societies, such as the US and the 
UK, where patient autonomy is generally accepted as the cornerstone of healthcare ethics 
when it comes to choices in medical care and end-of-life decisions. However, the following 
case is very similar to the earlier cases and indicates that Irish culture is, often, closely aligned 
with cultures that place much emphasis on the role of the family and religious beliefs in the 
lives of terminally ill loved ones.
 
Family at the Centre 
After training as a doctor in the United States for many years, I accepted an academic position 
at a medical university in Pakistan. One of my first experiences there was to tell two brothers 
sitting across the desk from me that all investigations indicated their elderly father had 
widespread metastatic cancer, and therefore not long to live. The patient, who lived with the 
oldest son and his family, was not present during this conversation, although an adult daughter, 
a daughter-in-law, and an adult grandson were. After listening attentively to what I had to say, 
and obviously upset at this news, one of the sons said, ‘We do not want him to know that he has 
cancer. How long he lives is in the hands of God in any case, and it is not right to make my father 
lose hope while he is so ill.’ He then added, ‘Doctor Sahib, tell us what we should do next. You 
know best. You are not just our doctor, you are like our mother’ (Moazam, 2000).
6.3.1 Discussion
In Case 3, like Case 2, the family, not the patient, takes centre stage. Also central to this case 
is the deference to the decision-making authority of the doctor. This deference combines 
with a respect for family and a belief that family knowledge is essential regarding diagnosis 
and prognosis in order to protect a loved one from emotional suffering. This attitude is not 
unique to Pakistan. Many Eastern and African cultures also share this view of clinician and 
family participation taking precedence over patient knowledge and autonomy. According to 
Candib (2002), in cultures such as these, the family, not the individual, is the unit of identity 
and responsibility: ‘The patient knows that family is protecting her and that this is what 
families should do […] non-disclosure is not a matter of lying. Ambiguity may be seen as the 
most suitable strategy to allow the patient to maintain tranquillity’ (Candib, 2002, p.214). 
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As illustrated by the narratives from health professionals (Quinlan and O’Neill, 2008; 2009), 
Irish family members are also protective of their loved ones when they insist that they, and 
not the patient, are to receive medical information. In coping with this diversion of autonomy 
from patient to family, health professionals, working in Ireland, have explained that it is most 
challenging and stressful especially when families are insistent. 
Interviews with health professionals from both rural and urban hospitals around Ireland, 
illustrated in Cases 1 and 2, reflect the difficulties for some health professionals in trying 
to keep the patient’s right to honest information primary in face of family requests to the 
contrary. The motive for doing this, from the family’s point of view, may be paternalistic – 
wishing to protect the loved one from distress and anxiety associated with knowledge of 
their near death. Alternatively and/or in addition, the family may not be able to communicate 
directly/at all with the patient in the face of current, immediate frightening news and so 
can cope better by talking about and making decisions from a distance. In sum, it may be a 
question of limited ability rather than, simply, protection.
Medical Authority
For the most part, within the cultural setting of Case 3, the doctor remains the authority in 
matters relating to diagnoses and prognoses, treatment interventions and life prolonging 
decisions. The family wishes the doctor to direct rather than just facilitate medical decision-
making. The important religious perspective of trust in the deity is also firmly part of the 
religious and cultural context of this case. As in Ireland, religious customs may be very 
important at the time of death and provide identity and comfort for families of the deceased. 
The case from Pakistan suggests also that for persons embedded in the faith tradition shown 
in this case, end of life may ultimately be perceived to be in the hands of God and issues of 
faith may be integral to overall healing at the end of life. 
Drawing on the empirical research undertaken by the HfH (Quinlan and O’Neill, 2008, 2009; 
Weafer, 2009a, 2009b) as well as other relevant existing Irish studies there is a body of 
evidence suggesting that in Ireland too, many family members tend to respect divine and 
also medical authority over individual autonomy.
Both Cases 2 and 3 involve a conflict between family wishes and health professionals’ 
convictions about givi ng information to the patient. The families of the elderly gentlemen 
in both cases tell the doctors, with conviction, that their fathers should not be told any bad 
news about their condition. These cases highlight the question: whether the practice of 
telling family members bad news before (or instead of ) a competent and conscious patient, 
is ever morally justifiable? When health care professionals gather at meetings and are asked: 
who should be given information about a patient’s diagnoses or prognoses, virtually all 
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information first. Yet, in spite of this verbal nod towards patient entitlements, in practice, even 
in many countries in the Western world, and, certainly, in Ireland, this still does not happen. 
Reasons given for this discrepancy are that it is simply easier to tell relatives first (or only). 
Facing relatives’ distress is simply not as difficult as facing the likely greater distress of the 
patient hearing of a serious condition. But is this a valid moral justification for over-riding  
the entitlement of the patient to know? 
The first point to make is that the health professional’s difficulty or ease in the 
communication process does not amount to a moral justification. Intimidation by insistent 
relatives can be stressful but similarly such intimidation is not tantamount to a moral 
justification. Emotional discomfort is a psychological report not an ethical explanation. 
The communication process in clinical settings is one of the obligations or duties of health 
professionals. Many obligations and duties are difficult and that is clearly part of the 
challenge and sometimes anxiety associated with a chosen career. 
In most cases, it is the health professional’s responsibility to judge how much information to 
give to a patient, how to communicate this and over what kind of time-frame. Randall and 
Downie comment on this type of situation: ‘The carer’s feelings in this regard are not morally 
relevant. This may seem a hard thing to say, but it needs to be said if the patients’ right to the 
truth is to be upheld’ (1996, p.84).
If the good of the patient is paramount, and, if we assume that respect for the patient 
requires allowing them self-determination or voice of some kind in decisions, then it is at 
least important that the doctor tries to get some evidence that the patient in Case 3 wishes 
his voice to be heard through his family. One way of achieving this might be to offer the 
patient the ‘option of truth’ when breaking bad news regardless of where the patient comes 
from. Candib (2002) suggests using questions like: ‘Will you want to be making the decisions 
about your care with the doctors, or do you want your family to be making those decisions? 
And ‘When we understand what is causing your illness, will you want us to tell you about it, or 
to talk with your family about it?’
In addition, the health professionals in both Cases 2 and 3 can do more to try and understand 
the relatives’ request not to inform their father. Health professionals do not need to second 
guess the family’s reasons, precarious speculation at best. However, doctors and nurses 
can initiate a conversation in private with relatives (and separately with different family 
members) about why they think their father should not be told. Note that consensus may 
not be reached within families that the patient should/should not be told bad news and 
so disagreements emerge from within the ‘family’. One way of addressing this might be to 
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can deal with directly regarding care decisions about the patient. This can provide valuable 
information for health professionals about the patient’s personality and whether there are 
previous situations where their father coped badly with distressful news and crises (Randall 
and Downie, 1996).
6.3.2 Suggested Professional Responsibilities
•	 The question is: should health professionals simply agree with the request and proceed 
to treatments or provide only comfort care without informing patients about their 
diagnoses and prognoses? Respecting the cultural values of many families in Ireland 
or in Pakistan may not justify a generalisation of all Irish or Pakistani individuals. The 
doctor, in brief, should not ignore the possibility that the patient may wish to have a 
conversation with the doctor. He or she might offer the patient the ‘option of truth’.
•	 One of the questions that diverse cultural values raise is whether or not the respect 
owed to the family’s cultural practices about information giving is sufficient moral 
reason for health professionals to proceed not to tell the patient about his condition. 
Respecting diverse cultural values does not mean that the doctor automatically takes 
the word of the family. Does the doctor, for example in Case 3, know that the father 
does not wish to be informed of his grave situation? He should try to confirm the word 
of the family that their father wishes communication to be with them? Doctors and 
nurses can and perhaps must try to test the validity of this request from family.
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6.4 Case 4: The Right Not to Know – Must She Know?
Case 4 is drawn from research funded by the Irish Hospice Foundation that investigates 
the grief experiences of same-sex couples in an Irish context. According to the authors of 
the research, the ‘belief by health professionals that patients should be informed of their 
diagnosis, resulted in one of the participants being what she perceived as “forced” to inform 
her partner of her diagnosis [of terminal illness]. This was despite the fact that her partner 
had previously told her she did not want to know her diagnosis.’ (Higgins and Glacken 2009, 
p.172). The authors report on Brid’s distress at having to share ‘the devastating news of her 
impending death with her partner’:
 
Must She Know?
 
‘I said [to the doctor], “Surely her right to not know should be adhered to”. And he said, “No” … 
and the following morning I went in [hospital]. I was in with her at 4 o’clock in the morning. And 
she was sitting in the chair beside the bed. And she said to me, “What are you doing here at this 
time?” And I closed the door and I pulled the curtains … I said to the nurses, “I’ve got to go in. If 
anyone’s to tell her, I’d have to tell her”. And I had to tell her … and it was the most difficult thing 
I had to do. [Very upset and tearful.] She looked at me and I said, “Will you forgive me for telling 
you?” “But” she said, “I didn’t want to know” ’. (Higgins and Glacken 2009, p.172)
6.4.1 Discussion
The reader is not aware of all of the circumstances surrounding Case 4, but what is clear 
is that the doctor in this case has an expression of the patient’s personal preference but is 
unwilling to respect it. Moreover, this case is similar to cases 1, 2 and 3: the family member of 
a competent patient is informed about the patient’s condition before and/or instead of the 
patient themselves.
A patient’s choice not to know is an exercise of their autonomy and ought to be respected 
as far as possible. However, as breaking bad news is best understood as part of an ongoing 
relationship where the news is shared and reviewed in an ongoing way; so too the process 
of not informing a patient is an ongoing part of the patient/ professional relationship 
and should also be subject to review in response to changing circumstances. In Case 4, 
the doctor’s brief and (seemingly curt) response, ‘No’, indicates that he has no interest in 
engaging with the patient or her partner in relation to the reasons why the patient does 
not want to be informed. It might be, for example, that some patients cope better with less 
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being sidelined in this respect. Whatever her reasons; an opportunity is lost here to address 
the patient’s concerns about knowing/not knowing and the patient’s partner, Brid, is left to 
cope with sharing the news alone. The task of doing so, may well add additional stress to the 
women’s relationship at a time when time is precious and in circumstances that are already 
deeply traumatic.
It might be that the doctor in this case is concerned that if the patient is not informed about 
the seriousness of her condition that there may be implications for the requirement of 
informed consent. In general, competent patients are both morally and legally entitled to 
information from professionals about their illness. The important caveat here is the expressed 
request from a competent patient that she does not wish to be informed or consulted. The 
difficulty might be that there may be need for on-going consent or refusal for therapies. 
Without knowing of diagnosis and prognosis, this consent process would be profoundly 
impeded. It follows that foregoing the possibility of consent conversations with a competent 
patient should be done only for very good reasons. However, it is not clear that the insistence 
on disclosure on the part of the doctor in Case 4 is based on concern about the informed 
consent process. If this were the case; it seems strange that he is happy to derogate the 
responsibility for sharing medical information to the patient’s family. 
This leads us to a further question that this case prompts: what kind of information is at stake 
here? Higgins and Glacken use the term, ‘diagnosis’, and the phrase, ‘news of her impending 
death’, in their description of the case. Few might dispute that ‘diagnosis’ is a medical term 
and, as such, it could be argued that communication about a poor diagnosis is something 
that health professionals, should undertake with (willing and competent) patients and family 
(where appropriate). 
The phrase, ‘news of her impending death’, however, highlights the profound human drama 
that underlies the medical terminology. This phrase could be viewed as medical information 
but it can also be understood as news that is profoundly personal, spiritual and existential. 
In short, news about dying and death is not a simple matter of fact and sharing it demands 
more of health professionals than, perhaps, health professionals, patients and society as a 
whole are willing or ready to acknowledge.
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6.4.2 Professional Responsibilities
•	 If, in spite of being told that her condition really needs discussion and is quite serious, 
the patient persists in declining conversations, it is difficult to justify imposing the truth 
about her condition on the patient.
•	 It is essential to view the patient’s refusal of information as part of an ongoing 
conversation that demands a willingness on the doctor to try to understand the 
patient’s reasons for not wanting to know.
•	 If the patient requires further therapeutic and/or palliative treatment for her condition; 
it is important to engage the patient as fully as is reasonably possible in planning her 
care. At the same time, health professionals should respect the patient’s resistance to 
knowing what undergoing these treatments implies about her medical prognosis. 
•	 The patient’s family should not be abandoned by the doctor, and perhaps, in turn, by 
the nurses. Sensitive communication with the patient and with Brid may address fears 
and worries and prevent conflict and confrontation from developing. 
•	 Health professionals should be aware of best practice in relation to patients who 
identify as lesbian or gay. See Health Service Executive (2009) for Good practice 
guidelines for health service providers working with lesbian, gay, bisexual and  
transgender people.
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6.5 Case 5: Communicating with Patients who Lack Capacity – The Forgetful Mourner
So far, this module has focused on the insights that can be gained from considering cases 
involving the breaking of bad news to competent patients in the light of the obligations that 
basic principles such as respecting patient autonomy and acting for the good of patients 
confer. The next case involves a patient who is not autonomous and it raises additional 
challenges and demands additional skills on the part of health professionals in order to 
ensure respectful and good patient care. The case involves the breaking of bad news to a 
patient who is suffering from Alzheimer’s disease. The bad news, in this case, relates not to 
the patient’s own condition but to the death of her son.
 
 
The Forgetful Mourner
An eighty six year old Italian American woman with moderate dementia, Joanna, is admitted 
to a nursing home when her son Tony, with whom she has been living, falls ill. When, after two 
years, Tony dies suddenly the staff in the nursing home are especially concerned for Joanna. 
In the days and weeks that follow the funeral, she continues to ask how Tony is doing as if he 
is still alive. After consulting with staff, the director of the Alzheimer unit decides that Joanna’s 
questions should be answered truthfully: she should be told that Tony has died. Each time this is 
done, however, Joanna becomes distraught, enduring the pain of her son’s death over and over 
again. While everyone finds this very hard, the Director hopes that their patience and persistence 
will enable Joanna to remember what really happened. The only alternative seems to be a grave 
and sustained deception on the part of everyone who has a relationship with her. 
As it turns out, Joanna is told of her son’s death at least fifteen times, and each time she 
experiences the grief of her loss anew. Then, one of the nurses suggests that Joanna put on the 
black dress she had been wearing on the day she attended Tony’s funeral. This she does and it 
seems to help her to remember. Even though Joanna continues to talk about Tony, she no longer 
asks how he is doing. (Adapted from Yang-Lewis and Moody 1995.) 
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6.5.1 Discussion
One response to the actions of the director might endorse the view that, however painful it 
is, in this case, telling the truth to Joanna, in whatever fashion, is the right and respectful thing 
to do because it conforms with the principle of truth-telling, avoids the sustained deception 
of Joanna and acknowledges the importance of her relationship with her son (Yang-Lewis 
1995). It is, after all, Joanna’s memory that is eroded, but not, necessarily, her sense of self and 
her relationships with others, especially her son. 
An alternative approach, however, might argue that the Director’s commitment to truth-
telling is misguided as it ignores the pointless anguish and pain that truth-telling visits on 
Joanna (Moody 1995). The experimental and imaginative approach of the nurse, on this 
view, is the more ethically acceptable because she focuses on the communication rather 
than the truth element of the principle of truth-telling. The nurse’s suggestion that Joanna 
wear the black dress is motivated by the desire to communicate with the patient in a way 
that is meaningful to her. The immediate effect of wearing the black dress, somehow, meets 
Joanna’s sense of loss and validates her feeling of grief around her son. Ultimately, it may or 
may not succeed in getting Joanna to intellectually understand and accept the truth about 
her son’s death. On this view, it is communication with the aim of meeting the patient in a 
way that is meaningful to them, not truth-telling, which is ethically important. 
6.5.2 Professional Responsibilities
•	 The ethical challenge in this case is that health professionals have a duty to consider 
both Joanna’s autonomy interests as well as her well-being. 
•	 Even though Joanna might not be considered competent or capable of understanding 
the news about her son in the usual way; she, nevertheless, has autonomy interests in 
the sense that she still has a sense of her own life, her relationships and concerns. The 
patient’s autonomy, thus broadly construed, needs to be respected.
•	 Respect for Joanna’s autonomy needs to be balanced by concern for her well-
being. Health professionals might consider the breaking of bad news as a task of 
communication in the widest sense where communication is understood as more  
than the provision of cognitive information. The goal of communication could be 
to enable Joanna to understand what has happened to her son in a way which is 
meaningful for her.
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6.6 Case 6: The Need for Sensitivity – Why Tell the Truth?
The final case in this module also raises a question about the appropriateness of always 
telling the truth. It involves a general practitioner (GP) whose breaking of bad news to a 
patient worries one of her colleagues and prompts him to reflect on the context within which 
the truth gets told. 
 
Why Tell the truth?
 
We all commiserated as our colleague told us about her awful consultation the previous day.  
She had had to tell a man in his fifties that his ultrasound scan had shown a mass in the head 
of his pancreas, almost certainly a carcinoma. The man clearly hadn’t been expecting bad 
news, and had turned up at the surgery on his own, with a rather jaunty manner. To make 
matters worse, she had never met the man previously—she was covering for someone else 
that day. We squirmed and offered our sympathy as she described the encounter unfolding 
from moment to moment. She was honest enough to admit that she hadn’t actually liked the 
man, who had been a bit smelly. At the end of the consultation she had wanted to hug him, or 
at the very least to touch him on the arm, but found herself unable to. We were all experienced 
educators as well as clinicians, and we tried to cover every angle in our discussion: the painfully 
inappropriate circumstances in which we often have to break bad news; the way in which 
negative impressions can disable our compassion; and how we aspire to the impossible task of 
spelling out a death sentence nicely, and feel like failures when it never quite happens that way. 
Yet afterwards I pondered on her story and I couldn’t get another, heretical thought out of my 
mind: why did the doctor have to tell the truth? 
(Launer, 2005, p.385)
6.6.1 Discussion
The author of this story is somewhat taken aback at the frankness of his colleague and he 
contemplates the variety of ways in which the GP might have postponed telling the patient 
of his full scan results, at least until a relative or friend could arrive or until the man’s regular 
doctor could be there. Launer imagines some prevaricating language that the GP might have 
used: ‘The result isn’t back yet’, ‘It’s back but it’s not entirely clear’, ‘I’m a bit puzzled about its 
significance and I need to discuss it with a colleague’. Even if such subterfuge had made the 
patient more anxious; it was still preferable, for Launer, to the shock he received without 
anyone to support him in it.
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prompt health professionals to assume that there is only one right action: to tell the truth. 
He advises caution and sensitivity towards the unique circumstances of each patient so that 
decisions and actions are focussed on the individual and sought through conversation rather 
than fixed prior notions of what should be done. 
Case 6 illustrates the tension that can exist for stressed and busy health professionals who, 
anxious to respect patient autonomy and to avoid acting paternalistically, are insensitive to 
the import of their conversations on unsuspecting and ill-prepared patients. In such cases, 
Launer advises not simple subterfuge but deception, even lying (‘The results aren’t back yet’). 
While it could be argued that lying is more ethically unacceptable than prevarification (see 
Further Discussion); what this case underlines is the need for health professionals to consider 
the unique circumstances of each patient and to exercise caution and sensitivity in relating 
bad news to them.
6.6.2 Suggested Professional Responsibilities
•	 Health professionals need to remember that the communication of bad news is more 
than the communication of matters of fact. 
•	 The views of patients in relation to when, and with whom, they might be provided with 
information about their condition should, where possible, be invited.
•	 Sensitivity to the unique circumstances of the patient is important. The need and 
availability of support from family members and/or others should be assessed and 
identified.
•	 The emotional labour of breaking bad news should be recognized by health care 
organizations. Every ward/unit/centre should have a disclosure policy and training 
in relation to communicating bad news and the documentation of disclosures. 
Psychosocial support for the professionals involved in communicating bad news and/or 
other members of the healthcare team should be considered. 
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s 7. Module 2 Further Discussion
The arguments for and against breaking bad news might also be framed in terms of two 
traditional moral theories where truth telling and respect for individual autonomy are seen as 
central to human relationships.
7.1 Deontology: Focus on Duty 
According to deontology, some actions are simply wrong (See Module 1). They are 
‘intrinsically wrong’. In claiming that some actions are intrinsically wrong, the 18th 
century German philosopher, Immanuel Kant, means that – no anticipated good outcome 
can give moral warrant or justification for carrying out these actions. To use an example, let us 
say that torturing innocent human beings is intrinsically wrong. This means that no amount 
of anticipated positive results or good outcomes from torture (such as getting valuable 
information) can make such torture ‘right’. Likewise, to say that lying cannot be morally 
defended means that no amount of seemingly good outcomes, for the liar or the one lied to, 
justifies lying.
Staying with these examples, why is it that good consequences would never warrant torture 
of the innocent or the act of lying? In the Metaphysical Principles of Virtue, [1797] (1968), Kant 
explains the relationship between truthfulness and the dignity of humanity in a person. 
Right actions promote or foster human dignity and respect for human beings. Wrong actions 
undermine dignity and respect, of the one lying and the person lied to. 
‘The greatest violation of man’s duty to himself considered only as a moral being is the opposite 
of veracity: lying. Dishonour, which goes with lying, accompanies the liar, like his shadow. Lying 
is the throwing away and, as it were, the obliteration of one’s dignity as a human being. Lying, as 
intentional untruth in general, does not need to be harmful to others in order to be blameworthy. 
Even a really good end may be intended by lying. Yet to lie even for these reasons is through its 
mere form a crime of man against his own person and a baseness which must make a man 
contemptible in his own eyes’ (Kant, [1797], 1968, p.90-91).
Notice that from this rigorous deontological perspective, lying, even for reasons of supposed 
kindness or benevolence is still wrong because it debases the one lying. Secondly, Kant thinks 
that lying also treats the person we lie to with disrespect for their autonomy: we are using 
the other person as a means for our own ends – perhaps to make the job easier or because 
we cannot bring ourselves to share bad news. Kant puts it this way: ‘Lying is a crime of man 
[woman] against his [her] own person.’ He asks: ‘Should I lie to extricate myself from a difficult 
situation?’ No, is the categorical response. No matter the motivation, in Kant’s philosophy, 
expected good consequences do not make the lying right. Consequences are irrelevant to 
the moral evaluation of actions.
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The deontological theory is strikingly different from other ethical theories such as 
utilitarianism. Whereas deontology argues that some actions are simply wrong regardless  
of the good consequences, utilitarianism is a consequentialist theory (See Module 1).  
This indicates the centrality of consequences of actions when we are morally evaluating 
an action. Acts are not right or wrong in themselves. Utilitarians stress that the rightness or 
wrongness of an act is determined by looking to what follows from the choices of individuals. 
If we maximise human well-being or happiness it is a moral action. If human suffering and 
degradation occur then the action is immoral. The challenges of utilitarianism become clear: 
human beings take great responsibility for anticipating the outcomes of choices. 
Rather than argue, as Kant did, that consequences are irrelevant to the moral quality 
of actions, the 19th century utilitarian philosopher, John Stuart Mill, took the maxim of 
utilitarianism to be: ‘Do what has the best effects over-all’. Unlike Kantian ethics, Mill argues 
that it might be necessary to lie if doing so would likely, and in a particular situation, protect 
individuals from harm. Mill asks: ‘What if lying would serve to achieve the greater happiness 
and welfare of individuals and society?’ Utilitarians see their great strength in emphasizing 
what is good or bad for people based on the preferences of people. What matters in terms of 
the goal of morality are specific consequences for happiness and human well-being affecting 
persons’ lives. This is in contrast with deontologists who stress the importance of abstract 
rules, divine commands or intuitions that are supposed to define what is moral. 
7.3 Moral Principles and Exceptions
7.3.1 Justification
In many situations of health care you may be asked to explain how you would justify 
or defend your views about, for example, truth telling, confidentiality, or constraints on 
autonomy. Being prepared to give reasons means that we are willing to continue to grow as 
moral agents. Justification involves giving reasons for adherence to truth telling in general. 
But, justification is also about giving reasons why an exception to truthfulness is necessary 
in a particular situation. For example, the doctor in Mary’s case (case 1) may generally agree 
with the practice of truth telling but judge now in the concrete circumstances, that it is 
not (immediately) appropriate. If this is so, then the doctor is clearly choosing to make an 
exception to the general principle of truth telling. This path requires justification.
The nature of the general ethical principle of truth telling is precisely that: it expresses a basic 
value or set of values that we wish to protect. We can, with consistency, strongly affirm the 
general principle and yet recognise that there might be circumstances where we must set 
aside the general presumption because other competing values are deemed more important 
at this point in time. So the rule in the general principle operates ‘most of the time’ and 
functions as a ‘rule of thumb’ for most situations.
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If we find ourselves appealing to the exceptions much more than the general principle, then 
we are probably beginning to seriously doubt the value contained in the general rule or 
principle. Alternatively, we might verbally endorse the value of being truthful but through 
repeated exceptions reveal a lack of sincerity or ‘weakness of will’ in our conviction about the 
value of truthfulness. 
Accepting general principles is one way of endorsing the cumulative experience of human 
valuing. When we endorse the moral importance of certain values we are agreeing to the 
general acceptability of what is called an ‘ethical norm’. The norm of ‘telling the truth as 
a general rule’ is defended by appeal to the moral value of respect for the autonomy of 
individuals whose condition of health is primarily their business, their concern and an area of 
profound meaning in their life. 
Like all exceptions to ethical principles, if we put aside the general rule in a particular case, 
reflection is required regarding the concrete patient and specific clinical realities that are 
known. Taking the full range of human, patient, personal and health realities into account, 
we must then consider the reasons for thinking that a particular case is an exception and that 
withholding information, partial deception or total deception is called for.
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8. Module 2 Summary Learning Guides
8.1 Truth Telling
•	 is defended as a fundamental moral value in health care practice
•	 is founded on respect for personal autonomy
•	 can be expressed in the form of a general principle
•	 requires skilful communication and listening to foster hope for coping with one’s illness. 
The principle of truth telling is not absolute but it: 
•	 allows for exceptions in certain specific situations.
•	 requires that any exceptions be justified or defended by evidence from the concrete 
realities of a case
•	 considers therapeutic privilege as one such exception but one that requires caution in  
its use.
8.2 Arguments For and Against Breaking Bad News
1. Patient Autonomy
•	 For: The patient as a human being has an entitlement to know what is discovered about 
their health and what options are available for treatment and care. 
•	 Against: The patient does not wish to know and has made this clear. The patient is not 
capable of understanding the truth. 
2. Clinical Benefit 
•	 For: Treatment is considerably facilitated if the patient knows what they are being treated 
for, what therapeutic options they could choose and why doctors or nurses might 
recommend certain treatments over others. 
•	 Against: If the patient is informed about their diagnosis, the concern is that they will 
refuse to adhere to treatment and care that would benefit them. 
3. Psychological benefit 
•	 For: Knowing and understanding diagnoses that are communicated with hope helps to 
provide psychological support against isolation in illness. 
•	 Against: The truth would harm the patient by causing serious distress and taking  
away hope. 
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•	 For: The patient will find out their diagnosis whether they are told by a health professional 
or not. 
•	 Against: The patient is not in a position to find out the truth.
8.3 Traditional Ethical Approaches to Truth Telling
If you approach truth telling as a Kantian deontologist you would believe,
•	 that lying is intrinsically wrong 
•	 that lying is against the moral law
•	 that, by lying to others, we treat both them and ourselves with disrespect
•	 that no anticipated good consequences from lying will make it right. 
If you approach truth telling as a consequentialist or utilitarian, you would believe,
•	 that no actions are intrinsically and always wrong
•	 that the rightness or wrongness of lying depends on the consequences of lying
•	 that the consequences must foster well-being and minimise suffering 
•	 that the judgement of likely consequences is rigorously demanding and requires that you 
know the patient and context thoroughly.
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9. Module 2 Activities
9.1 Recall the principle of truth telling: 
a. Would you add anything further to these points on truth telling?
b. Would you challenge anything in this statement?
c. Use the following web link: http://www.hospicefriendlyhospitals.net/resources-and-
courses/itemlist/category/20-resources-communications.html  
www.newgrange-process.net to download the document, Irish Hospice Foundation 
(2009) How do I break bad news. Retrieved 1 December, 2009. Read the Guidelines and 
identify three of the ethical values that inform these guidelines. Source Buckman (2005) 
and critically consider the SPIKES strategy for communicating bad news.
9.2 Reflect back on the particulars of Case 1:
a. In reading Case 1, jot down your first, unanalysed response to the decisions taken.    
b. If Mary does not understand her illness because she has not been taken seriously as a 
questioning patient, the possibility of achieving consent to treatment is undermined.  
What if the doctor decides to administer steroids in an effort to control Mary’s pain? Mary 
may well ask, What is the medication? Will it help? What would you tell her?
c. Are the consequences of not informing Mary in Case 1 more conducive to maximising the 
good (for who?) than the results of informing her? 
d. How would you gauge the likely consequences of telling or not telling Mary the truth of 
her condition? 
9.3 Reflect back on the particulars of Case 2:
a. What do you think the doctor in this case means by ‘backwards autonomy’? What other 
ethical values besides truth telling have been set aside here?
b. The strong paternalism practiced by the family in Sean’s case involves more than limiting 
his access to information; it also has repercussions for his care. What are the ethical 
dilemmas for the health professionals involved?
c. Gauging consequences is difficult but very important if one is reasoning as a utilitarian. 
A good utilitarian has to ask: Were there good reasons for obstructions to Sean’s liberty? 
How would you gauge the likely consequences of telling or not telling Sean the truth of 
his condition? 
d. If you were the consultant involved, how might you respond to the conditions that the 
family place on you, the palliative care team, and the GP?
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9.4 Reflect back on the particulars of Case 3:
a. Notice how different the focus is if one approaches the family as a group of people bound 
together by relationships and stories that tie them: the focus turns on the family as an 
integral whole needing help and listening. Consider how a health professional might help 
this family absorb and negotiate their father’s illness. 
b. Identify the ethical values that are at risk in Cases 2 and 3. Compare and contrast Cases 2 
and 3 from an ethical perspective.
9.5 Reflect back on the particulars of Case 4:
a. It might be suggested that the couple in this case were treated insensitively because the 
doctor was uncomfortable with the fact that the patient was in a lesbian relationship. 
Consider this possibility. Consider in what ways homophobia might impact on the 
care and treatment offered to lesbian and gay patients. Jot down your first unanalysed 
response.
b. Download the Health Service Executive Guidelines on good practice with LGBT patients at 
the following link: http://www.hse.ie/eng/newsmedia/Archive/LGBT_HEALTH_Towards_
meeting_the_Health_care_Needs_of_Lesbian,_Gay,_Bisexual_and_Transgender_People.
html
c. Are there any guidelines that you might have difficulty in applying? Have you any to add?
9.6 Reflect back on the particulars of Case 5
a. What are the values at risk in this case? What are the values that need to be nurtured?
b. Critically consider the motivation of the director and the nurse in this case. What values 
might underpin their different responses to Joanna’s situation?
c. Read Case 5 and consider the principle of truth telling in the light of Joanna’s situation. 
Note that the principle includes emphasis on the role of communication in the 
process of truth telling. What, in your view, is the difference between ‘truth telling’ and 
‘communication’?
112
Mo
du
le 
2 
Th
e 
Et
hic
s o
f B
re
ak
ing
 B
ad
 N
ew
s
9.7 Reflect back on the particulars of Case 6:
a. Take each of the four arguments for and against disclosing bad news and apply them to 
this case. 
b. In your view, was the GP right to tell the truth? Or, are concerns about the consequences 
of telling the truth more persuasive?
c. It could be argued that if health professionals are obliged to provide information, patients 
also have a responsibility to face the truth and to participate in a meaningful way in 
decisions about their treatment and care. This is all the more compelling when a patient’s 
resistance to being told the truth may have implications for the well-being of others. See 
Module 4 for discussion of the harm principle and Module 7 for application of the harm 
principle to confidentiality. Consider whether or not the harm principle is applicable to 
the circumstances of Cases 5 and 6.
d. Practically speaking, some claim that it is difficult, if not futile, to impose the truth on 
someone who really does not want to hear it (Biggar 2009). Can you recall any cases from 
practice which would lend support to this claim?
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ts 1. Module 3 Key Points
1.1 Patients have rights and these must be respected in healthcare decision-making: 
Patients have both moral rights and legal rights which must be respected in healthcare 
decision-making. This includes decisions about the end of life.
1.2 Moral rights and legal rights are different: 
A person may have a moral right to something but this moral right may not be enforceable 
in a court of law. This does not mean that the moral right is less important than a legal right. 
However, it can mean that a moral right is more difficult to enforce.
1.3 Rights are both positive and negative: 
Rights can be seen as a right to something – a positive right and a right that someone does 
not do something to you – a negative right. Most legal rights tend to be negative rights. This 
does not mean that negative rights are more important than positive rights. However, the 
enforcement of positive rights can be more difficult to achieve. In particular, positive rights 
may require the allocation of resources.
1.4 All patients have rights: 
Rights are not restricted to certain patients only. All patients have rights. Patients who are 
children, patients who have disabilities, patients who lack the capacity to make decisions 
for themselves all have rights and these must be respected in healthcare decision-making in 
respect of these patients.
1.5 Rights can sometimes be viewed in too limited a way: 
Rights should not be thought of as negative rights or as legal rights only. This is too limited a 
view. It is essential to remember that people have positive rights and moral rights.
1.6 Rights are not absolute: 
Rights may be restricted for a number of reasons, including the protection of the rights 
of others or the protection of societal interests. The extent to which a person’s rights may 
legitimately be restricted varies depending on the circumstances. 
1.7 A Rights-based approach offers important possibilities in respect of patient care: 
A rights-based approach to decision-making can have important advantages for patient care. 
It places the patient at the centre of the decision-making process. In an end of life context, it 
recognises that all decisions must centre on the patient and his or her needs.  
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ts 1.8 An exclusive focus on rights can be problematic: 
A focus on rights without reference to the social situation in which people live (and die) can 
provide too narrow a focus. 
1.9 Good care requires more than just respecting people’s rights: 
It is not enough simply to respect patients’ rights. Good care requires more than this. Yet, 
while respect for rights does not provide the whole basis for care, it is an important aspect of 
appropriate patient care.
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ts 2. Module 3 Definitions
2.1 Positive Rights: 
an individual’s right to some social or personal or institutional benefit or provision.
2.2 Negative Rights: 
the right to demand that a person or persons desist from doing something to you
2.3 Moral Rights:  
a justified claim that entitles us to demand that other persons act or desist from acting in 
certain ways.
2.4 Legal Rights: 
rights enforceable in a Court of Law
2.5 Constitution of Ireland: 
A legal instrument which provides the foundation for all laws in Ireland. The Constitution 
was adopted in 1937 and sets out certain fundamental rights. All laws must comply with 
the Constitution and if a law is found to be unconstitutional, it must be repealed. The 
Constitution may be amended only by a referendum of the people. 
2.6 European Convention on Human Rights: 
A human rights instrument adopted by the Council of Europe in 1950 to protect human 
rights and fundamental freedoms in Europe. Until 2003, Ireland was a signatory to the 
European Convention on Human Rights but judgments of the European Court of Human 
Rights in Strasbourg were of persuasive effect only. The European Convention on Human 
Rights Act 2003 made the Convention part of domestic Irish law. This means the Convention 
can be argued in an Irish court. 
2.7 Charter of Patient Rights: 
The European Charter of Patient Rights agreed in Rome in 2002 sets out 14 rights of the 
patient. The Charter is not legally enforceable but is an important indicator of best practice.
2.8 The United Nations Convention on the Rights of the Child: 
An international human rights instrument adopted by the United Nations in 1989 which sets 
out the human rights of children. Ireland has signed and ratified the Convention. This means 
that Ireland is bound by the Convention.
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ts 2.9 The United Nations Convention on the Rights of Persons with Disabilities: 
An international human rights instrument adopted by the United Nations in 2006 which sets 
out the human rights of persons with disabilities. Ireland has signed the Convention but has 
not ratified it. This means that Ireland is not bound by the Convention.
2.10 Council of Europe Recommendation Concerning the Legal Protection of Incapable 
Adults: 
A recommendation adopted by the Council of Europe in 1999 covering the protection of 
adults lacking decision-making capacity. This Recommendation is not legally binding but is 
an example of best practice in this area. 
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ts 3. Module 3 Background
3.1 Medical Ethics and the Rise of Rights 
For much of the history of medicine, the most important imperatives were doing good for 
the patient, frequently referred to as beneficence and the protection of life, often referred to 
as the sanctity of life principle. This ethical view derives from the Judaeo-Christian tradition 
whereby life was seen as having an intrinsic value unrelated to the individual’s views 
regarding his own life. The principle is based, in Paul Ramsey’s words, on the fact that ‘[e]
very human being is a unique, unrepeatable opportunity to praise God. His life is entirely an 
ordination, a loan and a stewardship’ (Ramsey, 1971, p.11). The matter of patient rights was 
largely irrelevant. However in the late 1960s, attitudes began to change. Medical ethicists, 
especially in the United States, began to emphasise the importance of patient rights and in 
particular to draw attention to the role of patient autonomy. The right of autonomy is of such 
significance in the context of healthcare decision-making that it is considered in more detail 
in Module 4.
It has now become commonplace to speak about patient rights in the context of healthcare 
decision-making.  As the philosopher Onora O’Neill writes, since the mid-1970’s ‘no themes 
have become more central in large parts of bioethics, and especially in medical ethics, than 
the importance of respecting individual rights and individual autonomy’ (2002, p.2). However, 
as O’Neill has also argued, this focus on rights is not unproblematic. She points to the cost 
to other values, including trust, which derives from a fixation with rights. Others, (Callahan, 
2003) have argued that the individualistic focus on rights fails to recognise the social context 
within which individuals operate.
In this module, we look at the issues which arise in respect of a rights-based approach 
to healthcare decision-making in decisions made towards the end of life. The goal is to 
understand the possibilities and limits of a rights-based approach to decision-making at the 
end of life and to appreciate how a rights-based approach operates in practice.
3.2 Different Kinds of Rights
In order to appreciate the role of rights in decision-making at the end of life, it is important to 
distinguish between different kinds of rights. The first distinction is between positive rights 
and negative rights. The second distinction is between moral rights and legal rights.
3.2.1 Positive Rights and Negative Rights
Rights impose either negative or positive duties or obligations on others. We develop this 
distinction in the context of what we mean by ‘a right to die’.
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Negative rights: the right to demand that a person or persons desist from doing something 
to you. Applied to the ‘right to die’, this means, for example, that we have a negative right to 
refuse treatments or life prolonging therapies.
Positive rights: the right to some social or personal or institutional benefit or provision.
Applied to the ‘right to a good dying’, this means that we can claim or expect some state or 
health care institutional provisions that would facilitate a ‘good dying’, for example, adequate 
pain relief, appropriate information, a caring and private environment. 
A positive right to die might also be interpreted to mean a right to have active steps taken to 
end a person’s life or to assist a person in ending his or her own life. The term ‘euthanasia’ is 
often used to refer to these situations. Additionally, the term ‘assisted-suicide’ is sometimes 
used (where a person seeks assistance in ending his or her own life). The legal and ethical 
issues to which these issues give rise are discussed in more detail in other modules. For 
present purposes, the important point is that neither is permissible under Irish law. 
Under Irish law, any person who deliberately ends the life of another person is potentially 
guilty of murder. It makes no difference that the person consented to the action or even that 
he or she requested that this should happen. The law does not permit a person to consent to 
his or her own death. A person who assists another person in ending his or her own life is also 
criminally liable. Under Irish law, suicide ceased to be a criminal offence under the Criminal 
Law (Suicide) Act 1993. However, the Act states that anyone who ‘aids, abets, counsels or 
procures’ the suicide of another person commits a criminal offence which is punishable with 
a possible maximum sentence of 14 years.
Therefore, a positive right to die in the sense of a right to have active steps taken to end one’s 
life or to assistance in ending one’s life would run contrary to the law. This is not the meaning 
of positive rights adopted in this module. However, other aspects of positive rights, such as a 
right to a ‘good dying’ are lawful and are very significant if we are to develop the best way to 
ensure that people have the most appropriate care and treatment at the end of their lives.  
3.2.2 Moral Rights and Legal Rights
When thinking about role of rights in healthcare decision-making, it is important to 
distinguish between moral rights and legal rights.
A moral right, if accepted within a community, is a justified claim that entitles us to demand 
that other persons act or desist from acting in certain ways. 
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ts For example, we have a moral right to be treated with dignity and that people do not act in a way which is degrading or inconsistent with our dignity. Moral rights are politically 
important. The existence of a moral right is empowering for the individual whose right is 
recognised and the recognition of the right can have powerful rhetorical force. However, the 
existence of a moral right does not create a legal obligation in others to respect that right.
A legal right is a right which is legally enforceable in a court of law. Legal rights create legal 
obligations in another person or the State. Some legal rights are also moral rights but not all 
moral rights are legal rights.
To date, most legal interventions in respect of rights in an end-of-life context have involved 
the cessation of unwanted interventions rather than the delivery of appropriate care.  
This means that most legal rights have tended to be seen as negative rights rather than 
positive rights. 
The fact that legal rights tend to be negative rather than positive, means that the 
contribution of the law in this area is inevitably limited. This means that, while law is 
important in decisions about treatment at the end of life, the law provides only a small part of 
the picture in developing an appropriate framework for end-of-life care.
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Both legal and moral rights are important in thinking about decisions at the end of life. As will 
be seen below, there are advantages in a rights-based approach to patient care. However, it 
is also important to recognise the limited scope of a rights-based approach. Rights are not 
absolute and may justifiably be subject to limitations. Nor can it be expected that a simple 
reference to rights will resolve difficult ethical questions. Rights may also be in conflict.  
There may be a conflict between the rights of the dying person and those of other people or 
a conflict between different rights of the dying person. There may also be a conflict between 
individual rights and broader societal interests. A classic example of this conflict in action has 
been the debate surrounding assisted suicide. There may also be a conflict between respect 
for individual rights and a societal commitment to the principle of sanctity of life. 
An exclusive focus on rights as the basis for a framework for a good dying is overly limited 
and does not, of itself, provide an appropriate approach to patient care. Other matters, 
including beneficence and care, are also essential components of an appropriate framework. 
4.1 Rights and Absolutes
Few, if any, rights are absolute. Even rights which we think of as fundamental, such as the 
right to life, may be restricted in certain circumstances. The most common basis upon which 
rights are restricted is that respect for one person’s right will have a negative impact on 
another person’s right.  In some circumstances, societal interests may also justify interfering 
with a person’s right. For example, as discussed in Module 4 in various legal cases in respect 
of a right to assisted suicide, the courts have held that the person’s right to autonomy (in 
choosing when to end his or her life) could be overridden on the basis of a societal interest in 
protecting vulnerable people from possible pressure to end their lives.  The difficult question 
is when such justifications will arise and how an appropriate balance may be struck between 
competing rights and interests. With legal rights, these questions are decided by courts. 
Increasingly commonly, courts adopt a proportional approach to the resolution of these 
kinds of question. If a right is found to exist, the court asks whether interference with the 
right can be justified and whether the degree of interference is proportional in light of the 
justification. With moral rights, resolution of the appropriate balance depends on informed 
debate and discussion. 
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ts 4.2 Rights and Responsibilities
Patients have rights but they also have responsibilities. Brazier (2006, p.401) identifies the 
direct link between increased recognition of patient rights and an increased recognition 
of patient responsibilities: ‘In a relationship where the recipients of medical care were 
infantilised, patients’ responsibilities seem to me to be of a much lesser order.’ Thus, she 
argues that ‘it is the empowerment of patients that brings responsibilities’. 
Freedom of choice (which is central to a rights-based approach centred on the right of 
autonomy) brings with it a moral responsibility to consider the impact of one’s choice on 
others. For example, a person’s decision to decline life saving treatment places an ethical 
obligation on the person to consider the impact of his or her decision on family members or 
others. Again, a distinction must be made between moral obligations and legal obligations. 
As Brazier (2006, p.422) reminds us, ‘identifying when and how these moral obligations 
become legally enforceable remains difficult’.   We may argue that a person has a moral 
obligation to take account of the impact of his or her decisions on others but imposing a 
legal obligation to do this is a different matter. 
4.3 The Contribution of a Rights-Based Approach
A rights-based approach to decisions taken at the end of life has important advantages for 
patient care. It places the patient at the centre of the decision-making process and allows a 
patient to exert a degree of control over how and when she dies. 
The value of this approach can be seen in one of the narratives outlined by Quinlan and 
O’Neill (2008, p.19):
‘Rita had a very peaceful happy death. She refused some treatment and her wishes were granted. 
She never discussed death with any staff, but in the end had a very peaceful pain-free death in the 
company of her family.’
Here, Rita’s rights, in particular, her right not to have treatment which she did not feel 
appropriate was respected and Rita’s death was peaceful and pain free.
Arguments based on positive rights can also make a very significant contribution to 
delivering appropriate care and in particular, in respect of the important matter of access to 
necessary resources. In end-of-life care, there are repeated concerns about resources to make 
a ‘good dying’ a more likely outcome. 
As Quinlan and O’Neill’s (2009, p.29-30) interviews show, the pressure on resources, even 
when people are dying, was evident. There is pressure for beds. A hospital may need the 
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bed for the next patient and practitioners recount how, even when a patient is still dying, 
staff may come to the ward and asking if the patient has gone to the mortuary yet. There is 
resource pressure in providing access to appropriate treatment and diagnostic processes at 
an appropriate time. There is resource pressure in facilitating dying people, both adults and 
children, in spending their last days at home. One incident recounted by Quinlan and O’Neill 
(2009, p.30) reminds us that, when someone has a short time to live, even relatively short 
delays can have a huge impact on the patient’s quality of life and death. The practitioner 
describes a young man who had to spend over five weeks in hospital in order to have routine 
procedures because resource pressures led to delays. For a young man with a limited life 
expectancy, this was time which he would have been happier and better to spend elsewhere. 
The impact of limited resources is also felt in respect of communication. Communication 
is fundamental if a patient’s right to a dignified dying is to be a reality. Yet, based on 
practitioner interviews, one of the most consistent frustrations experienced is in respect of 
communication. This frustration stems in large part from shortage of staff and lack of time on 
busy wards. 
Resources have to be pleaded for in social and political arenas. While positive rights may not 
necessarily be legally enforceable, the rhetoric of rights ensures that the issue of resources 
is recognised as an ethical issue as well as a political one. As Munro (2001, p. 463) notes, ‘the 
rhetorical value of rights discourse must not be underestimated.’ It is essential that rights are 
understood as encompassing both positive and negative rights and that it is recognised that 
people have positive rights to a ‘good dying’. 
4.4 The Limits of a Rights-Based Approach
While a rights-based approach makes an important contribution to an appropriate 
framework (and in respect of legal rights, is a legal obligation), an exclusive focus on rights is 
limited in several respects. First, rights are formulated in an abstract way and, sometimes, the 
rhetoric of rights may seem far removed from the reality of treatment decisions in practice.  
It is one thing to say that a patient has rights, it is quite another to understand what respect 
for a patient’s rights requires in any particular situation. 
Secondly, while rights can be both positive and negative, very often, a rights based approach 
will be seen to extend only to negative rights. This is in part because the law has tended 
to recognise negative rights rather than positive rights. This approach to rights can lead 
to a rights-based approach which protects a patient’s right to refuse unwanted treatment 
but does little in furthering the provision of appropriate treatment (in the broadest sense 
including medical treatment but also an appropriate environment, communication, etc). 
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beneficence, nonmaleficence and justice alongside autonomy. An appropriate framework for 
decisions at the end of life requires more than simply respecting patients’ rights. If we look 
at the example of Rita’s situation discussed earlier, the fact that her right to refuse treatment 
was an important aspect of her peaceful death but so too was the fact that her family were 
present and the care of the professionals involved. Focussing on rights alone fails to accord 
sufficient recognition to these broader but equally essential aspects of patient care at the end 
of life. 
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Rights must have a basis or source. It is not enough simply to assert that a person has a right 
to something. There must be a means whereby the existence of the right may be asserted. 
5.1 Sources of Moral Rights
Moral rights derive from our membership of the moral community. In this sense, moral rights 
may sometimes be contested. For example, some people may argue for a moral right to 
choose to die even if this requires active steps, such as euthanasia, while others may equally 
vigorously contest the existence of such a moral right.
5.2 Sources of Legal Rights
In relation to legal rights, the rights derive from a more tangible source. For a right to be 
legally enforceable, it must for the main part derive from some form of legal instrument. Like 
moral rights, legal rights can be contested. However, with legal rights, the final determination 
of whether or not a legal right exists, what the right means and whether interference with the 
right may be justified is made by a court. Legal rights tend to be more limited in scope and 
will often tend to be negative rather than positive rights. For this reason, it is important to 
remember that legal rights should not be thought of as providing the whole basis for patient 
rights in respect of healthcare decision-making (and that rights alone do not provide a full 
basis for care). 
Nonetheless, legal rights provide the foundation for healthcare decisions and therefore it is 
necessary discuss the sources of patients’ legal rights in more detail. 
5.3 Legal Rights as Citizens 
Patients at the end of life have the same rights as any other members of society. Therefore the 
human rights frameworks which apply to all citizens in general also apply to these patients. 
In Ireland, these rights derive first, from the Irish Constitution (Bunreacht na hEireann) and 
secondly, from the European Convention on Human Rights. Both of these human rights 
instruments impose obligations on others to respect rights and a patient may assert his or 
her rights in a court. These rights are practically important because a patient can take steps to 
enforce them and because health professionals are legally obliged to respect them. 
5.3.1 Rights and the Irish Constitution 
The Irish Constitution was introduced in 1937. It provides the basis for protection of 
individual rights. All legislation must comply with the provisions of the Constitution.  
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ts The ‘fundamental rights ‘part of the Constitution is found in Articles 40-45. Of these Articles, the most important source for patient rights is Article 40.3.1. 
This Article states as follows: 
The State guarantees in its laws to respect, and, as far as practicable, by its laws to defend and 
vindicate the personal rights of the citizen.
From this general statement, the Irish courts have identified a range of rights (often referred 
to as ‘unenumerated’ or unstated rights). The rights identified by the courts have included a 
right to autonomy or self-determination; a right to privacy; a right to dignity; a right to bodily 
integrity; a right to freedom from inhuman and degrading treatment. The Irish Constitution 
also expressly protects the right to life. Article 40.3.2 states that the State shall protect as best 
it may from unjust attack and, in the case of injustice done, vindicate the life of every citizen. 
Two other articles of the Constitution are relevant in respect of children. Article 41 protects 
the authority of the family (based on marriage) while Article 42 protects parents’ rights in 
respect of their children. Article 42.5 can be especially important in relation to healthcare 
decision-making involving children. This article states that, in exceptional cases, where 
parents for physical or moral reasons fail in their duty to their children, the State may 
endeavour to supply the place of the parents but always with due regard to the rights of  
the child. Other than this, there is currently no express statement of the rights of the child  
in the Constitution.
The Irish Constitution is much less strong in its endorsement of positive rights. Article 45 
sets out ‘directive principles of social policy’. This states that justice and charity must inform 
national institutions and that the vulnerable must be protected. However, these principles 
cannot be enforced in a court of law. Therefore, the other positive rights discussed above, 
these are matters for political and ethical engagement rather than legal enforcement.
5.3.2 Rights under the European Convention on Human Rights.
Since 2003, the European Convention on Human Rights (ECHR) has been incorporated into 
Irish law. This means that the ECHR is directly enforceable in the Irish courts. However, if 
there is a conflict between the Irish Constitution and the ECHR, constitutional rights take 
priority. The ECHR was adopted in 1950 to protect human rights and fundamental freedoms 
in Europe. A number of the rights protected by the ECHR are important in the context of end-
of-life decisions. These include: the right to life which is protected by Article 2; the right to 
freedom from inhuman and degrading treatment which is protected by Article 3; the right to 
respect for private and family life which is protected by Article 8; and the right to freedom of 
thought, conscience and religion which is protected by Article 9. 
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ts 5.4 Other Sources of Rights
5.4.1 Charter of Patients’ Rights
In addition to general rights under the Irish Constitution and the ECHR, there is a specific 
Charter of Patient Rights. Unlike rights protected under the Irish Constitution and the ECHR, 
these rights are not directly enforceable in a Court. They are also stated in general terms and 
many are aspirational in nature. However, they are important indicators of best practice.  
The European Charter of Patient Rights agreed in Rome in 2002 sets out 14 rights of the 
patient. The following rights are most important in the context of healthcare decisions, 
including decisions at the end of life. 
Right to Information: Every individual has a right of access to all kinds of information 
regarding their state of health. 
Right to Consent: Every individual has a right of access to all information that might enable 
him or her to actively participate in the decisions regarding his or her health; this information 
is a prerequisite for any procedure and treatment
Right of Free Choice: Each individual has the right to freely choose from different treatment 
procedures and providers on the basis of adequate information
Right to Privacy and Confidentiality: Each individual has the right to the confidentiality of 
personal information, including information regarding his or her state of health and potential 
diagnostic or therapeutic procedures
Right to Avoid Unnecessary Suffering and Pain: Each individual has the right to avoid as much 
suffering and pain as possible, in each phase of his or her illness. 
5.4.2 International Human Rights Instruments 
There are also a number of international human rights instruments which have a broader 
remit than application to patients but which relevant to certain kinds of patients. Among the 
most important of these instruments are:
The United Nations Convention on the Rights of the Child:
This Convention was adopted by the United Nations General Assembly on 20 November 
1989 and entered into force on 20 September 1990. Ireland signed the Convention on 30 
September 1990 and ratified it without reservation on 21 September 1992. This means that 
Ireland is bound by the Convention. The Convention sets out the human rights of children 
which must be observed by states. The Article of the Convention which is most relevant to 
healthcare decision-making is Article 12. This says that:
135
Mo
du
le 
3 
 H
ea
lth
ca
re
 D
ec
isi
on
-m
ak
ing
 a
nd
 th
e R
ole
 o
f R
igh
ts States parties shall assure to the child who is capable of forming his or her own views the 
right to express those views freely in all matters affecting the child, the views of the child 
being given due weight in accordance with the age and maturity of the child.
This requires that, in healthcare decisions, including decisions about dying, the child has a 
right to participate in the decision-making process and his or her views must be taken into 
account increasingly as he or she becomes older and/or more mature  
(Kilkelly and Donnelly, 2006).
United Nations Convention on the Rights of Persons with Disabilities:
This Convention was adopted by the United Nations General Assembly in December 
2006 and entered into force on 3 May 2008. The Convention was signed by Ireland on 30 
March 2007. However, it has not yet been ratified by Ireland. This means that the State has 
not agreed to be bound by the Convention. It is likely that, when legislation relating to 
adults lacking capacity is introduced (expected to happen in 2010), the State will ratify the 
Convention and it will then be bound to observe the rights set out in the Convention. 
The Convention sets out a framework to protect the human rights of people with disabilities 
– both physical and mental/intellectual disabilities. Among the Articles of most relevance to 
healthcare decision-making, and in particular to decisions at the end of life are:
Article 3 sets out general principles underpinning the Convention. These include respect for 
inherent dignity and individual autonomy, including the freedom to make one’s own choices, 
and independence of persons
Article 10 reaffirms the inherent right to life of all persons with disabilities
Article 17 states that every person with disabilities has a right to respect for his or her physical 
and mental integrity on an equal basis with others
Council of Europe Recommendation Concerning the Legal Protection of Incapable Adults:
This Recommendation was adopted by the Council of Europe in 1999. The Recommendation 
adopts as its fundamental principle ‘respect for the dignity of each person as a human being’. 
It requires that the laws, procedures and practices relating to the protection of adults lacking 
capacity should be based on respect for their ‘human rights and fundamental freedoms.’ The 
Recommendation is an indicator of best practice and is not legally binding.
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It is a relatively straightforward matter to list the rights relevant to end-of-life decisions. 
The most obvious of these are the right to life, the right to autonomy or self-determination, 
the right to bodily integrity, the right to dignity, the right to freedom from inhuman and 
degrading treatment. However, it is a much more complex and difficult matter to determine 
how rights apply in practice and how a rights-based approach to end of life decisions should 
work. This section will explore some of the issues through four case studies. These show the 
contribution which a rights-based approach can make but they also show the limits of a 
rights-based approach and remind us that good care requires more than simply respect  
for rights.
6.1 Case 1: The Limits of Negative Rights - refusing pain relief
Consider the following case which is based on a narrative from a practitioner recounted 
by Quinlan and O’Neill (2008, p.18) and which shows some of the limits of the rights-based 
approach to care. As is clear from the narrative, the incident described did not occur in 
Ireland. Nonetheless, the issues to which it gives rise are applicable here:
 
Refusing pain relief
In Australia, a young mother in early 30’s had an inoperable tumour at back of her nose and 
throat. In the end stages, this girl refused pain relief or sedatives. She did not want much medical 
intervention. It was the most distressing death I ever witnessed as she could not breathe and 
depended on a nasal tube as her only airway. This frequently blocked and needed regular 
suctioning. It was very distressing for her, her family and staff. She was from a very poor social 
background and had little or no education. Staff tried to assist her as much as possible but it 
was an awful death for her. (Quinlan and O’Neill, 2008, p.18)
6.1.1 Discussion 3
This case shows the limits of an approach to rights which is based simply on negative rights. 
Here, the patient refused pain relief or sedatives. In this, she was exercising her right to 
autonomy by refusing medical intervention/treatment. This right is recognised under the 
Irish Constitution (In re a Ward of Court, 1995; Fitzpatrick v K, 2008) and under the European 
Convention on Human Rights (Pretty v UK, 2004). The right is undoubtedly very important 
and is discussed in more detail in Module 4. 
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narrative, very little was done in a positive way to improve the dying process for her. Respect 
for the patient’s autonomy here raised conflicts with the healthcare staff’s concern about the 
well-being of the patient and yet they believed that the value of autonomy as expressed by 
the patient should have priority.
Arguing that something positive should have been done to improve the dying process for 
this patient does not mean that the woman’s autonomous wishes should not be respected. 
However, if one thinks about the circumstances, there may have been positive ways in which 
the woman’s right to make her own choices and decisions could have been respected while 
at the same time helping to ensure that her death was made as bearable for her as was 
possible in light of her circumstances. 
For example, the narrative states that the woman was from a very poor social background 
and had little or no education. Presumably, also, she was very frightened and distressed.  
In addition to her physical pain, it is highly likely that she suffered ‘soul pain’ (discussed in 
detail in Module 5). It may be that, if it had been possible to talk with her, to explain and 
discuss her situation and to provide her with the support she needed, she might have been 
able to choose a way of dying which was less difficult for her (and less traumatic for her 
carers and family members). The choice should not be between respecting her right to refuse 
treatment and imposing treatment she does not wish. Rather it should be possible to find 
ways to provide positive help suitable for her situation. 
Contrast the very different approach evident in the following example, also drawn from 
Quinlan and O’Neill (2009, p.32):
‘A couple of years ago now when I was in Palliative Medicine in another centre, adult Palliative 
Medicine, we came across a gentleman who was referred to us after he had attempted to commit 
suicide and he had thrown himself into the local river, was referred to us then. The reason that he 
had tried to commit suicide was that he had a diagnosis of cancer which he’d lived with well for 
about eight years at this stage but was developing increasing pain and he was worried that if his 
pain was so bad at this stage and not controlled, how bad was it going to be when he was closer 
to death and it was really his fear about symptoms, you know, not being controlled. So he was 
able to relay all this to us, we then got his pain under control, relatively easily I suppose, it’s what 
we do every day, and we were able to reassure him that his pain would never have to be out of 
control as it had been and thereby his suicidal ideation completely resolved.’
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Because the health professionals were able to reassure this man, he was able to live out his 
life in the best way possible in the circumstances. Rather than ending his life by suicide, he 
felt content to live out his life to the end because he knew that his pain could be controlled. 
If one contrasts this example with Case 1, this example shows the contribution to be made by 
positive rights to a ‘good dying.’ This approach to rights is much broader in scope and much 
more significant for many patients than simply respecting patients’ decisions.  
Of course, respect for patients’ decisions is very important but so too is respect for the 
positive rights needed to ensure that patients’ decisions are made in a way which maximises 
patient control. Empirical research shows unanimity on the significance of adequate pain 
relief. As one hospice worker commented ‘the main thing is that it’s just pain relief. Our big 
thing in the unit is pain relief, that person is never in pain.’ (Quinlan and O’Neill, 2008) Without 
adequate pain relief, it is very difficult for patients to have and to retain control of their 
situation. It is just as important to remember that patients have a positive right to appropriate 
pain relief and to appropriate explanations and communications from professionals as it is to 
remember that patients have a negative right to refuse treatment.  
6.1.2 Suggested Professional Responsibilities 3
•	 Where a person refuses treatment, especially pain relief, efforts should be made to 
engage with the person and to understand the basis for the decision. Patients’ decisions 
may be based on fear or lack of understanding and communication may help to 
alleviate these factors. The person may still wish to refuse the treatment and if he or she 
does so and he or she has the necessary degree of decision-making capacity, his or her 
wish to do so should be respected. 
•	 Where possible, where a person refuses a particular treatment, alternative options 
should be made available to the person. Reasonable choice requires the availability of 
more than one option. 
•	 Efforts should be made to engage with the patient in a way which is accessible to him 
or her in light of education level, background etc. Different people require different 
kinds of communication and in many instances, a blanket approach based on simple 
provision of information will not suffice.
•	 Every effort should be made to ensure both that adequate pain relief is made available 
and that patients are reassured in this regard. Even if patients have not actively sought 
reassurance, they may have fears about pain which they find difficult to articulate. 
Sometimes it may be necessary to repeatedly provide reassurance about pain relief  
for patients. 
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ts 6.2 Case 2: Constitutional Rights - In Re a Ward of Court 1995
One of the reasons why rights tend sometimes to be thought of as negative rather than 
positive – with the limits which this involves – is that the law’s approach to rights usually 
focuses on negative rights rather than positive rights. This is evident in the following case 
study which is based on the facts of an important Irish Supreme Court decision on end of life. 
In the case study, we can see legal reasoning at work and we also see the possibilities and the 
limits of a law-focussed approach to rights. 
 
In Re a Ward of Court 1995
This case came before the Supreme Court in 1995. It concerned a woman who had been in a 
near- Persistent Vegetative State for 23 years. She was unable to communicate although she 
may have had minimal ability to recognise and track people with her eyes. She was unable to 
move or swallow and was fed by gastrostomy (PEG) tube. 
The Ward’s family asked the court to have the PEG tube removed which removal would, 
inevitably, lead to the woman’s death. In reaching its decision in favour of removing the 
tube, the Supreme Court regarded as relevant a number of rights protected under the Irish 
Constitution. These included the right to autonomy or self-determination, the right to privacy, 
the right to dignity, the right to bodily integrity, the right to life and the right to die and the right 
to equality. The Court stated that the fact that the woman lacked decision-making capacity 
did not diminish her rights. To distinguish between people with capacity and people without 
capacity would be ‘invidious’.
Bearing in mind the significance of the woman’s rights, the Supreme Court decided that 
decisions such as this should be made on the basis of the best interests of the person taken 
from the point of view of a ‘prudent and loving’ parent. In the circumstances, the PEG tube 
should be removed.
 
6.2.1 Discussion 3
The decision in In re a Ward of Court is important for many reasons. The fact that the case 
came before the court at all is striking. There was clearly a strong disagreement between the 
health professionals and family members. There is a suggestion that the ward’s family had 
attempted to communicate about the possibility of discontinuing life supports including 
re-insertions of the PEG tube and use of antibiotics and resuscitation when their loved 
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one arrested and that these efforts at communication were resisted. The institution where 
the Ward was cared for had ethical objections to discontinuing life supports especially 
discontinuing the PEG tube because they understood this as aiding the progression  
towards dying. 
Sometimes, disagreements between health professionals and family members will be 
inevitable; there may be very good reasons why family members and health professionals do 
not agree. If this is the case, it well may be that a situation such as this may only be resolved 
through recourse to courts. However, there may be situations where better communication 
between health professionals, family members and patients would resolve some of the 
difficulties and avoid the need for the engagement of the legal system. In particular, knee-
jerk reactions by professionals to family requests must be avoided. Resolution is much 
more likely in a context of engagement, communication and explanation rather than 
dogmatic assertions by professionals. And, even if resolution is not possible in the particular 
circumstances, a process of communication and engagement enhances the experience for all 
concerned: the patient, the family and the health professionals.
In re a Ward of Court is also important because it involves the Supreme Court setting out in 
the clearest terms that patients have rights in respect of dying and that these rights do not 
stop simply because a person lacks or loses capacity. The fact that the woman was in a near 
PVS did not diminish her rights. She still had rights to autonomy, bodily integrity, dignity and 
privacy. These rights arise under the Constitution and all people and institutions who deal 
with her (and with other patients) have a legal obligation to respect these rights. Failure to  
do so would leave the healthcare professional/institution liable for failing to respect 
individual rights. 
While the recognition that people have rights, regardless of capacity, was a very important 
contribution, the Supreme Court was less clear in setting out what exactly the rights actually 
meant in the circumstances of the case before them. In fact, the Court did little more than 
list the rights implicated and provided no analysis of how they operated and interacted with 
each other and with the principle of sanctity of life. The decision has been criticised for its 
lack of conceptual coherence (Keown, 1996; Hogan and Whyte 2004, p.1397-1401).  
The Supreme Court left many questions unanswered. For example, what does it mean to 
respect the right of autonomy of a woman who clearly lacks the ability to make decisions 
and who has not left any clear indication of what she would have wanted to happen in the 
situation which arises? This means that health professionals trying to provide rights based 
end-of-life care are left with limited legal guidance regarding what exactly is required. 
Patients’ rights have to be respected but the detail of what respect for patient rights requires 
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approach to healthcare decision-making must encompass positive as well as negative rights 
and moral as well as legal rights. 
In In re a Ward of Court, the Supreme Court did not differentiate between withdrawal of 
artificial nutrition and hydration (ANH) and other forms of treatment withdrawal. However, 
following the decision, both the Medical Council and An Bord Altranais issued statements 
making a clear differentiation on these grounds. This special status of nutrition and hydration 
is reflected in the current Medical Council Code of Ethics (2009) which states that ‘Nutrition 
and hydration are basic needs of human beings.  All patients are entitled to be provided with 
nutrition and hydration in a way that meets their needs’ (par.19.1).  However, the Code has 
moved away from the more absolute position of previous Codes, which had required that ‘all 
reasonable and practical efforts should be made to maintain’ nutrition and hydration.   
Rather, it now states that ‘[i]f a patient is unable to take sufficient nutrition and hydration 
orally, you should assess what alternative forms are possible and appropriate in the 
circumstances.’  Medical professionals are reminded that they should ‘bear in mind the 
burden or risks to the patient, the patient’s wishes if known, and the overall benefit to be 
achieved.’  The ethical issues to which withdrawal of ANH give rise are discussed in detail  
in Module 6. 
The decision of the Supreme Court in In re a Ward of Court shows both the potential and the 
limitations of legal rights. Recognising that patients have legally enforceable rights places 
patients in a stronger position in asserting their rights. However, legal rights are just the first 
part of the picture. Good care requires more than just respecting people’s legal rights.  
6.2.2 Suggested Professional Responsibilities 3
•	 It is essential to maintain good communication with family members. This does not 
mean that family members’ views should take precedence over the legal and ethical 
obligation of the healthcare professional to provide care to the patient. However, 
appropriate communication can alleviate family concerns and can sometimes prevent 
confrontational situations developing. 
•	 If in doubt about the legal rights implicated in a particular decision, professionals 
should seek advice as to how to proceed. This is especially important in the event of 
disputes between family members or between professionals and family members. 
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Good care requires more than just respecting people’s legal rights.  This is shown in the next 
case study which is also based on a legal case but which shows a range of factors relevant to 
good decision-making which go beyond simply respecting legal rights.
Decisions involving children, especially decisions where children are dying, are very traumatic 
and difficult for all parties involved. As Quinlan and O’Neill (2009, p.56) remind us:
‘A sick child in a family is as much at the mercy of the family dynamics as any sick person within 
a family. Sometimes the dynamics are good and sometimes they are not so good. Where the not 
so good family dynamics interfere with the care of the child the clinicians may need to intervene, 
and facilitate a resolution, as they intervene in any such family. Such interventions are often 
unwelcome and as such they can be difficult and challenging for the clinicians as well as the 
families. All of this goes to further the complexity of the situation of the patient in hospital and 
expressions and experiences of patient autonomy and practices around patient autonomy in 
hospital care settings.’ 
The challenges involved in making decisions where children or young people are very ill 
or dying are very clear in the case discussed below. This case came before the European 
Court of Human Rights in 2004. The case had first been brought before the courts in the 
United Kingdom and these courts had held that there had been no breach of rights in the 
circumstances (which are outlined in more detail below). The family were unhappy with the 
conclusion and brought the case to the European Court of Human Rights. As in Ireland, the 
European Convention on Human Rights is part of domestic law in the United Kingdom and 
decisions of the European Court of Human Rights are binding on citizens and the State.
 
Glass v UK 2004
David Glass was a teenager with severe intellectual and physical disabilities and with a very 
poor life expectancy. He had been admitted to hospital many times in the past with respiratory 
failure and this was a pattern which was likely to continue. 
David was admitted to hospital following respiratory failure. The health professionals 
responsible for his care considered that his condition had reached the point where any further 
resuscitation was futile. They put a DNR (do not resuscitate) order on his file without consulting 
with his family. 
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palliative care in the form of morphine, again without consulting his family. David’s family 
objected to the placing of the DNR on this file and to the administration of morphine which 
they feared would speed up his death. They attempted to remove the DNR from the file and 
to disconnect the morphine feed. A fracas ensued between family members and the health 
professionals and family members were physically ejected from David’s room by security staff.
David’s mother (acting as representative for the family) first brought the case before the English 
courts arguing that the placing of the DNR and the administration of morphine without 
the consent of David’s family was a breach of the family’s rights and also of David’s rights. 
The action was unsuccessful before the English courts. Mrs Glass brought the matter to the 
European Court of Human Rights. She argued that the hospital had failed to respect both her 
own right and David’s right to private and family life as protected by Article 8 of the European 
Convention on Human Rights. 
The European Court held that the hospital authorities had breached David’s right to private and 
family life. The professionals involved should have consulted with David’s family before reaching 
the decisions on his care. The Court did not consider that the family’s views should have decided 
the matter. Ultimately, the important question was whether the decision made was in David’s 
best interests. This could be decided by the professionals involved or in the event of a dispute, by 
a court. However, David was entitled to have his family consulted before a decision regarding  
his best interests was reached. The Court did not offer any view on whether Mrs Glass’s rights  
were breached.
6.3.1 Discussion 3
This case is important for a number of reasons. First, even if one does not consider the matter 
from a perspective of legal rights, it is very obvious that the hospital’s way of dealing with 
the Glass family was inappropriate. Cases like this can come to litigation precisely because 
of failures on the part of health care staff to communicate in an on-going way and assure 
families that they are being heard. This case also arose in part because the resuscitation 
process was neither clarified nor documented on the ward and the family’s wishes or family 
expectations were not documented. Once again, a failure of communication by staff with 
family intensified the family’s frustration. 
Some of the practitioner perspectives recounted by Quinlan and O’Neill (2009, p.81) remind 
us of how important it is that resuscitation status is clear and that patients and family 
members are aware of the position. Failure to clarify can result in the patient, family and staff 
being insecure and anxious about a DNR (Do not resuscitate) order.  
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This can be made more difficult because some consultants may be reluctant to document the 
existence of a DNR order. The position may also raise difficulties when, as happened in Case 3, 
families may insist on resuscitation and a conflict arises on the ward. 
More than anything, Case 3 serves as a reminder of the need for good communication. 
This does not mean that families and professionals will always agree. But it does maximise 
the chances of agreement and an appropriate resolution and it ensures that, even if the 
participants fail to reach agreement, the discussion takes place in the best possible way for 
the patient, the family and the health professionals. 
The second reason that Case 3 is important is that it recognises that patients are members of 
families. It was David’s right that his family be consulted. Respect for patient rights requires 
family involvement. In Ireland, family rights are further enhanced by Articles 41 and 42 of 
the Irish Constitution. Here, the rights recognised are the rights of the family and of parents. 
In North Western Health Board v HW and CW (2001), the Irish Supreme Court held that 
parents had a constitutional right to make healthcare decisions for their children (in this 
case, the parents sought to refuse the routine PKU test aimed at detecting certain genetic 
abnormalities). The right is not absolute. The State can intervene where parents fail in their 
moral duty but this may arise only in an ‘exceptional case’ (as set out in Article 42(5) of the 
Constitution of Ireland).  
A great deal has been written about the way in which families have been treated in 
healthcare decision-making in respect of children (for example, Bristol Royal Infirmary 
Inquiry, 2001; Kilkelly and Donnelly, 2006). In the inquiry into practices surrounding children’s 
heart surgery at the Bristol Royal Infirmary, it became clear that some professionals dealing 
with parents were not giving clear indications to parents about their children’s situations. 
Sometimes this was a deliberate practice, aimed at ensuring that parents maintained hope or 
did not communicate distress to children. However, as the Bristol parents recognised (2001, 
p.282): ‘I think you need to know. It hurts … It hurts to hear it, but you need to know the 
truth. I do not want to be told that everything is going to be jolly and fine. It is a fact of life … 
You do not want people to be cruel to you but you need honesty in a situation like that.’
Case 3 reminds us that children and their families have a right to full information and 
appropriate communication. Families have to be consulted in decisions at the end of life of 
their children and their views must be taken into account in reaching decisions. This does not 
mean that family views will or should always prevail but consultation, communication and 
engagement is essential.
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consulted as regards what was in his best interests. But the decision was not wholly that of 
David’s family. Rather the decision had to be what was best for David. His family were an 
important part of this decision but ultimately it was David’s best interests which were at 
stake. These were to be determined by the health professionals in consultation with his family 
and if a dispute continued, by the Court. 
Family involvement is, of course, not just an issue in respect of children. It can equally arise in 
the context of elderly people as the following example from Quinlan and O’Neill (2009, p.37) 
makes clear:
‘I have a very recent experience that upset me greatly and that I’m still trying to have conversations 
with the individuals concerned and it was for a patient who had, whom I happened to come 
across on their admission to the hospital four days previously. So I knew their history very well. 
They had had palliative radiotherapy for CA of the lung, a gentleman in his early 80s, and he had 
a chest infection on admission to hospital. I met up with the family about three days later when 
I took a report from a colleague at 5 pm in the evening, to hear that the patient’s condition had 
deteriorated. His oxygen saturations had dropped. He was on the medical unit and had been 
transferred to the high care unit and he was disimproving. I asked what the plan of care was for 
him and I was told that the family wanted him to have every possible chance. The consultant was 
not on duty that day. There was someone acting for him until 5 pm in the evening and as far as 
they were aware, the gentleman was to be resuscitated. I asked had the fact that he had a chest 
infection as well as CA of the lung, (he knew what was wrong with him), been discussed with the 
patient and I was told no, because the family wanted him to have every chance. Before I got to the 
end of that report the emergency bleep went off and it was for this patient. When I got to the unit 
the patient was intubated. I asked the nurses about it. They said yes the family wanted - the doctor 
had discussed it with the family and they did want resuscitation measures taken if anything 
happened. They knew that their father was getting worse. The father himself had expressed that 
he didn’t want tubes or anything like that, so I was very annoyed really. I couldn’t understand how 
it had gotten to this stage.’ (2009, p.34)
Here, it would seem that the family’s views took precedence over those of the patient (who 
died an hour later). Quinlan and O’Neill’s study of practitioner perspectives suggest that this 
is not unusual. One practitioner quoted states:
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the patient quite well and know that they probably want conservative treatment or palliative care. 
The families might want this done or want them transferred to (named acute hospital). The next 
thing they’re getting bloods and x-rays and the whole lot done and know in your heart and soul, 
this is not what this patient wants.’ (2009, p.37)
It is easy to understand why families respond in these kinds of ways. Families may find it 
difficult to ‘let go’ of a loved one; they may be suspicious of medical professionals perhaps 
doubting that the professionals have their loved one’s best interests at heart; they will often 
be frightened and traumatised by the impending death. With these difficult challenges 
around life support decisions, one contributor suggests that perhaps a Palliative Care Team 
would be of great benefit to sound decision-making. This team would deal specifically with 
end-of-life families. The contributor suggested:
‘…if there was a system there or there was services there, that we actually had a team that were 
able to approach a family and say: ‘Listen, this is what we’ll do over the next few hours’ or ‘listen, 
this is what you have in the weeks ahead’. 
Once again, communication does not solve all the difficulties which may arise but good 
communication provides the basis for the best experience possible.
As discussed above, the challenges for a rights-based approach to decision making are 
significant when family members are involved. Patients who are children have a right to have 
their families involved in decisions about their dying. But ultimately, the patient must be 
central. His or her views must provide the basis for decisions about care. Of course, it will not 
always be possible for a patient to express his or her views. In Case 3, David had very serious 
intellectual and physical disabilities and very limited abilities to communicate. Very young 
children may also have difficulty communicating what they want although most children are 
able to express preferences from a relatively young age (Alderson and Montgomery, 1996; 
Kilkelly and Donnelly, 2006; Bridgeman, 2007). The issue of children’s autonomy and respect 
for children’s choices will be discussed in more detail in Module 4. 
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ts 6.3.2 Suggested Professional Responsibilities  3
•	 Professionals should maintain communication with family members. This is especially 
important in respect of highly charged situations such as the recording of a DNR on a 
patient’s file.
•	 Where possible health professionals should inform families about what to expect in the 
dying process. Many families will not know what to expect and informing them of what 
is likely will make the process easier and reduce the possibilities of conflict between 
families and health professionals. This may also involve reassurance about pain relief 
and distress. 
•	 Professionals should think about the time at which they talk to family members and the 
environment in which discussions take place. Rushed conversations in public places 
cannot provide the kind of reassurance needed and may lead to feelings of resentment 
and anger among family members which may create further difficulties for the patient, 
the family and the health professionals involved.
•	 Resuscitation status should be made clear to family members and, if a DNR is recorded 
on a patient’s file, the reason why a DNR is considered appropriate should be made 
clear. The meaning and limits of a DNR should be explained in full to family members.
•	 While families should be informed and involved and their views should be sought and 
weight should be accorded to these, the duty to act in the best interests of the patient 
must always remain central.  
•	 When dealing with children and young people, professionals should make efforts to 
explain what is going on in a way that is accessible and should involve children and 
young people in decisions about their care insofar as this is possible in light of the 
child’s age and maturity. 
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ts 6.4 Case 4: Rights, Incapacity and Decision-making – why resuscitation?
This case study explores the rights issues which arise where patients have difficulty 
formulating their views or communicating their preferences, perhaps because they have 
dementia, Alzheimer’s disease, intellectual disabilities or other conditions which limit their 
decision-making abilities. The role of advance healthcare directives in such circumstances 
will be discussed in more detail in Module 4. However, even if these measures are legally 
provided for, they will not apply in all situations. The question which then arises is how are 
patient rights to be respected when there is no indication of what the patient would have 
wanted and he or she is not in a position to communicate. The final case examined in this 
module on the role of rights in healthcare decision-making looks at rights, incapacity and 
decision-making.
This case study is based on a case adapted from Quinlan and O’Neill. It is based on a real 
experience as recounted by a practitioner – however, as recounted it is not clear whether the 
patient had given any indication of preference or, indeed, whether or not he had the capacity 
to do so. The facts have therefore been adapted in order to allow discussion of the situation 
where a patient clearly lacks capacity and is nearing the end of life. 
 
Why Resuscitation?
‘I’m on the resuscitation team, when we arrived at the scene, you know, the first thing I could 
see, God, this is such an unethical resuscitation, if it was my relative in the bed I’d be so upset. 
It was an 86 year old gentleman with Alzheimer’s disease that was admitted that night by a 
medical registrar that had not consulted with his consultant, and had not consulted with the 
anaesthetic consultant, to review this patient. He had end stage chronic obstructive airway 
disease that was on maximum medical treatment and home oxygen. So, I mean, the sort 
of thing we’re talking about - resuscitation, that’s why often patients and relatives are not 
explained to properly, or talking about will they benefit from their heart being shocked or will 
they benefit from being put on a life support machine? Now, this gentleman would not have 
benefited from that because he would never come off of the life support machine, research 
would have shown with end stage COPD. The poor little gentleman was very skeletal and he 
had a pigeon chest as well. You know, and the first thing I could say - I arrived at the scene the 
same time as the anaesthetist and the medical registrar that called the rest of us there -  
and I said, 
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all his ribs were cracking as we were doing the procedure. And I said, God, this is very unethical, 
has this been discussed with the gentleman or relatives? And the registrar said, ‘No’ and the 
anaesthetist just chimed in as well, he said, ‘This is quite unethical.’ And he just was continuing 
leading on, and he just said, ‘Oh well, we won’t compress as much on the chest compressions, 
we’ll do it gentler.’ But the thing with resuscitation, you either do it properly or you don’t do it 
at all. There are no half measures; we don’t act out the role. He died; once the resuscitation 
was called off he died. He wasn’t going to survive resuscitation’ (Adapted from Quinlan and 
O’Neill, 2009, p.31).
6.4.1 Discussion 3
This case raises the issue of rights outside of the situation where a patient has given a clear 
indication of his or her treatment preferences.  It raises a number of ethical issues regarding 
futility, the use of life-prolonging methods and moral distress which are explored in more 
detail in Module 6. The present discussion is concerned with the issue of rights and whether 
intervention in a situation such as this is respectful of the patient’s rights.
A number of rights are relevant to a discussion of Case 4. First, the patient had a right to 
life. As discussed above, the right to life is protected by the Irish Constitution, the European 
Convention on Human Rights as well as under United Nations human rights instruments.  
The right to life is one of the most fundamental rights. It derives from the ethical principle of 
the sanctity of life and it is a right which is universal. A person cannot be deprived of his or 
her right to life because he or she is disabled or because he or she lacks capacity. It would be 
both unlawful and unethical to deny treatment to a patient on this basis. Yet, the right to life 
is not absolute. It is generally accepted that treatment is not required where treatment would 
be futile or in Keown’s words, ‘not worthwhile’ (Keown, 1997, p.485). Keown, (1997, p.485) 
describes a treatment as not worthwhile in this sense ‘either because it offers no reasonable 
hope of benefit or because, even though it does, the expected benefit would be outweighed 
by burdens which the treatment would impose, such as excessive pain.’
Other rights are also at stake. A person has a right to dignity, a right to freedom from 
inhuman and degrading treatment and a right to bodily integrity. The patient in Case 4 
had his ribs cracked during the administration of resuscitation. By any standards, this is 
an invasion of his right to bodily integrity and by many standards, it constitutes inhuman 
treatment. His right to dignity was also compromised. His last moments of life were spent 
having his ribs broken during a highly invasive process.
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Of course, in many cases, if a person had his or her ribs cracked during the administration of 
CPR, we would accept that, while this was an invasion of his or her right to dignity or bodily 
integrity, it was justified because it saves his life. Imagine if the man in Case 4 had been 30 
years younger and had been admitted following a heart attack. Nobody would argue that 
CPR should not be administered even if there was a risk of broken ribs and of loss of dignity 
during the process. However, in a case such as Case 4, a real question arises as to whether the 
administration of the CPR was worthwhile and whether the violation of the patient’s right 
to dignity, bodily integrity and freedom from inhuman and degrading treatment could be 
justified on the basis of the patient’s right to life. 
The interplay of rights in these kinds of situation was explored in an English case of R 
(Burke) v the General Medical Council and Others (2004). Although the Irish courts might act 
differently, this case is helpful in showing how complex the interplay of rights can be and 
how difficult it is to reach appropriate conclusions. The case concerned a 44 year old man 
named Leslie Burke who had motor neurone disease – a progressive condition which would 
ultimately lead to his death. The likely progression of the disease was that a time would come 
when Mr Burke would be completely unable to move or to communicate with his carers but 
he would still be sentient. Mr Burke was concerned that, under the General Medical Council 
(GMC) Guidelines: Withholding and Withdrawing Life- prolonging Treatment: Good Practice 
in Decision-Making (2002), at this stage of his illness, the medical professionals caring for him 
would be able decide that it was in his best interests to have artificial hydration and nutrition 
removed. He would not be able to object to the decision. Mr Burke considered that death 
from deprivation of ANH would be undignified and he was very concerned that he should 
not die in this way. He wanted an express confirmation that this would not occur. 
In the English High Court, Judge Munby found that the GMC Guidelines failed to protect 
the patient’s right to autonomy in determining when ANH should be withdrawn. In his view, 
where a patient has made his or her views known (in a case like this, by means of an advance 
instruction), this should determine when ANH should be withdrawn. Where a patient has 
not made his or her views known, Judge Munby held that the relevant factor in deciding 
when life-sustaining treatment should be withdrawn was ‘intolerability’. It was only if life was 
intolerable for the patient that the withdrawal of treatment leading to the patient’s death 
should take place. Judge Munby’s decision was overruled by the English Court of Appeal 
which approved the GMC Guidelines. The Court of Appeal considered that it was for the 
medical professionals acting in a patient’s best interests and not for the patient to decide 
when ANH should be withdrawn. The Court also rejected the use of a standard based on 
intolerability where the patient’s views are not known and said instead that a simple best 
interests test should apply. 
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should be withheld or withdrawn depending on the circumstances. Following Burke, and 
taking account of other developments, including the introduction of the Mental Capacity Act 
2005, government strategies on end-of-life care in England and Scotland, new GMC guidance 
on Consent: Patients and Doctors Making Decisions together (2008), and new research, 
the GMC has issued new draft guidance on withholding and withdrawing treatment (GMC, 
2009). This draft guidance lays down a framework in respect of decisions on life prolonging 
treatment for patients with and without capacity. The guidance advises doctors to encourage 
patients to plan for end-of- life care in respect of both advance requests for treatment and 
advance refusals of treatment. The role of advance planning is discussed in more detail in 
Module 4. In a substantial change from the current GMC guidance (which was at issue in 
the Burke case), doctors are advised that ANH may be withdrawn from a patient who lacks 
capacity, where death is not imminent, if provision of the treatment would be ‘intolerable in 
all the circumstances’ (Dyer 2009, p.875). 
6.4.2 Suggested Professional Responsibilities 3
•	 Professionals have an ongoing duty to respect the right to life of a person who lacks 
decision-making capacity. However, this duty must be balanced with the duty to 
protect the patient from inhuman or degrading treatment and the duty to respect the 
patient’s right to dignity and bodily integrity. 
•	 Patients should be encouraged to plan for end of life care while they have the capacity 
to do so. In this respect, communication and (appropriate) reassurance is essential to 
ensuring that patients can make decisions which are informed and which represent 
their considered views. 
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ts 7. Module 3 Further Discussion 
Rights are important tools in the provision of appropriate care for patients at the end of 
their lives. The rights to autonomy, to dignity, to bodily integrity, to freedom from inhuman 
and degrading treatment as well as the rights to information, to consent and to free choice 
are powerful ideals and, in some cases, legal obligations. To state the rights applicable in 
decisions at the end of life is easy enough but, as the practitioner interviews show, giving 
practical effect to rights is much more difficult. Patients may get little information about their 
condition and so are unable to form realistic expectations or they may get no information or, 
indeed, misinformation. Decisions may be made in emergency situations by professionals 
who have not had the opportunity to reflect on the rights involved or indeed who may not 
have a full picture of the circumstances at issue. 
There is a recognisable gap between these rights and their application in end-of-life care.  
This is not meant to be pessimistic but rather to signal the need to take account of the 
practical operation of patient rights in developing a framework for end of life care. It is 
essential that resources are allocated to allow for patient-focussed communication and for 
education and training to ensure that professionals who are involved in these important 
decisions are aware that patients have rights and to ensure that these rights are respected in 
one of the most important decision-making situations that any of us will encounter – that is, 
decisions about care at the end of life.
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ts 8. Module 3 Summary Learning Guides
8.1 The Nature of Rights 
•	 There are different kinds of rights. The rights discussed in this module have been: 
Positive Rights: Right to something 
Negative Rights: Rights that someone should desist from something  
Moral Rights: Rights justified on the basis of membership of the moral community 
Legal Rights: Rights enforceable in a court of law
•	 Each aspect of rights is important. An appropriate framework for rights in respect of 
decisions at the end of life must recognise positive as well as negative rights and moral 
rights as well as legal rights. It is especially important that, in discussing rights, the 
discussion is not limited to (largely negative) legal rights.
8.2 The Contribution of Rights
•	 Rights make an important contribution to patient care because 
Respect for patient rights makes the patient central to the decision-making process 
•	 Arguments based on positive rights provides a basis for essential resources 
•	 There is a legal obligation to respect patients’ legal rights  
But good patient care requires more than just respect for rights.
8.3 Sources of Legal Rights 
•	 Irish Constitution
•	 European Convention on Human Rights
•	 European Charter of Patients’ Rights (not legally enforceable)
•	 United Nations Conventions
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ts 8.4 Positive Rights Implicated in End of Life Care
•	 Right to information 
•	 Right to pain relief
•	 Right to communication
•	 Right to a ‘good dying’
These rights have a basis in legal rights, including the right to dignity, to protection 
from inhuman and degrading treatment and the right to bodily integrity. They are also 
moral rights. An appropriate framework for end of life care requires that these rights be 
recognised. 
8.5 All Patients have Rights
Rights are not restricted to adult patients with decision-making capacity. All patients have 
rights. 
Children’s rights include:
•	 The right to participate in decisions about their care – including end of life care – in 
accordance with their age and maturity
•	 The right to have their family consulted and involved in the decision-making process
•	 The right to have treatment decisions made in their best interests
•	 The right to life, to dignity, to protection from inhuman and degrading treatment
Adults who lack decision capacity have rights. These include:
•	 The right to participate in decisions made insofar as this is possible
•	 The right to life
•	 The right to dignity
•	 The right to protection from inhuman and degrading treatment
The right to life is not absolute but must be balanced with other rights. 
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ts 9. Module 3 Activities
9.1 Recall the distinction between positive and negative rights: 
a. Would you add anything further to these points on the distinction?
b. Which kind of rights seem to you to contribute best to appropriate decision-making at 
the end of life?
c. Which negative rights do you think are most relevant to treatment decisions at the  
end of life?
d. Which positive rights do you think are most relevant to treatment decisions at the  
end of life?
Reflect back on the particulars of Case 1:
a. In reading Case 1, jot down your first, unanalysed response to the facts set out.       
b. Do you think that health professionals should have done more for the woman in  
this case? 
c. What kind of structures would facilitate health professionals in doing more in a case 
along the lines of Case 1? 
d. Compare Case 1 with the contrasting example given. Is the approach taken in the 
contrasting example a better way of protecting patient rights than the approach outlined 
in Case 1? If so, why?
Reflect back on the particulars of Case 2:
a. In your view, is it a good or a bad thing for cases like this to come before the courts?
b. In your view, what should the Supreme Court have done when faced with this case?
c. The Supreme Court listed a set of rights, including the right of autonomy, dignity, 
bodily integrity and dignity. How do you think that these rights were relevant to the 
circumstances which arose in Case 2? 
d. Can you think of any other rights (both positive and negative) which may have been 
relevant in the facts arising in Case 2?
e. If you were the health professionals involved, would you have taken a similar position to 
that taken by the health professionals? If so, why; if not, why not?
f. Was the Supreme Court correct in the approach taken to ANH?; Would you take a similar 
approach? Is the approach taken by the Medical Council Guide consistent with the 
approach of the Supreme Court?
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ts 9.4 Reflect back on the particulars of Case 3:
a. Were the health professionals wrong in placing a DNR order on the patient’s file without 
consulting his family?; were they wrong in administering morphine without consulting 
his family? Is there any difference between the two decisions?
b. How involved should parents be in end-of-life decisions about their children? 
c. Is it justified to retain information about a child’s situation from parents in order to 
preserve hope/prevent the parents from distressing the child? 
d. How would you resolve a conflict where you believe that parents are making 
inappropriate decisions about their dying child? What factors would influence you in 
resolving the conflict?
9.5 Reflect back on the particulars of Case 4:
a. What are the rights at risk in this case? 
b. How should the right to life be balanced against other rights where a patient lacks the 
capacity to make his or her own views or preferences known? 
c. Do you agree with a standard for withdrawing or withholding treatment based on 
whether the treatment is ‘worthwhile’ or based on whether the patient’s life would be 
‘intolerable’? Can you think of other possible standards which might be used in  
resolving the conflict between rights in making decisions about end-of-life care for 
patients lacking capacity? 
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1. Module 4 Key Points
1.1 Autonomy is not just about the right to say no: 
The right of autonomy is not just about refusing treatment or procedures; it is also about the 
positive right to be involved in decisions about treatment.
1.2 Respect for autonomy is especially important in a hospital setting: 
A patient in a hospital setting is in an inherently vulnerable position; he or she is part of a 
big and sometimes impersonal institution and is inherently restricted in many of the choices 
which he or she can make.
1.3 Autonomy is a contested notion: 
There is ongoing debate among healthcare ethicists and others regarding the proper status 
for autonomy. For some, autonomy provides the basis for patient rights and is the most 
important of all the ethical standards. However, this claim is disputed by others who place 
importance on values such as trust and maintaining personal and social relationships. 
1.4 A capable/competent patient has the right to refuse treatment: 
This is a legal right which is protected under the Irish Constitution and the European 
Convention on Human Rights.
1.5 There are three requirements for autonomous decisions: 
Information, Capacity and Freedom: Not all decisions are autonomous: an autonomous 
decision is one which is made with adequate information; where the patient has decision-
making capacity and where the patient is not unduly influenced or pressured by others. 
1.6 The legal right of autonomy does not extend to allow patients assert a ‘right to die’:
Courts in a number of countries have rejected the argument that the right of autonomy gives 
people a ‘right to die’ in the sense of a right to have active steps taken to end a person’s life or 
to assist a person in ending his or her own life.
1.7 Information is key to autonomous decision-making: 
Without adequate information, a patient cannot make autonomous decisions. Protection of 
patient autonomy imposes a positive duty to provide information in an appropriate way. 
However, simply providing information does not ensure autonomous decision-making. 
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1.8 Legal capacity is a threshold and not a comparison: 
A person’s legal capacity is decided according to whether or not he or she meets a 
designated standard. 
1.9 Every adult is presumed to have capacity to make decisions: 
Regardless of age, intellectual disability, mental illness, all adults are presumed to have the 
capacity to make decisions.
1.10 The legal test for capacity asks three questions: 
Can the patient understand the information relevant to the decision? Can he or she believe 
this information? Can he or she make a decision based on the information?
1.11 Capacity assessment: 
Respect for the principle of autonomy requires that capacity be assessed in a way which is 
fair and appropriate and which is free from prejudices based on external factors such as old 
age, mental illness or intellectual disability.
1.12 Respect for the principle of autonomy requires efforts 
to be made to develop and enhance patients’ capacity and to facilitate them in making 
decisions where this is possible 
1.13 Autonomous decisions are decisions which are freely made: 
The positive right of autonomy requires that efforts be made to ensure that patients are free 
to make their own decisions and that patients have the maximum control possible over the 
manner of their dying.
1.14 Advance Directives provide vital control for patients over their dying: 
An Advance Directive can prolong lives as well as decide when life should end. 
1.15 Autonomy and incapable adults: 
It should not be presumed that simply because a person lacks the capacity to make an 
autonomous decision, his or her views should simply be disregarded: An autonomy centred 
approach to end of life decisions requires that efforts must be made to facilitate the 
participation of patients lacking capacity in making decisions.
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2. Module 4 Definitions 
2.1 Autonomy 
is the capacity of self-determination; it is a person’s ability to make choices about their own 
life based on their own beliefs and values. 
2.2 Absolute Right: 
A right which cannot be interfered with in any circumstances. Autonomy is not an absolute 
right
2.3 Advance Directive: 
a decision made by a person while he or she has decision-making capacity regarding the 
medical treatment which he or she would wish to receive (and more frequently not to 
receive) if he or she subsequently loses capacity.
2.4 Capacity/Competence: 
The ability to make decisions based on designated standards. 
2.5 Duty to Disclose: 
The duty of a medical professional to disclose material risks to a patient in advance of 
treatment
2.6 Enduring Power of Attorney: 
Power which a person grants while he or she has capacity giving another person the 
power to make certain designated decisions if the person granting the power of attorney 
subsequently loses capacity. 
2.7 ‘Living will’: 
Another term for an Advance Directive.
2.8 Paternalism: 
involves an action that overrides a person’s decision or controls their actions in the interests 
of what is considered to be their own good. 
2.9 Principle of Autonomy: 
requires that, in a healthcare context, health professionals recognize and support the unique 
values, priorities and preferences of patients.
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2.10 Principle of Beneficence: 
Doing good for the patient.
2.11 Right to Refuse Treatment: 
A legal and ethical right of a patient.
2.12 Sanctity of Life: 
A principle whereby life is seen as having an intrinsic value unrelated to the individual’s views 
regarding his or her own life.
2.13 Self-determination: 
Another way of saying ‘autonomy’ – sometimes used in legal discussions.
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3. Module 4 Background 
3.1 A Matter of Policy
One of the goals of the Irish Health Service Executive Strategic Plan for 2008-13, is ‘to develop 
the role of the “expert patient”, especially those with long-term illnesses, in developing their 
own care plan and in looking after their own condition’ (p.14).
Two of the related actions to achieve this goal are; the promotion of patients as ‘partners with 
health professionals’ and; the education of staff on the ‘importance of patient involvement 
in their care’ (National Strategy for Service User Involvement in the Irish Health Service 2008-
2013). The document defines ‘involvement’ as: 
‘A process by which people are enabled to become actively and genuinely involved in defining the 
issues of concern to them, in making decisions about factors that affect their lives, in formulating 
and implementing polices, in planning, developing and delivering services and in taking action to 
achieve change’ (2008, p.6). 
In emphasizing the idea of individual patient participation in care planning and self-care, this 
HSE strategic plan brings Ireland in line with international efforts to change the way in which 
illness is managed in the 21st century by health professionals and, increasingly, by patients 
themselves. This focus on patient-directed and patient-centred care is construed as giving 
expression to patient autonomy and it is articulated in the 7th Edition of the Irish Guide to 
Professional Conduct and Ethics for Registered Medical Practitioners (2009) in relation to the 
requirement of the informed consent of patients to medical treatment:
‘You should ensure that informed consent has been given by a patient before any medical 
treatment is carried out. The ethical and legal rationale behind this is to respect the patient’s 
autonomy and their right to control their own life. The basic idea of personal autonomy is that 
everyone’s actions and decisions are their own. Therefore, the patient has the right to decide what 
happens to their own body.’ (Section 33.1, p.34)
The notion of patient autonomy is particularly relevant to one particularly vulnerable group 
of individuals: patients who are dying. 
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3.2 Defining Patient Autonomy 
The term, autonomy, derives from the Greek words, autos (‘self’) and nomos (‘rule’, ‘law’, 
‘governance’), and originally referred to the self-rule of Greek independent city-states. Today, 
however, autonomy is associated, not just with nations but also with persons, decisions and 
actions and it is linked with other meanings such as self-governance, liberty, self-authorship, 
free will and self-determination. 
The moral principle of autonomy requires that, in a healthcare context, health professionals 
recognize and support the unique values, priorities and preferences of patients. In end-of-life 
care, they can do this by enabling patients to direct their own journeys from living to dying 
and death. This requires that patients be encouraged to participate in decisions relating to 
their treatment and care. 
Respecting patient autonomy does not mean that health professionals only respect the 
choices of persons who are deemed autonomous. It requires that they respect whatever level 
of autonomy the person is capable of. Where the dying person is incompetent or impaired or 
suffers from some psychological, emotional, physiological or social disability, the principle of 
autonomy obliges health professionals and organizations to create the conditions that foster 
capacity. They do this through, for example, the early provision of treatment or care plans 
and consulting with family members and friends about what the person would have wished 
in the circumstances.
3.3 The Nature of the Right of Autonomy
The right of autonomy or self-determination protects the individual’s ‘interest in making 
significant decisions about his or her own life’ (Buchanan and Brock, 1989, p.36). This right 
is often seen as being encapsulated by John Stuart Mill’s ([1859], 1991, p.4) words, ‘Over 
himself, over his own body and mind, the individual is sovereign’. 
Respect for autonomy requires that autonomous decisions must be respected even if we 
do not agree with them. In the words of Ronald Dworkin, ‘[w]e allow someone to choose 
death over radical amputation or a blood transfusion, if that is his informed wish, because we 
acknowledge his right to a life structured by his own values’ (1993, p.27). 
The right of autonomy is both a moral right and a legal one. As members of the moral 
community, we have a moral obligation to respect our fellow citizens’ right of autonomy.  
We also have a legal obligation to respect the right. In this sense, autonomy may be seen as a 
negative right (see discussion on positive and negative rights in Module 3). It is a right not to 
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context; the legal right of autonomy is often viewed as simply the right to refuse treatment. 
3.4 Autonomy is Not an Absolute Right
Autonomy is not an absolute right. The most commonly recognised justification for 
interference with autonomy is that respect for the right will cause harm to another person 
(often described as the ‘harm’ principle; see Further Discussion). For example, where a person 
has a contagious and dangerous disease, say tuberculosis, a degree of interference with his 
or her autonomous rights (to refuse treatment, to freely interact with others) may be justified 
on the basis of the harm which would be caused to others who might well become infected 
with the disease if the person’s right of autonomy were respected. 
Respect for autonomy is also premised on ‘all the persons concerned being of full age, 
and the ordinary amount of understanding’ (Mill, [1859], 1991 p.84). Children and people 
without decision-making capacity do not have the same right of autonomy as capable adults. 
However, this does not mean that their views are irrelevant. Insofar as is possible, account 
should be taken of the views of people lacking capacity in healthcare decisions, including 
decisions at the end of life. 
3.5 Autonomy as a Positive Right
The right of autonomy should also be viewed as a positive right. Respect for the right 
is as much about empowering patients as about patients refusing treatment. Many in 
the healthcare profession would argue that the right of patient autonomy should be 
accompanied by more positive help to enable patients to die in a context that protects 
their dignity and privacy. This is clear in the range of practitioner responses to Quinlan and 
O’Neill’s request to define patient autonomy (2009, p.44-45). Practitioners responded:
‘I suppose it’s the right and the ability of the patient to make a choice’.
‘it’s the choice of what kind of treatment the patient is going to receive and the degree of 
treatment, if it’s going to be just like minimal or more aggressive’.
‘I suppose it’s more the patients’ right to make choices around that and, you know, that we would 
be respectful to the patients’ wishes […]’.
‘[…] that we would take their wishes into consideration and act on them at all times […]’.
‘It’s to do with, maybe not just the treatment, but things like patients’ family involvement and 
special particular requests that the patient might have as to whether we can, you know, the 
balance between whether we can have whatever the patient wants from a practical point  
of view’.
 
171
Mo
du
le 
4 
Pa
tie
nt
 A
ut
on
om
y i
n 
La
w 
an
d 
Pr
ac
tic
e This means that autonomy is not just about the right to say no; it is also about the right to 
be involved in decisions about how one’s treatment proceeds and the environment in which 
one dies. 
This is the view of autonomy developed in this module – a view of autonomy as a positive 
right to be involved in decisions at the end of life and to have the steps taken to ensure that 
this happens. 
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4. Ethical Debates Regarding the Status of Autonomy
As discussed in Module 3, the principle of autonomy has traditionally played a very limited 
role in medical ethics. Historically, healthcare decisions were based on the principles of 
beneficence (doing good for the patient) and sanctity of life (recognising an intrinsic value in 
life) with little or no reference to the patient’s own views of their interests or of the value of 
their lives. However, from this position of insignificance in traditional medical ethics, in recent 
decades, the principle of respect for patient autonomy has come to be widely recognised in 
healthcare decision-making. 
Autonomy is now regarded as a fundamental ethical principle (Beauchamp and Childress, 
2008) governing healthcare decisions. However, it is a contested notion. For some, it is the 
most fundamental ethical principle governing the relationship between medical professional 
and patient (Gillon, 2003). For others (O’Neill, 2002; Callahan, 1984, 2003), autonomy 
provides, ‘a thin gruel for the future of bioethics’ (Callahan, 2003, p.499). 
4.1 Critiques of Autonomy
The elevated role of autonomy has been criticised for a number of reasons. Critics argue 
that the autonomy principle is too individualistic and that it fails to take account of the 
essential interconnectedness of people or the complexity of the ways in which people make 
healthcare decisions (Schneider, 1998; Callahan, 1984, 2003; O’Neill, 2002). Many argue that a 
broad and more concrete understanding of autonomy is required. 
One significant deficiency in the way that autonomy is usually understood is that it supports 
an abstract view of persons as independent, self-sufficient centers of decision-making. When 
associated with free market economies such as ours, this view of autonomy conjures up an 
image of an independent individual who chooses from amongst an array of commodities; 
in the healthcare arena, the patient is a consumer and the commodity is a medicine or 
treatment. It could be argued that this distorts the relationship between the patient and  
the professional, and between the citizen and the state which has responsibility for 
healthcare provision. 
Daniel Callahan puts his criticism as follows: 
‘[Autonomy] buys our freedom to be ourselves, and to be free of undue influence by others, at 
too high a price. It establishes contractual relationships as the principal and highest form of 
relationships. It elevates isolation and separation as the necessary starting point of human 
commitments’. (1984, p.41) 
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Onora O’Neill (2002) identifies the cost to other values and in particular, the important value 
of trust, which is exacted by the elevation of autonomy. Contrasting the different features 
of trust and autonomy, she notes, ‘[t]rust flourishes between those who are linked to one 
another; individual autonomy flourishes where everyone has “space” to do their own thing’ 
(2002, p.25). 
Rather than fostering trust between patients and professionals, it is argued that elevating 
autonomy pits the patient and professional against one another. In situations in which 
disagreements engender conflicts and disputes, these are increasingly referred to the courts 
or Fitness to Practice Committees to resolve. Such a narrow a view of autonomy conceives of 
the obligations of health professionals in terms of what they cannot do. This reinforces the 
already widespread culture of demoralization and fear of litigation which focuses the minds 
of health professionals on expedience, pragmatism and self-protection.
It must also be remembered that not all cultures adopt identical views of autonomy or take 
an individualistic view of the person (Blackhall, 1995; Gaylin and Jennings, 2003). Thus, while 
respect for autonomy may be in line with western liberal thinking, it may be wholly alien to 
people from other cultural backgrounds. 
While identifying important questions about the status accorded to autonomy, critics of 
the principle do not advocate a return to old-style paternalism. In Callahan’s words, there 
cannot be a ‘return to those good old days that understood doctors to be good old boys 
who could work out moral problems among themselves in the locker room’ (1984, p.42). If 
autonomy is to be preserved and to have relevance, it is argued that a broader account is 
needed to provide substantive basis for decision making. One such account is described by 
George Agich as ‘actual autonomy’ which focuses on paying attention to concrete actions 
carried out in everyday shared social life (Agich, 2003, p.19). This perspective; pays attention 
to the conditions which foster capacity, provides treatment or care plans from which patients 
choose, and tries to ensure that available options are meaningful to the patients involved
See Further Discussion for philosophical supports for, and critiques of, the notion of 
autonomy. 
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4.2 The Importance of Autonomy
Although the elevated role of autonomy can be criticised and the cultural context in which 
autonomy is valued must be recognised, the principle provides an important foundation 
for decisions about healthcare, including at the end of life. Autonomy is a more complex 
ideal than simply respecting the right to say no. The right to say no – to refuse interventions 
– is important but so too is the more positive right of autonomy in the sense of facilitating 
patients in exercising control over how they live, and how they die. One practitioner 
recounts:
‘I’ve yet to remember when a patient had full, you know, control over what they exactly wanted. 
We feel we’re doing what’s best for the patient and we do, we do what’s best, but I don’t know 
whether we question enough by asking the patient “is this what you want”. So I think as yet 
patients haven’t got great control over end-of- life decisions’ (Quinlan and O’Neill, 2009, p.52).
The especially strong need for protection of autonomy in this broader sense in a hospital 
context is evident when we consider one the practitioner responses recounted by Quinlan 
and O’Neill (2009, p.69):
‘Once you put your foot in the door of the hospital as a patient you lose that power, that power 
you have as an individual. A hospital is an institution and it has to tick, it has to keep going, staff 
come and go, there’s rotas, there’s crises, there’s personalities, there’s conflict, there’s tension. People 
who are dying usually want to go home and they want to die at home. The journey they have had 
with cancer – could have involved a number of hospitals - and then they end up let’s say in this 
facility here. My experience of working here for nearly 2 years is that, and I’m sure it’s no different to 
any other institution or hospital, a lot of stuff gets lost, the emotional stuff doesn’t get dealt with. 
That could be because of a combination of family dynamics and ward dynamics and hospital 
dynamics. So my experience is that people lose an awful lot of autonomy and I’ve seen a lot of 
people die who have been totally disempowered […] and people have good deaths I’m sure as 
well - but it’s kind of sad’.
Autonomy in this sense might be seen as an aspiration or a goal. In many cases, it will not 
be possible for patients to be fully autonomous; the circumstances of their illness and 
their hospitalisation may limit this. But recognising that respect for autonomy and the 
empowerment of patients are important values is an essential component of an appropriate 
framework for end of life decision making.
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5. The Legal Right of Autonomy
Autonomy is an important ethical principle. It is also a recognised and enforceable legal right. 
While the existence of a legal right does not, of itself, guarantee that an ethical principle 
will be respected, legal endorsement allows patients to make ethical principles enforceable 
in their individual situations (Donnelly, 2008, p.34). An understanding of the legal right is 
essential in order to appreciate health professionals’ legal obligations. However, it is crucial 
that the legal right is not seen as the only relevant factor in providing appropriate protection 
for patients’ autonomy. Respect for the right of autonomy also imposes positive obligations 
to enhance patient autonomy and to ensure that patients are able to control to the 
maximum extent possible their own living and dying.
5.1 The Scope of the Legal Right
The legal right of autonomy has sometimes tended to be viewed primarily as a right to say 
‘no’; a right to refuse treatment rather than a positive right to appropriate treatment. 
5.1.1 A Right to Refuse Treatment
The Irish Constitution protects the right to refuse treatment. This has been recognised by 
the Irish Supreme Court in a number of cases, beginning with the decision in In re a Ward 
of Court (1995). In this case, the Supreme Court recognised the right of a patient to refuse 
medical treatment. The right to refuse treatment was again recognised by the Irish courts 
in JM v Board of Management of St Vincent’s Hospital (2003) and in Fitzpatrick v K (2008). 
Speaking in Fitzpatrick v K (2008), Judge Laffoy said that it ‘could not be argued that a 
competent adult is not free to decline medical treatment’. 
The right of autonomy is also protected under the European Convention on Human Rights. 
In Pretty v UK (2002), Mrs Pretty was an English woman who suffered from motor neuron 
disease. She was concerned that a time would come when she would wish to end her life. 
She did not wish to die by withdrawal of ventilation – which she would be legally entitled 
to request – as she had a fear of suffocation and did not wish to die in this way. Instead, she 
wished her husband to assist her in bringing her life to an end. She was concerned because 
assisted suicide is against the law in England (as is also the case in Ireland). She was worried 
that, after her death, her husband might be prosecuted for assisting her. She did not wish this 
to happen and sought a reassurance from the public prosecutor that it would not happen. 
The prosecutor declined to give this reassurance because the law on assisted suicide in 
England did not allow for any exceptions. Mrs Pretty applied first to the English courts. She 
argued that the blanket prohibition on assisted suicide was a breach of her human rights 
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case and she brought her case to the European Court of Human Rights. 
The European Court recognised that a person has a right of autonomy which is protected 
under Article 8 of the European Convention on Human Rights which protects the right to 
private and family life. The Court also found that respect for the right of autonomy required 
that people have the right to refuse medical treatment. The Court also accepted that the 
prohibition on assisted suicide was a breach of Mrs Pretty’s right of autonomy (although 
as discussed below, it found that interference with this right could be justified in the 
circumstances). 
 
5.1.2. The Right in Practice
Perhaps the most striking feature of the Irish cases on the right to refuse treatment is that, in 
all cases, while the right to refuse treatment was recognised, the right did not actually apply 
in any of the cases (Donnelly, 2008, p.36). In In re a Ward of court (1995), the woman had 
been in a near PVS for 23 years and evidently lacked decision-making capacity. Nor had she 
given any prior indication of how she would have wished a situation like this to be dealt with. 
The decision to withdraw ANH from the woman was made on the basis that withdrawal was 
in her best interests and not on the basis of her right to refuse treatment. 
In JM v Board of Management of St Vincent’s Hospital (2003), the woman had refused a blood 
transfusion on the basis of her religious beliefs (she was a Jehovah’s Witness). The woman had 
made her views known and then she lost consciousness. The issue for the court was whether 
her advance instruction should apply. The woman’s husband gave evidence to the Court that 
the woman had converted to become a Jehovah’s Witness on her marriage to him and that 
she did so because her cultural background meant that she was culturally disposed to adopt 
her husband’s religion. On this basis, the Court held that the woman’s decision was not a 
‘real’ or ‘true’ decision. Because the decision was not a real or true one, the Court considered 
that it was not autonomous and therefore the woman’s advance refusal of the blood was not 
upheld and a blood transfusion was administered. 
Fitzpatrick v K (2008) also concerned refusal of a blood transfusion for religious reasons. 
Here, the woman, who had recently given birth, refused a blood transfusion. She suggested 
that her condition should be treated instead with tomatoes and coca cola. Judge Laffoy 
found that the woman lacked the capacity to appreciate the seriousness of her situation 
and held that the administration of blood was justified in such circumstances. The role 
played by capacity and decision-making freedom in end of life situations will be discussed 
in more detail below. For present purposes, the important point is that the Irish courts have 
recognised the right of autonomy in the sense of the right of the competent adult to refuse 
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right has actually been held to apply.
 
5.2 Limits on the Legal Right
The legal right to refuse treatment is not absolute. The right of autonomy may sometimes 
be limited because of duties owed to other people – so for example, it may be justified to 
interfere with a person’s right to refuse treatment if the person has a contagious disease 
which may infect other people. 
A more unusual example of duties owed to others may be seen in one Irish case, Re K, 
(2006). Here, a woman was not permitted to refuse a blood transfusion on the basis of her 
religious beliefs (she was a Jehovah’s Witness) because, if she died, her infant son would be 
left without a parent. Judge Abbott held that child’s welfare should take priority over the 
woman’s right of autonomy. This case was later reconsidered by the Irish courts under the 
name Fitzpatrick v K, (2008). Judge Laffoy found that the woman had, in fact, lacked the 
necessary capacity to make the decision to refuse the blood transfusion and for this reason, 
her decision was not an autonomous one. This meant that there was no need to consider the 
question of whether or not the child’s welfare should take priority over the woman’s right of 
autonomy and Judge Laffoy did not consider the matter.
In Pretty v United Kingdom (2002), the European Court held that the protection afforded to 
the right of autonomy under the European Convention was not absolute. It was permissible 
to interfere with a person’s right of autonomy if it was necessary for the protection of 
the rights and freedoms of others. The Court held that the United Kingdom had made a 
reasonable case that its prohibition on assisted suicide was intended to protect the rights 
and freedoms of others (in particular vulnerable people who might feel pressured into 
ending their lives if assisted suicide were lawful). For this reason, the prohibition on assisted 
suicide was a permissible breach of Mrs Pretty’s rights. 
The effect of the decision in Pretty is that the right of autonomy does not extend to allowing 
a patient assert a right to die in the sense of a right to have active steps taken to end his or 
her life or to assist him or her in ending his or her life. Courts in Canada and the United States 
have reached similar conclusions on largely similar grounds (Rodriguez v British Columbia, 
1993; Washington v Glucksberg, 1997; Vacco v Quill, 1997). It is highly probable that the Irish 
Supreme Court would reach a similar conclusion. This does not mean that a country could 
not bring in legislation to allow for assisted suicide. For example, the Netherlands, Belgium 
and Luxembourg (all of which are subject to the European Convention on Human Rights) 
have done this in recent years. However, this is seen as a matter for politicians, following 
public debate, and not for the courts. 
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6. Cases: Autonomy in End of Life Contexts
As is often the case with rights, it is one thing to state the existence of a right of autonomy, 
it is quite another to determine what it means in practice in end-of-life contexts. This can be 
made more difficult because legal conceptions of the right of autonomy are often developed 
in once-off, usually dramatic situations such as the Jehovah’s Witness refusing blood 
products. This can create a very unrealistic view of what autonomy in practice means for 
most patients who are not proposing to make dramatic decisions or to refuse possibly life-
saving treatments. Most patients are simply trying to find the best way possible to deal with 
their illness and the end of life decisions which they must make. 
In the cases to follow, the practical application of the right of autonomy in end of life 
contexts will be explored. This includes an exploration of the way in which autonomy has 
operated in the law; the requirements for autonomy and how these may be used to further 
autonomy as a positive right as well as a right to refuse and a discussion of ways to preserve 
and protect autonomy even after a patient has lost capacity.
6.1 Case 1: Applying the Legal Right of Autonomy – Re B
This case, which is based on the facts of an English case which came before the courts in 
2002, shows the strength of the legal right of autonomy in those cases where the right is 
held to apply. The case is concerned with the withdrawal of ventilation. There has not been 
a similar case in Ireland. In an unreported case in 2001, ventilation was not withdrawn from 
a pregnant woman because the withdrawal would have ended the life of the foetus also. 
Because information on the facts of the case is restricted (the newspaper report provides 
only limited information), it is not possible to draw any conclusions from this. 
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Re B (Adult: Refusal of Medical Treatment), (2002):
 
Ms B was a 43 year old woman who was quadriplegic following a stroke which had occurred 
in the previous year. She also required artificial ventilation and had been hospitalised in an ICU 
since her illness began. She brought an application to court for ventilation to be withdrawn 
saying that she had decided that she did not want to live any longer in her condition. Ms B had 
earlier asked the court to have ventilation withdrawn. She had been severely depressed at the 
time and had been found not to have the capacity to make this decision. At the time of this 
case, however, there was no dispute regarding her capacity to make the decision.
The medical professionals caring for Ms B expressed some concerns about her decision. In 
particular, some carers pointed out that she had never had the opportunity to experience 
life outside of the restrictions of the ICU environment. There was a possibility that she could 
successfully complete a ventilation weaning programme and that she would be able to live a 
much more independent life. Therefore, some of her carers argued that she had not had the 
opportunity to make an informed decision about her future and that her decision should not be 
respected until after she had had such an opportunity. 
The English High Court held that the ‘personal autonomy of the severely disabled patient’ 
should be recognised and that Ms B should be permitted to have ventilation withdrawn. The 
judge asked Ms B to reconsider her decision but she said that she could not require Ms B to do 
so. Ms B remained committed to her decision and shortly afterwards, she moved to another 
hospital because her carers could not bring themselves to participate in the removal of 
ventilation. She had ventilation removed and shortly afterwards, she died. 
6.1.1 Discussion 4
Case 1 shows that, when the right of autonomy arises in the context of treatment refusal, 
it is a very powerful right. It takes priority even when the effect of the refusal is the death 
of the person. In these circumstances, the right to refuse treatment ‘trumps’ or outweighs 
the ethical principle of the sanctity of life. The nature of the legal right is perhaps best 
summarised by Lord Donaldson in the English case of Re T (1992) who stated: 
An adult patient who … suffers from no mental incapacity has an absolute right to choose 
whether to consent to medical treatment, to refuse it or to choose one rather than another of 
the treatments being offered…. This right of choice is not limited to decisions which others 
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rational, irrational, unknown or even non-existent (1992, p.486)
The judge in Case 1 could implore Ms B not to refuse treatment and she did so in the 
strongest terms. However, because of Ms B’s right of autonomy, she could not be forced to 
accept treatment which she did not wish to have.
Case 1 also shows that decisions which implement the right of autonomy can be difficult 
and painful. The judge and Ms B’s carers were all very anxious that she should continue to 
live. Some of Ms B’s carers strongly believed that her situation could improve in many ways 
and that she had not had the opportunity to avail of all the possibilities available to improve 
the life of a person in her situation. But ultimately, the court held that it was Ms B’s decision 
whether or not to avail of these possibilities. 
Case 1 also reminds us of the difference between engagement and discussion on the one 
hand and force on the other. There was nothing inappropriate in people caring about Ms 
B and wanting her to have the opportunity to experience life outside the unit. Indeed, it 
may be argued that Ms B’s carers had an ethical obligation to engage with her and to seek 
to persuade her to continue to live (Mclean, 2009). Healthcare provision would be much 
poorer if health professionals did not have an interest in the person they cared for or if carers 
simply accepted decisions such as Ms B’s without engaging closely with her and seeking to 
persuade her to change her mind. However, there is a very significant difference between 
engaging with, discussing, seeking to persuade and actually forcing a person to accept a 
treatment which the person rejects. In Case 1, Ms B’s carers did the right thing in engaging 
with her decision but the ultimate decision was for Ms B to make and her carers were bound, 
both legally and ethically, to respect this decision. 
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6.1.2 Suggested Professional Responsibilities 4
•	 If a person seeks to refuse treatment, especially life-saving treatment, health 
professionals should consider whether the person has the capacity to make this 
decision (capacity is discussed further below). If in doubt about capacity, professionals 
should consult a professional with expertise in this respect (perhaps a psychiatrist or 
geriatrician). Ultimately, if doubt remains, legal advice should be sought.
•	 Professionals can and should engage with patients who refuse treatment. If 
professionals believe that it would be in the patient’s best interests to have treatment, 
they can and should seek to persuade the patient to consent to the treatment. This 
attempt should be on the basis of dialogue and discussion which should be conducted 
in a way which is honest and which does not attempt to manipulate the facts. 
•	 A distinction must be made between honest persuasion and force. While persuasion is 
legitimate, the use of force is not (unless the person lacks the capacity to make  
the decision). 
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6.2 Case 2: Informed Consent - Information in Practice 
In order to be maximally autonomous, decisions must be fully informed. Tom Beauchamp 
(1997, p.194) describes informed consent as follows:
‘A person gives an informed consent … if and only if the person, with substantial understanding 
and in substantial absence of control by others, intentionally authorises a health-care 
professional to do something.’
Ethicists, Ruth Faden and Tom Beauchamp point out that informed consent requires the 
patient to be fully informed about the nature of the decision and also that any information 
of particular relevance to the patient should be available (1986, p.302). A patient who makes 
a decision on the basis of inadequate information cannot be said to have made an informed 
decision. This is especially true where the decision has life-changing consequences. For 
example, if a patient refuses life-saving treatment, he or she must be aware of the probable 
consequences of this decision and of the likelihood that this will occur. 
However, simply providing information does not of itself comprise a complete basis for 
autonomous decision-making. Nor is more information necessarily better (Manson and O’ 
Neill, 2007). Neil Manson and Onora O’Neill argue that a narrow focus on the disclosure of 
information can serve to obscure the issue of ‘effective communication and commitments 
between the parties’ (2007, p.184). For this reason, we should not simply focus on disclosure 
of information in an end of life context, for example, simply telling a person that he or she is 
terminally ill or providing information about treatment options, risks and outcomes. Instead, 
it is important to recognise broader issues of communication and engagement. 
In some situations, also, failure to provide adequate information in respect of material risks 
in advance of consent to a medical procedure will leave a health professional potentially 
liable in the tort of negligence (Fiztpatrick v White, 2007). However, the legal duty to disclose 
information falls far short of what is required for genuine informed consent (Donnelly, 2002). 
The legal duty has focussed primarily on risks and has paid little attention to the other 
important information for a patient, such as side-effects or alternatives. There has also been a 
tendency to focus on the detail of the information conveyed without paying much attention 
to the method of communication. Respect for the positive right of autonomy requires that 
much greater effort at communication be made than is required under the law of negligence.
The importance of communicating information in the broader sense is evident is Case 2 
which draws on a practitioner narrative provided in Quinlan and O’Neill (2009, p.49-50):
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Information in Practice
‘I did have the experience of a gentleman, you know, I got a referral to say that he was, you 
know, quite anxious and, you know, he needed to speak to somebody. He wasn’t really 
consenting to his treatment and, you know, I went to see him and his biggest thing was that 
he said he had got no information from the team as to what the treatment was, why he was 
getting it or what his outcome was going to be. Now he did say to me ‘I understand it’s not 
going to be good news but I’d rather know’. 
I think if people know good or bad they’ll find a way to deal with that or they’ll find a way to 
cope with that, it mightn’t be the best way but I suppose then you can come in and try and offer 
some support with that. But for that man, at that time, he just felt ‘I don’t know what they’re 
talking about’ and at the same time he had a sense, he knew it wasn’t going to be good, ‘but 
just tell me so I can get on with it’, so those sorts of things. 
I think just people being fully aware at all times of what’s going on. I suppose that they feel that 
their wishes are respected, that we’re not running off and ringing the family to say well ‘they’ve 
said no but we really think ...’, you know, and I would always feel that – I would always go and 
see a patient first and say to them ‘listen, is it okay if I call such and such?’, if they say ‘no’, that’s 
fine, that’s their decision and the team mightn’t like that or, you know, a lot of people don’t like 
that but that’s – I feel that they should know that their wishes were respected. And then, you 
know, I suppose just the amount of dignity they have around that as well’.
6.2.1 Discussion 4
This case as recounted by a practitioner shows a number of important issues in respect of the 
role of information in protecting patient autonomy. It reminds us that patients can respond 
in two different ways to lack of adequate information. Many patients will not object; they will 
go ahead with treatment and comply with their health professional’s directions. But, these 
are not autonomous decisions. Although the patient has given consent, the patient’s positive 
right of autonomy is not being respected. 
Patients may also respond like the gentleman in Case 2. He refused to consent. It turned 
out, when the practitioner investigated further, that the reason for the refusal was his lack 
of information. In a sense, he was using his refusal as a plea for information. However, not all 
patients will be as forthcoming as this gentleman. Some may withdraw or refuse treatment 
without ever explaining (or perhaps sometimes without even understanding) why they 
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with the patient and simply accepts the refusal at face value, the patient may continue to 
refuse treatment. If this happens, it would represent a failure to respect the patient’s rights, 
including his right of autonomy. Thus, Case 2 reminds us that respect for the patient’s right 
of autonomy requires more than simply not interfering with a patient who seeks to refuse 
treatment. In addition, respect for the right imposes a positive obligation to inform the 
patient and to discuss treatment options with him or her. 
Communication (giving information and listening to patients) is central if patients are to be 
sufficiently informed about their diagnosis and prognosis. Lack of information and even mis-
information can leave patients without power to make choices. One practitioner narrative 
notes ‘it is not unusual that people are let out of here with misinformation because we 
use language like ‘a shadow on the lung’ and patients don’t know that he had lung cancer. 
(Quinlan and O’Neill, 2009). It is not always easy to achieve good communication especially 
where a patient is dying. However, respect for patient autonomy requires positive efforts to 
be made. (The difficulties with honest engagement are explored in Module 2.)
A second notable aspect of Case 2 is the recognition which this practitioner clearly shows 
that autonomy is not a right respected in a once-off situation only, and that information is 
something which must be relayed on an ongoing basis. The practitioner says ‘I would always 
go to the patient first.’ The positive right of autonomy in the sense of control over one’s 
decision-making requires more than once-off information. Facilitating autonomy in patients 
requires on-going communication. Conversation to nurture autonomy is stressed as an 
indispensable ethical value in discussions on end-of-life care.
But good information and listening take time. There is a serious lack of time for 
communication with patients to find out their preferences, desires or wishes. Where this 
communication doesn’t happen, staff can’t help patients to be autonomous. Practitioners 
remind us that, ‘if we’re intent on nurturing and encouraging patient autonomy, then 
we need time to communicate with patients, with family and with each other on a ward’ 
(Quinlan and O’Neill, 2009). 
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6.2.2 Suggested Professional Responsibilities  4
•	 In order to ensure that patients’ decisions are as fully informed as is possible, health 
professionals must ensure that patients receive adequate information in respect of their 
condition. 
•	 Health professionals should address broader issues of communication rather than 
focusing simply on the information communicated. This requires that they understand 
the emotional and social context in which the information is conveyed.  
•	 Health professionals should recognise that information is not simply conveyed in a 
once-off way but that repeated efforts need to be made to engage with the patient. 
•	 Adequate communication requires listening as well as speaking; each patient has 
unique informational concerns and these can only be addressed if the professional is 
aware of what these are. 
6.3 Case 3: Capacity, a Pre-requisite for Autonomy? – Re C
Respect for autonomy principle is inherently linked to the requirement for capacity.  
The right of autonomy presumes that the person whose right is respected has the capacity 
to make the decision in question. Decision-making capacity is a requirement for the moral 
or ethical right of autonomy. It is also a requirement for the legal right. Legal autonomy, in 
Buchanan and Brock’s words is ‘a threshold concept, not a comparative one’ (1989, p.27).  
The law sets the required standard for capacity and asks simply whether the patient reaches 
the designated threshold. This means that the law is not concerned with whether someone is 
a good decision-maker as we might think of the concept in other contexts. The law does not 
ask whether the person is reflective and careful or impulsive and careless. The only matter of 
interest to the law is whether or not the person reaches the legal standard. 
A person may lack the capacity to make decisions at the end of life for two reasons. First, she 
or he may be too young to make the decision or secondly, she or he may lack the necessary 
decision-making abilities. This may be because the person is unconscious or because of 
intellectual disability, mental illness or dementia. In both cases, the law sets out a threshold 
point at which a person has capacity. In order to understand the legal right of autonomy, it 
is essential that these thresholds be appreciated. However, it is also important to remember 
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views and preferences can simply be ignored. This point will be returned to in the Further 
Discussion. 
First, however, it is necessary to consider Case 3. This case provides an example of the 
relevant threshold for legal capacity to make decisions for adults. This is based on an English 
case from 1993. In the Irish case of Fitzpatrick v K (2008), the Irish courts have held that the 
same standard applies in Ireland.
 
Re C (An Adult) 1993
Mr C had been detained in a mental hospital for many years. He developed gangrene in  
one leg and medical advice was that his leg needed to be amputated. Mr C resisted this and  
said that he would prefer to die with two legs than to live with one. Mr C also offered the view 
that God would save him and he referred to his own (delusional) belief that he was a world-
famous surgeon.
The Court held that Mr C had the necessary capacity to refuse the amputation even if the refusal 
would lead to his death. It was not relevant that Mr C had a mental illness. Everyone must be 
presumed to have capacity regardless of their underlying circumstances.  
The test for capacity related to his capacity to make this particular decision and not to his 
overall situation. The Court identified three questions as relevant in deciding if Mr C had  
legal capacity:
1. Could he understand the information relevant to the decision (to refuse the amputation)?
2. Did he believe the information?
Could he use this information to make a decision?
 
The Court found that Mr C understood the information relevant to his decision – including that 
if he did not have the surgery, he could die. He was also found to believe this information ‘in 
his own fashion’ and to be able to use this information to reach a decision. Therefore Mr C was 
permitted to refuse the amputation.
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6.3.1 Discussion 4
Although Case 3 happened in England, the test for capacity set out in Case 3 applies in 
Ireland as well. A Bill on Mental Capacity is due to be published and this is likely to become 
law in 2010. The standard for capacity set out in the Bill is likely to be more or less the same 
as that in Case 3. There are a number of features of the test for capacity as set out in Case 3 
which merit further reflection in an end of life context. 
First, all persons are to be presumed to have capacity. Just because a person is very old, or 
mentally ill, or intellectually disabled does not mean that a person can be presumed to lack 
the capacity to make his or her own decisions. It is especially important to remember this 
when dealing with older patients or patients with intellectual disabilities. Quinlan and O’Neill 
(2009, p.48) note the following view offered by one practitioner: 
‘I think the most obvious place where patient autonomy falls down is with ageism. If somebody 
is 30 or 40 or 50 we are much more likely to pay heed to what they’re saying and involve them. If 
somebody is 70 or 80 or 90 we’re much less likely to so. As a sweeping statement I think patient 
autonomy tends to decrease with age and I don’t think there’s a good reason for that but I think 
that is the practice of what happens’. 
A second important aspect of the test for capacity as set out in Case 3 is that, in most cases, 
it will be health professionals who will decide if a patient has capacity or not. This places an 
onus on health professionals to acquaint themselves with the legal test. As Shaun O’Keefe notes, 
this also presents challenges for many professionals (2008, p.44) who may be unfamiliar with the test 
for capacity or who may be unsure of what exactly is required. Respect for the principle of autonomy 
requires that capacity be assessed in a way which is fair and appropriate and which is free from 
prejudices based on external factors such as old age, mental illness or intellectual disability  
(Donnelly, 2009b). 
A final point about Case 3 is that capacity should be seen, not just as a characteristic which 
must assessed, but as a characteristic which must be developed. This view of capacity is 
consistent with the positive right of autonomy which is put forward in this module. Research 
shows that patients’ capacity can often be enhanced by quite simple steps, such as breaking 
down information into smaller ‘bites’ or making efforts to talk to patients in a way that 
they will understand (Gunn 1999, p.276). Clearly, this requires effort on the part of health 
professionals and, like many of the other efforts which delivering on the positive right of 
autonomy requires, this needs resource allocation. Time and commitment are crucial in 
deciding what can be achieved in terms of helping a person make autonomous decisions.
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Offences Against the Person Act 1996. This states that:
‘The consent of a minor who has attained the age of 16 years to any surgical, medical or dental 
treatment which, in the absence of consent, would constitute a trespass to his or her person, shall 
be as effective as it would be if he or she were of full age; and where a minor has by virtue of this 
section given an effective consent to any treatment it shall not be necessary to obtain any consent 
for it from his or her parent or guardian.’
This means that once a person is 16 years old, she or he can consent to treatment and the 
consent of her or his parents is not required. 
Section 23 does not mention the refusal of treatment. This leads to the question of whether 
a person aged 16 or more can refuse treatment in the same way as she or he can consent 
to it. This issue has not come before the Irish courts. It might be argued that consent and 
refusal are clearly two sides of the same matter and that the right to consent automatically 
includes the right to refuse treatment. However, the English courts, working with a broadly 
similar legal position, have held that the refusal of treatment is not the same as consent to 
treatment. This meant that a young person (below the age of 18) may have the automatic 
right to consent to treatment but does not have an equivalent right to refuse treatment. 
Instead, if a young person proposes to refuse treatment, the court must determine if this is in 
the best interests of the young person. 
There is a strong possibility that the Irish courts would adopt a position similar to that taken 
by the English courts. In such a situation, the young person’s views would have to be taken 
into account in deciding if treatment should be given.
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6.3.2 Suggested Professional Responsibilities  4
•	 If a question arises in respect of whether a person has decision-making capacity, it is 
the responsibility of the professional/s involved to investigate capacity.  
•	 If in doubt in this respect, the professional should seek a second opinion from another 
professional with expertise in the area of capacity assessment (perhaps a psychiatrist or 
a geriatrician depending on the circumstances).  
•	 If doubts remain, legal advice should be sought. 
•	 Professionals should familiarise themselves with the legal test for capacity as this is the 
relevant test to determine whether or not a person is legally entitled to make decisions.  
•	 Professionals should presume that patients have decision making capacity and should 
assess capacity in a way which is fair and free from prejudices based on old age, mental 
illness or intellectual disability. 
•	 Professionals should seek to facilitate people of borderline capacity in making decisions 
for themselves insofar as this is possible. This may require breaking information down 
into more easily understandable ‘chunks’ and making efforts to talk to patients in a way 
which they can understand
6.4 Case 4: Voluntariness and Decision-Making Freedom – Families and Patients
Respect for the positive right of autonomy requires that necessary efforts are made to ensure 
that patients are free to make their own decisions. This does not mean that professionals 
should not engage with patients or seek to inform them. Nor does it mean that professionals 
should not offer their own views as to what is the most appropriate treatment option or seek 
to persuade patients in this regard. The positive right of autonomy requires professional 
engagement not professional withdrawal. But, ultimately, the patient must be facilitated in 
feeling that he or she is free to make decisions and that decisions are not made simply to 
keep the relevant health professionals happy. 
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Interviews with hospital staff make clear that the role of family in decision making is among 
the most challenging of all ethical and legal topics. The challenges for a model of respect for 
autonomy of the patient while at the same time recognising the importance of families are 
evident in Case 4 which is taken from Quinlan and O’Neill (2009, p.59).
Families and Patients’ Decision-Making Freedom
 
I can think of an example a few weeks ago where this man just used to do the answering for his 
wife and, you know, like he did respect her decisions but he kind of – she had a brain tumour 
and he kind of used to answer the question before you’d get a chance to hear her answer and 
when we were offering her – her balance was very unsteady and we were offering her a place in 
the hospice and he said ‘no, no she can go home, we’ll manage at home’. 
And, you know, I suppose he was just not ready to let her go to the hospice and really keen to 
take her home and she went along with that but I felt that deep down, you know, if he was 
more open to the idea she’d have been more open to it as well because she was fearful that if 
she was at home the dogs would knock her over and that, you know, or that she’d be for periods 
on her own in the house – things like that.
6.4.1 Discussion 4
Keeping contact and communication with family is an essential component of a good 
framework for end-of-life decisions. Family input can be especially valuable with dementia 
patients. As one practitioner noted: 
‘We depend a lot on the relatives, you know, for the information we receive as well. 
Communication with family is a big thing really in the elderly. They know the person better. And 
I think it’s right that we listen to the family […] that’s one good thing here, that the family are 
always welcome all day and they’re involved a lot in the care.’ (Quinlan and O’Neill, 2008).
However, the position may not always be so straightforward. Another practitioner notes: 
‘There’s nieces an nephews who would know very little […] they turn up and make decisions that 
sometimes we know in our heart and soul the man would never have wanted.’  
(Quinlan and O’Neill, 2008)
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Case 4 reminds us that sometimes family members can limit patient autonomy. This can 
sometimes have negative effects for the patient and can lead to a patient being deprived of 
treatment which could make his or her dying easier or more pain-free. One palliative care 
physician explains in Quinlan and O’Neill (2009) that family can exert pressure to the point 
of not allowing their relative access to palliative care because they pressurise physicians to 
agree not to tell patients their diagnosis (See Module 2). Patients in this situation may also be 
placed in a very lonely and frightening position with nobody to talk to about their concerns. 
Respect for the positive right of autonomy requires that efforts are made to engage with  
the patient him or herself as an individual and not simply to deal with the patient through 
family members.  
6.4.2 Suggested Professional Responsibilities 4 
•	 Professionals have an obligation to provide honest advice to patients, including about 
treatment options. However, advice should not be allowed to become coercive. Patients 
should not be in any doubt that decisions are his or her to make.
•	 Professionals should recognise the pressures which families can place on p atients 
in end-of-life contexts. While recognising the importance of communication and 
engagement with family members, professionals should make efforts to ensure that 
the patient is not pressured into making decisions about end-of-life care which do not 
accord with what he or she wants or needs in order to keep family members happy. 
Health professionals may need to reassure both the patient and the family that the primary 
duty is owed to the patient. While this needs to be done sensitively, it is essential that this 
primary duty is maintained and that all parties involved are aware of it.
 
6.5 Case 5: Preserving Patient Autonomy - Advance Directives in Practice
While the role of patient autonomy where a patient has capacity is fairly straightforward, 
the issue becomes more complex when a patient lacks the capacity to make healthcare 
decisions. A lack of capacity can arise in two circumstances. A patient who formerly had 
capacity to make decision may have lost capacity, perhaps in an older patient due to 
conditions such as dementia or Alzheimer’s disease. Other patients may never have had 
capacity to make decisions. These may include very young patients or patients who have 
significant intellectual disabilities. 
For patients who once had capacity, it is possible in some circumstances to preserve patient 
autonomy, to a degree at least, even after a patient has lost capacity. There are two main 
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Powers of Attorney.
An Advance Directive or decision (sometimes known as a ‘living will’) is a decision made by 
a person while he or she has decision-making capacity regarding the medical treatment he 
or she would wish to receive (and more frequently not to receive) if he or she subsequently 
loses capacity. An Advance Directive may be stated in very general terms: i.e., ‘I would not 
wish to receive treatment for cancer’ or in much more specific terms: i.e., outlining specific 
treatments that a person would not wish to receive, for example, a patient may request a 
DNR or do-not-resuscitate order to be placed on his or her notes stating that he or she would 
not wish to be artificially resuscitated in certain circumstances. Advance Directives are  
usually made in writing and this is advisable because it provides a clearly indication of the 
person’s wishes.
An Enduring Power of Attorney is a document, again drawn up when a person has legal 
capacity, which gives another person (sometimes known as the donnee of the power) the 
power to make certain kinds of designated decisions if the person who drew up the Enduring 
Power of Attorney subsequently loses capacity. The principle behind this model for decision-
making is that the substitute decision-maker will act in way which represents the views of 
the person who has lost capacity. In this way, the autonomy of the person is preserved even 
though he or she has lost decision-making capacity. 
The advantage of the Power of Attorney model for decision-making when compared with 
the Advance Directive model is that it allows for a more nuanced and complex approach 
to decision-making. The person granting the power does not have to make firm advance 
decisions (although he or she may do so and communicate these to the person to whom 
the Power of Attorney is given) but can rely on his or her representative to act on his or 
her behalf. The substitute decision-maker can take account of all the factors, including 
developments in medical science, past wishes and current attitudes and situations in order 
to reach a decision about healthcare, including when life-sustaining treatment should be 
withdrawn. Clearly, however, this model requires a good deal of trust to be placed with  
the person granted the Power of Attorney. Depending on the circumstances, he or she  
has enormous control over the health and possibly even the life of the person who now  
lacks capacity. 
Legislation regarding Advance Directives has been common place in the United States since, 
at least, the mid 1990s. More recently, in England and Wales, the Mental Capacity Act 2005 
allows for advance refusals of treatment (but not for advance requests regarding treatment) 
and for the appointment of Enduring Powers of Attorney. There is no legislation in Ireland. 
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illness, an Advance Directive would be considered to be binding. Certainly, there is a strong 
ethical imperative to respect the stated wishes of the person in the Advance Directive. 
Three recent Irish reports have called for the introduction of Advance Directives in legislation 
(Irish Council for Bioethics, 2007; Law Reform Commission, 2008; Law Reform Commission, 
2009).  
This view seems to be shared by healthcare practitioners, one of whom says:
‘I actually think that we should start bringing in Living Wills, I really do because by the time 
it comes to the end of their lives, most of our patients don’t have a say because they’re either 
confused or they’re not compos mentis. You will try and listen to the ones that are and if you can 
make it possible you will make it possible but I do think we should bring in some sort of Living Will.’ 
(Quinlan and O’Neill, 2009, p.47)
The Law Reform Commission (2009) proposes the introduction of legislation dealing 
specifically with Advance Directives. The Commission’s Report sets out a draft Mental 
Capacity (Advanced Care Directives) Bill 2009. It proposes that this would apply to refusals  
of treatment only. However, the Commission recommends that a person should not be able  
to refuse basic care, which includes warmth, palliative care, nutrition and hydration.  
The draft bill also provides for the nomination of a healthcare proxy to carry out the wishes of 
the person.
Current Irish law does not permit Enduring Powers of Attorneys to be made in respect 
of healthcare decisions (although it does allow them in respect of property and welfare 
decisions). It is likely that a limited Enduring Power of Attorney to make healthcare decisions 
will be included in the forthcoming Mental Capacity Bill. However, it is unlikely that this will 
extend to decisions at the end of life.
As matters currently stand, very few people provide advance instructions as regards how 
they would wish to be treated towards the end of their lives (Weafer, McCarthy and Loughrey, 
2009). One practitioner notes that ‘a lot of people in Ireland don’t discuss or think about 
end-of-life decisions. I haven’t really had any experience where people have made a decision 
beforehand’ (Quinlan and O’Neill, 2009, p.42). In fact, research in other countries shows that 
this is not a uniquely Irish phenomenon (Francis 2001, p.561). In the United States, where 
legislation on Advance Directives has been in effect for many years, a relatively small number 
of people make Advance Directives. 
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There are many reasons why people, even people who are serious ill or elderly, may not 
choose to take this step. There may be an inherent privacy and reticence. Or there may be an 
understandable reluctance to face up to the unhappy prospect of death, serious illness or 
dementia. However, there are strong reasons why people who wish to make these kinds of 
decisions should be facilitated in doing so. 
An Advance Directive allows patients to direct their care even beyond incapacity. As Case 5 
shows, this allows patients a degree of control which would otherwise be impossible. Case 5 
is based on the facts of an English decision. 
 
Advance Directives in Practice
AK was a young man with progressive motor neuron disease. While he still had the ability to 
communicate, he made an Advance Directive setting out what should happen when he lost 
this ability. The directive stated that, when he signalled an intention – by blinking his eye in a 
particular way – this was a communication that ventilation should be withdrawn. 
The English Court approved the directive and when AK indicated that ventilation should be 
withdrawn, this was carried out with appropriate palliative care. 
6.5.1 Discussion 4
Case 5 is somewhat unusual in that AK did not lose the capacity to make treatment decisions 
as is normally the case where Advance Directives are employed. Rather, he lost the ability to 
communicate these decisions. However, from a practical point of view, loss of the ability to 
communicate decisions is similar in effect to loss of the ability to make decisions. 
Case 5 also reminds us that Advance Directives can serve to preserve life as well as decide 
when life should end. AK could have declined ventilation when it became necessary through 
a straightforward exercise of his right to refuse treatment. However, he was a young man 
who did not want to die at that time. He wanted to gain the maximum from his life for the 
time he had left. Because he could make an Advance Directive, he was able to avail of the 
possibilities for a longer life offered by ventilation while still ensuring that, at a time of his 
choosing, the treatment could be withdrawn. In this very sad situation, also, the knowledge 
that he had a means of control may have given the young man in Case 5 some consolation 
and fortitude and helped him to get the maximum benefit from the time he had left. 
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are not without ethical, or indeed legal, complexity. The liberal legal philosopher, Ronald 
Dworkin, himself a strong proponent of Advance Directives, uses an example based on a 
woman called Margo to explore the challenges to which Advance Directives give rise  
(1993, p.201). 
In the example, Margo has Alzheimer’s disease and has no long term memory and minimal 
short term memory. She is very contented and spends her days listening to music, reading 
(choosing pages at random) and painting pink circles. Her doctor described Margo 
as ‘the happiest person I know’. Dworkin imagines that Margo has made an Advance 
Directive stating that if she develops Alzheimer’s disease, she wishes to decline all medical 
interventions. He also imagines that Margo now develops a form of cancer which is easily 
treatable and for which treatment is relatively un-invasive and has a high likelihood of 
success. In other words, it is clearly in Margo’s current best interests that she should receive 
treatment. He asks whether Margo should receive the treatment notwithstanding her 
Advance Directive. 
Dworkin himself argues that Margo should not receive the treatment. He argues that her 
prior expressed wishes should take priority because respecting the autonomy of a capable 
person is the most important value. Other commentators such as Dresser (1986) disagree. 
She argues that Advance Directive are important but that they do not justify overriding the 
current best interests of a person who now lacks capacity. Dresser argues that the person 
lacking capacity should not be bound by the decisions of his or her former, capable self. 
Rather the current person’s best interests should take priority over his or her previously 
expressed views. Court cases on advance refusals of treatment have tended to support 
Dresser’s view rather than Dworkin’s. 
 
The ‘Margo’-type situation is unlikely to occur frequently. Most of the time, in end-of-life 
contexts, there will not be a clear conflict between what a patient’s Advance Directive 
proposes and his or her best interests. Rather, as in Case 5, the Advance Directive will dictate 
at a level of detail how the person should be treated. In this, Advance Directives can play an 
important role in allowing patients to retain control over their future care.
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6.5.2 Suggested Professional Responsibilities 4
•	 Although the legal framework for advance decision making is still limited in Ireland, 
professionals should engage with patients where possible in order to ascertain the 
treatment they would wish to receive if they lose capacity.  
•	 Most of the time, there will not be a clear conflict between the patients’ wishes 
expressed while capable and his or her best interests. In such a situation, the 
professional should take account of the previously expressed wishes in making 
decisions about treatment.
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7. Module 4 Further Discussion 
Autonomy is an important legal and ethical principle. The view of autonomy taken in this 
module is of autonomy as a positive right to control together with the steps required to 
make this meaningful, as well as a negative right to refuse treatment. This ethical conception 
of autonomy is broader than the legal conception. But this broader view is more helpful in 
thinking about decisions at the end of life.
7.1 Implications of the Positive Right of autonomy
Autonomous decisions must meet three requirements: the patient must have adequate 
information; he or she must have capacity and he or she must act freely without undue 
pressures from health professionals, family members or others. In respect of each of these 
requirements, there is a positive obligation to assist the patient in making autonomous 
decisions. This means that autonomy requires a good deal from health professionals and a 
commitment to autonomy will require resources. It is much less likely that pressured staff 
with limited resources and facilities will be able to dedicate the time and energy necessary to 
deliver autonomy as a positive right. 
7.2 Participation by People Lacking Capacity
An important final point to note relates to those patients who lack the capacity for 
autonomous decision-making, whether because they are too young or because they have 
dementia or another capacity-impairing condition. It should not be presumed that, simply 
because a person lacks the capacity to make an autonomous decision, his or her views 
should simply be disregarded. Patients who lack decision-making capacity have a right to 
participate in decisions made about them. 
As discussed in Module 3, the United Nations Convention on the Rights of the Child 
requires that children be permitted to participate in decisions in accordance with their age 
and maturity (Kilkelly and Donnelly, 2006). The United Nations Convention on the Right 
of Persons with Disabilities and Council of Europe Recommendation on Incapable Adults 
impose similar requirements in respect of adults lacking capacity. It is highly likely that the 
proposed Mental Capacity Bill will also include a requirement to this effect in respect of 
adults. 
It is not always easy for professionals to find a way to facilitate participation in end of life 
decisions by patients lacking capacity. As one professional interviewed by Quinlan and 
O’Neill (2009, p.54) recounts: 
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‘A child who is on the cusp of having their own autonomy, you’re looking at teenagers, and we 
see children here from premature babies up to 18, 19 and sometimes 20. We see children with 
intellectual disabilities as well and the whole role of autonomy for somebody with an intellectual 
disability and the challenges that poses, in terms of can they be autonomous? Are they allowed be 
autonomous? Whether that is from their parents’ side of things or from the medical point of view 
or the child’s own abilities. That’s a huge challenge.’
This professional identifies the challenges involved. However, there are ways in which 
patient participation can be facilitated notwithstanding the fact that a patient lacks capacity. 
The Code of Practice to the English Mental Capacity Act (2007) provides a useful resource 
in setting out ways to facilitate participation by adults lacking capacity. These include 
using simple language, speaking at the appropriate volume and speed, using appropriate 
words and sentence structure, breaking down information into smaller points, and using 
illustrations and/or photographs to help the person understand the decision to be made. 
Where a person has communication or cognitive problems, possibilities are offered by 
the use of picture boards, Makaton, signing, technological aids. For some people who are 
restricted to non-verbal methods of communication, their behaviour and, in particular, 
changes in their behaviour may provide indications of their feelings (Donnelly, 2009a). 
In making end-of-life decisions for patients lacking capacity, it is also possible to take account 
of the patient’s past wishes and preferences and to ask what the patient would have wanted 
if he or she had had capacity. Even if a person has not made a formal Advance Directive, 
there should be room for his or her prior preferences to be taken into account in determining 
what is in his or her best interests. In England, the Mental Capacity Act 2005 requires that, 
in making decisions about the best interests of a person lacking capacity, account should 
be taken of the person’s past and present wishes and feelings (and in particular any written 
statement made by the person when he or she had capacity) and of the beliefs and values 
that would be likely to influence the person’s decision if he or she had had capacity. It is likely 
that the proposed Irish legislation on capacity will contain a similar requirement. 
It is not always easy to find ways to take account of the prior views of a person when these 
have not been formally stated in an Advance Directive. It is crucial to consult with families 
and friends as to what the person was like before this illness and to ask what he or she would 
have wanted in the situation that now arises. It is essential that a space be created where 
the person who is now without decision-making capacity can influence the process to the 
maximum extent possible (Donnelly, 2009a). 
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7.3 Traditional Views of Autonomy
Because of the significance attached to autonomy, respect for autonomous choice is a 
core element of many different philosophical and political theories. Two philosophers, 
the eighteenth century German, Immanuel Kant (1724-1804), and the nineteenth century 
Englishman, John Stuart Mill (1806 - 1873), have greatly influenced the way in which we 
understand what respect for autonomy involves. 
7.3.1 Autonomy and Rationality
Kant appealed to the deontological belief that some things are intrinsically or inherently 
good, and that each person is intrinsically valuable or has unconditional worth because they 
have the capacity to be autonomous (See Module 1 for explanation of the deontological moral 
theory). For Kant, human dignity resides in the fact that each person has a free will which 
they can follow independently of their passions or desires. On his view, human beings can 
be distinguished from many other sentient creatures because, unlike animals, they are not 
wholly determined by their own immediate desires. 
Believing that human beings are able to act freely and independently of personal desires, 
loves and hates, Kant argued that they are capable of prescribing general moral rules or 
principles for themselves to follow. They can legislate for their own conduct. The neo-Kantian, 
Thomas Hill, takes this to mean that:
‘[T]he autonomy of a moral legislator means that, in debating basic moral principles and values, 
a person ideally should not be moved by blind adherence to tradition or authority, by outside 
threats or bribes, by unreflective impulse, or unquestioned habits of thought[…]. must try not to 
give special weight to his or her particular preferences and personal attachments […]. In other 
words, at the level of deliberation about basic principles, morality requires impartial regard for all 
persons.’ (Hill, 1991, p.45) 
On the Kantian view, human beings have a capacity for free, rational and impartial  
decision-making. This means that they are able to decide a course of action on the basis of 
careful reflection, and in the absence of coercion from authority or custom. In addition,  
they can decide the best course of action independently of their own personal preferences  
or inclinations. 
It is on the basis of this kind of autonomous capacity that each human being has a special 
status that deserves protection and respect for Kant. In his terms, failing to respect a person’s 
autonomy would involve treating that individual merely as a means to another’s ends, and 
not in terms of their own ineliminable value:
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‘So act as to treat humanity, whether in thine own person or in that of any other, in every case as 
an end withal, never as means only.’ (Kant, [1785], 1993).
7.3.2 Autonomy and Individuality
In his well-known thesis in On Liberty ([1859], 1991), John Stuart Mill also promoted respect 
for individual autonomy (or liberty), but on grounds different from those suggested by Kant. 
Mill viewed each person as worthy of respect, not because of their rationality or impartiality, 
but because of their unique individuality. He appealed to the utilitarian view – that an action 
is morally good if it gives rise to more good than evil – to support his position  
(See Module 1 for an explanation of the utilitarian theory). For Mill, respecting individual 
autonomy gives rise to more good than evil; society ought to respect autonomy because, in 
the long term, society benefits from doing so:
‘The worth of a State, in the long run, is the worth of the individuals composing it . . . a state which 
dwarfs its men in order that they may be more docile instruments in its hands even for beneficial 
purposes – will find that with small men no great thing can really be accomplished.’  
(Mill, [1859], 1981, p.187)
In other words, on the Millian view, individual freedom is compatible with, and contributes 
towards, the good of society as a whole. It follows that a person ought to be allowed to 
act according to their own life’s plan and their own beliefs and values, whether or not their 
actions are considered wise or good or foolish by everyone else. (One needs to read Mill’s text 
as referring to both genders when he uses the language of ‘small men’ etc.) 
For Mill, autonomy is not an absolute right. On his view, a state, or an individual, is justified 
in interfering with a person’s liberty when their action causes harm to others (this is known 
as the harm principle). He distinguishes between public and private morality, between 
those actions which affect others in society; ‘other-regarding’ actions, and those which affect 
only ourselves; ‘self-regarding’ actions. This is a classic liberal position which holds that the 
freedom of the individual can be compromised only when it is in competition or conflict with 
the rights and freedoms of other individuals. Respect for autonomy requires, on this view, 
that we refrain from interfering with the self-regarding acts and decisions that people make. 
‘[T]he only purpose for which power can be rightfully exercised over any member of a civilized 
community, against his will, is to prevent harm to others. His own good, either physical or moral, is 
not sufficient warrant. He cannot rightfully be compelled to do or forbear because it will be better 
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for him to do so, because it will make him happier, because, in the opinions of others, to do so 
would be wise, or even right. These are good reasons for remonstrating with him, or persuading 
him, or entreating him, but not for compelling him, or visiting him with any evil in case he does 
otherwise.’ (Mill, [1858], 1981, p. 68)
(See Module 7 for an example of the application of the harm principle in relation to patient 
confidentiality.)
7.4 Relational Autonomy
While, the principle of autonomy is one of the cornerstones of contemporary bioethics it 
is a highly complex and problematic one. Some thinkers repudiate the concept altogether, 
while others accept its value but dispute the meaning which has been attached to it. For 
example, some thinkers refuse to accept the concept of the autonomous self central to 
modern Western philosophy – namely, the depiction of the self in abstract, asocial terms as 
an independent and rationally self-sufficient individual – and demand a new conception of 
autonomy which recognises the inherently social nature of human beings (MacIntyre, 1981; 
Sherwin, 2008; Taylor, 1989). According to this interpretation, the self is essentially social: 
 ‘We are not isolated atoms, or islands, or self-contained entities, but rather products of historical, 
social, and cultural processes and interactions. The existence of any person is dependent on the 
existence and social arrangements of many others. Our interests are discovered by and pursued 
within social environments that help to shape our identities, characters, and opportunities. […] 
relational autonomy […] requires us to examine the types of options on offer and ask questions 
about how these have arisen and also about options that are not available or accessible.’  
(Sherwin, 2008, p.12)
One of the implications of viewing the self as profoundly social is to accept that one’s actions 
are determined or influenced by one’s social context. Secondly, one’s social attachments may 
motivate one’s actions, and, finally, one’s very identity may be constituted by these social 
attachments (Barclay, 2000). 
In the first of these senses, the relational autonomy position rejects the idea of autonomy 
as simply a matter of deciding what one wants or desires. Relational theorists insist that 
attention is paid to the social circumstances which inform or ground desires of any kind. 
Such social circumstances include social norms and oppressive patterns. The skills and 
competencies for the exercise of choice to begin with include self-trust, self-understanding 
and self-direction, self-worth – and these may be undermined or made possible in the  
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company of others. On this view, the actions of individuals are framed and contrained by the 
opportunities available to them. In addition, the ability to imagine and pursue a course of 
action depends on options available. 
Autonomous capacity, on the relational view, can be understood as the ability to negotiate 
the effects of socialisation by actualising certain capacities, including the capacity to choose 
preferences, goals and projects and make them one’s own (Barclay, 2000, p.54-5). The 
implication of this view for health professionals and organisations is to enable patients to 
develop their capacity to direct their care: autonomy is not simply something that is assessed 
but it is something that is developed (Barclay, 2000, p.57).  
A second implication of viewing the self as social is to see the self as ‘motivationally social’; 
that is, primarily motivated to act, not by rational self-interest or by a striving for self-
sufficiency – as caricatures of the modern ideal of autonomy would suggest – but by a sense 
of solidarity and by deep attachments to other people (Barclay, 2000, p.60). This view, is 
supported by international and Irish research with patients and families who are terminally 
ill and who often prioritize the interests of their loved ones over their own (Quinlan 2009a; 
Weafer, McCarthy and Loughrey, 2009). 
The third sense in which the self may be described as social – the ‘constitutively social’ 
self – involves understanding one’s identity as a product of one’s social relationships and 
attachments.On the view of the philosopher, Michael Sandel, for example, the goals and 
ends which define us as who we are, are not private, but shared; they are the goals and ends 
of the communities of which we are a part and they are formed by participation in these 
communities. We don’t so much choose these ends as discover them when we reflect on who 
we are and what we aspire to (Barclay, 2000, p.65). For Sandel, the classic expression of the 
rational exercise of autonomy involves a person ranking their desires and choosing that plan 
of action which will satisfy as many of their principal desires as possible. Against this, Sandel 
argues that even the evaluation of our desires presupposes a set of socially-shared values 
which constitutes who we are; it is this set of ‘constitutive values’, rather than our desires per 
se, which forms the foundation for our choices and actions. 
Finally, it has been suggested feminists such as Barclay (2000) and Sherwin (2008) that the 
fact that our choices are socially determined and our identities are socially mediated opens 
up the possibility of change and liberates us to choose reflectively which values to endorse 
and which goals to prioritise. And this reflection upon which relationships and attachments 
we choose to promote does not undercut, but reinforces, the importance of the capacity for 
autonomy, understood as relational.
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 8. Module 4 Summary Learning Guides
8.1 The Nature of Autonomy 
•	 The right of autonomy protects a person’s interest in making significant decisions about 
his or her own life
•	 Autonomy is not just a negative right – a right to say no but also a positive right – a 
right to be facilitated in taking control of one’s dying to the maximum extent possible
•	 Autonomy is especially important in a hospital setting
•	 Concern with autonomy is to some extent a cultural phenomenon which is especially 
associated with Western liberalism
8.2 The Legal Right of Autonomy 
•	 This right is protected under the Irish Constitution and the European Convention on 
Human Rights
•	 The legal right is very often seen as a negative right – a right to refuse treatment
•	 As part of protection of the legal right of autonomy, capable adults have the right to 
refuse medical treatment even if the refusal leads to their death
•	 But there are some limits: duties to others may arise –the extent of these duties is not 
clear
8.3 Information is Key to Autonomy 
•	 The positive right of autonomy requires that patients are informed
•	 ‘Informing’ in this sense requires more than simply passing on information: 
communication is essential
•	 ‘Informing’ is an ongoing process – it is not a once-off event
•	 Legal requirements in respect of information provision are insufficient in protecting a 
patient’s positive right of autonomy
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8.4 The Role of Decision-Making Capacity and Freedom
•	 Legal capacity is a prerequisite for the legal right of autonomy
•	 For adults, legal capacity requires that the person can understand information relevant 
to the decision; believe the information and use the information to make a decision
•	 Young people can consent to treatment from the age of 16
•	 There is still legal uncertainty regarding whether young people from the age of 16  
can refuse treatment (if the refusal is not considered to be in the young person’s  
best interests)
•	 To be autonomous, decisions must be freely made
8.5 Advance Decision-Making
•	 An Advance Directive or ‘Living Will’ is a binding instruction made by a person with 
capacity about the treatment that the person would wish to receive or to refuse if he or 
she subsequently loses capacity
•	 There is no legislation in respect of Advance Directives in Ireland. However, the courts 
have approved Advance Directives in principle
•	 An Enduring Power of Attorney allows a person with capacity to designate a person to 
make decisions on his or her behalf if he or she subsequently loses capacity. 
•	 Although there is legislation on Enduring Powers of Attorney in Ireland, it does not 
currently include healthcare decisions
•	 Advance Directives and enduring powers of attorney provide a means of preserving 
autonomy after losing capacity
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8.6 Autonomy and the Person without Capacity 
•	 The fact that a person lacks capacity does not mean that his or her views should be 
completely disregarded
•	 It is important that a person without capacity be facilitated in participating in decisions 
about end-of-life care where possible
•	 Efforts must be made to take account of the past preferences of a person without 
capacity and of what he or she would have wished to happen in a situation like  
this Consultation with family and friends about what the person would have wanted  
is essential
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9. Module 4 Activities
9.1 Recall the distinction between the positive right of autonomy and the negative right 
of autonomy: 
a. Would you add anything further to these points on the distinction?
b. What actions on the part of health professionals are needed to give effect to a negative 
right of autonomy?
c. What actions on the part of health professionals are needed to give effect to a positive 
right of autonomy?
d. Which form of autonomy is easier to deliver?
e. Which form of autonomy is most important? Or are both equally important?
9.2 Reflect back on the particulars of Case 1:
a. In reading Case 1, jot down your first, unanalysed response to the facts set out.    
b. Do you think that the woman in this case should have been required to experience life 
outside the confines of the ICU before her decision to have ventilation withdrawn  
was respected? 
c. In your view, is there a conflict between health professionals’ ethical duty to care on the 
one hand, and legal duty to respect a patient’s refusal of treatment, on the other? If there 
is a conflict, how should this be resolved?
9.3 Reflect back on the particulars of Case 2:
a. In your experience do patients often actively seek information towards the end of life? 
b. Why is information essential to the positive right of autonomy? 
c. Set out the information which, in your view, is most important for patients to receive in 
order to help them make autonomous decisions? 
d. Do communication breakdowns occur often in practice; if so, what steps can usefully be 
taken to avoid this occurring?
9.4 Reflect back on the particulars of Case 3:
a. What are the requirements for the legal test for capacity? Do these requirements strike 
you as sensible? Try to imagine yourself applying these requirements to a real patient 
that you have met in the course of your work? 
b. Does it strike you as sensible that the law regards capacity as a threshold concept and 
not a comparative one? Can you see any reasons for the law’s approach? Can you see any 
difficulties with applying this approach in practice? 
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c. In your view, do professionals in practice make assumptions about capacity in respect of 
certain categories of patient? If so, which categories?
d. Do you believe that a patient’s capacity can be enhanced? If not, why not? If so, what in 
your view are the most appropriate ways to enhance patient capacity?
9.5 Reflect back on the particulars of Case 4:
a. In your view, is it ever possible for a patient to make a wholly independent decision? If 
not, why not? If so, why? 
b. At which point, in your view, does a professional begin to exert an inappropriate degree 
of influence on patients in decision-making at the end of life? 
c. To what extent does a professional have an obligation to protect a patient against the 
pressures of family members? What difficulties do you think professionals experience in 
this kind of context? 
9.6 Reflect back on the particulars of Case 5:
a. What role, in your view, should Advance Directives play in end of life care?
b. Reflect on the case of Margo. In your view, should Margo have had the treatment for 
cancer notwithstanding her express statement in an Advance Directive that she did not 
want this treatment? If so, why; if not, why not?
c. Do you think that many Irish people are likely to make Advance Directives? If so, why? If 
not, why not?
d. Which form of advance decision-making do you think works best: Advance Directives or 
Enduring Powers of Attorney? What are the limitations in each model?
9.7. Read Chapter 3 of the Code of Practice to the Mental Capacity Act 2005 
available at www.justice.gov.uk/guidance/mca-code-of-practice.htm
a. Is participation important even for patients who lack decision-making capacity?  
If so, why? If not, why not?
b. Can you think of ways to enhance the autonomy of adults who lack decision- 
making capacity?
c. Can you think of ways to enhance the autonomy of children who lack decision-  
making capacity?
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Module 5
The Ethics of Managing Pain
MODULE FIVE
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ain 1. Module 5 Key Points 
1.1 Bad deaths 
often occur as a result of poor pain and symptom management, inadequate communication 
and the experience of abandonment and isolation. Very often bad deaths occur where there 
is inappropriate and, arguably, unethical active treatment and when obstacles prevent 
patients from accessing palliative care. 
1.2 Comprehensive pain management 
includes not only specialized clinical programs to control physical pain, but also counselling 
and human support to minimize psychological pain and soul pain, family and community 
support groups to counter social pain and pastoral care resources to address spiritual pain. 
These aspects of pain are interrelated and sometimes hard to distinguish. If efforts to manage 
pain focus on one aspect to the neglect of the others, the patient may not experience 
genuine relief. This can lead to the patient developing anxiety and concern about the ability 
of staff to control their pain. 
1.3 Family resistance to palliative care 
deserves a careful conversation with health professionals to see why they don’t want their 
loved one to receive such care. At times families can strongly influence health professionals 
who might think that palliative care would benefit a patient. Doctors and nurses can 
come under considerable pressure from patients and families who have assumptions and 
preconceptions about palliative care, such as ‘I’m going there to die’ or ‘I’ll be drugged to 
my eyeballs’ (Quinlan and O’Neill, 2009, p.31-34). This resistance can abandon patients to 
unnecessary suffering.
1.4 Good deaths are more likely to occur 
when the beliefs, values, preferences and individuality of patients are respected and all 
pain management services are put in place. The experience of pain can diminish the energy 
and clarity of thought in attempts to exercise autonomy. Thus, the possibility of autonomy 
in practice is nurtured and enhanced by the management of a person’s pain. Unrelieved 
pain experience is the most debilitating part of illness. In characterising a ‘good death’, the 
absence of pain is central. 
1.5 Health professionals may fail to give patients adequate relief from pain 
for a number of reasons including: basic ignorance of the magnitude of the doses needed to 
relieve severe pain, an inappropriate fear of causing respiratory distress, a misplaced anxiety 
about the hazards of addiction or a fear of civil or criminal prosecution. 
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The reasons for this vary according to gender, cultural background, religious beliefs, age etc. 
Patients also say they do not know how to describe their pain so as to get the right kind of 
help from health professionals. Their pain may be a combination of physical, psychological 
and soul pain. There are also concerns about being viewed as weak or a ‘complainer’, or the 
patient may observe that staff resources are low and think that time is simply not available to 
discuss pain relief.
1.7 The principle of beneficence 
or active concern for and promotion of, patient well-being would rank pain relief and 
management among the most important objectives in caring for patients suffering from 
painful illnesses. Engaging the patient in discussion about their pain, about their concerns 
in relation to that pain and about what they hope for is reassuring for any person in the 
institutional setting of a hospital. 
1.8 Slippery Slope concerns apply to many areas of decision-making. 
The form of the concern is this. If we take a particular decision, even if it is a good decision, 
we need to ask: is it likely to lead to another decision which we would not desire or think 
is good? Slipper-slope concerns in allowing competent patients to decline all life supports 
would be that we might slowly come to think it is justified to discontinue all life supports 
for patients lacking competence who seem to us to lack a good quality of life. One of the 
difficulties with slipper slope worries is that they can frustrate very good decisions out of fear 
that less desirable consequences will follow.
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ain 2. Module 5 Definitions
2.1 Euthanasia: 
is a deliberate act or omission whose primary intention is to end another person’s life. 
Literally, it means a gentle or easy death but it has come to mean a deliberate intervention 
by one person with the clear intention of ending the life of another. This is often described 
as ‘mercy killing’ of people in pain with terminal illness. Decisions to withdraw or discontinue 
life supports are not equivalent to euthanasia if they are validly authorised by a competent 
patient’s consent or if a clinical decision is made that further life supports, based on all 
available evidence, would be futile – lacking in benefit for the patient and merely prolonging 
the dying process. 
2.2 Life Prolonging Treatment (LPT): 
is any medical intervention, technology, procedure or medication that is administered to 
provide benefit for a patient and to forestall the moment of death. These treatments may 
include, but are not limited to, mechanical ventilation, artificial hydration and nutrition, 
cardiopulmonary resuscitation, haemodialysis, chemotherapy, or certain medications 
including antibiotics. 
2.3 Palliative Care: 
a comprehensive approach to treating serious illness that focuses on the physical, 
psychological, spiritual and existential needs of the patient. Its goal is to achieve the best 
quality of life available to the patient by relieving suffering and controlling pain and other 
symptoms associated with the particular illness of the patient.
2.4 Palliative Sedation: 
is offered to patients if standard opioids are ineffective in managing their pain. It is used 
to induce an artificial coma especially in cases in which a dying person is experiencing 
severe, intractable suffering. The intention in using palliative sedation is to induce a state 
of decreased, or absent, awareness (unconsciousnss) in order to remove the burden of 
suffering in an ethically acceptable way for patient, family and healthcare providers. The term 
‘palliative sedation’ has largely replaced the previously used term of ‘terminal sedation’. 
2.5 Physician Assisted Suicide (PAS): 
the act of assisting a person to die by providing the means for them to take their own life. 
A recurring example of PAS is the act of giving a prescription or supply of drugs to a patient 
who has requested this. The doctor providing the lethal dosage of drugs thus enables a 
patient to end his or her own life. 
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ain 2.6 Principle of Double Effect (PDE): 
an ethical rule which holds that effects of treatment which would be morally wrong if 
brought about intentionally are permissible if they are foreseen but unintended. The 
principle is often cited to explain why certain forms of care at the end of life which may risk 
and/or hasten death are morally permissible while others are not. 
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One of the classic themes of healthcare ethics concerns the moral acceptability of 
interventions to modify the dying process. Developments in the practice of palliative care 
give rise to new discussions about the ethical aspects of medical care at the end of life.  
This module focuses on these discussions. 
3.1 Ethical Principles in Pain Management
3.1.1 Respect for Patient Autonomy (See Module 4, 4.2)
The moral principle of autonomy is pivotal in conversations with competent patients 
when considering options for pain management. The experience of pain can diminish the 
energy and clarity of thought to exercise autonomy. Thus, encouraging and fostering a 
patient’s understanding and decision making in relation to these options through sensitive 
information sharing shows interest in the facilitation of patient autonomy. In fact, the 
possibility of autonomy in practice is nurtured and enhanced by the management of a 
person’s pain (See Module 3). 
3.1.2 The Principle of Beneficence
The active concern and promotion of patient well-being would put pain relief and 
management among the most important objectives in caring for patients suffering from 
painful illness. Engaging the person of the patient about their pain, about their concerns  
with that pain and what they hope for is reassuring for any person in the institutional setting 
of a hospital. 
Patients may have difficulties in speaking about their pain and seeking pain relief. This can 
apply to adults but applies especially to children. Describing pain is not easy and sometimes 
a patient may think they will be perceived as a complainer and incur the displeasure of staff 
(McCracken and Keogh, 2009).
One narrative recounted in an Irish hospital setting makes clear that some patients are 
assertive about their preferred pain relief methods:
‘Recently I became aware of a 90-year-old lady who is in long term care in a residential unit. The 
lady is as fun-loving and active as her physical abilities allow. The lady has terminal cancer. She 
has no relatives and receives weekly visits from the palliative care team. Approximately 6-8 weeks 
ago the lady decided that she had had enough of the pain medication as it wasn’t helping her 
and she indicated she would prefer whiskey at night instead. The staff discussed this with her  
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and she remained very clear that this was her wish. The palliative care team was in agreement. 
Arrangements were made for a supply of whiskey to be on hand and the lady reported that 
the whiskey in her tea is a far more effective means of pain relief. She said she feels better in the 
morning as she is guaranteed a more peaceful night.’ (Quinlan and O’Neill, 2008, p.26-7)
This amicable result came about not simply as a result of listening but by actively hearing 
what the patient was saying. The staff was flexible in responding positively to this request for 
‘whiskey therapy’. The 90-year-old lady was shown respect and her subsequent contentment 
showed her delight at this concern for her well-being. The staff’s decision to provide whiskey 
heightened the patient’s sense of self and allowed sleep and serenity. With this simple 
method of pain management for this lady, staff showed moral respect for her unique person. 
The scenario that follows describes a less fortuitous outcome than in the case of the elderly 
lady above.
‘An 82-year-old lady with a diagnosis of COPD respiratory failure was being managed by the 
respiratory team. There were numerous requests from her for pain relief and symptom control. 
Inappropriate analgesia was prescribed and the patient was unable to swallow. While on night 
duty at 9.30 pm, I had to contact the Registrar on call and insist on analgesia, anti-emetics and 
hypocrite to dry secretions and promote comfort. The family were very distressed. The registrar 
came at 11.30 pm and spoke to the family and infusions were commenced. The patient was only 
comfortable at 12.30 am. When I looked at the Nursing and Medical Notes, this had been going 
on for four days.’ (Edited narrative, Quinlan and O’Neill, 2008, p.1)
It would seem that the pain suffered by the 82-year-old lady in this scenario is not all that 
rare internationally. Cassel, (1999) claims that a great deal of pain is inadequately treated. He 
explains that, ‘too much suffering is unrelieved and undiagnosed, a situation more common 
now than a generation ago because current treatments keep people alive long enough to 
enter the chronic, terminal phase of their illness: the duration and severity of their suffering 
are thereby increased’ (Cassel, 1999, p.531). He also traces the prevalence of untreated pain, 
in part, to deficits in physician training which focuses on organs, diseases and aetiology 
rather than on persons as individuals with their unique fears and hopes.
‘The diagnosis of suffering is often missed, even in severe illness and even when it stares physicians 
in the face. A high index of suspicion must be maintained in the presence of serious disease, and 
patients must be directly questioned […] Often, questioning and attentive listening, which take 
little time, are in themselves ameliorative. […] The language that describes and defines  
the patient’s  
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suffering is different from the language of medicine – there is too often an actual disconnect 
between our case history and the patient’s narrative […] Physicians are trained primarily to find 
out what is wrong with the body – in terms of diseases or pathophysiology; they do not examine 
what is wrong with persons […] when physicians attend to the body rather than to the person, 
they fail to diagnose suffering.’ (Cassel, 1999, p.531)
3.1.3 Nonmaleficence
 The value of nonmaleficence, or, ‘Do no Evil’ is closely linked to the objectives of pain 
management. Lack of adequate pain management causes harm to the patient. The harm, 
worry and, at times, consequent depression of painful suffering, and accompanying anxiety 
needs no elaboration beyond the ethical and empirical research on end-of-life care. (O’Shea, 
Keegan and McGee, 2002; Bon Secours Health System, 2007; German National Ethics Council, 
2006) Unrelieved pain is the single factor accounting for patient experiences of a ‘bad death’
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The discussion in this module shows that pain and suffering are not homogeneous 
realities and that the practice of thinking beyond the conventional limits of physical pain 
management serves patients well. Pain relief is one of the most important goals of palliative 
care where such care is universally understood as a comprehensive philosophy of care 
which includes pain and symptom management, support for patient and family and the 
opportunity to achieve meaningful closure to life (Deandrea, Montanari, Moja et. al., 2008).  
A good death survey has shown that one of the elements in a good dying is skilled pain and 
symptom management and that lack of such skills ensures a ‘bad death’ (Steinhauser et. al., 
2000). If the elements of a good death call for good pain and symptom management, the 
provision of syringe drivers, the management of nausea and vomiting, and the establishment 
of good relationships between patients, families and health professionals, then the earlier 
palliative care can become involved with the patient the better. 
4.1 Family Reluctance
The research conducted by Quinlan and O’Neill (2009) shows that adequate pain relief 
is sometimes not achieved because, for a variety of reasons, family members choose not 
to have their loved one receive palliative care. As one health professional interviewed 
commented:
‘I find on the ward that Palliative Care isn’t brought in soon enough. I do feel that, especially with 
pain management because it’s something I feel very strongly about. I still find that sometimes 
teams are resistant to involve palliative care for pain control. I don’t know why, I just feel there’s 
some resistance.’ (Quinlan and O’Neill, 2009, p.35)
Another health professional observed:
‘[W]e would have patients who end up not seeing the palliative service because that’s not 
acceptable to the family and there’s been backwards autonomy in the first place, I mean that the 
autonomy has been given to the family – the family decides whether or not the patient is seen by 
Palliative care. It should never arise [...] and the family say ‘well you’ve got to guarantee me you 
won’t tell them that they have cancer otherwise I’m not bringing them in.’  
(Quinlan and O’Neill, 2009, p.68, see also, p.27)
The role of families in healthcare decision making is a profoundly important issue. If family 
involvement in decision making is judged to be damaging to the well-being and proper care of a 
patient, then health professionals cannot, with good conscience, comply with family requests.  
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The family may tend to claim proxy authority to decide for the patient, especially when the patient 
either lacks capacity or has declined to be involved in decision-making about pain management. 
However, there is a mandate here for staff to engage families and report the harm they are doing 
to their loved ones in denying them pain management or access to palliative care. Failure to seek 
palliative care often means that pain continues needlessly and the moral obligation of carers to 
provide for the well-being of patients is not met. Reluctance to use palliative services points to 
a very urgent need for education in palliative care for health professionals and the wider public 
(Randall and Downie, 2006). 
4.2 Staff Collusion 
But unfortunately, there can be unwitting collusion among some clinicians in a family’s 
refusal to have palliative care for their loved one. 
‘There is a patient who is at home who I know from the referring physician and […]this patient is 
very unwell, needs the type of palliative support that we can offer and our community teams can 
offer but this patient went home and the doctor whose care they were under agreed not to tell 
them their diagnosis. They are now at home, the family isn’t telling the diagnosis and the patient 
isn’t being allowed access to palliative care because, we, palliative service, will not agree, if the 
patient asks us why this has happened, to not telling them the diagnosis (Quinlan and O’Neill, 
2009, p.63). See also Module 2, 6.1.1 and Module 4, 6.4.
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ain 5. Dimensions of Pain
Pain is an intriguing phenomenon and we have only begun to understand its complexity. 
Pain most often is multi-dimensional, consisting of a range of symptoms and types of 
suffering: physical, psychological, social, spiritual and ‘soul’. In the cases that follow in this 
module, there is often a combination of different types of ‘suffering’, resulting in each 
patient’s set of unique pains. The pain experienced in terminal illness is much more than 
physical. The combination of many dimensions of pain can overwhelm dying patients and 
weaken their sense of control, sense of purpose and meaning. It can also weaken their sense 
of connectedness to others. If effective patient care is to ensure pain relief, the patient needs 
to be seen in holistic terms as integrating emotional, physical, spiritual, cultural and social 
causes of pain. Michael Kearney uses the phrase, ‘total pain’, to refer to the combination of 
the different pain components most often encountered (Kearney, 1996, p.24). 
5.1 Physical Pain
Physical pain is the most obvious form of pain and major cause of suffering. It impairs 
physical functioning, mood, and social interaction. Physical pain serves as a clear warning 
that something is out of order in the normal functioning of the body. But, since pain affects 
the whole person, it can easily exceed its function as a warning signal. Severe pain can drive a 
person to request its removal at any price, even to the point of asking for death for oneself or 
for others. 
5.2 Psychological Pain
Psychological pain often arises when facing the inevitability of death, losing control over 
the process of dying, letting go of hopes and dreams, or having to redefine the world one is 
about to leave in terms that never quite satisfy one’s needs. Psychological pain is evident in 
the mood swings and strong feelings that often accompany terminal illness. (See Case 6.1)
5.3 Social Pain
Social pain is the pain of isolation. The difficulty of communicating what one is experiencing 
while dying creates a sense of aloneness at a time when companionship is most needed. 
The unwillingness or inability of others to keep company with the dying by visiting 
them, listening to their feelings and experiences or discussing the implications of what 
is happening to them only aggravate the isolation. The loss of a familiar social role is also 
painful. For example, letting go of the role of being a self-sufficient, caring parent and 
becoming the one who is dependent and cared-for can be socially and psychologically 
painful (Ranger and Campbell-Yeo, 2008).
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ain 5.4 Spiritual Pain
Spiritual pain arises from a loss of meaning, purpose and hope. Despite society’s apparent 
indifference to the ‘world beyond this one’, spiritual pain is inescapable and widespread. 
Everyone needs a framework for meaning – a reason to live. People who are dying often seek 
a larger landscape of meaning and therefore need to feel part of a community that shares 
that meaning. Some patients can find meaning and solace in a religious belief.
Spiritual pain endured by those patients with religious belief can arise from: 1) concern and 
anxiety about their relationship with their God; 2) worry that they might not remain steadfast 
in their faith while suffering pain and illness; 3) worry about whether a priest or chaplain will 
be with them when needed to offer spiritual companionship and religious solace. 
Issues of faith are frequently mentioned by dying patients as integral to the overall healing 
at the end of life. This often becomes more important as the patient declines physically 
(Steinhauser et. al., 2000). As evidenced by research with patients, spiritual pain can cause 
genuine suffering when patients are either denied spiritual companionship or have it 
provided without respect for their refusal (Quinlan and O’Neill, 2009, p.32).
5.5 Soul Pain 
is a particularly profound and excruciating form of pain. ‘Soul’ is here used in its more classical 
sense as meaning ‘psyche’ and is without religious connotations (Kearney, 1996, p.57). It is 
manifested in an all-pervading sense of emptiness, hopelessness and meaninglessness and 
characterised as anguished, tortured and restless (Kearney, 1996, p.62). Patients experiencing 
soul pain may request help to become unconscious as seen in the following case.  
(See Case 6.5)
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ain 6. Cases in the Ethics of Pain Management
6.1 Case 1: Psychological Pain of Anticipation – ‘I Dread What May Come’
The following case illustrates the pain that can accompany psychological dread of what is  
to come.
 
‘I Dread What May Come’
[...W]hen I was in a centre of adult Palliative Medicine, we came across Maurice, a young 
gentleman of 32, who was referred to us after he had attempted to commit suicide and he had 
thrown himself into the local river. The reason that he had tried to commit suicide was that 
he had a diagnosis of cancer which he’d lived with for about eight years at this stage but was 
developing increasing pain. He was worried that if his pain was so bad at this stage and not 
controlled, how bad was it going to be when he was closer to death? It was really his fear about 
symptoms, you know, not being controlled. So he was able to relay all this to us, and we then 
got his pain under control, relatively easily I suppose, it’s what we do every day, and we were 
able to reassure him that his pain would never have to be out of control as it had been and 
thereby his suicidal ideation completely resolved. (Quinlan and O’Neill, 2009, p.34) 
6.1.1 Discussion 5
This case looks at the stressful reality of what we term anticipatory pain. Such pain is not 
uncommon even in ordinary life as we wait for the colonoscopy or go into the nursing home 
to see our failing elderly parent. What we call anticipatory pain comes under the heading 
of psychological pain. Psychological pain is indeed a form of authentic suffering. It is not 
illusory, nor is it simply ‘in the mind’. Anticipating the real probability that one’s manifest 
pain will increase in severity and regularity as one’s disease progresses can exacerbate 
psychological suffering. Anticipatory suffering can be excruciating and requires relief using a 
variety of interventions. 
Case 1 is a good news story in terms of the result for this patient and for the health 
professionals who listened to Maurice’s desperate pleas for relief from his present pain and 
excruciating anticipatory pain. Maurice was not only saved from his attempted suicide but he 
was given an opportunity to speak openly about his dread of increasing pain.  
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He was given relief and hope, through being assured of on-going pain management.  
This young man’s act of attempted suicide secured for him the therapeutic pain management 
and compassionate conversations with staff that he needed. Health professionals responded 
when the patient demonstrated dramatically by means of a suicide attempt that he needed 
solace, communication, pain management and emotional support (Cassel, 1999).
The psychological pain for this man has at least three sources.
•	 He has lived with his cancer diagnosis for eight years and, given to reflecting on this 
reality, he experiences on-going stressful pain. There is a belief among some patients 
with a diagnosis of cancer that it is only a matter of time before the cancer cells all go 
haywire (Steinhauser et. al., 2000). The unique character of the person suffering certainly 
affects the nature, intensity and stressful nature of this prolonged pain of thinking ‘how 
will this end, will I die in pain like this? What will it be like?’  
(Terry, Olson, & Wilss, et. al., 2006, p.342).
•	 The second source of psychological pain was the fear and hopelessness that led to 
his attempted suicide in the local river. Again, the unique personal nature of his ever-
present worries about his condition would have drained him of energy both physical and 
emotional. One difficulty with psychological pain is that the depression associated with 
it often leads the individual to believe (even subconsciously) that there is no solution. 
This is the essence of hopelessness and often can only be counteracted by human 
intervention. Persistent hopelessness is not a normal part of dying; it requires therapeutic 
attention (Cassel, 1999).
•	 A third source of psychological pain came for this patient with the measurable increase in 
his pain. With this increase, Maurice became very frightened and assumed that the cancer 
was all over his body. 
This situation might have been prevented earlier if Maurice’s family, GP or a trusted friend 
had heard about his pain, or had heard his concerns however subtle and encouraged him 
to seek help. An outpatient drop-in-clinic for patients in need of pain relief, while quite 
uncommon in Ireland, would provide patients like Maurice with help in reviewing and 
monitoring his developing symptoms and give him reassurance. With help from hospital 
staff and on-going sessions with his GP, Maurice might now continue living his days with his 
illness but in greater psychological security.
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•	 Suicide is a cry for help and clear reaction to fear, frustration, sense of isolation and 
hopelessness. In a conversation with Maurice, hospital team should find out if there was 
any previous history of suicide attempts or suicide ideation. 
•	 A consultation with the clinician (preferably pain specialist) needs to give Maurice 
reassurance, as the case indicates, that any developing pain can and will be treated. 
•	 An assessment can be offered to see what medicinal or other therapeutic help can be 
offered to Maurice for possible depression associated with his anxiety and  
anticipatory pain.
•	 A report of Maurice’s attendance in hospital should be prepared and sent to Maurice’s 
family doctor stating that the hospital clinician advised Maurice to see her within the 
next couple of weeks. 
•	 Since Maurice’s worries are linked to his fear of dying as pain increases, a careful 
assessment of Maurice’s cancer condition should be arranged with the oncologist.  
This assessment can follow with a conversation about his cancer condition and 
specifically what therapeutic helps can be offered to him.
•	 This consultation and recommendations for Maurice should be documented for the 
hospital records so continuity of care can be better ensured if or when Maurice returns  
to hospital. 
6.2 Case 2: Interpreting Children’s Pain – ‘I Never Saw Anyone Suffer Like That in My Life’ 
Managing the pain of hospitalised children, even very young children, is one of the more 
profoundly challenging tasks in pain management. The ethical principles of the duty to 
benefit another (beneficence) and the duty to do no harm (nonmaleficence) oblige health 
professionals to provide pain management to all patients, including children, who are 
extremely vulnerable because of the constant developmental changes they undergo and 
the attendant insecurities of being ill and hospitalized in a strange setting (Kortesluoma, 
Nikkonen and Serlo, 2008, p.143-144). Evidence also shows that we often underestimate 
the need to give room to a child’s voice, failing to pay attention to verbal or bodily cues 
and therefore we fail to promote the child’s incipient autonomy during hospitalisation 
(Royal College of Paediatrics and Child Health (RCPCH), 2008, p.9). Attentive observations of 
children by staff and regular conversations with parents can achieve significant insights into 
the uniqueness of children’s experience of pain (Walco, Cassidy and Schechter, 1994).
230
Mo
du
le 
5 
Th
e E
th
ics
 o
f M
an
ag
ing
 P
ain  ‘I Never Saw Anyone Suffer Like That in My Life’ 
During her last month of life, 4-year-old Madeleine lay on her bed in too much pain to watch 
her beloved Barney on TV. The little girl’s pain was so great that she cried when her mom 
touched her, when she tried to speak to her, or when she turned on the lights. Just a few months 
had elapsed since Madeleine was first diagnosed with leukaemia. 
‘I’ve never seen anyone suffer like that in my life’, said her mother. Madeleine was given 
chemotherapy with the onset of the disease, and after a relapse, doctors proposed another 
round of chemotherapy treatments, which, if successful, would prepare her for a bone marrow 
transplant.  
 
The doctors assured her family that the pain she experienced from the chemotherapy could be 
controlled.
But when the pain came, and it came within three days after the first treatment, her mother said 
nothing worked to alleviate it. It took Madeleine 5 minutes just to roll over in bed because each 
movement was so painful. When the family pleaded for relief for their daughter, doctors seemed 
slow to act. In addition, Madeleine had a serious bout of pneumonia that went undiagnosed for 
two weeks. Madeleine’s mother reported that ‘All they were interested in was the cancer and the 
[white blood cell] counts going up. They didn’t look beyond that.’ 
On Valentine’s Day 1999, five months after she was diagnosed, Madeleine died. 
(adapted narrative from Linsker, 2000)
6.2.1 Discussion 5
The above case illustrates the need for focus, attentiveness and on-going conversation in the 
relationship between the health professionals, Madeleine and her family. Were parents kept 
informed by doctors and/or nurses about the meaning of the diagnosis of leukaemia? Did 
the family understand its severity, the prognosis, how amenable it might be to chemotherapy 
and what methods of pain management are available? (See Module 2) 
The emotional narrative of the mother needs to be heard. It is a narrative based on four years 
experience of rearing Madeleine and interpreting her pain, her body language, her fatigue, 
her nausea, her effort to do the simplest thing (Lesho, 2003, p.2429-2430). Here, the mother is 
the proxy voice for Madeleine and listening to her story of knowing her daughter intimately 
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and witnessing her pain is perhaps vital to diagnosing the child’s pain. Through team effort 
and on-going communication with Madeleine, a strategic plan might have been devised 
to try and relieve the child’s distress, a strategy that would also require negotiating and 
engaging with the parents. 
The alleviation of children’s pain has been investigated through the eyes of health 
professionals and parents, but the children’s own perspectives have largely been ignored. 
Children have their own descriptions and expectations for pain management interventions. 
The evidence shows that children themselves, perhaps somewhat older than Madeleine, 
should be regarded as experts on their own pain in order to maximise the options for pain 
management and provide high-quality care (RCPCH, 2008, p.9). Respecting the incipient 
autonomy of the small child in the case above calls for a concerted effort to communicate 
with the child by paying attention to all bodily cues available and any verbal signals provided 
by Madeleine. By focussing exclusively on her white cell count, the physicians may have 
focussed on the hopes for curative treatment and failed to diagnose and deal with the 
degree of Madeleine’s suffering (Lesho, 2003, p.2430). 
The ethical values of beneficence and nonmaleficence (Do No Harm) can be combined with 
the aim of respecting the incipient, developing, autonomy of this small girl as she suffers 
with leukaemia. Was another round of chemotherapy appropriate here? Was this treatment 
extraordinary for a dying four-year-old? Perhaps if active treatment for leukaemia stopped, 
the focus on pain management would yield more comfort and calm for the young patient 
(Linsker, 2000, p.2).
If the healthcare team had reasons to believe that further chemotherapy and possibly a 
bone marrow transplant would be beneficial, then this would need to be explained to the 
family. It seems from the information available in this case, that the level of conversation and 
communication for understanding was deficient. Adequate pain relief in this case was not 
achieved and perhaps had even been thwarted by the focus on more aggressive treatment 
rather than on palliative care. One doctor’s statement may sound a note of truth in relation to 
this case: ‘As physicians, we are trained to cure, not trained to support the dying patient.  
We lack training in that and must acquire it on our own’ (quoted in Linsker, 2000, p.1). The 
desire to cure is powerfully strong and is taught as a primary objective in medical training. 
In this case of Madeleine, cure was given precedence over care. As carer, her mother, also 
needed care from health professionals for she failed to understand why white cell counts 
seemed more important to clinical staff than her daughter’s experience of continuing pain. 
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•	 A thorough review of this case needs to be undertaken by the healthcare team who 
managed Madeleine and the concerns of her parents. The objective is to reflect on 
decisions taken and honest self-scrutiny about the human outcomes. What clinical 
evidence contributed to decisions taken? 
•	 Team review of the management of Madeleine’s case should consider it a priority to ask 
whether Madeleine’s mother may have been correct: Was the medical management of 
this child’s chemotherapy aggressive? If not, an explanation should have been offered 
to the parents for the recommendation of further chemotherapy and, possibly, a bone 
marrow transplant. 
•	 Documentation needs to be provided for the records of any diagnostic tests conducted 
on Madeleine, team consultations, number and evidence basis for chemotherapy 
sessions and prognosis justifying considerations of a bone marrow transplant.
•	 Following Madeleine’s death, attention can turn to comforting the grieving parents and 
efforts made to heal some of the rift in the family-health professionals’ relationship. Can 
the healthcare team honestly say to the parents that ‘all that could be done was done’?
•	 The team might take time to reflect on the case and address the question: Was the 
manner of pain management in Madeleine’s dying deeply regrettable and overtaken by 
drive to ‘cure’ or ‘keep alive’ at all costs? If so, how, precisely, can a similar situation in the 
future be improved? 
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The patient in the following case is explicit about his excruciating suffering and asks for more 
pain relief. 
 
‘I Don’t Want to Die. I Want to Be Without Pain!’
Paul is a 68-year-old man with metastatic small-cell lung cancer. He is suffering from 
excruciating bone pain and he is near death. Initially, he responded to a combination of 
chemotherapy and radiation and had a 3-year remission. His disease recurred four months ago 
and he decided to choose a palliative approach. Paul’s pain from extensive bone metastases 
was initially well managed with high-dose, around-the-clock opioids supplemented by 
radiation and nerve blocks.
Paul prepared for death through talks with his partner, Tom, and clergy and felt he had no 
remaining ‘unfinished business’. In the end stages, he weighed 80 pounds, was bed-bound, and 
his pain averaged 8 points on a 10-point scale. Paul had always loved life and even now did not 
want to die but he told his doctor and the nurses on duty that he was willing to accept the risk 
of an earlier death which might come from further increasing doses of opioids. 
After a palliative care consultation, his doctor increased his total opioid doses by 25% each day 
until the pain was adequately controlled, or, if sedated, until he would appear comfortable. 
On the third day after this dose increase, Paul became very sleepy but arousable. He appeared 
relatively free of pain. The doctor shifted an equi-analgesic amount of opioids from oral to 
transcutaneous administration because Paul was unable to swallow reliably. Tom was  
with him as he became unresponsive, appearing comfortable, neither restless nor struggling. 
Paul remained in that state until he died 2 days later.  
(Adapted narrative from Quill, Coombs Lee and Nunn, 2000a, p.490)
6.3.1 Discussion 5
In this case the doctor and Paul were both willing to accept the likelihood of an earlier death 
as a result of the increased opioid dose. This was a foreseeable possible consequence of 
increasing the pain dosage. However, the health professionals caring for Paul reassured him 
that his suffering was severe enough to warrant taking the risk of a hastened death due to 
depressed respiration. The intention here to increase pain medication was consistent with 
the aims of palliative care: the compassionate and beneficent relief of Paul’s suffering. 
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Principle of Double Effect (PDE)
One ethical rule, originally formulated in the Catholic tradition during the twelfth century, 
and used in moral reasoning in defence of providing pain relief methods without incurring 
accusations of killing, is the principle of double effect (PDE). 
The PDE permits an act which is foreseen to have both good and bad effects, provided:
a. the act itself is good or at least morally neutral (the act of providing pain relief );
b. the good effect must be primary intention and not the effect of shortening a patient’s 
life. The possible earlier demise of the patient is said to be ‘foreseen’ but not explicitly 
intended or desired.
c. the good effect is not caused by the bad effect (the relief of pain was not caused by Paul’s 
dying but by adequate pain medication); (See Case 4)
d. a proportionate reason exists for causing the bad effect (shortened life justified by need 
for relief from pain);
 
According to the ethical rule known as the ‘principle of double effect,’ effects that would be 
morally wrong (dying) if caused intentionally are permissible if foreseen but unintended. 
This principle is often cited to explain why certain forms of care at the end of life that 
result in an earlier demise are morally permissible and others are not. So, according to the 
principle, administering high-dose opioids to treat a terminally ill patient’s pain may be 
morally acceptable, even if the medication hastens a patient’s death. By contrast however, 
the principle does not authorise practices such as physician-assisted suicide, voluntary 
euthanasia and some instances of foregoing life prolonging treatment. 
The discussion of this case should clarify that there are some relatively uncomplicated clinical 
situations in which the PDE can help clinicians overcome a hesitation to prescribe sufficient 
dosage of pain medication for a particular patient’s suffering. The following text defends the 
use of the PDE when providing pain relief:
‘[T]he intensive use of painkillers is not without difficulties, because the phenomenon of 
habituation generally makes it necessary to increase their dosage in order to maintain their 
efficacy […] Is the suppression of pain and consciousness by the use of narcotics […] permitted 
by religion and morality to the doctor and the patient (even at the approach of death and if 
one foresees that the use of narcotics will shorten life? Yes. If no other means exist […] In this 
case, of course, death is in no way intended or sought, even if the risk of it is reasonably taken; 
the intention is simply to relieve pain effectively, using for this purpose painkillers available to 
medicine. (Edited from O’Rourke and Boyle, 1993, p.223)
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An expansion of Case 6.3 might allow us the license to eavesdrop on an invented 
conversation among members of the team. Such eavesdropping may help in clarifying some 
distorted views of the PDE.
‘One intern, Colum, said he knew the principle of double effect and said “we seem concerned 
here but, we’re not wishing or aiming for Paul’s death but we can’t let him suffer in pain this way. 
I know this is ok.” However, another colleague, Clare said, “yes, it’s true that we’re not giving this 
increased dosage to kill Paul but, I have to admit that, under the circumstances, dying without 
pain for Paul would be a blessing, not a bad thing. If that were to happen, how do I know that 
the increased medication dosage I provide is not really my way of achieving Paul’s death? Could I 
clear my conscience that I have not killed Paul?”’
 
This exchange may not always be verbal or explicit. However, research indicates that these 
sentiments often cause health professionals to wonder about the clarity of their intentions 
and motivations in providing pain relief (Quill, 1993). Many clinicians have learned of 
the principle and, when administering pain medication, their ‘lesson in PDE’ sometimes 
resurfaces, causing them to wonder whether they are doing the ‘right’ thing and if they are 
being honest about their state of mind and intentions. 
Returning to the scenario between Colum and Clare, if Clare thinks that Paul’s passing may 
be a blessing, why should this be a source of concern or anxiety? This is a thoroughly normal 
thought in the presence of anyone who is suffering from serious illness. ‘God would be good 
to take him’ is a common utterance. It is not our compassion that brings about the person’s 
death? Qualms of conscience expressed by Clare are not trivial and call for understanding 
from the medical team. If persistent qualms or scrupulous worries about excessive opioid 
provision are left to take hold of one’s moral reasoning, the result is serious under-treatment 
of pain in suffering patients which is a concern of many health professionals when writing of 
pain management.
‘The more severe and intractable the patient’s pain, the greater is the justification for risking an 
earlier death. Thus, the amount of opioid pain reliever that is given and the rapidity with which 
it is increased must be in proportion to the amount of pain and suffering. Some physicians have 
been reluctant to use sufficient doses of opioid pain relievers, even when their patients are dying, 
in part because of fears (both ethical and legal) about contributing to an earlier death. The rule 
of double effect has helped some physicians to overcome this hesitation. Yet other clinicians 
remain unwilling to prescribe sufficient doses in part because they do not distinguish morally or 
psychologically between actions performed with the intent to cause death and those performed 
with the foreseen possibility of causing death.’ (Quill, Dresser and Brock 1997, p.1769-70; 
See Further Discussion of PDE)
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Utilising the concepts of adequacy and proportionality in making decisions about pain 
management prove helpful in the clinical setting and do not embroil one in the difficult task 
of making clear and distinct intentions that are, in fact, often unclear and ambiguous  
(Woods, 2007, p.40).
Adequacy and Proportionality
Palliative treatment relies on the twin concepts of adequacy and proportionality in order to 
try to verify the intention of a doctor or nurse and consider whether they are consciously and 
knowingly trying to cause the patient’s death.
Utilising these concepts, an intervention like managing a patient’s pain is justified when  
and if: 
•	 the particular treatment used (type of medication and dosage) is adequate for the relief 
of pain in the case of this particular patient and,
•	 the particular treatment used is proportionate in its effect to the symptoms this particular 
patient is experiencing
•	 a patient’s pain is responsive to opiates, then the appropriate aim is to stabilize the 
patient on a regime that keeps them comfortable with minimum side-effects
•	 a patient experiences pain, while taking morphine, then the aim is to increase the dose 
progressively until the patient’s pain is relieved (dose titration). 
With this recognised method, even a large dosage of morphine can be proportionate to a 
particular patient’s pain experience (Woods, 2007, p.130-131). This manner of providing pain 
relief contrasts starkly with cases in which patients were administered a disproportionate 
dose of an opiate without on-going reference to the patient’s level of comfort or tolerance 
for the drug. The latter would not be morally justified under the condition of proportionality 
of treatment to the patient’s pain. It is possible, with attention to adequacy and proportion, 
to ensure that a person can be kept pain-free and conscious on a dosage of morphine, which 
would likely be fatal to a person naïve to the drug, indicating that even a large dosage of 
morphine can be proportionate and therefore morally justified (Woods, 2007, p.131).
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In conclusion, the ethical justifications for providing the pain relief which ran the risk of 
hastening Paul’s death are five-fold:
a. Competence is evident: Paul was clearly competent when expressing his wishes to 
increase the pain medication.
b. Imminently dying: Paul was unambiguously and ‘imminently dying’ and the relief of his 
pain is a widely-acknowledged moral good to aim at even while recognising the prospect 
of hastening death.
c. Consent is given: Paul consented to this pain management decision and was clearly 
heard to say he wished to have an increased dose of medication administered
d. No desire to die: The case describes Paul’s love of life even as his health diminished. Paul 
was not seeking death and nor could he be accused of seeking ‘euthanasia’ by the back 
door through his request for pain management. He understood the possibility of an 
earlier demise as a consequence of increasing the medication dosage and yet he agreed 
to this. The companionship of family and clergy gave Paul solace in his dying moments 
(Terry et.al, 2006)
e. Adequate dosage to relieve this pain: The healthcare team attending Paul were not 
complacent about the increase in Paul’s dosage. They had discussed the dosage of 
opioids required to keep Paul comfortable though they were aware that Paul would 
probably suffer an earlier death. In spite of this, they believed that the increased dosage 
was justified. 
6.3.2 Suggested Professional Responsibilities 5
•	 The healthcare team should document the series of palliative decisions taken in Paul’s 
case since the process and outcome proved sensitive to both patient and family needs. 
Included in the documentation should be Paul’s understanding and consent to the pain 
management recommended. 
•	 Palliative care specialists are a necessary resource in critical care settings and, if such a 
specialist is lacking, a recommendation for this resource should be made a priority. The 
assistance of a palliative care specialist insured a compassionate, and expert response 
to Paul’s pain. It was adequate and proportionate to the needs of Paul.
•	 A provision of comfort and privacy is essential when a patient is in their dying days. 
Family and clergy need that space as much as the dying patient for whom noises in the 
environment can be especially stressful.
•	 It was fortunate that Paul remained conscious until near his death thus facilitating 
solace and companionship with the priest and family.
•	 When Paul dies, attention and care can be given to his partner and other family 
members, asking if there are other ways they might be helped at this time. 
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Reflecting on the key concepts of adequacy and proportionality can offer a health 
professional moral assurance or raise serious questions about legitimacy when giving large 
doses of opioids in the treatment of a patient’s extreme suffering and intractable pain.  
The following case reflects a compassion to relieve pain but at the price of a lethal injection. 
 
R v. Cox
In 1992 Dr. Nigel Cox, a consultant rheumatologist, was convicted of attempting to murder Mrs. 
Lillian Boyes, one of his patients. Mrs. Boyes had been terminally ill with rheumatoid arthritis; she 
suffered from septicaemia and had abscesses and ulcers on her limbs. Her heart was calcified, 
her lungs were malfunctioning. She had gangrene and a number of fractures of the lumbar 
spine. There is no doubt that Mrs. Boyes was in excruciating pain. Dr. Cox had administered 
heroin in an effort to alleviate her suffering but to no avail. It was then that he injected her with 
potassium chloride and she died shortly thereafter. 
Many people praised Dr. Cox for his humane act and expressed hope that they might be treated 
similarly by their doctors if in equally severe pain during the final stages of terminal illness. It is 
clear, however, that the criminal law in the UK views his behaviour quite differently since he was 
charged with murder and, the body having been cremated before a conclusive cause of death 
could be established, convicted of attempted murder.  
(Edited case from Ferguson 1997, p.368)
 6.4.1 Discussion 5
The case of R. v Cox [1992] is a helpful illustration to show that it is sometimes possible to 
have objective evidence of the intention to hasten death. As the case explains, Dr. Cox was 
convicted of attempted murder when his patient, Lillian Boyes, died following an injection of 
potassium chloride. A fundamental question that was asked at the time was: Were all other 
avenues of proportionate pain relief exhausted? It does not seem so.
‘Cox was convicted of attempted murder because his chosen means, potassium chloride, had 
no analgesic effect and had no therapeutic uses in the circumstances, thereby falling short of 
one of the sufficient conditions of a justified act. Dr. Cox may have tried but could not claim that 
potassium chloride had a double effect.’ (Ferguson, 1997, p.368) 
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One does not give an injection of potassium chloride to alleviate pain unless it is 
administered to alleviate pain by inducing death. Had Dr. Cox killed Lillian Boyes with an 
opiate that was given in very high doses, then it is highly unlikely that his action would have 
resulted in a conviction (Woods, 2007, p.130). In this case, the evidence that Dr. Cox used 
potassium chloride makes it clear that what he clearly intended was to relieve Lillian’s pain by 
means of ensuring that her life ended. (see 3rd condition of PDE)
Case 4 is a clear case of euthanasia because if the intended goal is to relieve the patient’s 
profound suffering, potassium chloride may work by causing death but it fails to fulfil the 
criteria of adequacy and proportionality which would give evidence of moral justification 
for the action. Potassium chloride is not an opioid for treating the suffering arising from 
rheumatoid arthritis. 
There is a significant moral difference between ensuring that the natural process of 
dying is made as comfortable as possible and actively precipitating someone’s death by 
employing known lethal means. The former is clearly compatible with a health professional’s 
commitment to preserve life and relieve suffering – the latter is not. 
The crux of the difference lies in the intention behind the act and use of appropriate and 
proportionate means consistent with that intention. It cannot be accepted as a policy 
guideline that doctors can consider death among their range of treatments to relieve 
suffering. This would make doctors equal to a profession of executioners (Thomson, 1999,  
p.81-82). (For a discussion of ethical and legal positions on euthanasia see Module 6, sections 
7.2 and 7.3).
6.4.2 Suggested Professional Responsibilities 5
•	 The case of Lillian Boyes raises a fundamental question for discussion: Is adequate and 
specialist pain management available in acute care hospitals in Ireland?  
If not, how can a hospital address this important resource deficiency?
•	 Ensure that a palliative care specialist is available for consultation and advice in acute 
care settings where pain management is meeting with little success.
•	 Discuss with the palliative care specialist whether palliative sedation would be an 
appropriate pain remedy in the case of Mrs. Boyes. (See Case 5 following)
•	 In attempting to manage the pain of a patient, attention to the adequacy and 
proportionality principles are essential. Applying these principles requires that the 
healthcare team know the extent of pain suffered by the patient in order to respond 
adequately. Assessments need to be put in place to get to know patient’s depth of pain.
•	 Encourage patients not to be timid and to let health professionals know if their pain is 
not being relieved. Many patients fear if they speak up about their pain they may come 
to be known as a crank or constant complainer. 
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As part of the skills and services of palliative care, health professionals need strategies for 
responding to the troubling problems of patients who develop intolerable suffering despite 
receiving excellent care. Comprehensive palliative care is highly effective but survey data 
show that 5% to 35% of patients, even in hospice programmes, describe their pain as severe 
in the last week of life, and 25% describe their shortness of breath as ‘unbearable’  
(Coyle, Adelhardt, Foley et. al., 1990). Understanding each patient’s unique situation is the 
crux of palliative medicine and moral response. 
Pain is usually understood as a sensation caused by physiological phenomena and so 
is deemed treatable with pharmacological agents such as opioid, hypnosis or other 
mechanisms. However, pain is not simply physiological. With analgesics one can relieve a 
great deal of pain but might not touch the ‘soul suffering’ an individual may experience. 
Michael Kearney understands soul pain as: ‘[t]he experience of an individual who has become 
disconnected and alienated from the deepest and most fundamental aspects of him or 
herself’ (Kearney, 1996, p.60). The holistic experience of the dying that is ‘total pain’ combines 
physical, emotional, spiritual and social dimensions of pain. Soul pain finds emotional 
expression as fear and behavioural expression as the ‘fight’ of an agitated struggle to find 
a way out of the awful situation. Observing a patient in this ‘total pain’ puts impossible 
demands on carers of patients to do something, anything: ‘Can’t you see I’m in agony?’ 
(Kearney, 1996, p.62).
Kearney explains that when a patient is in soul pain, this is accompanied by an all-pervading 
sense of emptiness, hopelessness and meaninglessness. In such situations, the clinical team 
may recommend ‘palliative’ or ‘terminal’ sedation – sedation to unconsciousness – until 
the patient dies, a decision which relieves the patient of his or her complex physical and 
psychological experience of the unique suffering termed ‘soul pain’.
The following case illustrates respect for the uniqueness of Maura in administering palliative 
sedation for her soul pain. 
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Maura was a music teacher in her early fifties known by all students and friends as ‘bright, 
brusque and breezy’. A malignant tumour invaded the nerves in her leg and was treated with 
radiotherapy and painkillers. Yet, this did not relieve Maura’s suffering, profound and deep soul 
pain. Maura was anguished, terrified, agitated and would not settle. Eventually her defences 
‘cracked in an eruption of uncontrollable fear, paranoia and pain. She writhed about in her bed 
as she groaned, hyperventilated and cried out, wide-eyed, for someone to help.’ These symptoms 
were treated with a morphine infusion but no medical workup was done and no antibiotic 
treatment was given. As the dose of morphine was increased to try and relieve symptoms, the 
patient became delirious and agitated. When the dose was decreased, Maura became more 
lucid but was very uncomfortable. She asked the doctors and nurses to help her escape from 
her agony.
The team offered to sedate her to the point of unconsciousness and then withhold further 
treatment including intravenous fluids. The patient was reassured that the sedative dose would 
be increased until she appeared to be resting comfortably and that it would not be cut back 
until she died. The healthcare team, the patient and her family reached the consensus that this 
was the best of the available options. It would allow Maura to achieve the death that she saw 
was good for her without violating the law or forcing her to suffer unnecessarily. She was given 
a midazolam infusion which was titrated upward until she achieved a sedated state and was 
then maintained at that level. She died within 24 hours. (Edited case variation from Quill, 
Coombs Lee and Nunn, 2000a, p.491 and Kearney, 1996, p.22-24)
6.5.1 Discussion 5
Palliative sedation, also known as ‘terminal’ sedation, is sometimes provided in end-of-life 
care, e.g. 
•	 in end of life weaning from ventilator support 
•	 in the management of refractory symptoms at the end of life
•	 for psychological or existential suffering (also termed ‘soul pain’)
However, it is important to understand that it is not always restricted to end-of-life care. 
It may sometimes be used as a temporizing measure in trauma, burn, postsurgical, and 
intensive care. 
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withholding such treatment in certain circumstances would be inhumane. Because most of 
the patients who receive heavy sedation are expected to recover, careful attention is paid to 
maintaining adequate ventilation, hydration, and nutrition.’ (Quill and Byock, 2000, p.409)
In these cases, while patients are sedated; all other life prolonging measures are carefully 
maintained with a view to patients eventually recovering consciousness and recovering from 
their illness.
However, a small percentage of patients who are receiving care, such as Maura in Case 5, 
reach a point where their anguish, suffering and restlessness become severe and unremitting 
despite the unrestrained palliative efforts. Where the patient is close to death – a matter of 
hours, days or at most a few weeks – the following process is an option that is considered a 
last resort. 
In the context of far-advanced disease and expected death, artificial nutrition, hydration, 
antibiotics, mechanical ventilation and other life prolonging interventions are not instituted and 
are usually withdrawn if they are already in place. These measures are withheld […] because they 
could prolong the dying process without contributing to the quality of the patient’s remaining life 
(Quill and Byock, 2000, p.409).
Such was the decision in the case of Maura. The decision to administer palliative sedation  
to patients whose death is imminent is based on clinical reasons but it clearly has  
ethical implications. 
‘The question of withdrawing artificial nutrition and hydration is often difficult to address with the 
patient and family because nutrition has such a high symbolic value. Withholding food can be 
perceived as neglect, abandonment, or hastening death.’ (Lesage and Portenoy, 2001, p.124)
Ethical concerns and challenges arise in cases where the clinical decision is that the patient 
will be sedated until his or her death. In many cases, the patient has already ceased artificial 
nutrition and hydration (ANH), antibiotics and other life prolonging therapies before sedation 
is applied (Kahn, Lazarus and Owens, 2003). In other cases, life prolonging measures may be 
withheld during palliative sedation. Failure to keep the reasons for a decision on sedation 
distinct from the reasons for ceasing all life prolonging measures can lead to concerns that 
the decisions taken together amount to camouflaged euthanasia or physician assisted 
suicide (PAS). (See discussion of euthanasia and PAS in Module 6, section 7)
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‘[T]terminal sedation can be distinguished from euthanasia and, furthermore, is an ethical 
alternative to euthanasia in countries where the general ethos is against euthanasia [...] sedation 
ought to be considered a valid option at the end of life [...] but I believe that the distinction 
between sedation and euthanasia is much harder to sustain when other decisions, for example, 
to withhold hydration and nutrition are not considered as distinct decisions in their own right.’  
(Woods, 2007, p.127)
In brief, Woods is stressing the reasoning that, when considering palliative sedation for a 
patient, there need to be clinical reasons why withholding other life prolonging therapies 
(LPTs), such as ANH, are also indicated. 
Reasons for this may be that LSTs such as ANH:
•	 have been refused by the patient when competent and not under sedation
•	 are futile – may not provide any benefit for the patient and do not contribute to the 
quality of the patient’s remaining life 
•	 intensify the patient’s suffering
•	 may prove too stressful or burdensome for the patient’s system to bear
(Woods, 2007, p.127; Quill and Byock, 2000, p.409).
In the two decisions, (sedation and withdrawal of LPTs), it is not only essential that clear 
reasons for each be thought through but the process involved in making the decisions with 
accompanying clinical and ethical reasons needs to be documented. The need to document 
decisions of this nature can contribute to clearer, more reason-based decision-making. 
Palliative Sedation Remains Controversial 
It is important to stress that palliative sedation still remains a highly controversial practice 
among acute care clinicians. Palliative care specialists are also concerned about the widening 
of indications that are cited for its use. The case of Maura discussed here poses one of the 
more problematic indications for palliative sedation: existential or soul suffering.
‘Perhaps the most controversial indication for sedation is unresolved psychosocial or existential 
distress. As palliative care physicians we must reflect on whether the role of medicine is to relieve 
all human suffering. Suffering is an essential part of the human experience and may have 
meaning for patients and families […] refractoriness should be determined only after repeated 
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evaluations by a skilled clinician who has a professional relationship with the patient.  
This implies that a single psychiatry consultation to rule out depression or anxiety is insufficient. 
Involvement of a social worker, chaplain, and ethicist, including evaluation of the family and 
social circumstances may also be needed before decisions are made. Existential distress is perhaps 
the most important place for intermittent or respite sedation: time for rest and reorganization 
may resolve some of the distress.’ (Hauser and Walsh, 2009, p.578)
Extensive on-going debate about the medical and ethical indications for palliative sedation 
continues. Some authors express worries that the use palliative sedation and discontinuation 
of ANH by a consenting, competent patient may, in effect, be physician assisted suicide. 
Proponents of palliative sedation continue to clarify that ‘the purpose of the medications is 
to render the patient unconscious to relieve suffering, not to intentionally end his or her life’ 
(Quill and Byock, 2000, p.561). On this understanding some commentators claim that the 
Principle of Double Effect would apply in the careful use of palliative sedation. (See Case 2 for 
a discussion of PDE)
Three features of Case 5 give evidence of moral reasoning in the clinical judgment to use 
palliative sedation as a last resort to ease Maura’s ‘soul pain’. Are these sufficient?
Do these reasons show that, with Maura’s comprehension of and consent to palliative 
sedation, the case seems to be a clinical and ethically based decision to withdraw further life 
prolonging treatments and provide adequate pain relief? 
a. Maura’s symptoms reveal genuine ‘soul pain’ – the case narrative illustrates ‘soul pain’ as it 
is described by palliative care physicians and patients alike (Kearney, 1996).
b. Competence to arrive at consensus: Maura appears competent and sufficiently lucid to 
participate in the consensus reached in conjunction with the healthcare team and her 
family that this method of relief from suffering is the best of the available options for her 
suffering even though it involves the withholding of nutrition and hydration.
c. Requesting help – exercising autonomy of choice: Some may worry that Maura’s 
appeal to her doctors and nurses to help her escape from her agony may be a request 
for assisted suicide. However this worry might be alleviated with the realisation that a 
competent patient in the throes of terminal illness can, with moral legitimacy, exercise 
their autonomy and decline life support therapies? One burning question for patients 
and professionals making such a decision in an Irish context is the status of nutrition and 
hydration – should it be considered as simply another medical treatment or should it 
be understood as universally obligatory basic care? (See Module 6, section 6.5 for more 
detailed discussion of ANH).
 The European Association for Palliative Care have carried out an extensive review of the use 
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of palliative sedation in clinical settings (Cherny, Radbruch and the Board of the European 
Association for Palliative Care [EAPC], 2009). The following are only a few of the problem 
practices cited as cause for concern about mis-use of palliative sedation.
Problem Practices in Use of Palliative Sedation
There are a number of ways in which patient care can be undermined by the injudicious, 
abusive or unskilled use of sedation. There is, unfortunately, strong data indicating the 
prevalence of abuse but little is known about the prevalence of substandard sedation 
practices. The following four practices are problems in the use of palliative sedation and 
undermine the credibility of therapeutic effectiveness when used ethically and expertly.
Abuse of palliative sedation: This occurs when health professionals sedate patients 
approaching the end of life with the primary goal of hastening the patient’s death.  
This has been called ‘slow euthanasia’. Indeed, some physicians administer doses of 
medication, ostensibly to relieve symptoms, but with a covert intention to hasten death. 
Others, on request from patients would use palliative sedation as a method of performing 
assisted suicide.
 
Excess dosage of pain medication, for example, can compromise physiological functions 
such as spontaneous respiration and haemodynamic stability. These duplicitous practices 
represent an unacceptable and often illegal deviation from normative ethical clinical practice 
(Cherny et. al., 2009, p.581).
Injudicious use of palliative sedation: This occurs when sedation is applied with the intent of 
relieving symptoms but in clinical circumstances that are not appropriate. This means that 
the patient indications are inadequate to justify such a radical intervention. What accounts 
for injudicious use of palliative sedation? 
1. Instances of inadequate patient assessment where potentially reversible causes of 
distress are overlooked.
2. Before resorting to sedation, there is a failure to engage with health professionals who 
are experts in the relief of symptoms despite their availability.
3. The situation of an overwhelmed physician resorting to sedation because he or she is 
fatigued and frustrated by the care of a complex symptomatic patient.
4. Situations in which the demand for sedation is generated by the patient’s family and not 
the patient him/herself. The family may be emotionally distressed watching the suffering 
of their relative (Cherny et. al., 2009, p.582).
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Substandard clinical practice of palliative sedation: Examples include inadequate 
communication with the patient and/or family to ensure understanding, the goals of the care 
plan, anticipated outcomes and potential risks. 
In addition are substandard clinical practices of inadequate monitoring of symptom distress 
or adequacy of relief; inadequate assessment of psychological, spiritual or social factors 
that may be contributing to the patient’s distress; use of inappropriate medications to 
achieve sedation (i.e., opioids). (See under Further Discussion for several other important EAPC 
guidelines)
6.5.2 Suggested Professional Responsibilities 5
•	 Health professionals must be carefully trained in the methods and management of 
palliative sedation or have a palliative care expert give advice on use for a specific 
patient. It is advisable to get a second opinion regarding the decision to use palliative 
sedation with a particular patient.
•	 A diagnosis of a terminal condition must be given with a life expectancy of days to 
weeks.
•	 Competent patients must give informed consent based on conversation, information  
and reassurance.
•	 A documented advance directive must be sought if the patient needing sedation lacks 
capacity or competence. 
•	 In the absence of an advance directive, the patient’s family must be consulted to 
determine what is in the best interest of the patient. Discussion with the family should 
include an open discussion about the advantages and concerns associated with  
palliative sedation. 
•	 Where appropriate, open discussion with family around the withholding of life 
prolonging therapies should take into account the emotions and religious beliefs that 
may underpin perspectives on these procedures. 
•	 In sedating the patient, the family should be present if possible; nasal oxygen should be 
provided as well as a single room in a quiet part of the hospital  
(Quill and Byock, 2000; Royal Dutch Medical Association, 2005).
•	 The reasons why a decision might be taken to discontinue life prolonging therapies if 
these are to accompany palliative sedation should be documented separately. 
•	 The family should be supported in their bereavement and reassured that nothing more 
could be done to provide a good dying for the patient. 
•	 The healthcare team should facilitate discussion of any member’s reluctance or queries 
in the use of palliative sedation. 
•	 The European Association for Palliative Care recommended framework for the use of 
sedation in palliative care should be considered and reviewed. 
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7.1 The Ambiguity of Clinical Intentions in Pain Management
Palliative care consultant, Dr. Timothy Quill, has written extensively on pain management, the 
principle of double effect and ambiguity of intentions. Quill claims that a common belief that 
our intentions are always clear, uncomplicated and transparent is a serious mistake.  
It is a mistake especially because many doctors and nurses realise that their intentions in  
pain management decisions are often complicated, and are not transparent or clearly 
obvious to them. 
Nurses and doctors may believe that the lack of clear and uncomplicated intentions might 
mean that, in truth, they are aiming for the death of a patient, or committing euthanasia.  
On the other hand, believing strongly that euthanasia is not only illegal but unethical; they 
may seriously under-treat pain and suffering to avoid this even when a patient is dying  
(Quill, 1993, p.1039). Indeed, uncertainty about intention should not discourage the 
potentially lethal use of drugs, provided that that use is strictly governed by what is 
necessary to palliate in a given case.
More than anything we may need to move away from an idealized ethical perspective which 
argues that intentions must be clear and distinct if we are going to be sure of our moral 
propriety. If we probe intentions in much of human life we find that they may be ambiguous, 
complex and often contradictory. It is useful to consider a quotation from Quill, on this point, 
because it provides food for thought, and helps tease out the complex reasons why many 
health professionals continue to under-treat pain and suffering. It explains the multilayered 
complexity of human life, the life that any person seeking to act morally must live. Quill 
writes of the ambiguity of intentions in treating suffering patients while urging realism in the 
process of moral reflection.
‘[M]ulti-layered intentions are present in most, if not all, end- of- life decisions. To understand 
physicians’ reluctance to stop life-sustaining treatment once it is started, or to prescribe adequate 
amounts of narcotics to patients who are dying and in severe pain, we would do well to look 
beneath the sanitized intentions espoused by many medical ethicists to the actual experience of 
doctors and patients.
•	 If we do not clarify the ethical and legal status of such actions as prescribing barbiturates to 
terminally ill patients, with their inherent complexities and contradictions, then most physicians 
will remain too fearful to help patients with these delicate deliberations. 
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•	 If we do not acknowledge the inescapable multiplicity of intentions in most double-effect 
situations, physicians may retreat from aggressive palliative treatment out of fear of crossing the 
allegedly bright line between allowing patients to die and causing their death.  
•	 Our current ethical thinking and legal prohibitions reinforce self-deception, secrecy, isolation, and 
abandonment at a time when the exact opposite is needed.  
•	 Perhaps a key to humanizing medical ethics and the law, as well as clinical medicine, lies in being 
more forthright and explicit about our intentions and responsibilities in working with dying 
patients.’ (Quill,1993, p.1040)
7.2 Ethical Concerns over the Use of Palliative Sedation 
Four concerns of an ethical and clinical nature merit scrutiny when deciding on  
palliative sedation. 
7.2.1 Fear of Euthanasia
Recall that the intent of palliative care is to relieve suffering, even if treatments for pain relief 
hasten death. Intent matters in law and ethics, with the rule of double effect stating that 
foreseeable adverse consequences of treatment are acceptable only if they are unintended, 
i.e., not the explicit aim and goal of the treatment. For many palliative doctors it is a matter of 
great importance to draw a clear distinction between palliative care and euthanasia  
(Douglas et. al., 2008, p.390). However, research that examines the intentions of doctors in 
palliative care settings is fraught with difficulties: 
‘In particular, one needs to be sure that the distinction between intention and foresight has been 
recognized by respondents who report their own actions. Furthermore, intentions in the setting of 
end-of-life-care may be multiple and ambiguous, and respondents may have limited insight into 
their own intentions, or may recall them inaccurately, particularly in light of societal pressures that 
approve some intentions and disapprove of other.’  
(Douglas, Kerridge and Ankeny, 2008, p.390).
7.2.2 Suppressing Patient’s Consciousness
This concern arises in relation to the perceived importance of maintaining consciousness 
and awareness – even when one is suffering and dying. The question is whether it is justified 
to control, curtail or reduce considerably the experiences of awareness for a dying person, 
as happens in some cases of deep sedation. The emphasis here is on the importance of 
sustaining a level of mental awareness in order to allow for communication with loved ones, 
family or healthcare staff. On this view, the aim of maintaining a patient’s awareness to the 
greatest degree possible should temper when and how sedation ought to be used.  
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Without awareness a person cannot avail of opportunities for reconciliation. Likewise, 
without awareness the patient may feel that they are being abandoned (Woods, 2007, p.126; 
Craig, 1994). 
Woods reassures on this point:
‘Even if a patient were to be deeply sedated, they would still be cared for with respect and dignity; 
with someone watching over them, turning them, keeping them clean, going to the bedside, 
quietly and discreetly, to observe and so on.’ (Woods, 2007, p.126)
In addition, for some religious believers, consciousness may be considered a necessary 
condition of spiritual reconciliation with oneself or one’s god. In this regard, the following 
statement on pain relief from a religious perspective claims that health professionals need to 
take special care in considering suppression of pain and consciousness through sedation. 
‘Is the suppression of pain and consciousness by the use of narcotics [...] permitted by religion 
and morality for the doctor and patient (even at the approach of death and if one foresees that 
the use of narcotics will shorten life)? If no other means exist and, if in the given circumstances, 
this does not prevent the carrying out of other religious and moral duties. Painkillers that cause 
unconsciousness need special consideration (cited in O’Rourke and Boyle, 1993, p.223).
The text concludes: 
‘It is not right to deprive the dying person of consciousness without a serious reason’ (cited in 
O’Rourke and Boyle, 1993, p.223). 
The fundamental emphasis on respecting the values of the patient when making clinical 
decisions arises here. Where patients either explicitly request the therapy of sedation or 
consent to it when it has been explained to them by a health professional that it is necessary 
in order to relieve suffering, anxiety and restlessness, then health professionals can proceed 
with confidence that it is one way that they can facilitate the autonomy and choice of the 
patient who is suffering. 
Woods urges health professionals and families not to substitute their own values for those 
of a competent patient or one who has left an Advance Directive about their wishes. He 
claims that palliative sedation should remain a morally justified option for the patient who is 
competent to choose it.
‘Deliberately aiming to alter the experiences of the patient is a legitimate goal in the use of 
sedation [...] the possible meaning that people may find in their experiences of coping with 
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challenging situations is boundless. However, whatever the meaning this experience may have 
for a person, it is the meaning he or she alone finds in the experience that endows it with value 
[...]Individuals may find meaning in suffering, and the principle may be a sound one, but to claim 
that there is virtue in the suffering of a person if they find no meaning or value in the experience is 
a corruption of the virtue. The patient’s own testimony should be the main reference point when 
adjusting the pain relief’ (Woods, 2007, p.125).
7.2.3 Fear of the Slippery Slope
A further concern about palliative sedation is that one may too easily mount the slippery 
slope which involves a move from employing it as a method for alleviating the pain of 
those who are terminally ill to employing it in treating depressed patients or those who 
have simply lost meaning in life. Where some health professionals could justify its use with 
patients who are unambiguously dying, they could not morally defend its use for profoundly 
depressed patients who are not ‘terminally ill’ or near death but seek escape from their 
chronic and profound suffering. 
This concern voices a legitimate worry about the use of palliative sedation to treat 
profoundly depressed patients who are not terminally ill but nevertheless seek escape 
from profound suffering. The concern about using palliative sedation when a person is not 
‘terminally ill’ is very much debated since it is widely agreed that alleviation of suffering is 
one goal of medicine. If this is the case, it is not clear why such relief from suffering should 
be limited to the imminently dying. However, if sedation for chronic depression were 
considered, it is not morally justified also to discontinue all life supports unless there is clear 
evidence of a competent patient’s refusal of such supports. 
Out of respect for patient self-determination, such discontinuation of life supports would 
need serious consideration. The serious problem here is that a patient who is acutely or 
chronically depressed may lack the capacity to decide on life prolonging treatment or 
palliative sedation. A decision to use alternative therapies for depression would be essential 
and a psychiatric consultation with the patient advised before depression is cited as a 
condition warranting palliative sedation.
7.3 European Association for Palliative Care Guidelines
To ensure consistency in practice and also to allow for the on-going review of pain 
management decisions, the European Association of Palliative Care (EAPC) published a 
decision-making framework in 2009. The 10-item framework incorporates an extensive 
literature review of the practice of palliative sedation. Expert peer review of the initial  
draft was invited from a wide range of palliative care clinicians both within and outside  
of the EAPC. 
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palliative sedation was used. Two other significant points which are rarely stressed in such 
guidelines documents include the needs of carers – family and medical professionals.
7.3.1 Care and Informational Needs of the Patient’s Family
Families need extensive support to understand the decision-making process, and be 
clear about the goals and expected outcomes of palliative sedation. Identifying a family 
spokesperson (preferably one chosen by the patient) may help communication, especially for 
large, geographically scattered or conflicted families. 
‘Without effective communication families may be left with feelings of profound confusion, guilt 
or remorse, which complicate their subsequent bereavement. For these reasons, evaluation and 
decision-making by a multi-disciplinary team skilled in palliatve care is essential prior to initiating 
[palliative sedation]. (Hauser and Walsh, 2009, p.577).
Further advice is offered from the EAPC to improve compassionate care and attention for 
family of patients undergoing palliative sedation. 
‘A patient’s family often experiences profound distress. If the patient is hospitalised, all efforts 
should be made to provide privacy for emotional and physical intimacy. To promote the family’s 
sense of well-being and peace, consideration should be given to the aesthetics of the care 
environment including an opportunity to sleep in the room or nearby.’  
(Cherny et. al., 2009, p.587)
The health care team should counsel the family in the ways that they can continue to be of 
help to the patient: by being with, talking to and touching the patient, providing mouth care, 
managing the atmosphere of the patient’s care (providing patient’s favourite music, scents, 
saying prayers or reading to the patient). 
Families of sedated patients need to be kept informed about the patient’s well being and 
what to expect. This includes appropriate notification that death is approaching and what 
can be expected in the dying process. 
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Health professionals and healthcare staff may also express profound distress when a patient 
is sedated. This is particularly true if there is discord regarding the appropriateness of the 
intervention and in situations when the process is protracted. Staff distress can be mitigated 
if there is development of a culture of sensitivity to the emotional burdens involved in care. 
Sharing information and engaging in multidisciplinary discussions can offer the group or 
individuals opportunities to express their feelings. This context can be therapeutic for staff 
distress and address any confusion about the procedure of palliative sedation  
(Cherny et. al., 2009, p.588).
‘Staff need to develop awareness of their own preferences about care of the dying, and the 
potential role of frustration, sense of failure and burnout in decision-making. Individual physician 
person and professional factors may influence the practice of [palliative sedation], including 
prevalence, determination of refractoriness, level of sedation used, and drugs employed  
(Huaser and Walsh, 2009, p.577).
7.4 Critics and Proponents of the Principle of Double Effect (PDE)
7.4.1 Critics of the PDE
Critics have criticized the principle of double effect because:
a. The analysis of intention used in the principle is problematic and inconsistent with 
other analyses of human intention. According to modern psychology, human intention 
is ambiguous, subjective, multilayered and often contradictory. The principle of double 
effect does not acknowledge this complexity (Quill, 1993, p.1040; Bennett, 2001; Davis, 
2001; Foot, 2001; Marquis, 2001). In addition, the PDE claims that where there are two 
outcomes of an action, one good and one bad, the doctor must focus on the good end 
that she or he intends and realise that the other bad effect is not intended but only 
foreseen. 
Critics claim that this distinction between intended and only foreseen effects of an action 
is unconvincing. We cannot splice up our mental ‘intentions’ in this way. What we foresee is 
likely to happen must be included in our over-all intention for an action. 
b. The principle is ‘absolutist’ in the rigour with which it specifies kinds of act that are ‘evil’ or 
‘bad’. The evil of aiming for ‘death’ is seen to be a prohibition without exception. For some, 
death is not seen as evil in all circumstances. 
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c. The principle may be paternalistic. This is because the absolute prohibition against taking 
human life can be interpreted to mean that a doctor cannot accept a request from a 
competent, terminally ill patient who seeks to end suffering through the cessation of life 
prolonging therapy. This interpretation would endorse a strong form of paternalism that 
is difficult to harmonise with respect for patient autonomy  
(Quill, Dresser and Brock 1997, p.1768-1771).
7.4.2. Proponents of the PDE
a. The PDE has desirable effects on clinical conduct. 
‘The principle has reassured clinicians that prescribing high-dose opioids for pain in terminally ill 
patients is morally permissible and that is all to the good.’  
(Quill, Dresser and Brock, 1997, p.1770)
b. Theory is faulty but PDE is correct. Proponents acknowledge that PDE is based on an 
inadequate theory of human intention and actions. But they claim that we do not 
have to accept the theory of intention and action regarding foreseen but unintended 
consequences. Proponents believe they can concede deficiency in theory of action 
and yet argue that the fundamental thrust of PDE is correct: When the positive goal 
of alleviating human suffering, is at stake, then the obligation of the doctor is to take 
adequate action that is proportionate to the needs of the suffering patient. This would 
always assume the action is within the law of the jurisdiction of medical practice.  
c. Many physicians embrace it as a better option than active euthanasia or physician-
assisted suicide both of which are often motivated by poor pain relief. It is not a trivial 
matter that the PDE may be useful as a way of justifying adequate pain management and 
other palliative measures for dying patients. 
d. The PDE is not perfect but it is a coherent doctrine of moral justification and, 
unfortunately, suffers from being misunderstood. These proponents make considerable 
effort to explain their position. One misunderstanding is the idea that PDE is absolutist in 
prohibiting some actions categorically. These proponents say that PDE does not specify 
what makes an immoral act immoral. Traditional teachings or ethical views have handed 
down certain actions as prohibited but any ethical theory that allows that there are kinds 
of acts which are good and bad could be consistent with the PDE and could make use of 
PDE (Boyle, 2001, p.7-20; Woods, 2007, p.129-135)
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8.1 Effective Pain Management is the Primary Objective in Patient Care
•	 Pain experience is cited in empirical studies as a central element in a ‘bad dying’, 
whereas successful pain relief is a primary element in a ‘good dying’. 
•	 Unrelieved pain can cause depression and hopelessness.
•	 The experience of pain in illness can distract from all other factors in one’s life.  
Pain can diminish an individual’s capacity for clarity of understanding and the 
possibility of companionship.
•	 Pain can hinder the ability to participate in conversations about one’s  
treatment decisions.
•	 The encouragement and facilitation of patient autonomy is frustrated if pain 
management is not effective. 
8.2 Principle of Double Effect (PDE)
•	 The PDE is one way for reasoning through the moral complexity of pain management.
•	 Accounts for actions which have two effects: one intended good effect (relief of pain) 
and one not specifically sought or willed (earlier death).
•	 An effect that might be morally wrong if caused intentionally (taking someone’s life) is 
permissible if foreseen but unintended.
•	 Human intentions are complex and ambiguous. As a result, a person cannot always be 
completely clear or certain about the cluster of intentions they hold when deciding on 
pain management methods for a patient.
•	 The PDE does not authorise practices such as physician-assisted suicide or euthanasia. 
•	  The PDE helps health professionals to overcome a hesitation to prescribe a sufficient 
dose of pain medication for a particular patient’s suffering.
•	 Clinical evidence about the sincerity of one’s intentions can be facilitated if one 
observes the criteria of adequacy and proportionality. To be morally justified, a 
particular medication and dosage must be adequate for and proportional to this 
particular patient’s pain. 
•	 The PDE can be a helpful tool in decision-making but it is not a moral calculus to ensure 
ethically correct decisions if the decision-maker is using the PDE in a cynical way. 
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•	 Sedation to unconsciousness may be used as a temporizing measure in trauma, burn, 
postsurgical and intensive care.
•	 Called ‘terminal sedation’ by some and ‘palliative sedation’ by others, this refers to 
the administration of high doses of sedatives normally given to patients who are 
imminently dying and are not expected to recover from sedation.
•	 Can be indicated when a patient is suffering severe and intractable suffering often 
called ‘soul pain’
•	 Soul pain. = the experience of anxiety, restlessness and hopelessness in a person who 
has become disconnected and alienated from the deepest and most fundamental 
aspects of themselves.
•	 If palliative sedation for the dying patient is administered, the decision may be 
taken to discontinue all other life prolonging measures as well. The reasons must be 
documented but the central rationale is that these life support measures often do 
not improve the quality of the patient’s remaining life and may be more stressful than 
beneficial.
•	 Competent patients (often involving family in the conversation) may consent to 
palliative sedation and discontinuation of all life supports.
•	 Where patients lack capacity and have not left an Advanced Directive stating their 
wishes, the clinical staff and family must discuss the adequacy and proportionality of 
palliative sedation for the relief of their loved one’s pain and consider the factors that 
make this decision in the ‘best interests’ of the patient. 
•	 Compassionate care and understanding for the bereaved family members remain 
important features in the humane use of palliative sedation.
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ain 9. Module 5 Activities 
9.1. Review Case 1 
and reflect on the experiences of Maurice with a diagnosis of cancer and suffering  
increasing pain. 
a. What are particular features of ‘psychological pain’?
b. What measures might have been taken by health professionals to prevent this patient’s 
‘anticipatory pain’?
c. Maurice explained that he attempted suicide because he dreaded the continuing 
intensification of pain that had already begun. What clinical evidence would you look for 
to validate whether, in addition, the man may be depressed and need help for  
that affliction?
d. The reassurance to the patient that his pain would be managed brought relief. Given that 
Maurice is an out-patient, how can the staff now ensure effective pain management  
for him?
9.2 Re-read the particulars of Case 2
a. Consider yourself the nurse or doctor in charge of Madeleine. Specifically, how would 
you deal with the mother’s concerns about Madeleine’s continued pain? Consider jotting 
down a conversation you might have with Madeleine’s mother.
b. Although Madeleine is very young, how can the health professionals try to discern  
her level and quality of pain? Provide a few concrete suggestions as to how you  
would proceed.
c. Madeleine’s mother is particularly annoyed with what she sees as an erroneous clinical 
focus on white cell count and further administration of chemotherapy while greatly 
minimising the need for effective pain management. Do you think the mother was 
correct and deserves to be heard? Write a few notes on how you would respond to the 
mother’s annoyance and concerns for her daughter’s suffering.
d. On a scale of 1-10, how would you rate the acute care hospital provisions (space, privacy, 
pain management, decoration etc.) for the care of seriously ill children?
9.3 Reflect back on the particulars of Case 3. 
In this case, Paul is suffering from end-stage metastatic, lung cancer and the health 
professionals involved recommend palliative care.
a. From your experience of managing pain for patients, do you think that Paul would have 
had equally effective relief from his suffering if he had not chosen a palliative  
care approach?
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b. Discuss your own experience of caring for terminally ill patients like Paul. Would you find 
that it is a common occurrence to have a conversation with a patient about the risk of an 
earlier death following adequate pain medication? Explain.
c. In situations like this case scenario, how would you go about determining the patient’s 
competence or capacity to consent?
d. Paul was comforted by the presence of family and clergy. Explain how you might provide 
solace and companionship for a patient who is not so fortunate to have this emotional 
and spiritual support. 
9.4 Case 4 
is presented as an apparently clear example of euthanasia. Consider the details of the case 
and wonder:
a. Considering that Dr. Cox has, with stated compassion, relieved Mrs.Boyes of excruciating 
suffering, what is it about the action of Dr. Cox that you think makes it morally 
objectionable in law? What is the law protecting here?
b. Would the Principle of Double Effect work as a moral defence in this case?
c. Do you think that Euthanasia is ever morally (if not legally) justified? Why or why not?
d. If you were the doctor or nurse in care of Mrs. Boyes, what alternative to an injection of 
Potassium Chloride would you have offered her to ensure pain relief? 
9.5 Re-read Case 5 
and reflect on the treatment offered Maura for her soul suffering. 
a. Do you consider that the provision of palliative sedation was ethically warranted as a 
response to Maura’s request ‘to relieve her from her agony’? 
b. Consider the query about whether relief of unresolved psychosocial or existential distress 
falls within the role of medicine. Discuss with your colleagues whether the provision of 
palliative sedation to Maura was warranted. Try to write down your reasons why or  
why not. 
c. Maura exercised her autonomous request to be released from suffering by agreeing to 
this process of palliative sedation. With such a serious degree of suffering, how would you 
ensure that Maura’s capacity to make this decision is intact?
d. Discuss with your colleagues whether they think that this method for managing suffering 
is equivalent to physician assisted suicide? Explain.
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ain 9.6 Recall the empirical research 
discussed in this module where Quinlan and O’Neill document clinical and family scepticism 
about referring patients to palliative care. 
a. What reasons would you give to explain the reluctance of health professionals to refer 
patients for palliative care?
b. Try and explain why some families are very reluctant to refer their loved ones for 
palliative care even though it would mean diminished suffering and improved quality  
of life?
c. Do you think this sceptical attitude toward palliative care is mistaken? If so, what are  
your reasons? 
d. Using your creative thinking in the interest of better pain management, what would you 
do to try and moderate or correct this scepticism about palliative care? 
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1. Module 6 Key Points
1.1 Advance Care Planning (ACP) 
is at the centre of efforts to promote patient-centred care. ACP offers choice and respects the 
right of persons to consent to or refuse treatment and care offered. At present, legislation 
in Ireland covering advance care plans such as advance directives is not available though in 
2009 the Law Reform Commission published a report recommending that provisions be put 
in place to recognise validly drawn up advance directives. Nothing in ACP can authorise a 
health professional to do anything that is illegal.
1.2 Withholding and Withdrawing LPTs 
such as ventilators, dialysis machines, chemotherapy and the sophisticated technology of the 
intensive care unit are ethically and legally accepted practices that should ideally be specified 
in advance care plans or directives. 
1.3 Withholding a Particular Treatment 
for a particular patient is generally viewed as morally justified if the treatment is considered 
futile (without benefit) or unnecessarily burdensome. It is often recommended that 
decisions by a healthcare team to withhold life supporting treatment require the consent 
of the patient and/or the patient’s family. However, such a viewpoint about the obligation 
to achieve consent of patient/or family is contested. This would especially be the case 
when the treatment under consideration is, on the basis of clinical evidence, deemed futile. 
However, where conversation with patient/and or family is pursued, an essential element in 
that conversation is that it must provide information on the nature of the treatment under 
consideration, the likely consequences of its use, and the benefits and/or burdens expected 
in the use of a particular LPT. This level of information is essential to help achieve patient 
and/or family understanding so that they are better positioned to give genuine and valid 
authorisation for refusal of LPTs. 
1.4 Withdrawing Treatment Already Begun 
is legally and ethically justified if it can be shown that the burdens of continued treatment for 
a particular patient outweigh the benefits. If a patient is competent and if they so wish, they 
should be central in the determination of what constitutes a ‘burden’. Withdrawal is normally 
a decision taken with the patient and/or the patient’s family through conversation about the 
patient’s sufferings and prognosis. If a patient lacks capacity, then the health professional, 
usually in conjunction with any family or proxy, determines what is in the ‘best interests’ of 
the patient. 
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1.5 A Common Misconception on the Topic 
of withholding and withdrawing LPTs is that it is morally more serious to stop a LPT than it 
is to withhold it. This perception is explained by the belief that ‘stopping’ a life support is an 
‘action’ and ‘withholding it’ is only an ‘omission’. Add to this perception, the belief that ‘actions’ 
are much more serious than ‘omissions’ and we can see how misunderstandings occur. 
However, omitting a therapy can be morally just as serious as any action taken in treating 
a patient. Whether something is an act or an omission is never adequate to determine the 
morality of the action. 
1.6 Judgements of ‘Futility’ 
of treatments in end-of-life care are part of everyday life especially in ICU settings. Doctors 
have come to accept patients’ rights to refuse treatment yet they have increasingly 
encountered patients, or more commonly the families of incompetent patients, demanding 
treatment that the health professionals judge to be futile.
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2. Module 6 Definitions
2.1 Advance Care Planning (ACP): 
is a process of discussion between an individual, their care providers and often those close 
to them, about their values and preferences for on-going healthcare. This process may lead 
to formulation of an advance directive, an advance decision to refuse treatment or the 
appointment of a personal proxy to help interpret a person’s advance directive preferences. 
2.2 Artificial Nutrition and Hydration (ANH): 
is a term commonly used in medicine to refer to methods for preventing or treating 
malnutrition and dehydration where a patient has a problem taking fluids or food orally. ANH 
requires invasive procedures supplied through the patient’s nose and throat (nasogastric 
tube), veins (IV line), stomach (gastrostomy), intestine (jejunostomy) or major vessel into the 
heart (hyper-alimentation). ANH is ethically controversial. Viewpoints differ about whether 
ANH is a form of universal human care and so always morally obligatory or whether it can be 
considered an optional treatment based on a benefit-burden judgement. 
2.3 Cardiopulmonary Resuscitation (CPR): 
is a group of treatments used when someone’s heart and/or breathing stops. CPR was 
developed as a treatment intervention for cases of sudden unexpected cardiac or respiratory 
arrest. CPR is used in an attempt to restart the heart and breathing. It may consist of mouth-
to-mouth breathing; chest compression, bag-and-mask positive-pressure ventilation, 
intubation and defibrillation. Electric shock and drugs are also frequently used to stimulate 
the heart.
2.4 Do Not Resuscitate (DNR): 
A DNR order may generally be described as a note primarily written and signed by a doctor 
but which could involve the patient, healthcare team and family, stating that in certain 
circumstances should the patient suffer from cardiopulmonary failure, cardiopulmonary 
resuscitation (CPR) should not be attempted. Such an order is only relevant to not attempting 
CPR and not to the withholding of any other treatment.
2.5 Euthanasia: 
is a deliberate act or omission whose primary intention is to end another person’s life. 
Literally, it means a gentle or easy death but it has come to mean a deliberate intervention 
by one person with the clear intention of ending the life of another. This is often described 
as ‘mercy killing’ of people in pain with terminal illness. Decisions to withdraw or discontinue 
LPTs are not equivalent to euthanasia if they are validly authorised by a competent patient’s  
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consent or if a clinical decision is made that further life supports, based on all available 
evidence, would be futile – lacking in benefit for the patient and merely prolonging the 
dying process. 
2.6 Life Prolonging Treatment (LPT): 
is any medical intervention, technology, procedure or medication that is administered to 
provide benefit for a patient and to forestall the moment of death. These treatments may 
include, but are not limited to, mechanical ventilation, artificial hydration and nutrition, 
cardiopulmonary resuscitation, haemodialysis, chemotherapy, or certain medications 
including antibiotics. 
2.7 Physician Assisted Suicide (PAS): 
Assisted suicide is the act of helping a person to die by providing the means for them to take 
their own life. An example of physician assisted suicide is the act of giving a prescription or 
supply of a lethal dosage of drugs to a patient who has requested this. The doctor providing 
the lethal dosage thus enables a patient to end his or her own life. 
2.8 Principle of Double Effect (PDE): 
is an ethical rule which holds that effects of treatment which would be morally wrong 
if brought about intentionally are permissible if they are foreseen but unintended. The 
principle is often cited to explain why certain forms of care at the end of life which may risk 
and/or hasten death are morally permissible while others are not. 
2.9 Principle of Proportionality: 
states that whether or not a particular LPT for a patient is morally required should be 
evaluated in terms of its potential risks or burdens and probable benefits. If the risks or 
burdens to the patient outweigh the benefits, then the treatment is clinically inappropriate 
and not morally required. A fundamental ethical question in applying the principle concerns 
the issue of who takes part in any decision that determines the relative burdens and benefits 
of an LPT? If a patient has capacity and wishes to participate in decision-making, then their 
input is important in any judgement about benefits and burdens of treatments proposed. 
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3. Module 6 Background
In times past, people died from minor illnesses because science had not yet developed 
medical cures. Today, an impressive range of medical therapies and life-support technologies 
offer not only amelioration of disease but, at times, a considerable extension of good quality 
of life. A key ethical challenge that these medical and technological advances present is to 
determine whether there is always an obligation to prolong human life simply because it 
possible to do so. 
In The Patient as Person (1970) Paul Ramsey claims that there are limits to our moral 
obligations to sustain life. Questions arise such as the following. 
‘Must a terminal cancer patient be urged to undergo major surgery for the sake of a few months’ 
palliation? What of fragmented creatures in deep and prolonged coma from severe brain 
damage, whose spontaneous cerebral activities have been reduced to those arising from the 
brainstem but who can be maintained “alive” for years by a combination of artificial activators 
and by nourishment? Is there no end to the doctor’s vocation to maintain life until the matter is 
taken out of his hands?’ (Ramsey, 1970, p.115).
Admittedly, new treatments often benefit patients, restoring them to well-functioning lives. 
However, such treatments can also be used in situations where they may be neither a benefit 
to, nor wanted by, patients. Once pneumonia was an ‘old man’s best friend’ and was one way 
that nature ended a life that had become debilitated. Now the technology of LPTs brings 
new ethical decisions to decide when such technology is warranted and respectful of patient 
autonomy. In considering decisions to prolong life, one is also considering postponing the 
dying process. If decisions about the use of LPTs are made without attempting to understand 
the values and preference of patients in this regard, then such use of LPTs may be imprudent, 
inhumane and certainly unethical in failing to respect the patient’s own views of what  
should happen.
3.1 Autonomy and its Limits
In most European jurisdictions, it is well established that a patient with capacity has an 
unequivocal right to refuse medical treatment. This right of refusal is ethically defended 
by the principle of respect for patient self-determination or autonomy. Such a principle 
recognises that people have a right to act freely according to a self-chosen set of values 
and plan of life (See Module 4). This right to refuse treatment imposes limits on medical 
interventions and curtails judgements of clinicians to provide LPTs. Patients may request that 
a particular treatment not be given or, if it is already in place, that it should be withdrawn. 
The cases in this module illustrate this point. 
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Refusals by patients can be stressful for doctors and nurses especially if their own judgement 
would indicate a contrary decision to that given by the patient. However, it is generally 
accepted that unless health professionals have concerns about a patient’s capacity or 
consent, they should respect these refusals even contrary to their expertise, their best 
judgement and their emotional response. 
Autonomy has its limits too. In law and to a great extent in ethics, the principle of autonomy 
confers mainly a negative right, a right to non-interference as explained in Modules 3 and 4. 
If patient autonomy were interpreted as conferring a positive right to treatment, this could 
entitle individuals to any requested treatment while ignoring medical advice and judgement 
and ignoring alternative claims for scarce healthcare resources (Gedge, Giacomini and 
Cook, 2007). A patient’s request for LPT does not have to be granted if health professionals 
judge the request to be without benefit for this patient in this particular condition. In brief, 
the clinician does not have to grant what he/she judges ‘futile treatment’. However, it is 
important that informative conversation with any competent patient be offered to ensure 
understanding of why a clinician refusal is given. Such communication is also an important 
opportunity to give hope to the patient and/or the family that a medical refusal of the 
patient’s request for an LPT or other therapy does not mean that they will be abandoned by 
health professionals or left without optimal palliative care. 
3.2 Advance Care Planning (ACP)
Advance Care Planning (ACP) has become the gold standard for patient-centred care.  
The ACP might include an advance statement of wishes and preferences (Advance Directive), 
and/or an advanced decision to refuse treatment (ADRT) in a predefined potential future 
situation. The ACP may also include the appointment of a personal-proxy representative 
who would interpret the stated wishes of a patient when/if they lose capacity. This personal 
representative is not currently part of an Enduring Power of Attorney in Irish legislation but 
could be an informal provision requested by a patient and/or their family. ADC has been 
strongly recommended by numerous societies and medical and nursing colleges. National 
UK guidelines published by the Royal College of Physicians (2009) state the role of ACP in 
achieving the ethical objective of patient-centred care. 
‘At the core of current health and social care are efforts to promote patient-centred care, offer 
choice and the right to consent to or refuse treatment and care offered. This can be difficult to 
achieve when an individual has lost capacity – the ability to make one’s own, informed decision. 
ACP may help in such scenarios.’ (Royal College of Physicians, 2009, p.2) 
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In many countries, most deaths in intensive care are preceded by a decision to withdraw or 
withhold life support. However, clinicians, sometimes in conjunction with families, generally 
make the decisions about life support in intensive care as most patients are too ill to 
participate. Unfortunately, research indicates that few patients have ever discussed their life 
support preferences with a family member or their family doctor. This means that decisions 
by proxy or surrogate decision makers about end-of-life care and use of life supports may not 
accurately reflect patient’s wishes (Way, Back and Curtis, 2002). 
3.3 Goals of Care 
If healthcare decision making is be truly patient-centred and respectful of a patient’s wishes, 
then the goals of care must be clarified. The conversations toward patient consent discussed 
above are an essential part of establishing the goals of care. In fact, decisions about futility 
or starting or withholding life supports are impossible, in any case, without defining what 
the goals of caring for a patient are. It is necessary to consider such questions as: Should the 
focus be on pursuing curative therapies? On prolonging life? On palliating symptoms? 
Determining the goals of care needs to consider the stage of a patient’s disease or prognosis 
and uncertainties related to this. What are the realistic treatment options and, very 
importantly, does the patient understand what these options are? What are the personal 
hopes, values and understandings of the decision-maker and the patient? The goals of care 
for any patient are not set in stone. They are dynamic and can change rather quickly.  
On-going reassessment of goals and on-going documentation is necessary to ensure 
quality of care that is clinically judged feasible and in keeping with the particular patient’s 
preferences. 
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4. Central Issues and Concepts in Decisions about LPTs 
The moral concepts that are discussed in this section are guiding concepts in the process of 
making decisions at end of life. In the discussion of the concepts, readers may notice that 
there are certain recurring insights that reinforce elements of moral reasoning. 
4.1 Starting and Stopping LPTs
Is the decision to stop an LPT morally more serious than the decision not to start an LPT? 
Health professionals sometimes feel morally uneasy about stopping a treatment that has 
been started. What explains this un-ease? In part, it is because stopping a treatment or 
therapy seems to ‘feel’ like ‘killing’ the patient. Stopping a treatment seems more akin to 
an active move that will certainly have consequences. In contrast, not starting a therapy or 
treatment seems more acceptable, apparently because it involves an omission rather than 
an action. Health professionals may believe that decisions to stop treatments are more 
momentous and consequential than decisions not to start them. Stopping a respirator, for 
example, seems to cause a person’s death, whereas not starting the respirator does not seem 
to have this direct causal role. In fact, both actions and omissions can have a causal role in a 
patient’s demise. 
If we adopt the view that treatment, once started, cannot be stopped, or that stopping requires 
much greater justification than not starting, then it is likely this view will have serious adverse 
consequences. Treatments might be continued for longer than is optimal for the patient, even 
to the point where it is causing positive harm with little or no compensating benefit. An even 
more troubling wrong occurs when a treatment that might save life or improve health is not 
started because the healthcare personnel are afraid that they will find it very difficult to stop the 
treatment if, as is fairly likely, it proves to be of little benefit and greatly burdens the patient.
Fear of being unable to stop treatment can lead to failure to treat. Ironically, if there is any call to 
draw a moral distinction between withholding and withdrawing, it generally cuts the opposite 
way from the usual formulation: greater justification ought to be required to withhold than to 
withdraw treatment. (President’s Commission 1983: 75-6)
Morally speaking, then, in some circumstances, it may be more serious to withhold than to 
withdraw treatments. It may be highly uncertain whether a particular treatment will have 
positive effects before it has been tried. Therefore, if we decide not to start a treatment for a 
particular patient who is not imminently dying, we may be losing the opportunity to glean 
evidence of patient response – perhaps even improvement from the treatment. 
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than mere surmise) to support stopping because the therapeutic benefit that earlier was a 
possibility has been found to be clearly unobtainable.’ (President’s Commission1983: 76).
Feelings of reluctance about withdrawing treatments are understandable but
‘not starting’ and ‘stopping’ can both be justified depending on the circumstances of a 
particular case. 
‘We conclude that the distinction between withholding and withdrawing is morally untenable 
and can be morally dangerous. Decisions about beginning or ending treatment should be based 
on considerations of the patient’s rights and welfare, and, therefore, on the benefits and burdens 
of the treatment, as judged by a patient or authorised surrogate.’  
(Beauchamp & Childress 2001: 122)
 
4.2 Ordinary and Extraordinary Treatment
A Spanish Dominican theologian, Franciso De Vitoria (1486-1546), offered the first explicit 
treatment from the Catholic tradition about one’s obligation to prolong life by providing food 
and medicinal drugs. However, it was Domingo Bañez (1528-1604) who introduced the terms 
‘ordinary’ and ‘extraordinary’ into the discussion of morally obligatory and morally optional 
means of preserving life. In a short time after this terminology was introduced, the distinction 
became firmly established in both the Catholic moral tradition and secular contexts of 
medical practice. This distinction still operates today and is often used as a rule of thumb by 
health professionals.
4.2.1 Ordinary Means
Ordinary means are all medicines, treatments, and operations, which offer a reasonable hope 
of benefit and which can be obtained and used without excessive expense, pain, or other 
inconvenience. Such treatments would normally be considered morally obligatory. 
A medical treatment, usually considered ordinary, such as antibiotics, or medically assisted 
nutrition and hydration, might be judged extraordinary for an individual because it will 
be ineffective or without benefit given the person’s poor medical condition and dismal 
prognosis. The immanence of dying can render ordinary therapies extraordinary. The goal 
then moves to palliative care and accompanying the dying (Panicola, 2001, p.18).
4.2.2 Extraordinary Means
Extraordinary means are all medicines, treatments, and operations, which cannot be 
obtained and used without excessive expense, pain or other inconvenience, or which, if used, 
would not offer a reasonable hope of benefit. 
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In conclusion, one is normally morally required to use only ordinary means – according to 
circumstances of persons, places, times and cultures: that is means that do not involve any 
grave burden. Ordinary means must also give reasonable hope of benefit to a particular 
patient.
In the 20th century it was the American Jesuit theologian, Gerald Kelly (1902-1964), who 
studied the Catholic tradition on one’s moral responsibility in end-of-life decisions. It is 
revealing that when clarifying the position, Kelly prefaced it by saying that 
ordinary and extraordinary means are always to be understood in terms of the patient’s 
duty to submit to various kinds of therapeutic measures. (emphasis added. Kelly 1950: 550). 
The point here is that the interpretation of what treatments are ordinary or extraordinary, 
obligatory or optional is always patient-specific. There are no lists of treatments that are 
labelled ‘ordinary’ or ‘extraordinary’. It is how proposed treatments are assessed vis-à-vis a 
particular patient that makes the judgement difficult. Kelly’s emphasis is that the role of the 
patient in such decision-making is primary. The reason for this emphasis is that, traditionally, 
the Catholic moral teaching on end-of-life decisions gives authority first to patients in 
decision-making, then family members and finally health professionals.
4.2.3 Clinically Difficult Judgements
The concepts of ordinary and extraordinary treatment are indicators to be considered 
in making decisions but still rely firmly on the understanding and judgement of health 
professionals and patients where appropriate. While these concepts have a long tradition 
they cannot be viewed as a facile method for determining precisely which means are 
obligatory and which optional. The determination of treatment obligations is clinically 
difficult in concrete cases. The reason for the difficulty is that, included in the definitions of 
the concepts, are several external factors, specifically relevant to a particular patient, that 
need to be considered such as: circumstances of medical and personal information available, 
value considerations about benefits and burdens, information gleaned from available 
advance directives.
The distinction between ordinary and extraordinary means of treatment does not remove 
disagreements. The differences of interpretation are especially apparent on the issue of 
prolonging lives of patients with the use of artificial nutrition and hydration (ANH). These 
disagreements persist today as we see in the discussions of ANH in case 6.5 below. On the 
topic of ANH in particular, a consensus is lacking among the general public, religious leaders 
and health professionals. It remains a matter open for discussion (Panicola, 2001, p.20-21).
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4.3 Principle of Proportionality
The principle of proportionality is a central principle when considering whether or not to 
utilise a LPT with a particular patient.
‘In clarifying goals, health professionals in conversation with patients or their proxies have the 
sensitive task of determining the benefits or burdens of procedures or treatments. This task 
requires a direct application of the proportionality principle. The proportionality principle states 
that a medical treatment is ethically mandatory to the extent that it is likely to confer greater 
benefits than burdens upon the patient.’ (Lesage and Portenoy 2001:122)
The text just quoted needs qualification: a medical treatment might be judged ethically 
required unless a competent patient has refused the treatment. The right of self-
determination of a competent patient to refuse a medical treatment is a fundamental ethical 
value in Ireland, even if a clinician judges the treatment necessary to save the patient’s life 
(See Module 3 and Module 4).
The principle of proportionality requires that the decision process about treatments should 
follow the general rule to maximise benefit and avoid undue burden. In conjunction with the 
ordinary/extraordinary distinction, this principle is widely cited a moral rule of thumb as the 
basis for decision-making about withholding or withdrawing LPTs. 
4.3.1 Benefits and Burdens 
While the principle of proportionality seems clear or perhaps self-evident, what is not 
obvious is that the patient with capacity should have a voice in determining, (according 
to their values), what should be understood as a ‘benefit’ and what constitutes a ‘burden’ 
(General Medical Council, 2009). 
If a benefit must accrue to one for a medical treatment to be considered morally obligatory, 
what constitutes a benefit? A holistic understanding of benefit means that one views the 
human person as a physical, psychological, social and spiritual being. 
‘In the medical context, a treatment is considered beneficial if it restores one’s health, relieves one’s 
pain, improves one’s physical mobility, returns one to consciousness, enables one to communicate 
with others and so on.’ (Panicola, 2001, p.22-23)
A claim that an LPT offers no hope of benefit simply means that the goods for which one 
seeks medical therapy are not forthcoming from the therapy. An ‘excessive burden’ means 
280
Mo
du
le 
6 
Th
e E
th
ics
 o
f L
ife
 P
ro
lon
gin
g 
Tr
ea
tm
en
ts 
(L
PT
s) that any benefits forthcoming from use of a therapy are outweighed significantly by the 
burdens. Given the holistic view of persons, it follows that burdens may also be spiritual, 
psychic, and economic as well as physiological. 
This holistic understanding of benefit and burdens has not been endorsed by everyone 
because it is too demanding in specifying the results of treatments. The effect of the holistic 
view would be that more physically or mentally impaired patients might have treatments 
withheld.
4.3.2 Competence and Incompetence 
Where competent patients are involved, making a concerted effort to try and understand 
how they interpret ‘burdens’ and ‘benefits’ demonstrates respect and commitment to shared 
decision-making with the patient whose life is at stake (See Case 3 and Case 5 below). Coming 
to know how a patient understands ‘benefits’ and burdens’ is not the result of a single 
conversation with the patient. A patient’s judgement of what is beneficial or burdensome 
may change over time, when the patient’s medical condition either improves or increases 
in severity. Similarly, the goals of care are not set in stone but may change with the patient’s 
experience of their condition. 
Where the patient is not competent, the process of clarifying goals involves a process of 
communication and consultation between the healthcare team and the family to determine 
if any input about patient preferences may be relevant for a decision. Few decisions are 
more momentous than those to withdraw or withhold a medical procedure that sustains 
life. In some cases it is morally unjustified for surrogates and clinicians to begin or continue a 
therapy knowing that it will produce a greater balance of suffering and pain for a patient  
who lacks the capacity to choose for or against such therapy. Taking cognisance of any 
advance directive the patient may have aids understanding of a patient values and 
preferences. In brief, what is required if the patient lacks capacity is a decision conforming 
to the ‘best interests’ of the patient (Joyce and The British Psychological Society, 2007; See 
Module 3 and Module 4).
4.4 Killing and Letting Die
Many distinctions and rules about LPTs derive from the distinction between killing and 
letting die. 
The killing-letting die distinction often underpins distinctions between:
  1) suicide and foregoing treatment and,
  2) euthanasia and so-called ‘natural’ death.
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undisputed in their meanings. However, these terms are vague and widely contested as the 
extensive amount of literature on the topic testifies. The concepts are discussed briefly here 
because they often arise in the context of decisions about LPTs as well as public  
policy debates.
Clarification may help to dispel some misunderstandings about ‘killing’ and ‘letting die’ in 
treatment decisions at the end of life. 
4.4.1 Conditions of Judgement
‘Letting die’ is generally acceptable in medicine where one or more of the following three 
conditions apply:
a. Patients or their chosen surrogates have validly refused an LPT. A valid authorisation to 
refuse an LPT alters the obligation of the health professional to treat.
b. A best interest judgement is made by the healthcare team in cases where a patient  
lacks capacity and where a valid surrogate may or may not be present to contribute to 
the decision.
c. An LPT is judged to be ‘futile’ because it yields no benefit for a particular patient and 
only postpones an imminent dying. The task of giving reasons for the ‘futility’ judgement 
and discussing the judgement with the patient and/or family is the responsibility of the 
healthcare team. This condition is the most contentious of the three. What if a competent 
patient or authorised surrogate does not accept the health professional’s or team’s futility 
determination? If a patient is competent and does not accept the futility judgement, then 
it is usually advisable to continue the LPT and hope to glean further evidence that it is 
without benefit (See discussion of Futility below).
In these circumstances (a-c), letting a patient die (following a decision to withhold or 
withdraw LPTs) is normally considered legally and morally acceptable. If none of the three 
conditions above are satisfied, then letting a patient die following withdrawal of treatment 
may involve negligence and be a form of unjustified killing. 
In conclusion: Valid authorisation by a patient, validly designated surrogate, or a reasoned 
argument from health professionals supporting a judgement of futility are conditions that 
morally justify a clinical decision to forego a LPT or to stop a treatment already begun. 
‘Although the shortening of the patient’s life is one foreseeable result of an omission, the real 
purpose of the omission was to relieve the patient of a particular procedure that is of limited 
usefulness to the patient or unreasonably burdensome for the patient and the patient’s family 
or caregivers. This kind of decision should not be equated with a decision to kill or with suicide.’ 
(O’Rourke and Norris, 2001, p.204).
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intentional and as immoral as actions that involve direct interventions to bring about death 
(and both can be forms of killing). Everything depends on other elements in the case and not 
whether the withholding or stopping of LPTs are omissions or actions.
The importance of ‘valid authorisation’ in assessing the morality of decisions at the end of 
life will be discussed below under Further Discussion. Suffice for now to conclude that the 
distinction between letting die and killing often suffers from vagueness and moral confusion. 
•	 ‘Letting die’ is not always morally justified by saying it is an ‘omission’ of treatment. 
•	 Neither is ‘killing’ always morally unjustified by saying it is an ‘action’ taken by the health 
professional to bring about death. 
‘Nothing about either killing or allowing to die entails judgements about actual wrongness or 
rightness, or about the beneficence or non-maleficence of the action.
Rightness and wrongness depend on the merit of the justification underlying the action, not on 
the type of action it is. 
Neither killing nor letting die, therefore, is wrongful per se. Accordingly, a judgement that an act of 
either killing or letting die is justified or unjustified requires that we know something else about the 
act besides these characteristics. We may need to know about the actor’s motive (is it benevolent 
or malicious?), the patient’s or surrogate’s request, or the act’s consequences. 
These additional factors will allow us to place the act on a moral map and make a normative 
judgement about it. In short, whether letting die is justified and whether killing is unjustified 
are matters in need of analysis and argument, not matters that medical tradition and legal 
prohibition have adequately resolved.’ (Beauchamp and Childress, 2001, p.141-142)
It is increasingly clear that laws and policies about end of life decision-making are often 
vague and unclear because of the confusions discussed above about acts and omissions, 
killing and letting die. The discussion above is meant to clarify the ethical nature of these 
distinctions and is not making claims about the law (See Module 3 and Module 4).
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4.5. Quality of Life Judgements
Thus far in these discussions, considerable weight is given to quality-of-life judgements 
in deciding whether treatments are ordinary or extraordinary, optional or obligatory, 
proportionate or disproportionate. The central premise in these discussions has been: 
‘When quality of life is sufficiently low and an intervention is likely to produce more harm or 
burdens than benefits for the patient, it is morally justified to withhold or withdraw treatment. But 
such judgements require evidence based and defensible criteria of burdens and benefits in order 
not to reduce quality of life to arbitrary judgements of personal preference and the patient’s social 
worth.’ (Beauchamp and Childress, 2001, p.136).
This latter point from Beauchamp and Childress is pivotal in understanding decisions based 
on estimated quality of life. It is also fundamental to objections to quality of life judgements. 
What worries all opponents of quality of life positions is that the view appears to define 
and prescribe the ‘good life’ in terms of the qualities necessary to live a minimal human and 
worthwhile existence. If this is an accurate reading of quality of life views, then the position 
becomes entrapped within the ‘exclusionary’ use of quality of life judgements. The lack of 
certain valued qualities in a patient’s life becomes a way of positively excluding potential 
patients from the normal standards of medical and moral treatment (Walter, 2004, p.1391). 
There is an apprehension and fear that decisions based on quality of life considerations  
could descend into an appraisal of a patient’s place in a society, or discriminatory assessment 
of a patient’s ethnicity or intelligence etc. It is fundamentally important that the involvement 
of patients and/or authorised surrogates in decisions about LPTs can help to address 
concerns that clinical decisions in assessing benefits and burdens may discriminate against 
some patients. 
Decisions based on quality of life considerations are judgements about what the likely 
outcomes (benefits or burdens) are for a patient if a particular treatment is given. It is 
impossible to determine what will benefit a patient without presupposing some quality 
of life standard and some conception of the life the patient will likely live after a medical 
intervention
‘Accurate medical diagnosis and prognosis are indispensable, but a judgement about whether to 
use life prolonging measures rests unavoidably on the anticipated quality of life, not merely on a 
standard of what is medically indicated.’ (Beauchamp and Childress, 2001, p.137)
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emphasizes the inherent dignity of every human being regardless of ability or status.
4.6 Sanctity of Life 
The sanctity of life tradition is associated with the major world religions. In Genesis from 
the Christian Holy Bible, for example, human life is seen as having an intrinsic value 
independently of the individual’s own view of it. Each life is viewed as unique, on loan,  
made in the image of god with an unrepeatable opportunity to praise god. Similarly, in the 
Islamic tradition, the Holy Koran (Al-An’am, Verse 151) states that human life has intrinsic 
value, that it is made sacred by Allah. It is a divine trust, created to discover god’s work and 
serve god’s plan.  
Historically, the sanctity of life position holds that the value of human life is not dependent 
upon its being valued by the individual themselves or by others or by the presence of 
certain functional capacities such as relationality or rationality. On this view, if the valuing 
of human life requires certain kinds of capacities, then their absence (for example, with 
patients who are considered to be in a persistent vegetative state) implies a different (lesser) 
kind of valuing. Conditions placed on the respect owed human beings results in an ethics of 
exclusion based on certain properties that some persons may lack through no fault of  
their own.
4.6.1 Challenges to the Sanctity of Life Position
A first challenge to the sanctity of human life commitment claims that it is intrinsically 
idolatrous. In talking of the ‘sanctity’ of human life this view overstates the nature of human 
essence in its insistence that human life is sacred and this is an attribute reserved only for 
God. Adherents of sanctity of life dispute this interpretation and claim that sanctity of human 
life only means that humans are set apart by God and are distinct in the created order. 
However, this response means that the special status attributed to humankind still requires a 
theological foundation and such religious reliance will not persuade those of different or no 
religious faith. 
A second challenge to the sanctity of life view is the charge of medical vitalism:
‘the notion that all means must be utilized to keep a human being alive in the face of death. 
Because human life has incalculable worth a commitment is required to keep patients alive at all 
costs. Many critics of the sanctity of life perspective have assumed that vitalism is an inherent part 
of the tradition’ (Hollinger, 2004, p.1404).
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position. They claim that there is a natural cycle to human life that must be accepted. 
4.6.2 Inalienable Human Rights
A respect for the inherent dignity of human persons central to a sanctity of life view also 
supports communal life in society. 
‘If laws were permitted to embody the idea that in some circumstances life loses its worth, or that 
some people lack sufficient worth to have their lives protected, individuals would no longer enjoy 
equal protection of the law so far as their lives are concerned’ (Hollinger, 2004, p.1404).
Others argue that religious arguments are not required to defend belief in the ‘sanctity of 
human life’. 
‘It is enough simply to say that all human lives are deserving of equal respect not because of 
what they have to offer or have offered or potentially will offer, but because they exist. The notion 
of inalienable human rights attributes force to the value of human life with the assertion that it 
needs no justification. This is the primary merit of the sanctity of life ethic – that a life requires no 
justification’ (Schwartz, Preece and Hendry, 2002, p.116).
 
The sanctity of human life position emphasizes that medical termination of life does require 
justification. In this sense the principle acts as a powerful bulwark against the devaluing of 
human life. Article 3 of the United National Declaration of Human rights asserts simply that:  
‘Everyone has the right to life, liberty and security of person’ (Schwartz, Preece and Hendry, 
2002, p.116).
 
4.6.3 Compatibility of Quality of Life and Sanctity of Life
If one removes a religious foundation as a requirement for acceptance of the sanctity of life 
view, then its essential meaning is compatible with quality of life judgements. 
Human life needs no justification if we once agree to the commitment that all human lives 
are accorded equal respect not because of what they can offer to society but because they 
simply exist. This respect for the dignity of human beings is harmonious with the belief that 
quality of life judgements are necessary when making decisions about LPTs. Those quality of 
life judgements deliberate on the possible efficacy or futility of LPTs in the life of the patient. 
Health professionals, in company with patients or authorised surrogates can acknowledge 
when further life supports are greater burdens than benefits for a particular patient. 
This acknowledgment, in unison with expert palliative care, allows patients to achieve the 
dignity of a good dying. 
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5. Futility
Judgements of ‘futility’ of treatments in end-of-life care are part of everyday life especially 
in ICU settings. Physicians have come to accept patients’ rights to refuse treatment yet they 
have increasingly encountered patients, or more commonly the families of incompetent 
patients, demanding treatment that the clinicians judge to be futile.
Historically, the debate about what constitutes ‘futile’ treatments began with decisions 
relating to the stopping of cardiopulmonary resuscitation but with increasing medical 
technology, it has expanded to other forms of life prolonging care. Paradigms of futile 
care often involve efforts to resuscitate a patient who is imminently dying as well as life 
prolonging intervention for patients in a persistent vegetative state. Other paradigms include 
the use of aggressive therapy such as surgery, chemotherapy and haemodialysis for patients 
with advanced terminal illness and without a realistic expectation of improvement. Even the 
use of less invasive treatments such as intravenous hydration or antibiotics in near-moribund 
patients might be considered ‘futile’ treatment. 
The impression may be that such judgements about futility are based on clinical criteria and 
can result in objective decisions that provide a certain and warranted basis for discontinuing 
further LPTs. The discussion that follows indicates that this is not the case. 
5.1 Debates on the Meaning of ‘Futility’
A central issue in the futility debate has been how to define futility.
‘Some try to narrowly restrict it [futility] to only those treatments known with certainty not to 
achieve their goal. The attempt is to eliminate value judgements from futility determinations and 
to make them only an empirical matter about which the physician should be expert. But others 
have pointed out that it is not possible to eliminate all value judgements. Others have more 
broadly characterised futility to include cases where the probability of benefit is considered too 
low, or the size of benefit too small, to warrant the burdens of treatment.’ (Brock, 2004, p.1418).
‘Futility’ judgements are typically used to express a combined value judgement and scientific 
judgement. There is a considerable subjective element in judgements that further treatment 
is ‘futile’ – precisely because decisions that weigh up benefits and burdens are not based on 
rocket science. It is easy to see how clinicians and patients might disagree about whether or 
when further treatment is beneficial for improving one’s function or one’s quality of life.  
The value judgement seems in most cases appropriately left to the patient or surrogate, not 
the physician.
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beneficial because it offers no reasonable hope of recovery or improvement or because the 
person is permanently unable to experience any benefit. In other cases the utility and benefit of 
a treatment can only be determined with reference to the person’s subjective judgement about 
his or her overall well-being. As a general rule, a person should be involved in determining futility 
in his or her case. In exceptional circumstances such discussions may not be in the person’s best 
interests.’ (Canadian Nurses Association, Canadian Healthcare Association, Canadian 
Medical Association and Catholic Health Association of Canada, 1999, p.4).
In discussing ‘judgements of futility’, it should not be people’s lives that are judged futile. In 
making judgements of futility, a health professional (often in company with patient or family) 
is not (or should not be) making a value judgement about the significance or worth of this 
person’s life. This point is most important to stress with family members where, for example, 
a Do Not Resuscitate (DNR) has been signed. Respect for the patient’s worth and concern to 
protect their dignity means that, if a patient has a DNR in their chart, they need reassurance 
that all pain management and compassionate care will continue.
5.2 Evolution of the Concept of Futility
What is beyond doubt is that the notion of futility is disputed and that it is very much a 
concept in evolution. For over twenty years now ‘futility’ has been debated in the hopes that 
a clear and determinate set of criteria might be formulated that would help doctors make 
decisions about providing or withholding LPTs. The concept of medical futility surfaced in 
the 1980’s largely in response to concerned families who insisted on LPTs for their loved 
ones while caregivers or health professionals deemed these treatments to be inappropriate. 
Clinicians felt providing futile treatment was cruel while studies of patients and families 
consistently stated that such care was valued and wanted (Burns and Truog, 2007).
The debate on ‘futility’ can be divided into three segments or three generations that mark the 
evolution of the concept. 
1. A first generation was taken up with efforts to define futility in terms of definite clinical 
criteria. This process seemed guaranteed to give objectivity and certainty to futility 
judgements. However, these efforts failed because they recommended ‘limitations to care 
based on value judgements for which there is no consensus among a significant segment 
of society’ (Burns and Truog, 2007). 
2. The second generation in the debates on futility offered a procedural approach that gave 
power to hospitals, utilising their ethics committees, to decide whether interventions 
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to try and distance the decision from health professionals by transferring it to ethics 
committees. Failure also resulted because it gave hospitals authority to make decisions 
that health professionals desired but any national consensus on what is ‘beneficial 
treatment’ remained under intense debate.
3. Burns and Truog (2007) predict the emergence of a third generation that should focus 
primarily on negotiation at the bedside and on-going communication. This third view 
places importance on developing and deepening understanding between patients, 
families and professionals. In addition, it acknowledges that conflict can surface among 
health professionals if families demand what is judged futile treatment and wish ‘all that 
can be done to be done’. While considerable stress can then be experienced by healthcare 
teams Burns and Truog advise that, rather than initiate an adversarial encounter with the 
patient and/or their family, the health professionals should support each other to help 
deal with the stress of ‘futility’ judgements and ensuing conflicts (2007, p.1992).
5.3 Divergent Views about Futility Judgements
There are diverse approaches to making judgements that certain kinds of treatments are 
futile.
1. One position thinks that ambiguity is fostered by the use of the term to refer to both 
quantitative and qualitative components.
‘Those who question the use of futility judgements to limit the treatment options offered to 
patients often argue that what effects are deemed desirable or beneficial may depend on whether 
the patient’s or the clinician’s perspective is adopted. They express concern that assertions of 
futility may camouflage judgements about the comparative worth of patients’ lives. It must be 
acknowledged that even seemingly objective claims about the likelihood that an intervention 
will produce some effect are tinged with uncertainty; for some patients, a vanishingly small 
probability of success will be viewed as preferable to foregoing the treatment.’  
(Centre for Bioethics, 1997b, p.5).
2.  A second position about futility debates claims that it would be more helpful if we just 
abandoned the term ‘futility’ in preference for more concrete and precise descriptions 
of a clinical situation being considered. The amount of divergence in subjective, and 
even apparently objective clinical estimates of futility, should suggest that the resulting 
confusion can be remedied by more accurate accounts of specific situations where 
treatment seems contraindicated because earlier efforts at therapy indicate that no 
further patient-benefit is expected. 
‘The term ‘futility’ is used to cover many situations of predicted improbable outcomes, improbable 
289
Mo
du
le 
6 
Th
e E
th
ics
 o
f L
ife
 P
ro
lon
gin
g 
Tr
ea
tm
en
ts 
(L
PT
s) success, and unacceptable benefit-burden ratios. This situation of competing concepts and great 
ambiguity suggests that we should generally avoid the term ‘futility’ in favor of more precise 
language.’ (Beauchamp and Childress, 2001, p. 134)
3. A third area of diverging perspectives pertains to the obligations of health professionals 
to consult patients and/or their families in making decisions about the use of LPTs, most 
especially where there is clinical agreement that a particular therapy would be futile 
for the particular patient. Some clinicians and commentators on the topic of ‘futility’ 
judgements do not agree that a clinician must respond positively to a patient’s insistence 
on a treatment that is judged to be without any discernible benefit. The argument is 
given that if a treatment is futile for a particular patient, this fact changes the doctor’s 
obligations to seek agreement from patients or surrogates. Health professionals may not 
even have an obligation to discuss such a treatment as if it were a realistic option. 
‘The physician is not morally required to provide the treatment (and in some cases may be 
required not to provide the treatment) and may not even be required to discuss the treatment[…] 
Increasingly hospitals are adopting policies aimed at denying therapies that physicians judge to 
be futile, especially after trying them for a reasonable period of time[…] respect for the autonomy 
of patient or authorized surrogates is not a trump that allows them alone to determine whether a 
treatment is required or is futile.’ (Beauchamp and Childress, 2001, p.134).
 
A recent study in one Dublin hospital seems to give credence to the above viewpoint that 
communication with patient and family is not always required when deciding on use of LPTs 
that are considered futile. The research focussed on communication with families of patients 
in intensive care. The study of end-of-life care in one Dublin hospital by Collins, Phelan, Marsh 
et. al. (2006) showed that the involvement of families with clinicians when making end-of-life 
decisions was low. Overall, almost a quarter of patients’ families studied were not involved 
in the decision to limit life prolonging therapy. Patients’ input in the decision-making was 
not discussed because all of the patients whose end of life condition was discussed lacked 
capacity. 
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The Collins et. al. (2006) study, explains that when a clinical judgement is made that further 
therapy or treatment would be futile because the patient is unresponsive to maximum 
medical therapy, health professionals tend not to consult a family about the possibility 
of providing such a treatment or discontinuing the treatment. The explanation given was 
that where a clinical judgement is made of acute physiological futility, consultation with 
family would be redundant. One might add that consultation with family may not even be 
obligatory. If a family were consulted and insisted on continued futile treatment, clinicians 
would face a serious conflict of conscience in believing that they would then have to provide 
futile treatment that may well harm the patient (Collins et.al., 2006, p.318; See Cases 1, 2 and 
4 below).
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6. Cases: Decision Making Involving the Use of LPT
6.1 Case 1: When is Treatment Futile? – Do Everything You Can 
Do Everything You Can
 
Ms. R. a 52 year old woman with severe rheumatoid arthritis and chronic immobility, was 
brought to the emergency department. Her health was poor, although stable, until the morning 
of admission when she became disoriented and lethargic. She was admitted to intensive care 
and put on a ventilator while being treated for septic shock secondary to decubitus ulcers and 
for acute renal failure. On the day after admission she required increasing doses of vasopressor 
drugs and developed acute respiratory distress syndrome. Some members of the intensive care 
team became increasingly concerned about the ‘futile’ care they felt they were providing.  
The patient’s family requested that the medical team ‘do everything’ to keep her alive. 
After several days of observation of Ms.R. and following conversations with the family, an ICU 
clinician agreed to meet with them to explain that Ms.R.’s underlying immune suppression and 
general health was such that she was most unlikely to recover from the progressive septic shock 
but if improvement were not possible, the aim and value was to ensure patient comfort. 
The clinician was sensitive to the family’s anxiety, sense of impending loss and fear of Ms.R.’s 
impending death. At the conference the family was asked to say how they understood the 
patient’s condition? The team learned from the conversation that Ms.R. was known for her 
energy and readiness to take on all challenges. The family expressed an unrealistic optimism 
about her condition and genuinely believed (or wanted to believe) that Ms.R. could recover to 
an earlier mobile and healthy self. Careful listening by the clinician and expressions of interest 
about the person of Ms.R. reassured the family that this conversation was not just a formality to 
be quickly concluded.  
The team continued in their efforts to help the family to adjust their hopes to more realistic care 
goals for Ms.R. The family were reassured that they would have time to think everything over. 
Life support would continue as long as the family believed it was what Ms.R. would want. 
After a few days, the family decided Ms.R. would probably not want ongoing life support. Here 
the team took time to explain the process of withdrawing life support while being careful not to 
alarm the family about Ms.R.’s ensuing pain. All drugs were stopped for Ms.R. except morphine.
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Ms.R. would be unlikely to survive for more than an hour after withdrawal. The team asked the 
family about spiritual needs and the family requested a chaplain. This was provided before 
extubation began. The family and chaplain were at Ms.R.’s. bedside when she died 30 minutes 
later (Adapted from Way et. al., 2002, p.1342-45)
6.1.1 Discussion 6
Many deaths in intensive care occur after withholding or withdrawing life support. In ICU 
situations, the decisions are often made by health professionals and families since the 
patient is frequently too ill to participate. But conflict can arise due to disagreements among 
healthcare staff in ICU or disagreements about treatment decisions by family members. 
‘Conflict surrounding decision-making in intensive care units is common. Conflict can arise 
about issues such as communication styles, interpersonal interactions, pain control as well as 
about treatment decisions […] The evidence on the best way to resolve conflicts suggests that 
communication, negotiation and consensus building are the most important tools.’  
(Way et. al., 2002, p.1343).
In Case 1, there is consensus on the part of the healthcare team that further provision of 
treatments aimed at cure would be futile. 
The case here illustrates a general rule of thumb in ICU care: When diagnosis and prognosis 
is unclear, it is preferable to commence treatment and keep the patient under observation. 
Before an LPT is started, it is not certain whether it will bring the hoped-for-benefits to 
the patient. Once it has been tried and it becomes clear that it does not produce the 
benefits sought, clinical evidence exists to justify stopping therapy that did not exist for not 
starting the ventilator. The principle supports the use of time-limited trails of LPT, with the 
understanding that if the treatment does not prove to be beneficial it will be stopped. .
‘Few decisions are more momentous than those to withhold or withdraw a medical procedure 
that sustains life. But, in some cases, it is unjustified for surrogates and clinicians to begin or 
to continue therapy knowing that it will produce a greater balance of pain and suffering for a 
patient incapable of choosing for or against such therapy.’  
(Beauchamp and Childress, 2001, p.135-6).
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that continued ventilator support and increasing vasopressor drugs served only to prolong 
the dying process. Their responsibilities now were to provide appropriate palliative care  
for Ms.R. 
Justified ‘Allowing to Die’?
A clinical decision to intentionally withdraw an LPT is often construed as a doctor’s ‘letting 
die’ rather than killing. The argument is that if the decision is validly authorised then it is 
morally justified. A valid authorisation can often transform what might be a maleficent act of 
killing into a nonmaleficent (and perhaps beneficent) act of allowing to die. Normally valid 
authorisation is provided by a competent patient who refuses or perhaps requests continued 
life support assistance. Ms.R. lacks capacity to decide for herself or provide authorisation 
for a decision. The team’s effort to involve the family in assessing benefits and burdens of 
continuing ventilator support, demonstrates attempts to achieve surrogate authorisation for 
the decision to discontinue ventilation and commence palliative care. 
Assessing the burdens and benefits of further LPTs for Ms.R. involves reasonable medical 
judgements and quality-of-life judgements:
‘We conclude that competent patients and authorized surrogates can use controlled quality-of-
life considerations with medical input to legitimately determine whether treatments are optional 
or obligatory.’ (Beauchamp and Childress, 2001, p.139).
Abandonment 
In conversations with the family of Ms.R. an important point was stressed throughout; if some 
treatments were to be discontinued because they lacked discernible benefit for the patient, 
good care and pain management would continue to be provided. For example, therapeutic 
sedation to ameliorate symptoms of breathlessness and anxiety are essential in end of life 
weaning from ventilator support.
Families often fear abandonment by health professionals once a patient is no longer seen 
as curable or as responsive to LPTs. Expert guidelines on caring for patients at the end of life 
emphasize the importance of not allowing the patient to feel abandoned especially when 
the care plan includes withdrawal of disease-modifying treatment (Cherny, Radbruch and 
The Board of the European Association for Palliative Care [EAPC], 2009, p.581; Lesage and 
Portenoy, 2001, p.125). Non-abandonment has been cited as a primary tenet of medicine 
and a key value in professionalism. Despite the professed importance of non-abandonment 
to end-of-life care, surveys show that patients and family care-givers still experience 
abandonment around the time of death (Back, Young, McCown, et. al., 2009, p.474)
 
294
Mo
du
le 
6 
Th
e E
th
ics
 o
f L
ife
 P
ro
lon
gin
g 
Tr
ea
tm
en
ts 
(L
PT
s) The family of Ms.R. felt their concerns were heard. The team did not appear rushed in their 
conversations and the family appreciated knowing the now revised care plans for Ms.R. Most 
of all, the family felt relieved that they had not been pressured into accepting withdrawal of 
life support. 
 
6.1.2 Suggested Professional Responsibilities 6
•	 Communicate with the family to help them to realistically understand the clinical 
condition of Ms.R. including likely prognosis.
•	 Give time and provide a proper atmosphere of privacy for the family to digest the 
reality of Ms R.’s illness. In this context, be aware of imminent grieving of family.
•	 Document in case notes the basis for a judgement that further ‘curative efforts’ were 
deemed ‘futile’. This includes clinical and quality of life judgements about burdens and 
benefits for the patient.
•	 In an effort to minimise distress for the family and patient, the healthcare team 
can show they are partners with the family in trying to make the right decision for 
Ms. R. When relatives feel the team are partners in the decision, they may feel less 
marginalized and/or burdened by guilt.
•	 Provide understanding and reassurance for the family that all comfort needs and pain 
management of Ms R will be carefully provided for in the dying process. 
•	 Make every effort to accommodate the religious perspective of the patient and family. 
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6.2 Case 2: DNR and Family Disagreement – When God Might Intervene
Case 2 presents a rather ordinary situation of advanced and complex illness in an elderly 
gentleman. His wishes have not been expressed and his family voice their serious concerns 
about the clinician’s suggestion that they agree to a Do not Resuscitate Order (DNR) for  
their father. 
 
When God Might Intervene
Mr. W. is 82 years old and has many serious medical problems, including ischemic heart disease, 
hypertension and diabetes mellitus. He has had a series of debilitating strokes that have left him 
severely disabled and unable to communicate his wishes. His health care providers feel that he 
would not benefit from resuscitation attempts if he were to suffer a cardiac arrest and suggest 
to his family that a DNR be placed on his chart.
The devout Christian family is quite upset and reject this suggestion. They can’t see that 
continuing to live is any burden on them or their father. They believe that God could still heal 
their father and they accuse the health care providers of trying to ‘play God’. They ask to see the 
hospital Chaplain. (Smith, RCSI Residency Programme case no.12, 2008, p.52)
6.2.1 Discussion 6
Normally, unless a specific order to the contrary (e.g. DNR) has been recorded on the person’s 
health record by the responsible doctor or a valid patient Advance Directive, CPR is used as a 
standard intervention in virtually all cases of sudden cardiac or respiratory arrest. 
What is a DNR Order?
A DNR order may generally be described as a note primarily written and signed by a 
doctor but which could involve the patient, healthcare team and family, stating that 
in certain circumstances should the patient suffer from cardiopulmonary failure, 
cardiopulmonary resuscitation (CPR) should not be attempted. Such an order is only relevant 
to not attempting CPR and not to the withholding of any other treatment.
What is Involved in CPR?
Cardiopulmonary resuscitation (CPR) was first developed as a treatment intervention for 
cases of sudden unexpected cardiac or respiratory arrest. CPR includes chest compression, 
bag-and-mask-positive-pressure ventilation, mouth-to-mouth resuscitation, ventilation, 
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Electric stimulation to the chest and special medicines may be used. This is usually done for 
15 to 30 minutes. A tube may also be put through the mouth or nose into the lung. This tube 
is then connected to a breathing machine. (American Academy of Family Physicians  
(AAFP), 2000)
Judging Disproportionate Means 
While very aware of the grief experienced by the family the doctor explains to the family that 
prolonging life with CPR would not benefit their father and the distress of the process itself 
is sometimes more cruel than compassionate. In the case of Mr. W., health professionals have 
judged CPR inappropriate and are relying on their benefit-burden judgement known as the 
principle of proportionality discussed above.
‘It needs to be determined whether the means of treatment offered are proportionate to the 
prospects for patient improvement. To forego disproportionate means is not equivalent to suicide 
or euthanasia: it rather expresses acceptance of the human condition in the face of death.’  
(Ashley and O’Rourke, 1997, p.419).
The family disagree. They cannot see what is so burdensome about continued life for their 
father. They might believe that prolonging their father’s life benefits him because:
a. Recovery of awareness by Mr.W. is remotely possible, perhaps by a miracle;
b. Their father is better off alive than dead.
Here, as in Case 1, it is essential that the healthcare team engage in conversation with  
Mr. W.’s family. This is not only out of respect for the family who are wondering about Mr.W.’s 
condition but the conversation also needs to ensure that the family understands the CPR 
procedure as realistically as possible. This understanding is seldom the case with families.
In their research with practitioners in Irish hospitals, Quinlan and O’Neill (2009) found that 
patients and families often lacked knowledge and understanding about active treatments 
mentioned. They didn’t know what was meant by ‘PEG feeding’, ‘subcut fluids’, ‘defibbing’ and 
‘shocking hearts back to life’ (Quinlan and O’Neill, 2009, p.36). It is easy to see how patients 
or families end up confused and are intimidated about asking ‘what does this mean?’ when 
hearing abbreviated jargon from doctors or nurses. 
Guiding principles about CPR and DNRs recur in statements offered by international medical 
and nursing associations (British Medical Association [BMA], Resuscitation Council UK, and 
Royal College of Nursing [RCN] 2007; General Medical Council, 2009; New South Wales 
Department of Health, 2005; Royal College of Paediatrics and Child Health, 2004).  
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patients and part of that difficulty is a result of the point made above that it is a complex 
procedure and very dependent on the precise clinical condition of the patient  
(O’Keefe, 2001). 
Some patients may ask that CPR be attempted should they arrest, even if the clinical 
evidence suggests that, in their case, there is only a very small chance of success. Health 
professionals may doubt whether the risks and burdens associated with CPR are justified 
with such a small chance of success but the individual – if properly informed, and whose life 
is at stake, may be willing to accept that chance.
Research continues to show that patients are not adequately informed:
a. Most patients are not aware or knowledgeable of possible risks and adverse effects of 
CPR in order to make an informed decision about whether or not they would want CPR.  
b. Many people, patients, families and even some health professionals have unrealistic 
expectations about the likely success and potential benefits of CPR and lack detailed 
understanding of what is involved.  
c. This failure of understanding makes it very difficult to achieve genuine informed consent 
to a DNR or to CPR in the event of cardiac arrest  
(BMA, Resuscitation Council UK, and RCN, 2007).
In the health professional-family conversation, it is important to find out whether the family 
understands what is actually involved in CPR, what likely outcomes can be anticipated, and 
what possible suffering might be involved for Mr.W. if it is attempted.
The potential benefits and risks of CPR need to be discussed with the family.
The Benefits of CPR
For a patient with an advanced life-threatening illness who is dying, the single benefit of CPR 
is that it may defer dying. CPR may prolong life if it’s done within 5 to 10 minutes of when the 
person’s heart stopped beating or breathing stopped. 
The Risks of CPR
Attempted CPR carries a risk of significant side effects (such as sternal fracture, rib fracture 
and splenic rupture) and most patients require either coronary care or intensive care 
treatment in the post resuscitation period. If there is delay between cardiopulmonary arrest 
and the resuscitation attempt, there is a risk that the patient will suffer brain damage. Some 
resuscitation attempts may be traumatic meaning that death occurs in a manner the patient 
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These full, graphic details of potential risks of CPR may not have to be provided to Mr.W.’s 
family but, on the other hand, without some explanation, the family may have a very 
unrealistic perception or image of what CPR involves. A possible misunderstanding such as 
this can obstruct a decision that could ‘benefit’ Mr. W. 
‘Information should not be forced on unwilling recipients and if patients indicate that they do not 
wish to discuss CPR this should be respected. All of these efforts in attempting to discover if the 
patient wishes to discuss CPR as well as the outcome of these attempts should be documented.’ 
(BMA, Resuscitation Council UK, and RCN, 2007, p.2). 
Based on interviews and narratives of Irish hospital staff, such conversations with patients 
and families to provide helpful information and aid understanding are uncommon 
occurrences. Documentation of such decisions with the circumstances and reasoning for the 
decision noted is also uncommon. Certainly, patient records do not show evidence of such 
conversations aimed at discovering patient wishes (Quinlan & O’Neill, 2009, p.37). The Irish 
Ethicus data with intensive care patients and families, show that documentation of end-of-
life decision making is sparse. This was especially the case with respect to CPR  
(Collins et. al., 2006, p.317).
Ethical and Legal Status of DNR in Ireland
‘As is the case with many other areas of medicine, there is a serious lack of ethical and legal 
certainty regarding DNR orders. There exist no Irish medical guidelines and there is neither 
legislation nor judicial wisdom to assist medical practitioners in this emotionally sensitive and 
legally uncertain area of medicine.’ (Sheikh, 2001, p.4)
In the absence of policy guidelines or legislation it is not surprising that health professionals 
may decide to ‘walk slowly’ if a patient arrests and CPR is thought to be a futile therapy for 
that individual. But in the absence of policies or legislation, families also have little recourse 
if they believe that they have been overlooked in a decision to provide or withhold CPR. The 
following report explains why a policy is required:
‘Because for every person there comes a time when death is inevitable, it is essential to identify 
patients for whom cardiopulmonary arrest represents a terminal event in their illness and in 
whom attempted CPR is inappropriate. It is also essential to identify those patients who do not 
want CPR to be attempted and who competently refuse it’ (Sheikh, 2001, p.6).
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When patients and their families are consulted, decisions about attempting CPR raise 
sensitive and potentially distressing issues for patients and people emotionally close to them.
Initially it is most important to determine the competence or incompetence of patients who 
are deciding on DNR or CPR. When an incompetent person’s wishes are not known, treatment 
decisions must be based on the person’s best interests as discussed above. This best interests 
judgement is not solely a clinical or legal judgement that lacks reference to the particular 
patient. Quite the contrary: ‘best interests’ based decisions need to take into account:
a. The patient’s known or ascertainable wishes, including information about previously 
expressed views, feelings, belief and values and whether those views might still be the 
same.
b. Information received from those who are significant in the person’s life and who could 
help in determining his or her best interests. 
c. Aspects of the person’s culture and religion that would influence a treatment decision.
As well as:
d. The likely clinical outcome, including the likelihood of successfully re-starting the 
patient’s heart and breathing for a sustained period, and the level of recovery that can 
realistically be expected after successful CPR.
e. The risks involved with treatment and non-treatment.
f. The patient’s human rights, including the right to life and the right to be free from 
degrading treatment.
g. The likelihood of the patient experiencing severe pain or suffering as a result of the 
treatment.
CPR can also be viewed as harmful and offensive to the dignity of a patient. The explanation 
above of the potential ‘risks’ involved in CPR is translated into reality in this anonymised Irish 
case cited in Quinlan and O’Neill (2009).
‘I’m a nurse on the resuscitation team and, to this day, a case still bothers me. An 84 year-old 
gentleman with end stage chronic obstructive airway disease (COPD) was admitted at night 
by a medical registrar who had not discussed this man’s case with her consultant and had not 
discussed it with the anaesthetic consultant to review this patient. The patient was on maximum 
medical treatment and home oxygen. He would not have benefitted from his heart being shocked 
nor will he benefit from being put on a life support machine because, with end stage COPD, he 
would never come off the life support machine. 
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same time as the anaesthetist and the medical registrar who called me […]
I asked: “Is this gentleman for resuscitation?” “Yes.” So we were going through with it and all his 
ribs were cracking as we were doing the procedure. I said: “God, this is very unethical!” Has this 
been discussed with the gentleman or relatives? The registrar said: “No.”’  
(Quinlan & O’Neill, 2009, p.31)
This decision to apply CPR is made without the consensus from the healthcare team. It also 
shows no effort to consult the family. It appears to be an unjustified decision to apply CPR 
since it was, on all the medical evidence, futile treatment. Finally, even a brief consideration 
of benefits and burdens of the LPT for this gentleman would show that CPR is not only 
proving to be a ‘futile’ treatment; it is also harmful – the burdens are overwhelming. 
Justification for this medical decision is wholly lacking. This case provides a good example for 
documentation of all decisions in patient records. If documentation were provided, it would 
have required the clinical team to reflect on their actions and see if any warrant for their 
decision could reasonably be provided. 
6.2.2 Suggested Professional Responsibilities 6
•	 Given the difference of perspective that exists between the healthcare team and 
the family in Case 2, it is important to allow time to observe the progress of Mr. W’s 
condition and continue conversations among health professionals and family. 
•	 The nature, benefits and risks of CPR as they apply to Mr. W’s situation should be 
explained to the family.
•	 The family should be reassured that a DNR decision applies solely to CPR. All other 
treatment and care which are appropriate, including palliative care are not precluded 
and will not be influenced by a DNR decision. 
•	 All the health professionals in the team and the family members should be clear 
that while they have a duty to protect life, they must also balance this value with the 
obligation not to subject the patient to inhuman or degrading treatment.
•	 Any decision that CPR will not be attempted for an incapacitated patient should be 
documented on the patient’s records and details given of components that went into 
the ‘best interests’ judgement.
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6.3 Case 3: Requesting Ventilator Withdrawal – ‘My Life has Lost Value for Me’ 
Decisions to apply a ventilator are difficult and, often in the busy days in ICU, patients may 
be ventilated as a stop gap until further review of the case can be provided. Research in Irish 
hospitals indicate that health professionals question the decision to provide ventilation in 
cases where the patient is ‘trying to die’:
‘At the moment, a gentleman is ventilated up in ICU. He has been diagnosed with Motor Neurone 
Disease. He’s ventilated and sedated. I suppose if things had been reviewed at the time when he 
was diagnosed, he probably would not have been put on the ventilator. Now that we’re there, 
he’s trying to die and just can’t die. That ventilator is keeping him alive up there. He took a turn 
on Friday and is now on his second syringe driver and the wishes of his wife are that he wouldn’t 
suffer any more. ICU is very curative and proactive. That’s a huge dilemma, a huge ethical 
dilemma really for that patient. At Christmas when he was able to talk he clearly said “I don’t want 
anything else”.’ (Quinlan & O’Neill, 2009, p.33-34).
Difficult challenges for health professionals are particularly acute when active or ‘aggressive 
treatment’ may be provided even when it seems inappropriate.
 
‘A patient might be end stage COPD, and they’re on continuous oxygen nebulizers and not able to 
do any kind of movement and then when they come in to ICU, they’re ventilated and end up with 
a tracheotomy and maybe full care at that stage. And then down the road often they die from an 
infection.’ (Quinlan & O’Neill, 2009, p.34).
The case of Katherine that follows tells the narrative of a patient with capacity to request the 
withdrawal of the ventilator required for her to live. She makes a quality of life judgement 
about her life prospects and chooses to discontinue ventilation. Katherine’s judgement is 
that this life support is posing a greater burden than any benefit for a functioning life that 
she wishes to live. 
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My Life has Lost Value for Me’ 
Katherine Lewis is a single, 40-year-old woman suffering from Guillain-Barre’s syndrome, a 
painful neurological illness that leaves its sufferers paralysed for unpredictable lengths of 
time. Many people recover from the syndrome more or less completely and live long, relatively 
healthy lives. However, Katherine’s case became severe. She has been paralysed in her limbs for 
three years now. Ten months ago, it was recognised that she was having increased difficulty in 
swallowing and speaking.  
The consultant had explained to Katherine that, due to swallowing difficulties, they may 
consider feeding intravenously or through a tube. Katherine was saddened to hear this but felt it 
was almost inevitable. She gradually found it was very difficult and painful to move or breathe 
on her own due to the extent of damage to her nerves and muscles. She now needs a ventilator 
to help her breathe.
You are a nurse on the ward who has come to know Katherine and develop methods of 
communicating with her during the night watch with her when all is quiet. You explain this 
prognosis to Katherine in a gentle but clear manner. Last week Katherine indicated that she 
wanted to communicate with you privately. She signals in her halting mode of communicating 
that she has considered her options and decided that she no longer wanted to continue living 
this way. She said her life held no value for her if it meant being in constant pain and without 
the freedom to move, eat or even breathe on her own. She said she discussed this with her 
family and they have accepted her wishes to have the ventilator removed  
(Edited from Schwartz et al., 2002, p.9).
6.3.1 Discussion 6
Ventilation is essential for life when a person cannot breathe on their own. Given the 
seriousness of this decision in Katherine’s case, the withdrawal of ventilator support may  
well be ethically and clinically difficult for members of the healthcare team, family and even 
the patient. 
For Katherine, life is no longer bearable. Ventilation is a burden and not a benefit to her. 
Katherine believes that, according to her values, continued use of the ventilator is futile. 
As discussed above, futility judgements are profoundly value laden, in part because the 
specification and choice of goals are so variable. The case of Katherine illustrates this 
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confusion and disagreement among health professionals. But Katherine does not see the 
goal of living with ventilator dependence as a positive personal value. The consideration 
that ‘merely being alive’ is a benefit would most likely not persuade Katherine to rethink her 
decision to remove the ventilator. Katherine seems to take the view that there is a profound 
difference between continued ‘biological life’ (merely being alive) and living a narrative of 
choices, relationships and opportunities that would be a ‘biographical life’.
‘There is a deep difference between having a life and merely being alive. Being alive, in a 
biological sense, is [on its own] relatively unimportant. One’s biographical life, by contrast, is 
immensely important; it is the sum of one’s aspirations, decisions, activities, projects, and human 
relationships. […] The doctrine of the sanctity of life can be understood as placing value on things 
that are alive [only in the biological sense]. But it can also be understood as placing value on 
‘lives’ and on the interests that some creatures, including ourselves, have in virtue of the fact that 
they are subjects of lives. […] The sanctity of life ought to be interpreted as protecting lives in the 
biographical sense, and not merely in the biological sense. (Rachels, 1986, p.24-27).
The value of simply being alive may be considered a ‘benefit’ to observers of Katherine’s 
suffering. But it is Katherine who is making a judgement about the quality of her life, 
about her prospects for her future which concludes that living in this way is no longer a 
‘benefit’. The burden for Katherine is that, for her, this current existence is not a ‘life’. It is 
biological endurance. Stress, frustration and relentless anxiety arise from the awareness that 
continuing to live in this way offers no prospect to make human choices, to relate to her 
family and friends outside the confines of her ventilatory context. In making the choice to 
request removal of the ventilator, the patient is effectively choosing her ‘good dying’. A life of 
anticipated incapacity and unremitting pain is of negligible value for her. Having reflected for 
ten months on the continuing distress of ventilator reliance is not tantamount to a hasty or 
ill-thought through decision. 
It is understandable that, initially, if a doctor or nurse were faced with Katherine’s request 
they might be reluctant to simply agree. Points that the healthcare team might discuss as a 
team are: 
•	 If Katherine is not ‘terminally ill’ or ‘imminently dying’, should her refusal of the LPT be 
respected?
•	 If they agree to respect this patient’s request to remove her ventilator, would they be 
complicit in assisted suicide? 
•	 Because of the seriousness of this request, should they review the evidence that 
Katherine has capacity to consent to withdrawal of the ventilator? 
304
Mo
du
le 
6 
Th
e E
th
ics
 o
f L
ife
 P
ro
lon
gin
g 
Tr
ea
tm
en
ts 
(L
PT
s) There is no qualification such as ‘imminently dying’ on a competent patient’s right to refuse 
life prolonging therapies. Katherine’s reasons for refusing the ventilator are important for the 
health professionals to discuss with her but ultimately, they need to be assured of Katherine’s 
valid refusal. 
If Katherine’s capacity to make this decision is, in any way in doubt, one option would be 
to seek a consultation by an expert psychiatrist to assess Katherine’s claimed competence. 
However, in this case, the behavioural symptoms that Katherine shows would not normally 
cause alarm sufficient to request a psychiatric assessment. It is rather the doubts and possible 
disagreements of staff about her choice that begin to engender reluctance to accept it.
Is Ventilator Removal Assisting in Suicide?
In a situation such as the case of Katherine, there can be a lingering belief and emotional 
response from family and health professionals that this withdrawal decision (stopping the 
ventilator) is equivalent to actively taking the patient’s life. The question may haunt health 
professionals: Is it always wrong to withhold or withdraw life supports such as a ventilator, 
artificial nutrition and hydration from a patient? Is this not euthanasia by omission? 
‘Euthanasia must be distinguished from the decision to forgo so-called “aggressive medical 
treatment” in other words, medical procedures which no longer correspond to 
the real situation of the patient, either because they are by now disproportionate to any expected 
results or because they impose an excessive burden on the patient and the patient’s family [… 
] [O]ne can in conscience refuse forms of treatment that would only secure a precarious and 
burdensome prolongation of life, so long as the normal care due to the sick person in similar 
cases is not interrupted […] It needs to be determined whether the means of treatment available 
are objectively proportionate to the prospects for improvement. To forego extraordinary or 
disproportionate means is not the equivalent of suicide or euthanasia; it rather expresses 
acceptance of the human condition in the face of death.’ 
(Ashley and O’Rourke, 1997, p.419-420).
One objection to the removal of the ventilator might be that a ventilator is not medical 
treatment but basic humane care that is universally required. Denying basic and humane 
care, the argument claims, would be tantamount to physician-assisted suicide or euthanasia. 
However, this objection overlooks an important ethical and legal right of this patient. When 
a competent patient has refused the use of a life prolonging therapy, its use would be legally 
tantamount to assault and, morally, would be a denigration of the competent patient’s 
liberty of choice and right to privacy and dignity. Katherine has the right, both legally and 
ethically to refuse medical treatment even if such refusal leads to death. (See Module 4, 
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The support of the family for Katherine’s decision is a positive feature of this case that the 
medical team can draw on to aid them in their understanding of Katherine’s choice. Much 
of contemporary writing has spoken of autonomy in highly individualistic terms but this 
case illustrates how a woman like Katherine who is judged competent and autonomous 
has involved her family as supportive companions in her choice and her approaching death 
(Donchin, 2000). The form of autonomy illustrated in this case could be termed ‘relational 
autonomy’ which takes into account others who have been important in one’s life and now, 
however haltingly, support one’s choice to die (See Further Discussion, Module 4 for more on 
relational autonomy). The family have offered support and respect for Katherine’s sense of the 
‘good life’ that seems no longer available to her. While the family support is apparent, they 
will undoubtedly still need reassurance, comfort and support in the period when ventilator 
removal occurs. 
Not everyone would agree with Katherine’s decision and some would clearly voice the 
concern that compliance in this request is assisting suicide. In this case narrative, the patient 
wants to exercise control over her dying so some semblance of human dignity remains for 
her. The concept of human dignity encompasses a range of human sentiments with regard 
to people’s place in this world, their relatives, the environment in which they live and their 
conception of the past, the present and the likely future. For sick people, the concept of 
human dignity includes a desire not to become a burden and the desire that their own 
suffering will not cause their loved ones to suffer (Cohen-Almagor, 2001). 
Patients often express fear of developing dependency on others or on machines; they want 
their death to somewhat reflect the way they lived. Katherine chose to control the process 
of dying as much as possible. Perhaps she feared dying without control over her body 
and feared relentless suffering. Katherine’s suffering was physical but also emotional and 
psychological in that she could anticipate the progression of her illness and knew what that 
would mean for her daily living. Health professionals who become poignantly aware of this 
can seek to reassure the patient that dying with dignity is a realistic possibility.
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6.3.2 Suggested Professional Responsibilities 6
•	 In view of the seriousness of this decision and the healthcare team’s commitment 
to respect human life, the health professionals should take measures to ensure 
competence, understanding and valid consent on the part of Katherine to withdrawal 
of the ventilator. It would also be reasonable for the clinician to encourage the  
patient to have a waiting period to see if her decision remains firm, reassuring her 
that this is not ignoring her distress and concerns but rather ensuring a careful and 
reflective decision.
•	 If Katherine continues in her determination to have the ventilator removed, then the 
healthcare team should agree to do this in moral recognition of her autonomy as a 
competent person to choose the meaning of her life in such illness. Health professionals 
need to show respect for Katherine’s decision, even if they do not agree with it. 
•	 The process of ventilator removal should be done with clinical care and expertise. 
Careful attention to pain management is vital if the patient is not to experience 
profound suffering from ventilator withdrawal. The process needs to be discussed with 
at least the family and, in this case, with the patient in order for them to achieve a clear 
understanding of what they are requesting but also to receive assurance that effective 
pain management will be provided.
•	 Given the stress that may be experienced by health professionals in situations such as 
this, it is important that collegial support be provided.
•	 Katherine and her family need to receive comfort, human presence and continued 
reassurance of care to company her in her dying days. It is important for Katherine that 
she does not feel abandoned by health professionals because of this choice she  
is making.
•	 For future reference in the healthcare unit, the full account of this decision needs to be 
documented. Included in such documentation is the evidence of the process seeking 
patient informed consent. Also for documentation are the specific measures taken 
to inform the family and patient of the actual process of removal of ventilator and 
promised follow-up care.
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6.4 Case 4: Withholding LPT in a Neonatal Unit – A Low Birth Weight Baby
As with adults, decisions about the limitation of therapy and life supports for neonates 
are based on clinical prognoses but also ethical considerations about future suffering and 
profoundly diminished quality of life. The following case illustrates the clinical and ethical 
challenges involved in such complex decision-making.
 
A Low Birth Weight Baby 
Jan C. was admitted to the labour ward in advanced labour at 23 weeks gestation. This was 
her fourth pregnancy, the others having ended in miscarriages before 20 weeks. At 43 years 
of age she felt time was running out for her to achieve a successful outcome and Jan was 
desperate for this baby to survive. Baby C was born with a severe spina bifida, malformation of 
the brain stem, hydrocephalus, vocal cord paresis and severe deformities of the lower limbs. He 
was relatively unresponsive, had little spontaneous movement and had difficulty swallowing, 
sucking and breathing. If baby C survived he would be unable to walk, be doubly incontinent, 
have no sexual function and probably require an artificial airway. He would certainly require 
multiple operations on his spine and lower limbs. The quality of his future life was estimated to 
be extremely poor. 
The healthcare team agreed that no active treatment was warranted. Feeding was restricted 
to that on demand and the baby was given paracetemol and phenobarbitone. The consultant 
obstetrician told Jan C. and her husband that, given the prognosis of baby C, the hospital’s 
special care unit would not be able to offer more than basic care to the baby. In spite of the 
couple’s pleas for everything possible to be done, when baby C was born, weighing 400g, he was 
wrapped in a blanket and given to his parents to cuddle until he died about half an hour later.
(Tibballs, 2007, p.231. Edited variation on case of Baby M)
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6.4.1 Discussion 6 
Within the last few decades, developments in life prolonging technology have meant that 
it is now possible to contemplate the survival of babies born at extremely low gestation 
and size. However, clinical and family decisions to withhold or withdraw LPTs can be very 
stressful and challenging in these circumstances. Disagreements can occur between parents 
and health professionals, and within the healthcare team itself. In these circumstances, 
differences of ethical opinion and feelings of being emotionally overwhelmed are usually 
important factors that need to be addressed. This is especially clear in the case of Baby C. 
While the healthcare team agree on withholding LPTs in the case of Baby C, the family do not 
have the background of neonatal experience that health professionals share. Moreover, the 
case of Baby C is particularly tragic for the parents since they have already suffered the grief 
of several previous miscarriages. A key challenge is that the health professionals do not usurp 
the parents’ input into the decision but, at the same time, the parents cannot be left without 
the full details of the newborn’s likely future. 
The UK Royal College of Paediatrics and Child Health (RCPCH) (2004) suggests the 
circumstances that may involve the withholding or withdrawal of treatment in the case of 
children: 
The Brain Dead Child – when brain stem death is confirmed the patient is, by definition dead. 
All life supports may be withdrawn with full emotional support for family and staff involved. 
(This condition does not apply to Case 4.)
The Permanent Vegetative State – in such circumstances treatment, inclusive of tube feeding, 
may be withdrawn while making the patient comfortable with nursing care. (This condition 
does not apply to Case 4.)
The ‘No Chance’ Situation – Prolonging treatment in these circumstances is futile and 
burdensome and not in the best interests of the patient; there is no legal obligation for a 
doctor to provide it. Indeed, if this is done knowingly it may constitute an assault or ‘inhuman 
and degrading treatment’ under Article 3 of the European Convention on Human Rights. An 
example would be a child with progressive metastatic malignant disease whose life would 
not benefit from chemotherapy or other forms of treatment aimed at cure. (The extent of 
serious impairment of Baby C would definitely be considered here as part of the clinical 
discussions with the parents.)
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treatment, but there are reasons to believe that giving treatment may not be in the child’s 
best interests. The child may not be capable now or in the future of mobility, speech or taking 
part in decision-making and other self-directed activity. (This condition applies as it is a 
component of the ‘best interests’ judgement being discussed with Baby C’s parents.)
‘The Unbearable Situation’ – This situation occurs when the clinician and family believe 
that further treatment is more than can be borne and they may wish to have treatment 
withdrawn or to refuse further treatment irrespective of the medical opinion that it may be 
of some benefit. (Parents in Baby C’s case may not consider further treatment unbearable.) 
(RCPCH, 2004, p.28-29).
In addition, European Specialists in Paediatrics offer the following ethical principles to guide 
decision making:
1. In the event of futile treatment, the primary obligation of the paediatrician is to counsel 
the parents and let the patient die with minimal suffering. The decision lies primarily with 
the physician 
2. The opinion of parents should be included in all medical decisions. Doctors treating the 
sick infant first should come to the conclusion on the basis of comprehensive facts. This 
should then be discussed with parents in thoughtful dialogue. 
3. In the case of unclear situations or controversial opinions between members of the 
healthcare team and parents, a second expert opinion can be helpful.  
4. Every form of intentional killing should be rejected in paediatrics. However, giving 
medication to relieve suffering in hopeless situations which may, as a side effect, 
accelerate death, can be justified.  
5. Decisions must never be rushed and must be based on evidence as solid as possible
(Sauer, 2001, p.365-367) 
Recent research indicates that supports and values that parents find most important 
during neonatal decision-making regarding use of LPTs are religion, spirituality, hope and 
compassion. These supports and values are not routinely acknowledged or incorporated by 
physicians. Parents in this research needed doctors to convey hope and compassion when 
discussing resuscitation options even when the infant’s outcome was likely to be poor  
(Boss et.al., 2008, p.585). 
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‘Physicians who were perceived as providing hope were not necessarily more likely to predict 
survival; in fact, some of the physicians whom parents described as hopeful predicted nearly 
certain death. These physicians gave parents hope because they expressed emotion and showed 
the parents that they were touched by the tragedy of the situation. […] Expressing their own 
emotions during intense patient interactions can be uncomfortable for physicians. Nevertheless, 
there is evidence that parents value physicians’ emotional reactions when the physicians 
communicate bad news.’ (Boss et. al., 2009, p.586)
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6.4.2 Suggested Professional Responsibilities  6
•	 The healthcare team may need to reiterate to the family how they determine the 
likely burdens and benefits that make up a judgement to withhold LPTs and promise 
provision of optimal palliative care. 
•	 With the decision to withhold and withdraw treatments, all members of the healthcare 
team should have an opportunity to voice their opinions and feelings. The final decision 
should be made in consultation with parents though the team must take the main 
responsibility for the decision. This can help alleviate the burden of guilt that some 
parents feel. 
•	 If the family disputes the decisions being taken, a procedure needs to be made 
available for another opinion (another independent clinician, the hospital ethics 
committee etc.)
•	 Baby C’s parents need time to be with their baby. They also may need reassurance that 
withholding LPT does not make them complicit in euthanasia. 
•	 Withholding LPT signals a change of focus to palliative care and the parents need to 
feel that they are not abandoned in their grief and their efforts to understand why  
this happens. 
•	 The family should be asked if they would like a member of the clergy or other spiritual 
support to be available. 
•	 With a view to keeping on-going records for occasional review by the healthcare team, 
the decision taken needs to be documented and the actions evaluated. The evaluation 
should include not simply the decision but the manner in which the decisions were 
made and the follow up with parent(s).
•	 Following the death of the baby, the consultant in charge and the nurse most involved 
should offer to see the parents, to discuss the death and the result of the post mortem 
examination if it were available.
•	 Given the parent’s history of multiple miscarriages, the healthcare team should offer 
suggestions about professional assistance for infertility difficulties. 
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6.5 Case 5: Artificial Nutrition and Hydration (ANH) – Is PEG Feeding Optional?
 
Is PEG Feeding Optional?
Nora is 62 years old and has had multiple sclerosis for 25 years. Initially the disease followed a 
relapsing and remitting course and Nora would have long periods of good health in between 
months of various disabling side-effects, such as temporary paralysis and visual problems. For 
the past ten years, however, her condition has become more disabling and Nora has had to 
move into a nursing home. The staff are friendly and she is well cared for. However, as a result of 
the insidious effect of her illness, most of her bodily functions have ceased to work. She is doubly 
incontinent. On the days when she is well enough to be aware of her surroundings, she finds 
her condition extremely distressing. She is embarrassed by her lack of bodily control and the fact 
that she has to have 24-hour nursing care. Her swallowing is unsafe and the decision was made 
a year ago to feed her via percutaneus endoscopic gastrostomy (PEG). She gets no pleasure 
from eating or drinking. 
She does not have relatives or visitors. Some days she is described as barely conscious. Staff had 
a conference yesterday to discuss the continued use of the PEG tube wondering if withdrawal 
of ANH would be right. Wouldn’t comfort care be more compassionate and appropriate? 
There was no consensus among the staff about withdrawal: some felt that providing ANH 
was a gesture of solidarity and wanted to ensure that Nora would not be abandoned. Others 
wondered if there is a moral or legal obligation to maintain life at all cost regardless of the 
quality of the life?
(Edited case from Johnston and Bradbury, 2008, p.161)
6.5.1 Discussion 6
An important consideration throughout the discussions on LPTs thus far is that any 
judgement about withholding or withdrawing treatments including ANH must be patient-
specific. Abstract principles alone will not be sufficient. Even accepting this advice, health 
professionals and ethicists differ on the moral evaluation of ANH. 
There is broad consensus that, if a patient is able to take food in the conventional way, then 
food should be offered and the patient encouraged to eat. However, when a patient is no 
longer able to take food in a conventional way, the difficult issue of deciding on ANH arises. 
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form of ANH should be removed. Case 5 is especially challenging because Nora’s competence 
is diminished though she experiences intermittent awareness and lucidity. Some days she is 
described as barely conscious and when she is aware of her environment, her lack of bodily 
control is a cause of distress and embarrassment. The questions that arise include:
1. Why do clinical doubts arise, after a year, about the wisdom of continuing the PEG tube? 
2. Is the withdrawal of ANH justified in this case? 
3. Is it in the ‘best interests’ of Nora to continue or withdraw ANH?
4. Is withdrawal of ANH equivalent to euthanasia?
1. Why question the continuing of the PEG tube after a year?  
The health professionals notice Nora’s distress with her disability and general condition. 
On days when she has intermittent awareness she seems particularly embarrassed by 
the ‘insidious effect of her illness’. Chronic disability makes her daily life a struggle and 
she is often ‘barely conscious’. With the PEG tube she derives no pleasure from eating or 
drinking. The reasons the health professionals wonder about continuing ANH are not 
obvious and there is not consensus among the staff about withdrawal. They need to 
continue their conversation about their reasons for considering withdrawal of ANH at this 
point in Nora’s life. Comfort care might be more compassionate and perhaps even more 
comforting but, in what sense is it more appropriate? Withdrawal of ANH will result in the 
death of Nora within a relatively short time, perhaps 10 days to two weeks.  
2. Is withdrawal of ANH justified? 
One issue that looms large in the debate about the ethics of feeding and often influences 
individuals in objecting to withholding or withdrawing of feeding is the powerful 
symbolism of feeding the hungry and giving drink to the thirsty. Feeding the hungry 
has been cited as the most fundamental of all human relationships and a perfect symbol 
of the fact that human life is inescapably social and communal. Food and water are 
undoubtedly powerful symbols of comfort and human care in our society. Through their 
provision we communicate such care and concern for others. Some people feel concern 
that withholding or withdrawing artificial nutrition and hydration will undermine our 
commitment to the values of comfort and care in medical institutions and society at 
large. On this view one would find it difficult to justify withholding feeding even if in the 
form of ANH (Centre for Bioethics, 1997a).
However a focus on the symbolic value of providing food and water might mask several 
important differences. ANH is provided to treat malnutrition and dehydration. But these 
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and thirst can sometimes be treated without having recourse to ANH, e.g., the sensation 
of thirst associated with a dry mouth can be alleviated by moistening the patient’s lips and 
mouth with glycerine swabs or ice chips (Meidl, 2006, p.335). Importantly, ANH requires 
invasive procedures that strain the symbolism of offering food and drink to those in need. 
For patients unable to take food or liquid orally, feeding and hydration are often supplied 
through the nose and throat (nasogastric tube), veins (IV line), stomach (gastrostomy), 
intestine (jejunostomy), or major vessel into the heart (hyperalimentation). All of these 
options highlight the profound difference between feeding the hungry with a meal 
and receiving nutritional support. It is also shown in some patients that withholding or 
withdrawing ANH may actually contribute to their sense of comfort. In brief, withholding or 
withdrawing ANH should not too readily be equated with ‘starving the patient to death’. It 
may even be considered by some to be a form of compassionate treatment (Meidl, 2006).
3. Is it in Nora’s ‘best interest’ to continue or withdraw ANH? 
This method requires the decision-makers to consider what the ‘best course of action’ 
is for a particular (incompetent) person in a particular situation. See Case 2 above and 
Module 4 for a discussion of ‘best interests’. 
Special Legal Challenges in Ireland
In the Ward of Court case in Ireland (1995), a central ethical and legal issue that arose was the 
question of whether it was justified to discontinue the ANH that was being provided to the 
Ward via a PEG tube. The moral reasoning involved in that case highlights the contentious 
terms of the ethical and legal debate about ANH. 
After a High Court judgement that allowed withdrawal of the PEG tube from the Ward, 
an appeal followed with a Supreme Court judgement upholding the High Court decision. 
The removal of ANH was defended by Justice Lynch in the High Court as a ‘best interests’ 
judgement. In their decisions to withdraw ANH from the Ward both the High Court and the 
Supreme Court took the view that ANH was equivalent to medical treatment and, as such, 
could be justifiably withdrawn because it was considered to be ineffective and burdensome. 
However, following the Supreme Court Judgement, the Irish Medical Council and Nursing 
Board issued statements that ANH is an ordinary and humane requirement of care and 
they claimed that it was a duty of their members to continue the provision of nutrition and 
hydration. In 2009, the Irish Medical Council has updated its position statement on feeding. 
The Medical Council new guidelines offer more qualified and nuanced advice than that 
provided in 1995. 
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with nutrition and hydration in a way that meets their needs. If a patient is unable to take 
sufficient nutrition and hydration orally, you should assess what alternative forms are possible 
and appropriate in the circumstances. You should bear in mind the burden or risks to the patient, 
the patient’s wishes if known, and the overall benefit to be achieved. Where possible, you should 
make the patient and/or their primary carer aware of these conclusions.’  
(Medical Council, 2009, p.20).
The 1995 statement of the Nursing Board has not been updated as yet and remains as 
follows:
‘The ethical principle requires that so long as there remains a means of nutrition and hydration 
of this patient it is the duty of the nurse to act in accordance with the Code and to provide 
nutrition and hydration. In this specific case, a nurse may not participate in the withdrawal and 
termination of the means of nutrition and hydration by tube. In the even of the withdrawal and 
termination of the means of nutrition and hydration by tube the nurse’s role will be to provide all 
nursing care.’ (An Bord Altranais, 18th August, 1995, cited in Dooley and McCarthy, 2005, 
p.284). (See Module 4, section 5.1.2 for reference to the Ward of Court Case and ANH)
4. Is withdrawal of ANH equivalent to euthanasia? 
If the decision to remove ANH is made with the clear intention of hastening Nora’s death, 
then there is reason to pause and consider that this may be an act of euthanasia, a 
deliberate act or omission whose primary intention is to end another person’s life.  
 
However, decisions to withdraw or discontinue life supports are not equivalent to 
euthanasia if they are validly authorised by a competent patient’s consent or if a clinical 
decision is made that further life supports including ANH would, on the basis of all 
available evidence, be futile – lacking benefit for the patient and merely prolonging the 
dying process. 
The following text offers one method of reasoning for decisions on ANH:
‘We should not assume that all or most decisions to withhold or withdraw medically assisted 
nutrition and hydration are attempts to cause death. To be sure, any patient will die if nutrition 
and hydration are withheld. But sometimes, other causes are at work. For example, the patient 
may be imminently dying, whether feeding takes place or not, from an already existing terminal 
condition. At other times, although shortening of the patient’s life is one foreseeable result of an 
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that is of limited usefulness to the patient or unreasonably burdensome for the patient and the 
patient’s family or caregivers. This kind of decision should not be equated with a decision to kill or 
with suicide.’ (O’Rourke and Norris, 2001, p.205-6).
 
The position of O’Rourke and Norris combines application of the principle of double effect, 
the principle of proportionality as well as the ordinary extraordinary distinction. The text 
does not provide an answer about the decision in the case of Nora but it highlights the 
questions that health professionals must reflect on and provide some answers for before a 
decision is taken and before they are confident that they can morally defend a decision to 
remove ANH. 
The above arguments, reasoning and questions about the morality of ANH are representative 
of an expanding literature on this topic. The following sources offer an opportunity to reflect 
on viewpoints that are widely discussed among theologians, ethicists, doctors and nurses 
alike (Center for Bioethics, 1997a, 1997b; GMC, 2009; Dooley and McCarthy, 2005; Lesage and 
Portenoy, 2001; Meidl, 2006; Meisel, 1992; O’Rourke and Norris, 2001; Panicola, 2001).
6.5.2 Suggested Professional Responsibilities 6
•	 The intermittent awareness that Nora experiences is mostly dominated by the distress 
felt in relation to her condition. During the brief periods when Nora might show partial 
awareness, a conversation could be initiated with her about possible withdrawal of the 
PEG tube. However, such a conversation might be very distressful and may not provide 
reliable evidence of Nora’s capacity to take part in this decision.
•	 In the absence of family or designated proxies, an assessment of Nora’s ‘best interests’ 
should be made. For a patient with an advanced life-threatening illness who is dying, 
there may not be many benefits. Admittedly, continued existence might be seen by 
some as an important ‘benefit’. 
•	 The burdens of providing ANH in Nora’s case should be assessed. There is always a risk 
to a patient being fed through a feeding tube. Feeding tubes may feel uncomfortable. 
They can become plugged up, causing pain, nausea and vomiting. Feeding tubes may 
also cause infections. 
•	 Any disagreements that may arise within the healthcare team should be aired and 
constructively resolved based on careful evaluation of benefits and burdens of 
continuing ANH in Nora’s case. 
•	 The decision in terms of the process and the final determination made about continue 
or withdrawing ANH should be documented.
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7. Module 6 Further Discussion 
7.1 Euthanasia and Physician Assisted Suicide
 ‘Euthanasia’ derives from the ancient Greek, ‘eu’, meaning good and ‘thanatos’ meaning 
death, thus a ‘good death’. Today, the term ‘euthanasia’ refers to the administration of death, 
the active intentional ending of life. 
In the medical context, ‘active euthanasia’ is the act of purposely ending the life of someone. 
This might be done by a health professional injecting a patient with a lethal dose of drugs 
that directly causes his or her death.
The withholding or withdrawal of LPT is sometimes described as ‘passive euthanasia’. 
However, it is argued that describing the withholding/withdrawing of treatment as passive 
euthanasia is not accurate. In such cases, it is argued that the person involved is not killed 
in the usual sense, nor is the death of the person intended by the withholding of additional 
treatment. Terms such as ‘allowing natural death’ are increasingly used as an alternative to 
‘passive euthanasia’.
Consent for euthanasia would be said to be voluntary if it were carried out at the patient’s 
request. 
If someone does not explicitly request euthanasia this does not mean that they do not 
want it; it would be reasonable, however, to assume that they do not. Euthanasia in such a 
case would be involuntary, and, even more obviously, it would be if someone had clearly 
expressed a wish to live as long as possible, whatever the circumstances. 
Newborn babies do not yet have, and comatose or severely brain-damaged adults have lost, 
the capacity to request or refuse euthanasia. In such cases neither consent nor the lack of it 
can be said to be a factor, so euthanasia, if considered, is neither voluntary, nor involuntary, 
but non-voluntary.
Assisted suicide is defined as the act of helping a person to die by providing the means for 
them to take their own life. An example of physician assisted suicide is the act of giving a 
prescription or supply of a lethal dosage of drugs to a patient who has requested this.  
The doctor providing the lethal dosage of drugs thus enables a patient to end his or her own 
life. The patient or individual may never use the drugs to end their life but it is suggested that 
having the means at their disposal, offers a patient the security of knowing they have the 
means to end their life and suffering if they choose. 
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physician-assisted suicide (PAS). International discussion of these topics has not abated but 
there are still relatively few countries that have legalised the practices. Reasons of public 
interest and threats to physician integrity are raised as justifications for unwillingness to 
legally endorse the practices. In the legal discussions (7.2 See Module 5, section 6.4. for 
discussion of the R v Cox case) that follow, the position in law on euthanasia and PAS is 
explained for a selection of countries. 
In the ethics discussion (7.3 and 7.4) positions are distinguished that (1) offer reasons and 
arguments that serve to morally justify the practices of euthanasia or PAS and (2) reasons and 
arguments to show that moral justification is lacking for the practices. 
7. 2 Legal Positions: Euthanasia and Physician Assisted Suicide
7.2.1 The Law – Ireland 
In Ireland, any person who takes active steps to end the life of another person is in breach 
of the criminal law. In this respect, a distinction may be made between assisting a person in 
ending his or her own life – perhaps by providing medical assistance – and actually taking 
the final step of ending the patient’s life. The first situation involves assisting the suicide of 
the person. Under Irish law, suicide ceased to be a criminal offence under the Criminal Law 
(Suicide) Act 1993. However, the Act states that anyone who ‘aids, abets, counsels or procures’ 
the suicide of another person commits a criminal offence which is punishable with a possible 
maximum sentence of 14 years. 
The situation which is sometimes termed ‘euthanasia’ involves the deliberate action of 
ending the life of the person. Under Irish law, this is legally categorised as murder. The law 
does not allow a person to consent to his or her own death and for this reason, the fact that 
the patient has consented to, or even requested, the action is irrelevant. A person who is 
convicted of murder is punishable on conviction by a mandatory life sentence. This means 
that the court cannot choose to give a lesser sentence because of a person’s underlying 
motivations.
There have been no prosecutions of Irish health professionals in relation to either assisted 
suicide or euthanasia. It is thought that the position taken in the English case of R v Cox 
(1992) is likely to be followed in Ireland effectively legally prohibiting euthanasia.  
(See Module 5 for discussion of the R v Cox case)
A number of efforts have been made in other countries, including the US, Canada, the UK 
and under the European Convention on Human Rights, to assert a legal right to die through 
the courts (See Module 4, section 5.2 for discussion of the UK Ms Pretty case involving an 
attempt to receive assurance that an act of assisted suicide would not be prosecuted.) 
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7.2.2 Switzerland
Although the law in most countries legally prohibits suicide and active euthanasia, there 
have been some moves in recent years to introduce measures to permit one or both 
practices. Both practices are permitted in Switzerland where they are not contrary to the 
criminal law and are largely unregulated. Because of the liberal regime in Switzerland, this is 
the most common country for people to travel to in order to avail of euthanasia. However, 
recent reports claim that the Swiss government is considering restricting or even banning 
organised assisted suicide in an attempt to reduce so-called ‘death tourism’. Concerns stated 
that their current laws on assisted suicide could be open to abuse. A study in 2008 suggested 
more and more people seeking help to die in Switzerland did not have a terminal illness 
(Pidd, 2009).
7.2.3 The Netherlands 
Both euthanasia and physician assisted suicide have been permitted by legislation in the 
Netherlands since 2001, in Belgium since 2002 and in Luxembourg since 2008. In these 
countries, the practices are more regulated than in Switzerland. In the Netherlands, for 
example, the Dutch Criminal Code states that a physician who terminates a patient’s life or 
who assists a patient’s suicide will be exempt from criminal liability provided that he or she 
complies with two conditions. These are, first, he or she must practice in accordance with 
the due care criteria and secondly, he or she must report the cause of death to the municipal 
coroner. 
The due care criteria apply to both euthanasia and physician assisted suicide. These criteria 
require that the attending physician must:
•	 be satisfied that the patient has made a voluntary and well considered request 
•	 be satisfied that the patient’s suffering is unbearable, and that there is no prospect of 
improvement 
•	 have informed the patient about his or her situation and prospects 
•	 have come to the conclusion, together with the patient, that there is no reasonable 
alternative in the light of the patient’s situation 
•	 have consulted at least one other physician, who must have seen the patient and given a 
written opinion on the due care criteria referred to above, and 
•	 have terminated the patient’s life or provided assistance with suicide with due medical 
care and attention.
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7.2.4 United States
Physician assisted suicide is also permitted in the American states of Oregon since 1996 
and Washington since 2008, although in much more restricted circumstances than in the 
European models. In Oregon, the Death with Dignity Act 1996 requires that the patient must 
have a terminal illness with a life expectancy of less than six months. The Act also requires the 
patient to have made two separate requests for assisted suicide and imposes a 15 day delay 
between the first and second requests. 
7.2.5 United Kingdom 2009: The case of Debbie Purdy 
Debbie Purdy, from Bradford was 46 and was diagnosed with MS in 1995. As her condition 
progressed and she knew of the likely prognosis, she considered going to Switzerland to end 
her life. However, she feared that her husband might be charged on his return to the UK. She 
wanted assurances from the DPP that her husband, Omar Puente, would not be prosecuted.
Ms. Purdy believed that, unless the law was clarified, she might be forced to end her life 
earlier than she planned because her husband would be unable to help her, without risking 
prosecution, if she became totally dependent. If the risk of prosecution was sufficiently low, 
she could wait until the very last minute before travelling with her husband’s assistance. If the 
risk of prosecution was high, Ms. Purdy would have to go earlier while she was still fit enough 
to travel without assistance. 
Purdy took her case to the House of Lords after the High Court and the Court of  
Appeal held that it was for Parliament, not the courts, to change the law which makes 
assisted suicide illegal in the UK. The offence of assisting suicide is a criminal offence 
under Section 2(1) of the Suicide Act 1961 and carries a maximum penalty of 14 years 
imprisonment. The act defines assisting a suicide as ‘aiding, abetting, counselling or 
procuring’ the suicide of another. Committing or attempting to commit suicide is not a 
criminal offence. No individual to date has been prosecuted for assisting a suicide in relation 
to suicides committed abroad, including the Dignitas clinic in Switzerland.
The Law Lords agreed that changes were a matter for Parliament but upheld Ms Purdy’s 
argument that the DPP, Keir Starmer QC, should put in writing an ‘offence-specific policy’ 
identifying the facts and circumstances he would take into account in deciding whether it 
was in the public interest to prosecute under the Suicide Act. 
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The Director of Public Prosecutions, Keir Starmer QC has called for public participation in 
a 12-week consultation on the factors he had identified which will be taken into account 
when considering whether prosecutions will be brought for the offence of assisting a suicide. 
Starmer stated: 
‘Assisting suicide has been a criminal offence for nearly fifty years and my interim policy does 
nothing to change that. There are also no guarantees against prosecution and it is my job to 
ensure that the most vulnerable people are protected while at the same time giving enough 
information to those people, like Ms. Purdy, who want to be able to make informed decisions 
about what actions they may choose to take.’ (Crown Prosecution Service, 2009).
Details of the interim policy on prosecuting assisted suicide can be found on this Crown 
Prosecution Service website: www.cps.gov.uk/news/press_releases/144_09/.
7.3 Ethical Positions: Euthanasia and Physician Assisted Suicide
Consciously deciding to end a person’s life is a profound and grave matter and actions which 
do, while motivated by compassion, are widely, intensely and heatedly considered and 
debated around the world. They engender strong feelings about 
•	 the right to demand one’s choice of dying
and
•	 that life is so precious there is a duty to preserve it at all costs. 
(Watson Lucas, Hoy et. al., 2009, p.14).
Considerable professional and public attention has focussed on voluntary euthanasia. This 
has partly been spurred by the publicity of the practice of euthanasia in the Netherlands and 
it is considered in this section.
7.3.1 Arguments in Support of Euthanasia
In general there are two kinds of arguments that support euthanasia. The first kind is a duty 
based argument:
•	 Public support for euthanasia reflects recognition that the same values of patient self-
determination and well-being that have been accepted as guiding treatment decision 
making in general, and decisions about LPT in particular, can, in some cases support 
voluntary euthanasia as well. For example, it is argued that permitting (voluntary) 
euthanasia respects patient autonomy and provides a more peaceful and humane death 
for some patients than they would otherwise have.
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permitting euthanasia in addressing the fear and the reality of suffering.
•	 In significant part, the public interest in and support for euthanasia reflects fear of loss of 
control and dignity while dying. 
•	 This fear includes concerns that, especially in acute care settings, aggressive use of life 
prolonging technologies would allow one to linger in a semi-comatose state, unable to 
relate to others or communicate the extent of one’s suffering. 
•	 There is strong belief that, even with the best of palliative care, pain cannot be fully 
relieved in terminal illness. 
The belief is that the availability of euthanasia will contribute to lessening these kinds of fears 
and concerns.
7.3.2 Arguments Opposing Euthanasia
In general there are also two kinds of arguments that oppose euthanasia. The duty based 
argument usually takes the following form:
•	 Any individual instance of euthanasia is morally wrong because it violates the duty not to 
kill innocent human beings. For some, even the consent of the one killed does not make 
the killing permissible. 
The second kind of argument appeals to anticipated (likely bad) consequences of permitting 
euthanasia. On this view:
•	 Although it might be morally justified in some individual cases, it would nonetheless be 
bad public policy to permit voluntary euthanasia. Among potential bad consequences 
opponents cite are: its seeming incompatibility with the proper aim of medicine to 
protect life in all its frailty; the erosion of the trust of patients in their caregivers; the 
erosion of the social commitment to provide appropriate care to the dying if euthanasia 
is seen as an acceptable alternative; the fear that providing voluntary euthanasia would, 
in time, lead to involuntary euthanasia or non-voluntary euthanasia of incompetent 
patients.
Evaluating and assessing the relative seriousnessness or likelihood of these consequences of 
permitting voluntary euthanasia is both controversial and difficult. 
7.4 Physician-Assisted Suicide (PAS)
The difference between active euthanasia and aiding in a terminally ill patient’s suicide is 
essentially that in active euthanasia the doctor determines the eventual course of action, 
whereas in PAS she merely assists the patient to realise his decision to end his life. 
It should be said at the outset that some commentators claim we should change the 
terminology of PAS and refer rather to physician-assisted death (PAD) in order to clearly 
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suicide should be only physician assisted? 
It is sometimes said that, similar to the distinction between ‘active’ and ‘passive’ euthanasia 
described above, withholding or withdrawing LPTs from a patient who has capacity to 
request this is equivalent to PAS. However, it could be argued that this is placing an emotive 
label on an action that is legally and morally valid. When a society prohibits PAS and a case of 
discontinuing LPT is labelled PAS, both the doctor and competent patient seem implicated 
in a legal and moral offence. However, the point to be noted is that, based on a fundamental 
respect for a person’s autonomy, competent patients have the moral and legal entitlement to 
discontinue LPT (See Module 3 and Module 4). If such decisions are labelled as PAS, this could 
be viewed as disrespecting the competent patients’ right to refuse unwanted treatments.
7.4.1 Arguments Supporting PAS
Arguments in support of PAS include those that are put forward in support of euthanasia. 
They centre on respect for patient autonomy and are perceived to address some patient’s 
fears about the possibility of a painful, distressful and/or undignified death. 
•	 Specifically, supporters of PAS argue that the provision of PAS is consistent with the aim 
of medicine which is to: respect the patient’s autonomy; ease the patient’s suffering; and 
do what is in the best interests of the patient (Dieterle, 2007). 
•	 It is also claimed that PAS differs greatly from the wrongful killing of innocent persons. 
Proposals to allow PAS do so on the assumption that the patient requests the medication 
– usually a number of times, the patient is terminally ill with less than 6 months to live 
and the patient is convinced over time that death would be far preferable than the life 
he or she is living. In brief ‘death is not a harm to those who seek and are granted PAS’ 
(Dieterle, 2007, p.138).
The philosopher, Tom Beauchamp, claims that PAS may be a morally justified action. On his 
view, valid requests and authorisation for assistance in dying can legitimate PAS. This means 
that a doctor would not be obligated to honour all requests but that valid requests make 
it morally permissible for them, or some other person, to lend aid in dying. A doctor might 
refuse to honour a particular request if there is good moral reason for doing so: autonomy of 
person seeking PAS may be impaired; excessive influence is being exerted on the individual 
requesting; the desire to avail of PAS is not stable over time; public trust in doctors would 
suffer etc:
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‘If letting die based on valid refusals of treatment does not wrong or harm persons or violate their 
rights, how can assisted suicide or voluntary euthanasia harm or wrong a person who died? In 
each case, persons seek what for them in their bleak circumstances is the best means to the end of 
quitting life. Their judgement is that lingering in life is worse than death.’  
(Beauchamp, 1999, p.438)
7.4.2 Arguments Opposing PAS
Arguments against PAS are, similar to euthanasia, duty based and consequential.
A first duty based argument opposing PAS derives from the perceived aims of medicine in 
the same way as the argument supporting PAS does. On this view, the intent of the doctor is 
said to offer grounds for rejecting PAS:
•	 Doctors should not kill; this is prohibited by the Hippocratic Oath. The doctor is bound by 
their profession to save life, not take it. The idea behind this argument is that the intent of 
a doctor should be always to heal or cure. 
A second argument considers the inherent wrongness of killing. 
•	 Killing an innocent person is inherently wrong. The doctor indirectly kills the patient in 
cases of PAS by providing the lethal medication. So the doctor does something inherently 
wrong. 
One of the most common forms of argument against PAS (similar to euthanasia) cites 
the possible negative consequences of the practice as a reason not to legalize it. These 
arguments rely on empirical claims about the future and, as a result, their persuasiveness 
depends on how likely it is that the predictions will be realised. 
Seven consequences are most typically cited as the basis for opposing legalisation of PAS and 
similarly would be cited to claim that PAS could not be morally justified. 
1. PAS could start us on a slippery slope to non-voluntary euthanasia.
2. Abuses of the law are likely: patients might be pressurised by family to seek PAS and 
vulnerable groups would be more susceptible to persuasion to accept PAS.
3. Allowing or encouraging PAS would corrupt medicine and health professionals.
4. Acceptance of PAS will weaken the prohibition on killing.
5. Patients will give up too easily and abandon hope.
6. Improvements in palliative care will cease or diminish.
7. Citizens will begin to fear hospitals and health professionals.
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In some research which assessed this list of possible consequences against the backdrop 
of the legalization of PAS in Oregon (US) and the Netherlands, it was found that the 
overwhelming majority of predicted consequences of PAS laws have not come to pass 
(Dieterle, 2007). This does not mean that concerns about the consequences of legalizing 
PAS have no basis in reality because these findings may be contested by findings from other 
research. What is important to note is the contribution that empirical research can make to 
informing ethical and legal debates on euthanasia and PAS. 
7.5 Insights from Oncologists on Euthanasia and PAS
One robust piece of research, carried out in the US in 2000, surveyed 3,299 oncologists on the 
subject of euthanasia and PAS. Four insights were gleaned from the study:
1. Concern among oncologists about performing euthanasia or PAS may limit their 
willingness to prescribe opioids, thereby leading to inadequate pain management. 
This reticence may reflect fear that increasing opioid dose increases the risks for 
respiratory depression and death and might be construed as a form of euthanasia.  
(See Module 5)
2. There seems to be a relationship between the likelihood of performing euthanasia and 
PAS and the inability of physicians to obtain adequate end-of-life care for their patients. 
Worry was voiced that inadequate access to palliative care might make euthanasia and 
physician-assisted suicide attractive alternatives. 
3. Physicians who reported receiving better training in end-of-life care seemed less likely to 
perform euthanasia or physician-assisted suicide. 
4. Results suggest that among US oncologists support for PAS and euthanasia has 
decreased substantially. Between 1994 and 1998, oncologists’ support for PAS declined 
by half, from 45.5% in 1994 to 22.5% in this study (Emanuel, Fairclough, Clarridge, et. 
al., 2000) This decline may reflect expanding knowledge about how to facilitate a ‘good 
death’ making PAS and euthanasia no longer appear as necessary or desirable (Emanuel, 
Fairclough, Clarridge, et. al., 2000).
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Cognisant of the arguments to support PAS that suffering and inadequate palliative care 
are often contributing factors, the Irish Association for Palliative Care strongly recommends 
the continued appropriate development of specialist palliative care services throughout 
Ireland. It is the clear duty of the doctor to ensure that a patient dies with dignity and with 
as little suffering as possible (O’Brien et. al., 2000, p.1). In addition the Irish Association holds 
the position that the legalisation of euthanasia has potential adverse effects on the patient-
health professional relationship, society’s expectations of health care and resources available 
to address serious illness (O’Brien et. al., 2000, p.2).
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8. Module 6 Summary Learning Guides 
8.1 Central Issues and Concepts in Decisions about LPTs
•	 Decisions to start or stop treatment should be based on the benefits and burdens of 
the treatment, as judged by a patient or authorised surrogate.
•	 The distinction between ordinary and extraordinary treatment is often used as a rule 
of thumb by health professionals to distinguish between medicines, treatments, and 
operations, which offer a reasonable hope of benefit without excessive pain or other 
inconvenience and those which do not. 
•	 The principle of proportionality requires that the decision making process about 
treatments should follow the general rule to maximise benefit and avoid  
undue burden. 
•	 The meaning of the distinction between killing and letting die is widely contested 
and often underpins distinctions between: 1) suicide and foregoing treatment and, 2) 
euthanasia and so-called ‘natural’ death.
•	 It is impossible to determine what will benefit a patient without presupposing some 
quality of life standard and some conception of the life the patient will likely live after a 
medical intervention
•	 Historically, the sanctity of life position holds that the value of human life is not 
dependent upon its being valued by the individual themselves or by others or by the 
presence of certain functional capacities such as relationality or rationality. 
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8.2 Futility
•	 The notion of futility is a disputed concept that is still evolving. 
•	 The debate about what constitutes ‘futile’ treatments began with decisions relating to 
the stopping of cardiopulmonary resuscitation but it has expanded to other forms  
of LPT.
•	 Futility judgements are typically used to express a combined value judgement and 
scientific judgement. 
•	 There is a considerable subjective element in judgements that further treatment is 
‘futile’ – precisely because decisions that weigh up benefits and burdens are not based 
on rocket science. 
•	 The debate on ‘futility’ can be divided into three approaches:  
the first defines futility in terms of definite clinical criteria.  
the second is a procedural approach that gives power to hospitals, utilising their ethics 
committees, to decide whether interventions demanded by families were futile.  
the third approach focuses primarily on negotiation at the bedside and on-going 
communication with patients, families and the healthcare team.
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9. Module 6 Activities 
9.1. Reflect back on the particulars of Case 1: 
a. Ms.R. was put on a ventilator when she was admitted to intensive care. The family asked 
that everything should be done to keep their loved one alive. Do you agree with the ICU 
team that further LPTs for Ms.R. would be ‘futile’? 
b. The team took time (a few days) to provide life support and on-going conversation with 
the family. In what way was this process therapeutic for the family?  
c. Based on your experience caring for patients, what is it in the procedures of the hospital 
setting that might contribute to a patient’s sense of abandonment?
9.2 Reflect back on the particulars of Case 2: 
a. Mr.W.’s life in the balance: Would CPR provide benefit?
b. The family of Mr.W. are experiencing the grief of potentially losing their loved  
one. They believe that providing CPR may give them a reprieve from this grief. What 
information or conversation would you provide that might give the family of Mr.W. 
reason to believe that CPR might be more harmful than helpful for their loved one?
c. Can you understand how the family of Mr.W. think that biological life can be construed 
as a benefit even if there is no realistic opportunity for Mr.W. to continue having a 
biographical life?
d. From your clinical experience, what is the likely outcome for Mr.W. if CPR proceeds? 
e. What means would you suggest for resolving the disagreements between the family, 
doctors and nurses? When faced with continued resistance to clinical advice, is it  
ever legally or morally justified to simply go ahead and write up a DNR without  
family consent?
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9.3 Re-read Case 3 
where Katherine requests removal of the ventilator and discuss the following with your 
colleagues:
a. Even if Katherine is competent, given the seriousness of this request, are there any further 
complications among health professionals that you anticipate?
b. You are the clinician in charge where Katherine is a patient. Explain what kind of 
information or understanding you would want to provide for Katherine. Since she had 
already approached a staff nurse about her desire to discontinue ventilator use, what 
conversation would you have with her?
c. Who should participate in the decision: family? The entire clinical team? Hospital ethics 
committee? On-site hospice clinician? 
d. How would you explain your choice of participants?
9.4 Reflect back on the particulars of Case 4: 
a. In this time of grief and desolation, can you suggest further clinical advice for Jan and her 
partner who have already experienced three miscarriages before 20 weeks? 
b. What appropriate after-care for the family’s grief can be provided in the confines of the 
hospital setting? Is this available in your work context?
c. Based on your experience and study, who do you think should be responsible for final 
decisions about CPR and DNR?
d. Are guidelines for CPR and DNR available in your work context? If so, what do they 
include? If not, is there a reason?
9.5 Reflect back on the particulars of Case 5: 
a. How would you evaluate the benefits and burdens of continuing ANH for Nora? 
b. In your experience, how would a clinical team deal with a case such as Nora’s? Who would 
be involved in the decision-making on the case?
c. Do you think there is realistic basis for clinical disagreement about what is in the ‘best 
interests’ of Nora? 
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Module 7
The Ethics of Confidentiality 
and Privacy
MODULE SEVEN
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1. Module 7 Key points
1.1 Confidential information is private information 
that a person shares with another on the understanding that it will not be disclosed to 
third parties. It includes identifiable patient information – written, computerized, visually or 
audio recorded – that health professionals have access to. Keeping patient confidentiality is 
important because it builds trust, respects patient autonomy and privacy and contributes to 
good patient outcomes.
1.2 Confidentiality is protected by professional codes and laws 
Ancient and modern medical and nursing codes stress the duty of confidentiality as a ‘time 
honoured principle’ that extends beyond death. Health professionals are also legally obliged 
to protect patient confidentiality under the Irish Constitution, the European Convention and 
the common law: legal sanctions are in place for breaches of patient confidence.
1.3 The principle of confidentiality is not absolute 
Exceptional circumstances where health professionals may ethically and legally qualify the 
principle of confidentiality centre on concerns about protecting the wellbeing of the patient 
themselves and protecting others from harm.
1.4 Health professionals should ask competent patients for permission to share 
information 
with third parties. In exceptional circumstances, such as abuse or threatened suicide, it 
may not be appropriate to seek permission on medical grounds. These circumstances have 
not been considered by the Irish courts but they are likely to look for very strong evidence 
regarding the medical grounds as to why it was not considered desirable to seek the  
patient’s consent.
1.5 If patients lack the capacity to consent to sharing information, health professionals 
may need to share information 
with relatives, friends or carers in order to enable them to be involved in decisions about 
the patient’s best interests. The sensitivity of the information and any known wishes of 
the patient in regard to it must be taken into account. The Irish law in relation to patients 
who lack capacity is currently unclear though a forthcoming Mental Capacity Bill will help 
to clarify the position. Under the current Irish law, those close to the patient – spouses, 
partners, family members, friends have no legal status in relation to healthcare decisions (and 
information in relation to decsionmaking) on behalf of people lacking capacity.  
While hospitals may routinely seek the consent of the ‘next of kin’ in relation to a healthcare 
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about a patient without capacity is likely to depend on whether it can be shown that it is in 
the patient’s best interests that information about his or her condition should be shared with 
those close to them.
1.6 In exceptional circumstances, 
health professionals may breach patient confidentiality in order to avoid serious risk of 
considerable harm to others (identifiable individuals and the public in general).  
The decision to disclose patient information should not be made in haste or without due 
care and consideration of all concerned in the situation. Where disclosure is necessary; only 
information necessary to avoid harm should be provided.
1.7 The duty of confidentiality extends beyond death 
Guidelines that protect living patients equally apply after patients have died. Exceptions 
to confidentiality also equally apply. National and international guidelines governing the 
release of medical records of deceased patients generally consider: the known wishes of 
deceased patients in relation to their information; the impact of non-disclosure on the 
wellbeing and welfare of third parties – avoiding harming them or benefitting them; the 
impact of disclosure on the reputation of the deceased; the possibility of anonymising the 
information. The impact that posthumous breaches of confidentiality may have on the care 
of dying patients is also a concern.
1.8 Family members of deceased patients may ask for information and/or medical records 
because they may be anxious about a misdiagnosis, negligence or hereditary condition. 
Third parties may also request medical records because they are contesting a patient’s will. 
Where disclosure is considered to be consistent with the wishes of the patient or to advance 
the best interests of the patient it is generally viewed as acceptable. Conflict arises where 
patients, while alive, did not consent to disclosure. In these circumstances, as with living 
patients, patients’ rights to confidentiality are important but not absolute and the rights of 
others’ wellbeing and welfare must also be taken into account. Recent legislation in relation 
to Freedom of Information confirm that access to information about deceased people may 
be obtained in some circumstances. 
1.9 Privacy is valued in ethics and law 
(e.g. Irish Constitution and European Convention). Protecting someone’s privacy involves 
protecting them from unwanted access or control by others. In this way it is linked with 
personal autonomy and it is also viewed as a key element of personal identity. Privacy can 
be thought of in terms of five dimensions: physical privacy, informational privacy, decisional 
privacy, personal property and expressive privacy.
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2. Module 7 Definitions
2.1 Anonymised Data: 
Data from which the patient cannot be identified by the recipient of the information.  
The name, address, and full post code must be removed together with any other information 
which, in conjunction with other data held by or disclosed to the recipient, could identify the 
patient. Unique numbers may be included only if recipients of the data do not have access to 
the ‘key’ to trace the identity of the patient.
2.2 Principle of Confidentiality: 
obliges health professionals to respect the confidences that patients share with them.  
By extension, health professionals are also obligated to keep confidential, information that 
they might gain from sources other than the patient in their care, e.g., medical records or 
other health professionals.
2.3 Minimalist Principle: 
where the interests of individuals or the general public require that patient confidentiality is 
qualified in some circumstances, the minimalist principle obliges health professionals 
to disclose to third parties only the patient information that is relevant to ensure their welfare 
or wellbeing. 
2.4 Privacy: 
refers to what belongs to individuals e.g. bodily integrity, property, information, space. A 
right or claim to privacy is a right to control access to one’s personal domain. 
2.5 Right: 
an entitlement that prohibits or obliges the actions of others. It is a justified claim that 
individuals or groups can make on other individuals or society generally. If a person is 
considered to have a right – to confidentiality, for example – they may be considered to be 
inviolable in some sense. In addition, a right may entitle a person to make certain claims on 
others for support or service – that their confidences will not be shared or that their medical 
records will be protected.
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3. Module 7 Background
3.1 Confidential Information
Confidential information is usually understood to be private information that a person shares 
with another on the understanding that it will not be disclosed to third parties.
Keeping patient confidentiality is considered important because of its role in building patient 
trust and protecting patient privacy and autonomy. It is also considered important because 
the consequences of respecting patient confidentiality are generally seen as positive.
The British Medical Association (BMA) offers a useful list of what is considered confidential 
between health professionals and patients:
‘All identifiable patient information, whether written, computerised, visually or audio recorded  
or simply held in the memory of health professionals, is subject to the duty of confidentiality.  
It covers:
•	 any clinical information about an individual’s diagnosis or treatment;
•	 a picture, photograph, video, audiotape or other images of the patient;
•	 who the patient’s doctor is and what clinics patients attend and when;
•	 anything else that may be used to identify patients directly or indirectly so that any of the 
information above, combined with the patient’s name or address or full postcode or the 
patient’s date of birth, can identify them. Even where such obvious identifiers are missing, 
rare diseases, drug treatments or statistical analyses which have very small numbers 
within a small population may allow individuals to be identified. A combination of items 
increases the chance of patient identification.
•	 Whilst demographic information such as name and address are not legally confidential, it 
is often given in the expectation of confidentiality. Health professionals should therefore 
usually seek patient consent prior to sharing this information with third parties.’ 
(BMA, 2008, p.5-6)
3.2 Confidentiality is Important
Confidentiality is a core element of all human relationships and, so, is basic to building trust 
between patients and health professionals. Keeping confidences is a form of keeping a 
promise or bond. In effect, the health professional promises the patient that they will keep a 
bond of trust – the patient trusts the health professional to keep confidence and the health 
professional trusts the patient to tell the truth (See Case 5)
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Secondly, the assurance of confidentiality enables patients to be open about personal issues, 
concerns and questions and enhances their capacity to make decisions about their health 
care. Respecting a patient’s choice to keep certain information about them confidential, e.g., 
deciding not to tell a family member about their illness, recognizes the patient’s right to 
autonomy and privacy (See Privacy). It also acknowledges that it is the patient who must live 
with the consequences of their decision (not the health professional). 
Finally, not only is the keeping of confidentiality considered worthwhile because it is 
viewed as an implicit part of the health professional/patient relationship, it is also seen as 
a means of ensuring other important benefits. For example, the trust engendered through 
confidentiality 
•	 creates an open and supportive environment that encourages patients to disclose more 
of their symptoms and worries, fears and phobias.
•	 ensures a better diagnosis and a higher quality of care – secures greater agreement and 
compliance with procedures and treatment.
•	 encourages individuals, in particular, vulnerable individuals to seek help and increases 
their contact with the health services. 
In sum, the keeping of patient confidentiality is considered important because it is basic to 
a relationship built on trust and respect. It is important also because the consequences of 
keeping confidentiality are generally beneficial to patients in that it ensures better outcomes 
for them.
3.3 Professional and Legal Accountability
3.3.1 Professional Codes
Because it has long been held as an honoured bond between health professionals and 
patients, the keeping of confidentiality has been enshrined in both professional and legal 
codes. It was first articulated in the Hippocratic Oath (c.5th Century BC):
‘What I may see or hear in the course of the treatment or even outside of the treatment in regard 
to the life of men, which on no account one must spread abroad, I will keep to myself, holding 
such things shameful to be spoken about.’ Translated by Ludwig Edelstein (1943), cited in 
University of Virginia Historical Collections (2007).
Florence Nightingale also set high standards for the nurse/patient relationship in relation to 
confidentiality. In 1859, she advised nurses in the following terms:
‘And remember every nurse should be one who is to be depended upon, in other words, capable of 
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situation; she must be no gossip, no vain talker, she should never answer questions about her sick 
except to those who have a right to ask them.’ (Nightingale, 1859, 1992, p.70)
While the ancient oath points to shamefulness on the part of the health professional for 
breaking confidence, Nightingale draws attention to breaches of confidentiality that can 
happen through gossip and self-aggrandizement. Nightingale also indicates that anyone 
who asks for information about a patient must have a right to do so.
Modern codes of professional conduct for health professionals echo both Hippocrates’ and 
Nightingale’s stress on the professional/patient relationship and they also place emphasis on 
the notion of a presumed right on the patient’s part to confidentiality. For example, the Irish 
Medical Council describes confidentiality as ‘a fundamental principle of medical ethics [that] 
is central to the trust between patients and doctors’.  
(Medical Council, 2009, p.26, section 24.1)
However, where contemporary codes differ from earlier ones, is in the acknowledgement 
they make that some circumstances may give rise to the need for the principle of 
confidentiality to be qualified in some way. Such circumstances include situations where the 
well-being of the patient or the rights of those other than the patient may be at risk.  
These codes are discussed in detail in the following sections.
3.3.2 Legislation
In addition to ethical obligations and professional codes, confidentiality is also protected by 
law, through legislation, in particular the Data Protection Acts 1988 and 2003, on the basis 
of court decisions and also on appeal to such mechanisms as the Irish Constitution and the 
European Convention on Human Rights. There is a legal duty on health professionals to 
respect the confidence of their patients. In the English case of Hunter v Mann (1974), the 
Court set out the nature of the duty as follows: ‘the doctor is under a duty not to [voluntarily] 
disclose, without the consent of the patient, information which he, the doctor, has gained in 
his professional capacity.’ (See Privacy below)
Failure to respect the duty of confidentiality may lead to an action for breach of confidence 
and the award of damages to the patient. It may also cause a complaint to be made to the 
regulatory body responsible for the healthcare profession in question. 
348
Mo
du
le 
7 
Th
e E
th
ics
 o
f K
ee
pi
ng
 C
on
fid
en
tia
lit
y
4. Qualifying the Principle of Confidentiality
While the principle of confidentiality holds an honoured place in professional codes and laws, 
serious extenuating circumstances occasionally call for the principle to be qualified in some 
way. The challenge for health professionals, faced with such circumstances is to consider 
them carefully, to examine the implications of relevant codes and laws and to decide a  
course of action that they think best fulfils their various obligations as carers, professionals 
and citizens.
4.1 Disclosure with Consent
Health professionals do not breach the rule of confidentiality when they disclose information 
with the patient’s permission. The least controversial circumstance that might arise is 
one where confidential information is shared between health professionals working in a 
multidisciplinary team (Medical Council, 2009, p.30). However, while many might presume 
that it is acceptable for members of a team to disclose confidential information about a 
patient to each other, even here, care needs to be taken (BMA, 2008; Medical Council, 2009).  
The An Bord Altranais, Code of Professional Conduct (2000a), for example, advises nurses to 
use their professional judgement in relation to such disclosure:
‘Information regarding a patient’s history, treatment and state of health is privileged and 
confidential. It is accepted nursing practice that nursing care is communicated and recorded as 
part of the patient’s care and treatment. Professional judgement and responsibility should be 
exercised in the sharing of such information with professional colleagues.’  
(An Bord Altranais, 2000a, p.5)
The UK General Medical Council (2009) advises doctors to ensure that patients are aware that 
information might be shared:
‘You should make sure that information is readily available to patients explaining that, unless they 
object, their personal information may be disclosed for the sake of their own care and for local 
clinical audit’ (p.6, section 7)
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The Irish Medical Council advises that information shared among health professionals in 
relation to clinical audit, quality assurance systems and education and training should be 
anonymised as far as possible (2009, p.30). Where anonymisation is not possible, patients 
should be made aware of the possibility that identifiable information may be disclosed and 
that any patient’s subsequent objections to such disclosure must be respected (2009, p.30).
In relation to end-of-life care, where a patient with the capacity to make healthcare decisions 
gives his or her consent to the sharing of information, then provided that the information 
sharing is done in accordance with the patient’s instructions and does not exceed these, the 
health professional will not be in breach of her or his legal duties. 
In other situations, patients are also likely to agree with disclosure to third parties when it is 
required to protect their interests e.g, where insanity is a defence in a criminal action or for 
insurance purposes. 
4.2 Disclosure without Consent
While these situations might be more contentious and troubling, there is considerable 
international consensus on what might be deemed grounds for qualifying the principle 
of confidentiality without the permission of a patient. Generally, codes delineate three 
circumstances where a health professional might, justifiably, share confidential information 
with people other than the patient or the multi-disciplinary team. These circumstances 
relate to the interests of; the law, the patient and other individuals and society. All three are 
explicitly detailed in the Irish Medical Council’s Guide to Professional Conduct and Ethics for 
registered medical practitioners:
1. Disclosure required by law
2. Disclosure in the interest of the patient or other people
3. Disclosure in the public interest (Medical Council, 2009, p.27-29)
4.2.1 When Obligated Under the Law
Circumstances where the law can require a health professional to disclose confidential 
information include criminal investigations where the records of a suspected individual in a 
crime (e.g., road traffic offence, shooting offence) may be sought and legal actions where a 
professional might be asked to testify in a court or tribunal. They may also relate to Infectious 
Diseases Regulations which place an obligation on doctors and other health professionals to 
disclose information about ‘notifiable’ diseases to the public health authorities  
(Health Protection Surveillance Centre, 2009)
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4.2.2 To Protect the Interests of the Patient or Other People
Patients with Capacity 
Ethical problems arise if the health professional and the patient disagree as to whether or not 
disclosing information is in their best interests. On such occasions, health professionals might 
find themselves torn between maintaining a patient’s trust on the one hand and their duty 
to protect a patient from harm on the other. Circumstances where such conflicts arise might 
involve patients who share information in relation to abuse, neglect or suicidal intentions. In 
cases of abuse or neglect, the patient – young or old – may feel so dependent or fearful that 
they refuse to permit their doctor or nurse to disclose the abuse (Medical Council, 2009, p.7; 
Department of Health and children, 2004). In cases of threatened suicide, the patient may be 
so severely depressed that they cannot rationally decide where their best interests lie. 
Some commentators, for example Mason and Laurie (2006, p.259) suggest that, in some 
limited circumstances, it may also be legally permissible for a health professional to share 
information about a capable patient without the patient’s consent where it is in the best 
interests of the patient that the information be shared and it is not desirable on medical 
grounds to seek the consent of the patient. Possible examples where this would arise would 
be sharing information between professionals responsible for the patient’s care or sharing 
information with a close family member. 
However, others, for example Brazier and Cave (2007, p.80) argue that paternalistic motives 
to protect the patient cannot justify the sharing of information about a patient with capacity 
without the patient’s consent.  The matter has not been considered by the Irish courts. 
However, even if the courts did adopt the first position, it is likely that the courts would take a 
strict view of the circumstances in which this exception would be allowed to arise and would 
look for very strong evidence regarding the medical grounds as to why it was not considered 
desirable to seek the patient’s consent.  
Temporary or Permanent Incapacity
If the patient lacks the capacity to consent to sharing information, health professionals 
may need to share information with relatives, friends or carers in order to enable them 
to be involved in decisions about the patient’s best interests. In such circumstances, it is 
permissible for health professionals to provide information to those close to the patient. But 
caution is advised. According to the BMA (2008):
‘Where a patient is seriously ill and lacks capacity, it would be unreasonable to always refuse to 
provide any information to those close to the patient on the basis that the patient has not given 
explicit consent. This does not, however, mean that all information should be routinely shared, 
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the patient is likely to want to be shared, and with whom. Where there is evidence that the patient 
did not want information shared, this must be respected.’ (BMA, 2008, p.28)
The Irish Medical Council advises the following:
‘While the concern of the patient’s relatives and close friends is understandable, you must not 
disclose information to anyone without the patient’s consent. If the patient does not consent to 
disclosure, you should respect this except where failure to disclose would put others at risk of  
serious harm.
If the patient is considered to be incapable of giving or withholding consent to disclosure, you 
should consider whether disclosing the information to family and carers is in the best interests of 
the patient.’ (Medical Council, 2009, p.26)
Unfortunately, Irish law in respect of patients who lack capacity is both unsatisfactory and 
unclear. The law is currently in the process of being reformed. A Mental Capacity Bill is due 
to be published but does not look like becoming law until well into 2010. Under the current 
law, a person who lacks capacity may be made a ward of court. If this happens, a committee 
of the ward (usually one person) is appointed to act on the person’s behalf. The committee 
has the legal right to consent to some medical treatment for the ward provided that the 
treatment is not serious – the committee does not have the legal right to consent to serious 
treatment. Although the matter has not been considered by the Irish courts, where a person 
is a ward of court, it would seem to be ethically appropriate and legally permissible for health 
professionals to share information with the ward’s committee. 
Wardship is still relatively uncommon in Ireland and most patients who lack capacity will not 
have a committee. Under the current Irish law, those close to the patient – spouses, partners, 
family members, friends have no legal status in relation to healthcare decisions on behalf of 
people lacking capacity. While hospitals may routinely seek the consent of the ‘next of kin’ 
in relation to a healthcare decisions, this consent has no legal basis. If a person is nominated 
by a patient as their next of kin, such a person may provide valuable insight to health 
professionals as to the patient’s wishes. However they have no right to the patient’s records 
nor can they consent to disclosing information about the patient to third parties. 
Ultimately, the lawfulness of healthcare decisions about patients who are incapacitated 
depends on whether the decisions are in the best interests of the patient. It is likely that the 
best interests principle will also apply to the sharing of information about a patient without 
capacity. If it can be shown that it is in the patient’s best interests that information about 
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sharing of information will be legally permissible. The lack of clear legal guidance can create 
difficulties for health professionals especially in situations of family conflict. The new capacity 
legislation is likely to clarify the position considerably. It will allow for the appointment 
of adult guardians who will be the relevant people for all actions in respect of the person 
lacking capacity.
Health care surrogacy laws in many states in the US give decision-making authority for 
incapacitated patients to appointed surrogates where advance directives or living wills have 
not been executed. In these cases, surrogates are often granted access to patients’ medical 
records. This might be ethically justified on the ground that it assists surrogates to make 
informed healthcare decisions which are consistent with the patient’s own wishes and are 
also in their best interests.
The key test highlighted by Jansen and Friedman Ross (2000) is the degree to which the 
information that the patient does not want disclosed is relevant to the treatment decisions 
that the surrogate must make. Where it not relevant; there is no justification for breaching 
confidentiality. Where adequate care requires information disclosure, then it would seem 
that the interests of the patient’s welfare should be prioritized over his confidentiality. In 
cases where clinicians might reasonably disagree as to the relevance of certain information 
to treatment decisions, Jansen and Friedman Ross advise consultation with an ethics 
committee and tend to favour disclosure out of respect for the decision making authority of 
the surrogate. However, we would urge caution in this regard on the grounds that it could be 
argued that, while the surrogate represents the patient, they are not themselves the patient 
and, so, their right to information is more limited. In any case, currently in Ireland, there are 
no legal means of appointing surrogates and, if there were, the level of decision-making 
authority is uncertain. 
In addition, the Freedom of Information Act 1997 (section 28(6) Regulations 2009 (SI 
387/2009) allow access to information about people lacking capacity in some situations.
Regulation 4 says that a request for personal information shall be granted where the 
requester is a parent or guardian of the individual to whom the information relates and 
the person has not reached the age of 18 or is a person with a mental condition or mental 
incapacity or severe physical disability provided that access to the information is in the 
person’s best interests.
To Protect the Interests of Another Individual
These circumstances concern, not the public at large or society as a whole, but particular 
identifiable individuals who are at serious risk of harm which disclosure of information 
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professionals had a legal obligation to breach confidentiality in circumstances where 
identifiable third parties were at risk is the Unites States case of Tarasoff v. the Regents of the 
University of California (1976) (See Section 7. Further Discussion for details). The case was 
initially dismissed but, after several appeals, the California Supreme Court overturned the 
dismissal. In 1976 it stated: 
‘[O]nce a therapist does, in fact, determine, or under the applicable professional standards 
reasonably should have determined, that a patient poses a serious danger of violence to others, 
he bears a duty to exercise reasonable care to protect the foreseeable victim of that danger.’  
(Tarasoff v. the Regents of the University of California, 1976) 
The court noted that the duty to protect might be fulfilled in different ways, such as issuing 
a warning to the presumed intended victim or others likely to tell the potential victim 
of the danger, notifying the police, or initiating steps reasonably necessary under the 
circumstances. 
The duty or obligation on the part of health professionals to warn an identifiable person who 
is at risk of serious harm that was articulated by the Californian Supreme Court in the Tarasoff 
case has also been expressed in many contemporary codes. The Irish Medical Council, for 
example, puts it in the following way.
‘Disclosure of patient information without their consent may be justifiable in exceptional 
circumstances when it is necessary to protect the patient or others from serious risk of death or 
serious harm. You should obtain consent of the patient to the disclosure if possible.
If you consider that disclosing patient information is justifiable, you should carefully consider 
whether anonymisation of the infor mation (sharing it without revealing the patient’s identity) 
would achieve the same potential benefits. You must also be careful to disclose the information to 
an appropriate person (or body) who understands that the information must be kept confidential. 
You should only disclose the minimum information that is necessary in the circumstances.
In the preceding instances, you should inform patients of the disclosure unless this would cause 
them serious harm.’ (Medical Council, 2009, p.28)
The position of the Medical Council in relation to disclosure in these circumstances is 
supported by the Irish Data Protection Acts 1988 and 2003 and the EU Data Protection 
Directive 1995 (Council of Europe 1995). Specifically, the Irish Acts permit disclosure of 
otherwise confidential information where ‘required urgently to prevent injury or other 
damage to the health of a person’ (Data Protection Acts 1988 and 2003, Section 8 [d]).
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While the law (legislation and court decisions) and professional regulations clearly stipulate a 
duty on the part of health professionals to warn those at risk, there remains some uncertainty 
in relation to the precise circumstances that would prompt the disclosure of information 
(who to warn) and also in relation to the process of carrying out such a duty (when, how and 
what). However, some guidelines exist. 
In relation to whom to warn: 
The Californian Supreme Court stipulates that the person at risk must be identifiable, and 
that the risk to them must be one of a serious danger of violence (Tarasoff v. Regents of the 
University of California, 1976). 
In relation to when and how:
The Data Protection Act 1988 permits disclosure in urgent circumstances to prevent injury or 
other damage.
The Irish Medical Council cites ‘serious risk of death or serious harm’ as a condition of 
disclosure (2009, p. 29, section 28.1).
The Californian Supreme Court advises taking steps that are reasonably necessary under  
the circumstances (Tarasoff v. Regents of the University of California, 1976). 
In relation to what:
If a health professional decides to disclose confidential information to a third party, either 
in the interests of the patient or to protect other individuals from harm, they might ask 
themselves a further question: what should they tell them? This question is based on a rule 
of thumb, the minimalist principle of disclosure. The principle can be formulated in the 
following way: ‘Only tell a relevant third party the minimum that is necessary to achieve the 
end of disclosure.’ This can afford protection of patient confidence as much as possible, while 
recognising an obligation to disclose pertinent information to protect patients, or others, 
from harm.
What these provisos indicate is a general concern that confidentiality is not breached lightly: 
that the decision to disclose is not made in haste without due care and consideration of all 
concerned in the situation. 
4.2.3 In the Interests of the General Public
As Module 4, 3.4 indicated, the right of an individual to exercise autonomy is limited by 
the similar rights of others to live autonomously. So also, in the case of confidentiality, 
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interests of others. Those interests may be deemed to outweigh an individual’s right to 
confidentiality in circumstances where nondisclosure threatens the well-being and welfare 
of others. The discussion in the previous section relates to the interests of identifiable other 
individuals but a health professional also has obligations in relation to society in general. 
For example, a health professional might be justifiably concerned if she or he becomes 
aware that an airline pilot or bus driver suffers from epilepsy or that a patient has murderous 
intentions and seems capable of carrying them out. In these circumstances, the health and 
even lives of members of the public are at risk if the health professional does not disclose 
what she or he knows to other relevant parties. 
4.3 Deceased Patients 
The status of deceased patients in uncertain in ethics and law, but there is general consensus 
that the obligation to respect patient’s confidentiality extends beyond death. Guidelines 
from the US and the UK:
4.3.1 US Guidelines
Opinion 5.051 - Confidentiality of Medical Information Postmortem
All medically related confidences disclosed by a patient to a physician and information contained 
within a deceased patient’s medical record, including information entered postmortem, should 
be kept confidential to the greatest possible degree. However, the obligation to safeguard 
patient confidences is subject to certain exceptions that are ethically and legally justifiable 
because of overriding societal considerations (Opinion 5.05, “Confidentiality”). At their strongest, 
confidentiality protections after death would be equal to those in force during a patient’s life. 
Thus, if information about a patient may be ethically disclosed during life, it likewise may be 
disclosed after the patient has died.
Disclosure of medical information postmortem for research and educational purposes is 
appropriate as long as confidentiality is maintained to the greatest possible degree by removing 
any individual identifiers. Otherwise, in determining whether to disclose identified information 
after the death of a patient, physicians should consider the following factors:
(1) The imminence of harm to identifiable individuals or the public health
(2) The potential benefit to at-risk individuals or the public health (eg, if a communicable or 
inherited disease is preventable or treatable)
(3) Any statement or directive made by the patient regarding postmortem disclosure
(4) The impact disclosure may have on the reputation of the deceased patient
(5) Personal gain for the physician that may unduly influence professional obligations of 
confidentiality
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disclose the results of the autopsy to the individual(s) that granted consent to the procedure.
(American Medical Association Council on Ethical and Judicial Affairs, 2000, p.5)
4.3.2 UK Guidelines
‘Your duty of confidentiality continues after a patient has died. Whether and what personal 
information may be disclosed after a patient’s death will depend on the circumstances. If the 
patient had asked for information to remain confidential, you should usually respect their wishes. 
If you are unaware of any instructions from the patient, when you are considering requests for 
information you should take into account:
(a) whether the disclosure of information is likely to cause distress to, or be of benefit to, the 
patient’s partner or family
(b) whether the disclosure will also disclose information about the patient’s family or anyone else
(c) whether the information is already public knowledge or can be anonymised or coded, and
(d) the purpose of the disclosure’ (General Medical Council, 2009, p.28, section 70)
‘You are personally accountable for your professional practice and must always be prepared to 
justify your decisions and actions’ (General Medical Council, 2009, p.2).
4.3.3 Irish Guidelines
The Irish Medical Council also addresses the issue briefly and confirms that the ethical duty of 
confidentiality extends beyond death:
‘Patient information remains confidential even after death. If it is unclear whether the patient 
consented to disclosure of information after their death, you should consider how disclosure of 
the information might benefit or cause distress to the deceased’s family or carers. You should 
also consider the effect of disclosure on the reputation of the deceased and the purpose of the 
disclosure. Individual discretion in this area might be limited by law.’ (Medical Council, 2009, 
p. 27, section 24.2)
What is at the heart of these guidelines is concern for the wishes of the patient, worry about 
harm to others and the need to anonymise information where possible.
Other good reasons for protecting confidentiality after death centre on the impact that 
posthumous breaches of confidentiality may have on the care that the dying patient receives. 
Robinson and O’Neill (2007) frame the problem in the following way:
‘Although certain ethicists may argue that the dead have no interests to protect, some individuals’ 
fear of disclosure of information posthumously may be as great as contemporaneous disclosure. 
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Individuals frequently withhold information from loved ones to protect them, and there is no 
reason to assume that this should be different after a person’s death. An expectation among the 
living that their private medical information may be released after death may inhibit the patient-
clinician relationship.’ (Robinson and O’Neill, 2007, p.634)
This obligation is particularly weighty if the patient requested confidentiality when they 
were alive. The usual exceptions remain, however, that the patient’s right to confidentiality 
is not absolute, and confidentiality may be breached in certain circumstances. Of these, the 
possibility that non-disclosure of confidential information may cause serious harm to other 
individuals or the general public are the most pressing.
The legal position is less clear. There is some authority from the European Court of Human 
Rights that a duty of confidentiality survives after death: see European Court of Human 
Rights Plon v France (2004). However, in Rotunda Hospital v Information Commissioner 
(2009), McCarthy J held that there was no right of privacy in deceased people. This decision is 
currently on appeal to the Supreme Court.
Access to information about deceased people may be obtained in some circumstances.  
The Freedom of Information Act (1997) and the Freedom of Information Act 1997 (Section 
28(6)) Regulations 2009 (SI 387/2009) allow access to information about deceased people 
to certain classes of requesters. These are: a personal representative of the deceased person 
acting in due course of the administration of the estate of the deceased person; a person 
upon whom a function is conferred by law in relation to the estate of the deceased person; 
the spouse or next of kin of the deceased person where in the opinion of the head of the 
body from whom the information is sought, having regard to all circumstances, the public 
interest, including the public interest in the confidentiality of personal information would,  
on balance be better served by granting than by refusing to grant the request.
The Regulations also define a ‘spouse’ and a ‘next of kin’. A ‘spouse’ includes a party to a 
marriage which has been dissolved or who is living apart from the deceased person under 
a deed of separation and a man or woman who is not married to the deceased but who 
has cohabited as husband or wife with the deceased person.  A ‘next of kin’ is ‘the person or 
persons standing nearest in blood relationship’ to the deceased person in accordance with 
the order set out in the Succession Act 1965.
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5. Privacy – a Space to Call One’s Own
5.1 Scope and Limits
‘Privacy’ is a rich concept that plays an important role in the assessment of healthcare 
policies and practices. The question of how to define privacy is a controversial one. Some 
say that privacy should be defined as a moral claim while others argue that privacy should 
be construed as a legal right. For a society to value individual privacy; it needs to specify 
and clarify what might be considered to be in the private domain and, therefore, worthy 
of protection. Bok offers a definition of privacy that is helpful when considering privacy in 
relation to end-of-life care:
‘the condition of being protected from unwanted access by others – either physical access, 
personal information, or attention. Claims to privacy are claims to control access to what one 
takes – however grandiosely – to be one’s personal domain.’ (Bok 1989, p.10-11)
The law also fleshes out the meaning of privacy and links it with dignity and autonomy. 
For example, the Irish courts recognize a right to privacy (and by implication, a right to 
confidentiality) which is loosely derived from the Irish Constitution:
‘Though not specifically guaranteed by the Constitution, the right to privacy is one of the 
fundamental personal rights of the citizen which flow from the Christian and democratic nature 
of the State […] The nature of the right to privacy must be such as to ensure the dignity and 
freedom of an individual in the type of society envisaged by the Constitution, namely, a sovereign, 
independent and democratic society.’ (Hamilton P. in Kennedy and Arnold v Ireland [1987] 
cited in Madden, 2002)
The European Convention on Human Rights also protects privacy under Article 8: ‘Everyone 
has the right to respect for his private and family life, his home and his correspondence.’ 
(Council of Europe, 1998, Art. 8.1, p.9).
However, just as professional codes consider exceptional circumstances where the principle 
of confidentiality might be qualified, so also, legal rights to privacy are not considered 
absolute. 
The European Convention, for example, also stipulates under Article 8 that: 
359
Mo
du
le 
7 
Th
e E
th
ics
 o
f K
ee
pi
ng
 C
on
fid
en
tia
lit
y
‘There shall be no interference by a public authority with the exercise of this right except such as 
is in accordance with the law and is necessary in a democratic society in the interests of national 
security, public safety or the economic well-being of the country, for the prevention of disorder or 
crime, for the protection of health or morals, or for the protection of the rights and freedoms of 
others.’ (Council of Europe, 1998, Art. 8.2, p.9).
What is at the heart of qualification of the right to privacy in Article 8 is a concern for the 
interests of others and the public interest generally.
While private matters are often kept secret; there is an important difference between privacy 
and secrecy. What is kept private does not have to be secret, and what is kept secret does not 
have to be private. For example, a private house or a private life is not always a secret house 
or life. In turn, a secret ballot for government elections is not a private concern, nor is a secret 
plan to assassinate a president.
‘Control over secrecy provides a safety valve for individuals in the midst of communal life – some 
influence over transactions between the world of personal experience and the world shared with 
others. With no control over such exchanges, human beings would be unable to exercise choice 
about their lives. To restrain some secrets and to allow others freer play; to keep some hidden 
and to let others be known; to offer knowledge to some but not to all comers; to give and receive 
confidences and to guess at far more: these efforts at control permeate all human contact. 
Those who lose all control over these relations cannot flourish in either the personal or the shared 
world, nor retain their sanity. If experience in the shared world becomes too overwhelming, the 
sense of identity suffers.’ (Bok, 1989, p.20)
Why should we have some control over our secrets? One reason is that having control over 
our secrets protects a key element of personal autonomy: identity.
‘[Secrecy] [p]rotects identity, the sacred, unique and unfathomable nature of human beings:
[Secrecy] protects vulnerable beliefs or feelings, inwardness, and the sense of being set apart; of 
having or belonging to regions not fully penetrable to scrutiny, including those of memory and 
dream; of being someone who is more, has become more, has more possibilities for the future 
than can ever meet the eyes of observers. […] Human beings can be subjected to every scrutiny, 
and reveal much about themselves; but they can never be entirely understood, simultaneously 
exposed from every perspective, completely transparent either to themselves or to other persons. 
They are not only unique but unfathomable.’ (Bok, 1989, p.20-21)
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autonomy, argues that conflicts about concealing or revealing personal information should 
be understood as conflicts of power. She claims:
‘Conflicts over secrecy – between state and citizen, … or parent and child, [or between health 
professional and patient] or in journalism or business or law – are conflicts over power: the 
power that comes through controlling the flow of information. To be able to hold back some 
information about oneself or to channel it and thus influence how one is seen by others gives 
power; so does the capacity to penetrate similar defenses and strategies when used by others.[…] 
To have no capacity for secrecy is to be out of control over how others see one; it leaves one open 
to coercion. To have no insight into what others conceal is to lack power as well.’ 
(Bok, 1989, p.19)
5.2 Dimensions of Privacy
Judith DeCew (1997) analyses a range of privacy theories and privacy claims and believes 
that, rather than think of privacy as a single concept, we should look at it as an umbrella term 
or broad and multifaceted cluster concept for a wide variety of interests. Drawing on DeCew’s 
and Bok’s (1989) work on privacy, we suggest that there are five dimensions of privacy that 
health professionals might consider: 
1. physical privacy
2. informational privacy
3. decisional privacy
4. personal property
5. expressive privacy 
5.2.1 Physical privacy
Physical privacy is a popular usage of the concept of privacy and it means freedom from 
unwanted contact with other people. This sense of privacy recognises the need for bodily 
privacy and environmental privacy and protects a desire for limited accessibility from others. 
Complete physical privacy is inconsistent with the requirements of modern healthcare. 
Patients know that medical and nursing care may involve touching, invasive probing, nudity, 
and observation as necessary aspects of many examinations, treatments and surgeries. 
This is the privacy price of hopefully gaining better health. Nevertheless, patients can 
rightfully expect doctors, nurses and other carers to take special care against unnecessary or 
insensitive bodily exposure or contact. When it is necessary to have physical examinations, 
it is important and courteous to offer a brief explanation of what is being done, why it is 
necessary and some indication of the time duration of the physical contact.  
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Because healthcare workers get accustomed to nudity and body exposure in various 
examinations and caring tasks they might too readily become inured to the customary 
embarrassment that patient modesty causes. Respect for physical privacy should alert 
health professionals to try and keep ‘alive’ their awareness of patient’s discomfort under 
examinations. 
Physical privacy can also respect desires for seclusion and solitude that allow for peace of 
mind and intimacy. However, it does not imply that all patients would want to be in a room 
by themselves. While privacy is a most important value for patients, being in a room with 
two or three other patients can often help pass the time with friendly banter. People vary on 
what they would consider intrusive but individuals might consider some of the following as 
invasions of their physical privacy: unexpected and unexplained physical touch, telephone 
calls, other patients and their visitors coming in at will, their own visitors, chaplaincy visits, 
photography.
A commitment to the goal of protecting patients’ physical privacy will also alert staff to:
•	 Introduce physical touch with request and explanation.
•	 Minimise the duration and the extent of exposure.
•	 Minimise or get permission for the bedside presence of medical/nursing students, 
spectators, or cameras producing photographs for study purposes
•	 Provide explanations to patients of what happens during times when they are 
unconscious
•	 The importance of expanding the number of single over shared hospital rooms
•	 The sensitivity of many patients to rooms of mixed sexes
•	 The possible preference of some patients for doctors or nurses of their own sex 
It may not always be possible to fulfil these aims but one can develop sharper sensitivity to 
these potential intrusions on patient privacy.
5.2.2 Informational Privacy
Secrecy, confidentiality, anonymity and protection of patient data would come under this 
meaning of privacy. Informational privacy calls for access to personal information to be 
limited and this is especially true with respect to health information, present and past. 
Limiting access to medical and insurance records are fundamental protections required 
under the principle of confidentiality in the professional-patient relationship.
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5.2.3 Decisional Privacy
Decisional privacy can be understood as having control over intimate aspects of personal 
identity. Under decisional privacy a person can expect to be allowed, if not encouraged, 
to make their own decisions and act on their decisions if they so choose free from state, 
governmental or health professionals interference. There is, however, at least one important 
constraint on decisional privacy. A person cannot make a decision that causes harm to a third 
party and expect that the decision will have no interference or opposition. Obviously, what is 
covered by ‘harming third parties’ would need to be clarified if individuals are to observe care 
and consideration when making decisions (See Module 4, 3.4).
This area of decisional privacy in healthcare contexts is a central issue in ethics, medical 
and nursing codes and hospital administration guidelines. In the healthcare context, 
decisional privacy concerns responsibility for very important choices about treatment, 
termination of treatment, and involvement in clinical trials. Who has the authority to decide 
about treatment, commencement and termination is often a point of contention. Patients 
may not wish to have decisional authority in these matters and give permission to health 
professionals to make those decisions for them (paternalism with permission). Health 
professionals have expertise to advise patients in decisions about treatment or life supports 
and most patients appreciate such advice (See Module 3, Module 4 and Module 6 for more 
on patient authority over decision-making)
5.2.4 Personal Property
Respect for personal property includes all of a patient’s personal belongings and, especially, 
those items that are considered by them to be most important, e.g., personal diaries, letters, 
handbags and wallets.
5.2.5 Expressive Privacy
This dimension of privacy protects a realm for expressing one’s self-identity or personhood 
through activity or speech. Self expression is critical for lifestyle choices that contribute 
greatly to defining oneself and one’s values. If expressive privacy is a value that facilitates or 
supports self expression and self-identity, then as an element of expressive privacy we add a 
concept of personal space. 
Iris Marion Young thinks privacy theories have given inadequate attention to material 
support for privacy in guaranteeing personal space. An essential element of privacy, for 
Young is:
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‘[…] having a dwelling space of one’s own to which a person is able to control access and in 
which one lives among things that help support the narrative of one’s life […] Services and 
institutions giving shelter and care to needy persons fail to appreciate what is required for 
individuals not simply to stay alive, physically well and nourished but to have the life of a person’ 
(Young, 2005, p.155-156).
Studies of older people’s feelings of at-homeness emphasize the embodied understanding  
of security in oneself as surrounded by familiar things – especially those that form a 
connection with a life lived. The sense of personal integrity and sense of self is linked to 
control. Older people, like people of all ages, resist attempts of organisers and managers to 
direct their routines and activities. The same can be applied to patients, residents of long stay 
units or residents suffering from dementia.
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6. Cases: Respecting Confidentiality of the Dying and Deceased
6.1 Case 1: The Rights of Relatives to Medical Records
Particular circumstances may arise where relatives of deceased persons may ask for 
information. The British Medical Association (BMA) cites a common example: ‘when the 
family requests details of the terminal illness because of anxiety that the patient might have 
been misdiagnosed or there might have been negligence.’ (BMA, 2008, p.47) Because such 
disclosure is likely to be what the deceased person would have wanted, and because it might 
also be a matter of justice, disclosure is usually justified in such cases. 
Medical records may also be requested in circumstances where a will is contested on the 
basis of doubts raised as to the capacity of an individual to execute it. Again, disclosure in 
this case is generally viewed as acceptable because it is considered to advance the interests 
of the patient. Robinson and O’Neill (2007) note that the situation is less clear in cases where 
the disclosure of a hereditary or infectious condition might benefit those close to the patient. 
Freedom of information legislation (FOI) in many countries, including Ireland governs access 
to personal information. In line with existing legislation protecting confidentiality, freedom of 
information laws protect private information but also allow for exceptions. The following case 
illustrates the balance that is sometimes struck between protecting patient confidentiality 
and the rights of interested others to access patient information. 
 
The Rights of Relatives to Medical Records
Ms X requested access to her deceased brother’s records held by Cork University Hospital but was 
refused by the Irish Southern Health Board. In refusing access to the patient’s records the Board 
Submission made the following general observations: 
•	 ‘that the doctor-patient relationship is inherently private and based on confidence; 
•	 following the death of a patient, it is reasonable to assume that his/her privacy rights will 
continue to be respected; 
•	 any public perception that medical records may be released to others, following the death of the 
patient, may inhibit the provision of relevant medical information by patients generally; 
•	 once records are released under FOI there are no restrictions on the manner in which they may 
be used’ (5th December, 2002)
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medical records were upheld. Specifically, the Commissioner took the following into account:
•	 all of siblings, who were his nearest next of kin, agreed to the records being released to Ms X (Ms X 
had provided evidence that her two sisters agreed to the release of the records to her); 
•	 the fact that Ms X’s sister was named as his next of kin and personal carer in his hospital 
admission records suggests that he had confidence in her judgement in relation to matters 
concerning him; 
•	 the fact that the patient had good relations with his siblings and that there was no evidence of 
estrangement between them - all three sisters visited him in hospital and were with him when he 
died; 
•	 there was no evidence that the patient would have objected to the release of the records; 
•	 there was nothing of unusual sensitivity in the patient’s records; and nothing that Ms X was not 
aware of in general terms; 
•	 the patient’s GP saw fit to release the records to Ms X
(Office of the Information Commissioner, 2003, Case 020561)
6.1.1 Discussion 7
On the one hand, in this case, the Southern Health Board were concerned about patient 
privacy, the lack of restriction on how the records might be used and the worry that it might 
change the public’s trust that confidentiality is protected. On the other hand, the Information 
Commissioner focussed on the wishes of the patient, the non-sensitive nature of the 
information requested and evidence of the (good) relationship between the requester and 
the patient. 
In Case 1, the family of the patient had concerns about the patient’ will. Considering the 
decision of the Commissioner in light of situations where patients’ relatives seek information 
because they are anxious about hereditary risks to themselves, Robinson and O’Neill 
propose that a more cautious approach to the release of information might serve to protect 
confidentiality and reassure relatives. They suggest ‘an expert review of the likelihood of 
genetic risk or of inadequate care’ rather than, necessarily, the release of full medical records 
(Robinson and O’Neill, 2007, p.635). Moreover, these authors suggest that such a review 
could form ‘part of a bereavement care program following death, ideally involving the 
patient’s personal physician’ who would have cared for the patient in the terminal phase 
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supplemented by providing the advice of expert clinicians who are independent of the 
institutions and individuals at the centre of the situation. 
However, while Robinson and O’Neill’s proposal goes someway towards balancing the 
obligation to protect patient confidentiality with the needs of those who might benefit 
from disclosure, critics of their position might see the reliance on ‘expert opinion’ to decide 
what should and should not be disclosed as overly paternalistic. Glen (1997) distinguishes 
between confidentiality, understood as respect for privacy, and confidentiality, understood 
as a means of control. She worries that the duty of confidentiality may be misused by health 
professionals and organisations in order to maintain control over information.
‘ “Confidentiality” can become a somewhat embellishing signboard for paternalistic caring. In 
essence, one needs to distinguish between confidentiality as a respectful attitude to a patient/
client, where it becomes credible that the caring professional will not misuse the information she 
or he obtains about the patient/client, and between confidentiality misused as an instrument 
of power to keep the patient/client outside the processes in which it might be important or 
advantageous for him or her to participate.’ (Glen, 1997, p.403)
In a similar vein, Bok draws attention to the way in which maintaining confidentiality might 
not serve vulnerable populations well. She notes:
‘The sick, the poor, the mentally ill, the aged, and the very young are in a paradoxical situation 
in this respect. While their right to confidentiality is often breached and their most intimate 
problems bandied about, the poor care they may receive is just as often covered up under the 
same name of confidentiality. That is the shield held forth to prevent outsiders from finding out 
about negligence, overcharging, unnecessary surgery, or institutionalization. And far more than 
individual mistakes and misdeeds are thus covered up, for confidentiality is also the shield that 
professionals invoke to protect incompetent colleagues and negligence and unexpected accidents 
in, for instance, hospitals, factories, or entire industries.’ (Bok, 1983, p.30)
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6.1.2 Suggested Professional Responsibilities 7
•	 Health professionals have an obligation to respect patient confidentiality which 
extends beyond the patient’s death.
•	 Consideration should be given to the wishes of the patient prior to their death in 
relation to the confidentiality of information relating to them if these are known or can 
be otherwise determined. 
•	 The sensitivity of the information sought should be taken into account.
•	 Health professionals also have a duty of care in relation the wellbeing and welfare of 
those who are bereaved.
•	 Access to patient information should not be considered as an automatic right. In 
deciding access to patient information professionals should be aware of legislation 
pertaining to Freedom of Information.
•	 Health professionals should consider carefully the particular circumstances that give 
rise to ta relatives request for access to the patient’s records.
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6.2 Case 2: The Patient with HIV – Silence of the Tomb
Consider the following case where the patient, Peter, has not made known whether or not 
information about his illness should be disclosed to anyone:
 
Silence of the Tomb
Peter died suddenly following a short illness. HIV was diagnosed post mortem. There had been 
no indication from Peter of his wishes with regards to telling his friends and family. Similarly, he 
had denied any risk factors for HIV. A week following his death, Peter’s sister, Ann visited from 
Australia and asked to see a doctor to discuss the cause of her brother’s death. She also wanted 
to know specifically if he had been infected with HIV. Ann was subsequently informed only of his 
heart failure and not of his HIV status […]. Before seeing her, the treating physicians were told by 
a representative legal body that: ‘the duty of confidentiality of Peter persists after his death – we 
may talk to her about the cause of death only as it appeared on the death certificate (which did 
not mention HIV)’. (adapted from Wildfire, Stebbing and Gazzard, 2007, p.474).
6.2.1 Discussion 7
According to Wildfire et al. (2007), the advice to Peter’s doctors implies that only publicly 
available information may be shared and that Peter’s HIV status was no one else’s business as 
it had no bearing on the health or welfare of anyone else.
Wildfire et al pose a number of questions in relation to this scenario that might be considered 
here:
1. Do dead patients have a right to confidentiality?
•	 if so, health professionals are obliged to respect their confidentiality but they must 
consider this duty in the light of their other duties to protect the health and wellbeing of 
others (individuals and society).
•	 if dead patients are not considered to have a right to confidentiality, then health 
professionals ‘can primarily consider the mental and physical welfare’ of any other 
relatives or persons who might benefit from the information shared (Wildfire et al., 2007). 
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2. Do health professionals have a right to tell the truth or avoid deception?
If we accept that the duty of confidentiality persists beyond death, Wildfire et al. (2007) 
present one argument for maintaining Peter’s confidentiality in the following way:
‘Patient P’s right to confidentiality has moral supremacy, as he is the patient with the problem and 
the vulnerable should be protected. His trust in the doctor, that was inherent in their professional 
relationship, is preserved by maintaining privacy and discretion. His right as the patient overrides 
the wishes of his sister, or the doctor’s right to tell the truth.’ (Wildfire et al., 2007, p.475).
6.2.2 Suggested Professional Responsibilities 7
•	 Health professionals have a duty of care towards the living as well as the dead. In 
response to requests for information about deceased persons, health professionals 
need to determine whether or not the disclosure of that information has any 
implications for the health and wellbeing of others. 
•	 In order to avoid situations where health professionals are torn between the duty 
of confidentiality and the duty to warn or protect others, those who treat HIV 
positive patients should discuss with them as early as possible the limits of patient 
confidentiality.  
•	 Such a discussion could include making a plan for what might happen should the 
patient lose their capacity to make decisions about their care and who might be 
involved (and, perhaps, informed) about their status in order that their best interests 
are preserved.  
•	 A balance has to be struck between respect for confidentiality and the legitimate 
interests of others.
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6.3 Case 3: Refusing to Disclose – Don’t tell anyone until I’m gone
Consider a slightly different scenario for Peter. The following case relates to the duty to warn 
and illustrates some of the complex ethical tensions that arise when a health professional 
must contemplate breaching confidentiality in these circumstances.
 
Don’t Tell Anyone Until I’m Gone
Peter is imminently dying and staff are aware that he has HIV/AIDS. Peter is in a coma and, prior 
to lapsing into the coma, Peter specifically asked that the fact that he has AIDs not be shared 
with anyone until after his death. Peter’s partner Salma and his sister have been regular visitors 
to the ICU unit where Peter is being cared for. They are not aware of Peter’s condition. One 
morning, Salma asks the nurse who seems to be Peter’s main carer to tell her more about Peter’s 
condition.
6.3.1 Discussion 7
One morally significant difference between Case 2 and Case 3 is that, in Case 3, there is an 
identifiable person who is at risk of harm (and of harming others) if the information is not 
disclosed. As Peter has given his permission to disclose that he has HIV/AIDs after his death, 
disclosure post-mortem would be ethically acceptable. The question that arises here relates, 
primarily, to the ‘when?’ of disclosure.
In Case 3, the nurse must decide whether he should inform Salma about Peter’s condition or 
whether he should protect the confidentiality of the therapeutic relationship. It seems that 
he must choose between two competing moral obligations, the obligation to keep patient 
confidentiality and the obligation to protect another person whose life may be at risk if 
he fails to disclose. To help him in making the decision, he must ask himself the following 
questions about the situation.
1. Is it within the scope of his practice to give this kind of information to anyone?
2.  What values are protected by the principle of confidentiality and are they relevant in  
this case? 
3. Does he have an obligation to protect a third party who is not his patient? 
4. If there is both a duty to a patient and a duty to a third party, which is the most 
compelling duty? 
5. If he is considering telling Salma, how much should be told? 
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is essential to the promotion of trust between health professional and patient and is an 
expression of respect for patient autonomy and privacy. The positive consequences to the 
patient of keeping confidentiality are also considered important. In Case 3, Peter has asked 
that no-one is told until after his death. In considering his situation, the nurse is obliged to 
maintain his trust in him as much as possible, he is also obliged to respect his autonomy, i.e., 
the decisions he makes in relation to his own life. (See Module 4. 3.2, 3.3)
In addition to these duties, the nurse must also consider the consequences of disclosure.  
Not everyone agrees that making exceptions to the principle of confidentiality is helpful 
in the longer run. Utilitarian ethicists, such as Helga Kuhse, are concerned that allowing 
exceptions to the rule of confidentiality with the intention of protecting third party interests 
will not achieve their intended effect in the long term (Kuhse, 1999, p.493-496). Kuhse’s basic 
concern is that a more relaxed confidentiality requirement on the part of health professionals 
will inhibit people, who are most in need of health services, from availing of them:
‘The point is that if known breaches of confidentiality are likely to prevent individuals from seeking 
treatment or to hinder them from seeking treatment in a timely fashion, then a rule requiring 
disclosure is likely to do more harm than good.’ (Kuhse, 1999, p.495)
The cost of breaches of confidentiality is the loss of patient trust and (though this doesn’t 
apply to Peter’s case) the subsequent inability to support patients to modify behaviour 
that is harmful to others. In brief, on Kuhse’s view, while harm might be prevented on some 
occasions, in the longer term, the overall harm to society will not be reduced.
On the other hand, even though Peters partner is not his patient, it could be argued that the 
nurse also has a moral obligation to protect her. Not just Peter’s, but also, Salma’s autonomy 
is very much at risk in this situation. While the consequences of disclosure might be serious 
for Peter, the consequences of nondisclosure are also serious for Salma. 
The most compelling argument for disclosure is a health related one based on general 
agreement that early access to anti-retroviral therapy and health care management are likely 
to prolong the health and welfare of individuals with HIV (Woodman, 2003, p.7).
The nurse might also consult relevant professional and legal regulations. For example, the 
guidelines of the UK Society of Sexual Health Advisers (SSHA) (2004) acknowledge that 
sexual health advisers have a professional duty to protect third parties and an important 
function of GUM clinics in Ireland and elsewhere is the process of partner notification. 
Partner notification, or contact tracing, describes the process whereby individuals who may 
have been in contact with a sexually transmitted infection (STI) are contacted (by the partner 
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From a legal point of view, the Tarasoff case and other legislation, indicate that there is a 
duty to warn an identifiable third party of serious danger. In this case, the third party is 
identifiable – the nurse needs to consider if she (and others) are also in serious danger: Salma 
may already be HIV positive and is in need of treatment. Additionally, the nurse needs to 
determine if she or other visitors need to take precautions against contracting the disease. 
The ethical dilemma that the nurse is faced with then is very real; he has a duty to the patient 
and he has a duty to protect the patients partner. It seems that he cannot fulfil both duties 
at once, if he fulfils his duty to Salma, he must neglect his duty to Peter and vice versa. Case 3 
seems to evolve into a ‘win-lose’ situation, where Peter wins and Salma loses or vice versa. 
6.3.2 Suggested Professional Responsibilities 7
•	 Health professionals must balance a duty to respect patient confidentiality with a duty 
to warn identifiable others at risk of serious harm. 
•	 The health professionals involved, must consider whether or not Peter will  
regain consciousness. 
•	 In general, those who treat HIV positive patients should discuss with them as early as 
possible the limits of patient confidentiality.  
•	 The health professionals in this case need to distinguish between the weight of 
two possible requests for information; from Salma and from Peter’s sister Ann. They 
must consider the health related argument in favour of disclosing information to 
Ann because she may benefit from access to anti-retroviral therapy and health care 
management. 
•	 The nurse must consider who is best placed to talk to Salma about Peter’s situation. 
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6.4 Case 4: Trust and Confidentiality – Privacy, a Bond of Trust
Consider the following case which illustrates the links between trust, confidentiality, privacy 
and identity and demonstrates how health professionals can nurture and protect all of these.
 
Privacy, a Bond of Trust
Julie, an otherwise healthy 66-year-old woman, presents to her doctor with a three-month 
history of weight loss, sleep disturbance, and loss of appetite. The exchange with the busy 
physician is brief:
‘Do you live alone?’
‘Yes.’
‘What about your husband?’
‘He died twenty years ago.’
The physician diagnoses depression and prescribes an antidepressant with follow-up in two 
weeks. When Julie returns, a different doctor is covering that day.
‘Who do you live with?’
‘No one – I’m alone.’
‘Is that a change for you?’
‘Yes.’
‘Tell me about what has happened recently.’
‘Sheila died.’
‘Sheila … did she live with you?’
‘Yes.’
‘How long did the two of you live together?’
‘Eighteen years.’
‘Were the two of you close?’
‘Yes. Very.’ (patient in tears …)
In addition to the antidepressant, the physician offers Julie bereavement counselling. In future 
follow-up, Julie reveals a relationship with Sheila that the two women had hidden from their 
children and community, all of whom assumed they were ‘just roommates’.
(Peterkin and Risdon, 2003, p.25)
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6.4.1 Discussion 7
Peterkin and Risdon (2003) draw attention to the need for health professionals to be 
especially sensitive and open to Lesbian, Gay, Bisexual and Transgender (LGBT) patients – 
this case illustrates the impact that a conversation that does not assume that all patients are 
heterosexual can have on the outcome for the patient. 
The need for health professionals to be more sensitive to the lives and health of LGBT 
patients, family members and health professionals is supported by international research 
on the physical and mental dangers that many LGBT individuals must face in every part of 
the world. One recent and sobering example of this is found in a very comprehensive report 
on levels of discrimination and homophobia across the European member states, which 
includes very large surveys of individuals’ experiences at the hands of health professionals 
(European Union Agency for Fundamental Rights, 2009).
Recent Irish research indicates that LGBT people living in Ireland face particular challenges in 
relation to the recognition of partners in healthcare contexts. This is especially true in relation 
to decision-making around end-of-life care, for example, withholding and withdrawing 
treatment, last rites and hospital visits (Higgins and Glacken, 2009). In addition, as the Health 
Service Executive (HSE) Report on LGBT Health (2009a) and the Equality Authority (2002) 
indicate ‘the invisibility of older LGBT people may lead to a reluctance to disclose a same-
sex relationship. This may impact on the ability to express grief when a partner dies or to be 
involved in the funeral arrangements.’ (HSE, 2009a, p.38)
6.4.2 Suggested Professional Responsibilities 7
•	 Don’t assume everyone is heterosexual (e.g. service users, carers, parents, colleagues).
•	 Respond positively when people disclose their sexual orientation and/or gender 
identity.
•	 Ensure respect, confidentiality and privacy is shown to all LGBT people.
•	 Address issues of same-sex partners and next-of kin in care settings in a sensitive 
manner.
•	 Be informed about the health issues of LGBT people.
•	 Ensure all relevant paperwork uses language which is inclusive of LGBT people and 
their families (e.g. information leaflets, questions used in history taking).
•	 Address unacceptable, offensive or discriminatory comments and/or actions relating to 
LGBT people. (Drawn from HSE, 2009b)
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7. Module 7 Further Discussion 
7.1 The Tarasoff Case (1976)
In that case, the California Supreme Court imposed on a psychotherapist a limited duty 
to warn a presumed intended victim of a patient’s aggression. The case came about when 
the parents of a murdered student, Tatiana Tarasoff, sued the University of California and 
the professionals involved for their failure to notify them that their daughter was in grave 
danger. Her killer, Prosenjit Poddar, had been undergoing outpatient psychotherapy with the 
student health services during which he had admitted to having violent fantasies in relation 
to Tarasoff. The therapist, who learned from Poddar’s friend that he had purchased a gun, 
took steps to hospitalize him for further evaluation, against his will, if necessary. However, 
Californian law makes involuntary hospitalisation difficult and, while Poddar was still at large, 
he shot and killed Tarasoff and was subsequently convicted of second-degree homicide. 
The parents claimed that the defendant (University of California, therapist and campus 
police) failed to notify them or their daughter that she was in danger. The providers 
involved claimed that they could not warn Tatiana Tarasoff because it would violate patient 
confidentiality. 
(Unites States case of Tarasoff v. the Regents of the University of California, 1976) 
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8. Module 7 Summary Learning Guides 
8.1 Confidential Information
Confidential information
•	 is private information that a person shares with another on the understanding that it 
will not be disclosed to third parties. 
Keeping patient confidentiality is important because it
•	 builds patient trust 
•	 protects patient autonomy and privacy
•	 contributes to good treatment and care outcomes
8.2 Professional Codes and Laws
•	 Professional codes stipulate that patients have a right to confidentiality. 
•	 Confidentiality is also protected by law: court decisions, the Irish Constitution and the 
European Convention on Human Rights. 
Qualifying the principle of confidentiality
The principle of confidentiality is not considered absolute. Exceptional circumstances 
where the principle may be qualified include:
•	 Disclosure required by law
•	 Disclosure in the interest of the patient or other people
•	 Disclosure in the public interest. 
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8.3 Privacy 
Privacy can be defined as the condition of being protected from unwanted access by 
others.
There are five dimensions of privacy that health professionals might consider: 
1. physical privacy
2. informational privacy
3. decisional privacy
4. personal property
5. expressive privacy
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9. Module 7 Activities
9.1 Consider again the principle of confidentiality:
a. Can you give one example from your professional experience where the breaching of a 
patient’s confidentiality undermined their trust in the health professions?
b. Re-read Bok’s argument that conflicts about disclosing or not disclosing personal 
information are about power. Can you think of any example from your professional 
experience that might support Bok’s view?
c. Nightingale suggests that confidentiality may be breached through ‘gossip’ and ‘vain talk’. 
Can you think of contemporary examples where such breaches might arise?
d. Can you think of any other circumstances where in the process of ordinary, everyday 
routine activities in a clinic or hospital, patient confidentiality might be breached?
9.2 Reflect back on the particulars of Case 1. 
a. Jot down your own unanalysed response to the position of the HSE and the position of 
the Information Commissioner. Which position is closest to your own?
b. Give reasons for your answer.
c. Critically consider the more cautious approach towards information sharing with relatives 
that Robinson and O’Neill advise. Do you think that they are being overly cautious and/or 
paternalistic? Or, do they have the balance right between protecting patients and  
their families?
9.3 Reflect back on the particulars of Cases 2 and 3.
Consider the following questions that clinicians and nurses might ask themselves:
a. How do I treat the information that a patient shares with me? 
b. How do I treat what I know about the patient from other colleagues or from the  
patient’s records? 
c. How much of a say does the patient have in what I do with this information?
d. Where do my loyalties lie: to the patient or the patient’s family? To my profession, my 
colleagues, my employer, other affected parties? 
e. If I were given a piece of information about a patient in the strictest confidence, would I 
be able to keep that confidence?
f. If I thought that not disclosing the confidential information of a patient might cause 
harm to another individual or individuals, what would I do? What level of harm is  
enough harm?
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9.4 Reflect back on the particulars of Case 4. 
a. Consider each of the HSE Good Practice Guidelines (2009). Decide the ways in which 
these guidelines might be applied to LGBT patients who are terminally ill and LGBT 
families of dying or deceased patients.
b. Check if the contact details, posters and literature of local and national LGBT services are 
displayed in the waiting areas of your place of work.
c. Consider what you might need to do to become familiar with local LGBT groups and 
services in order to develop working relationships with them.
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1. Module 8 Key Points
1.1. There is a need for formal ethics support in clinical practice. 
Recent advances in biomedical technology and the identification of an increased range 
of values and needs in the patient population have led to a growing awareness of the 
complexity of healthcare provision and the need for formal ethics support for health 
professionals in the day-to-day treatment of patients. In the US and UK, this support most 
commonly takes the form of a hospital or clinical ethics committee, although it can also be 
provided by an individual ethicist trained in the skills necessary for ethics consultation.
1.2. Constitution and terms of reference of ethics committees. 
Unlike research ethics committees, hospital or clinical ethics committees have no legal 
standing, and there are different interpretations of their mandate. However, central to 
the effective functioning of such committees is their multidisciplinary constitution, with 
members drawn from nursing, medicine, psychology, law, ethics, theology, social work and 
administration. This diverse range of expertise allows the members of these committees to 
explore more comprehensively the different aspects of an ethically challenging case  
or situation.
1.3. The role of hospital or clinical ethics committees. 
In the US, Europe and Australia, hospital ethics committees (HECs) or clinical ethics 
committees (CECs) perform a threefold function: they provide ethics education for health 
professionals, hospital staff, patients and families; they contribute to the formulation and 
revision of hospital policy, and they provide a consultation service to support practitioners 
in resolving difficult or demanding clinical cases. While the first two of these functions are 
relatively uncontroversial, the third is more contentious.
1.4. Defining clinical ethics consultation. 
Ethics consultation may take a number of forms. There are different models of consultation, 
as well as different methods for conducting consultations. Because the practise of ethics 
consultation is still evolving, there is no universally-accepted definition of its nature or 
purpose. However, commentators agree that the following tasks are central to the process of 
ethics consultation: the identification and clarification of values, the exploration of diverse 
perspectives, the creation of an open environment for discussion, the determination and 
analysis of available options, the facilitation of communication between involved parties, and 
the building of consensus.
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1.5. Reasons for ethics consultation. 
Historically, HECs or CECs were consulted primarily for guidance in relation to issues such 
as the withholding or withdrawing of treatment, competent refusal of treatment, advance 
directives and DNR (Do Not Resuscitate) orders, or in relation to problems involving capacity, 
consent and confidentiality. In recent years, however, the focus has shifted to questions of 
communication, negotiation and mediation. Requests for ethics consultations may arise as 
a result of conflict between the healthcare team and the patient or member of the patient’s 
family during the course of the routine provision of care, or from disagreements between 
members of the healthcare team concerning the nature of the treatment provided or the 
manner in which it is provided. They may also issue indirectly from flawed or short-sighted 
management practices, or they may arise as a response to the culture of the organisation, in 
the form of unease with decisions taken at the executive level and their implications for the 
quality of patient care.
1.6. Clinical ethics committees: concerns and challenges. 
As the provision of clinical ethics consultation services becomes more widespread in the US 
and Europe, the role of HECs and CECs is subject to increasing scrutiny. Issues raised include 
concerns about the moral authority, expertise and qualification of members of CECs, in 
addition to concerns about the legitimacy of their recommendations, and concerns about 
the lack of standardisation in relation to the objectives and terms of reference of HECs and 
CECs. Some commentators have drawn attention to the need for more information about 
the efficacy of the HEC or CEC in improving the moral quality of decision-making within 
a healthcare institution, and to the need for the provision of ethics education and further 
training for committee members. Liability and lack of regulation pose further challenges for 
clinical ethics services.
 
1.7. Research ethics governance and research ethics committees. 
Abuses perpetuated on vulnerable populations in the name of research during the twentieth 
century have led, over the course of the past forty years, to the creation of a number of 
mechanisms for the regulation of research and the protection of research participants. 
Guidelines for the ethical conduct of research include the Nuremburg Code (1947), the 
declaration of Helsinki (World Medical Association, 1964, 1975, 1883, 1989, 1996, 2000, 
2002, 2004, 2008), the Belmont Report (National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research, 1979) and the guidelines of the Council of 
International Organisations for Medical Science (CIOMS) (1982 and revisions 1993, 2002). 
In the US, research is subject to stringent regulations which are enforceable by federal law 
(United States Department of Health and Human Services, 2005: Code of Federal Regulations 
45, section 46). The European equivalent of the 45CFR 46 is the EC Clinical Trials Directive of 
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2001 (European Parliament and Council of the European Union, 2001). Both sets of legislation 
mandate the establishment of research ethics committees (RECs), whose function it is to 
review research protocols for any ethical issues which may arise in the process of conducting 
the research in question. While in jurisdictions such as the US, Canada and the UK, the system 
of research ethics review is highly regulated and systematic, there is no central coordination 
of research review in Ireland and this has given rise to a certain amount of concern.
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2. Module 8 Definitions
2.1 Accreditation: 
a process of self-assessment and external peer assessment for evaluating the performance 
of healthcare organisations against a set of pre-determined standards, with the aim of 
improving the quality and safety of patient care and implementing strategies for  
continuous improvement. 
2.2 Clinical Ethics: 
an approach to resolving conflicts arising in the context of clinical care which relies on a 
fusion of clinical and ethical expertise and employs frameworks for clarifying, analysing and 
mediating value-differences.
2.3 Clinical Ethics Committee (CEC): 
a multidisciplinary committee which functions within a healthcare organisation on three 
levels: to educate health professionals and staff in relation to ethical issues, to create and 
revise institutional policies related to ethical issues, and to provide an ethics consultation 
service to staff and patients. In this module, the terms ‘clinical ethics committee’ and ‘hospital 
ethics committee’ will be treated as synonymous. In what follows, the term ‘hospital ethics 
committees’ (HECs) will be used when discussing the situation in the US, and ‘clinical 
ethics committees’ (CECs) will be used in the European context. In some contexts, both in 
the US and in the Netherlands, these committees may also be referred to as ‘institutional 
ethics committees’ (IECs). Although clinical ethics committees are not yet a common 
feature of healthcare provision in the Republic of Ireland, the past ten years have seen the 
establishment of a number of clinical ethics committees in major hospitals around  
the country.
2.4 Clinical Ethicist (sometimes referred to as a ‘bioethicist’ or ‘ethics consultant’): 
a trained consultant with a professional qualification in clinical ethics employed by a 
healthcare organisation to oversee all aspects of the delivery of clinical ethics services, 
namely, education, policy development and ethics consultation. In-house clinical ethicists are 
not a feature of the Irish healthcare landscape, although they are increasingly prevalent in 
the North American context.
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2.5 Clinical Ethics Consultation: 
a service provided by an individual ethics consultant, team or committee to enable managers 
or health professionals to address the ethical issues involved in a specific clinical case. 
Its central purpose is to improve the process and outcomes of patient care by helping to 
identify, analyse and resolve ethical problems and by providing health professionals with 
decision-making support. 
2.6 Decision-making Framework: 
a method used for the analysis of ethical issues arising in the context of the provision 
of clinical care, which focuses on the identification and clarification of the values and 
perspectives of the parties involved.
2.7 Ethical Leadership: 
activities carried out by an organisation’s leaders to foster an environment and culture which 
supports ethical practices throughout the organisation.
2.8 Governance: 
derived from the Greek word gubernator, meaning ‘helmsman’, the term ‘governance’ refers 
to the overseeing of processes designed to improve the quality of an institution’s or entity’s 
performance. In this module ‘governance’ refers to the regulation and standardisation of 
clinical and research ethics activities, in addition to attempts at the organisational level to 
promote ethical conduct throughout the organisation. 
2.9 Organisational Ethics: 
is concerned with the ethical issues faces by managers and governors of healthcare 
organisations, and the ethical implications of organisational decisions and practices on 
patients, staff and the community. 
2.10 Research Ethics Committee: 
a multidisciplinary committee which functions to review research proposals (‘protocols’) in 
any organisation in which research involving human subjects is carried out; this includes 
research involving biological samples and human tissue, as well as behavioural and 
observational studies.
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2.11 Value-system: 
a set of beliefs – personal, social or institutional – about what is valuable, or good, or 
desirable or worth pursuing.
2.12 Value Pluralism: 
the – sometimes uneasy – coexistence in a given society of a number of different value-
systems, some of which may be in conflict, although none has authority over the others.
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3. Module 8 Background 
3.1. The Need for Formal Ethics Support 
During the course of the past three decades, advances in medical technology and a growing 
awareness of the range of diverse needs and values in the patient population have led 
to an acknowledgement of the ethical complexity of healthcare provision (Shelton and 
Bjarnadottir, 2008, p.49) and the need for formal ethics support in healthcare institutions. 
Awareness of the ethical obligations inherent in healthcare provision may be said to date at 
least as far back as the time of Hippocrates, yet developments in modern biomedical science 
have created possibilities undreamt of by Hippocrates. New diagnostic techniques and  
therapeutic interventions, coupled with advances in life-prolonging technologies and 
rapid expansion in the field of clinical research, provide healthcare teams with an ever-
increasing array of options in their treatment of patients. These advances have important 
ramifications for the day-to-day provision of care; for example, health professionals now 
have to make choices in situations whose outcome would previously have been determined 
by the progression of the patient’s illness. Moreover, not only may the availability of these 
technologies create unrealistic expectations amongst patients and families, so too do they 
confront health professionals and hospital governors with an increased variety of choices 
about how best to allocate expensive and scarce resources. More often than not, clinical 
education does not provide doctors and nurses with the resources needed to make these 
difficult decisions. The establishment of hospital ethics committees (HECs) in the US and 
clinical ethics committees (CECs) in Europe has been driven by the recognition that health 
professionals require additional decision-making support in the day-to-day provision of 
treatment to patients. 
Historically, the call for the establishment of ethics committees in healthcare institutions 
arose in the US as a response to several specific developments in medical technology and 
the new ethical dilemmas engendered by them. The first successful heart transplant in 
1967 led to a determination of the criteria for brain death, for use in pronouncing death in 
patients who were being maintained on ventilators, so that their organs could be used for 
transplantation without physicians incurring the risk of prosecution (Wilson Ross, Bayley, 
Michel et. al., 1986, p.4). Debates about the acceptability of these criteria for brain-death and 
about the acquisition of donated organs formed the foundation for the emerging bioethics 
movement. Similarly, the introduction of haemodialysis in the 1960s led to a wide-ranging 
public discussion about the criteria employed in selecting patients for dialysis.  
These discussions resulted in the consolidation of bioethics as a discipline, with its own 
dedicated scholars, institutes and publications. By the early 1970s, professional organisations 
had begun to establish committees to examine ethical issues in health care, and hospitals 
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(Wilson Ross et. al., 1986, p.5). 
Around the same time, the revelation of research abuses involving vulnerable populations 
– such as the infamous Tuskegee study of untreated syphilis carried out between the 
1930s and the 1970s – gave rise to public outrage and mandated the formation in 1974 
of the National Commission for the Protection of Human Subjects of Biomedical and 
Behavioural Research (the Research Commission). This Commission was responsible for 
the publication in 1979 of the Belmont Report, (National Commission for the Protection of 
Human Subjects of Biomedical and Behavioral Research, 1979) which remains a seminal 
achievement in articulating the need to protect research participants from exploitation. In 
a parallel development, the founding of the Research Commission was followed in 1978 
by the establishment of the President’s Commission for the Study of Ethical Problems in 
Medicine and Biomedical and Behavioural Research (the President’s Commission). Between 
1978 and 1983, the Commission published several high-profile reports which underpinned 
the ‘organised and socially-sanctioned’ study of the ethical implications of high-technology 
medical care and drew attention to the need for ethical regulation of the healthcare industry  
(Wilson Ross et. al., 1986, p.5).
The first HECs were created to deal with the ethical issues which emerged around the 
provision of dialysis to patients with chronic kidney disease. Insufficient numbers of 
dialysis machines during the 1960s and early 1970s necessitated selecting patients for 
treatment on the basis of specific criteria. Critics of the selection process argued that the 
standards guiding these life-or-death decisions were based on partial or biased judgements 
concerning the value of certain people’s lives (Murphy, 2008, p.215). Controversy surrounding 
the selection process employed by these ‘dialysis treatment committees’ – sometimes 
referred to as ‘God committees’ – was quelled in 1972, when the federal government opted 
to fund all life-prolonging treatment for end-stage renal disease. But the role of the HECs 
was revisited in 1976 in the Quinlan case, when the US Supreme Court ruled that Karen-
Ann Quinlan’s respirator could be withdrawn at the behest of her family if the HEC agreed 
with her attending physician that she would never be restored to a ‘cognitive sapient state’ 
(Wilson Ross et. al., 1986, p.6). Subsequent to this ruling, small groups began to form in 
hospital settings to discuss the ethical issues inherent in the clinical application of advanced 
technologies. During the late 1970s and early 1980s, some of these groups came to take on a 
more formal role than others, providing institution-wide education programmes, developing 
decision-making guidelines and, in some cases, providing a forum in which specific cases 
could be discussed. 
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Why the Need for Clinical Ethics Support?
•	 The provision of healthcare involves achieving a balance between promoting the well-
being and best interests of patients and respecting their right to be partners in decisions 
made about their treatment. This balance requires accommodating a number of different 
value-systems, some of which may be in conflict with one another. Clinical ethics support 
contributes to the clarification and resolution of these value-conflicts.
•	 Excellence in the delivery of care requires ongoing education of staff in relation to patient 
rights, issues of consent and confidentiality, communication methods and mediation 
techniques.
•	 Mechanisms and frameworks for ethical decision-making are needed to assist 
practitioners in making difficult decisions. 
•	 There is a need for a fair and reasonable process for the resolution of conflicts arising in 
the context of the provision of care.
•	 There is a need for past mistakes to be acknowledged and skilfully converted into 
learning opportunities for health professionals and staff, in order to prevent re-
occurrence.
•	 There is a need for advocacy on behalf of those who do not have a voice because they 
lack power in the medical hierarchy (patients, members of minority populations, staff in 
vulnerable positions, low-paid contract employees)
3.2 The Formation of HECs and CECs
3.2.1 HECs in the US
In the early 1980s, a number of controversial cases involving treatment decisions made on 
behalf of patients lacking decision-making capacity, particularly neonates – specifically the 
cases of Baby Doe and Baby Jane Doe – focused public attention on the ethical difficulties 
inherent in such cases and the need for guidelines and policies to assist health professionals, 
with special reference to the withholding or withdrawing of treatment. Recommendations 
were made for the establishment of ‘infant care review committees’ which would assume the 
role of reviewing decisions to withhold life prolonging treatment from severely handicapped 
neonates. In 1983, a report by the President’s Commission suggested that HECs might 
provide a reasonable means of promoting effective decision-making through education, 
policy recommendations and case review (Wilson Ross et. al., 1986, p.7) – the three principal 
responsibilities of the present-day HEC. With this endorsement, the interest of the healthcare 
industry was finally awakened, and a rapid increase in the number of number of ethics 
committees in the US followed. By the mid-eighties, an estimated 50% of American hospitals 
had an ethics committee, and by 1987, this figure had risen to 67% (Edwards and Street, 
2007, p.254). In 1992, the Joint Commission for the Accreditation of Healthcare 
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defined mechanism for the consideration of ethical issues arising in the care of patients, and 
to provide education to caregivers and patients on ethical issues in health care’ (JCAHO, 1992, 
p.104). Currently almost every hospital in the US has an ethics committee – although there 
is considerable variation in the size, function and effectiveness of these committees (Hackler 
and Hester, 2008, p.4).
3.2.2 CECs in the UK
In the UK and mainland Europe, the establishment of clinical ethics committees (CECs) took 
place in a more piecemeal fashion and at a slower rate than in the US (Slowther, Johnston, 
Goodall and Hope, 2004a; Doyal, 2001). Reasons for the more rapid pace of development 
in the US may include a longer tradition of federal and state regulation of ethico-legal 
aspects of clinical activity in the US, a more accessible legal system and less tolerance of 
overt paternalism in medicine (Doyal, 2001, p.i44). During the early 1990s, a small number of 
isolated CECs existed in the UK, with an impetus to the establishment of further committees 
provided in the mid-1990s by the need expressed by some health professionals for support 
in the decision-making process (Edwards and Street, 2007, p.255). In 2000, the UK Clinical 
Ethics Network, an unofficial network of CECs, was established under the auspices of the 
Oxford Centre for Ethics and Communication in Health Care Practice (ETHOX). At that time, 
there were 20 CECs in the UK. By 2002, this figure had risen to 47, with 85 CECs currently 
registered with the Clinical Ethics Network. The aims of the Clinical Ethics Network are to 
promote the development of clinical ethics support in the UK, to encourage a high level of 
ethical debate in relation to clinical practice, and to facilitate the sharing of best practice 
between CECs (Slowther, Johnston, Goodall and Hope, 2004b, p.950). Recently, both the 
Royal College of Physicians and the Nuffield Trust have endorsed the role played by CECs in 
healthcare provision in the UK. In its report on Critical Care Decisions in Foetal and Neonatal 
Medicine (2006), the Nuffield Council on Bioethics explicitly recommended that difficult 
decisions in neonatal medicine should be reviewed by CECs, particularly those relating to the 
withholding or withdrawing of treatment. 
While the number of CECs in the UK has increased steadily since 2000, not every trust within 
the NHS has a CEC to date. Nor is there a uniform mandate shared by the diverse CECs within 
the NHS as a whole. Most of these committees function within the working context of a 
particular NHS Trust and have evolved in response to the particular needs and resources of 
the institution they serve; they are linked to the functioning of a particular organisational 
system and have no ‘absolute’ authority (Edwards and Street, 2007, p.256). A 2001 survey of 
UK CECs found that some of the committees surveyed were not yet clear about the exact 
nature of their role within the institution (Slowther, Bunch, Woolnough and Hope, 2001). 
Despite their increase in status in the intervening years, another survey conducted in 2007 
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(Williamson, McLean and O’Connell, 2007, p.4). 
3.2.3 CECs in Europe
The role played by CECs in Europe varies from country to country, with some countries 
having legislation in place recommending the establishment of CECs, and others – including 
Ireland – still lacking a formally-recognised ethics support structure. In most European 
countries - with the exceptions of Belgium and Italy - clinical and research ethics are regarded 
as separate jurisdictions and are dealt with by different committees (Meulenbergs, Vermylen 
and Schotsmans, 2005, p.319). In Belgium it is a legal requirement that every hospital should 
have an ethics committee which addresses both research and clinical issues (Slowther, 
Johnston, Goodall, and Hope, 2004a, p.7). The Norwegian parliament has recommended 
the establishment of a CEC in every hospital, and funding has been made available for 
the creation of a national centre for the coordination of these committees (Slowther et al., 
2004a, p.7). Although they have existed in various forms in the Netherlands since the 1980s, 
institutional ethics committees (IECs) have become an accepted part of the healthcare 
landscape over the course of the past decade. In most Dutch healthcare institutions, 
an institutional ethics committee may serve a number of functions: it may provide the 
opportunity for consultation in relation to complicated cases, it may provide advice on 
institutional policy, or it may simply raise moral awareness among the institution’s employees 
(van der Kloot Meijburg and ter Meulen, 2001, p.i36). Their function clearly distinguishes 
these institutional ethics committees from research ethics committees (RECs), alongside 
which they serve in many of the larger hospitals in the Netherlands. The separation of clinical 
and research ethics committees in the Netherlands was deemed necessary to prevent 
research from dominating the committees’ agenda.
 
3.2.4 CECs in Australia 
A survey of 79 CECs conducted in Australian hospitals between 1991 and 1994 revealed 
that CECs in Australia function primarily as policy formation bodies, although some have an 
educational function in the hospitals they serve, with very few performing any advisory role 
(McNeill, 2001, p.443-444). Those few committees which do provide patient care advice, do 
so within a very limited remit, and generally only in relation to those issues dealt with by the 
policies under consideration by the committees. McNeil concludes that, while CECs do have a 
valuable role to play, the range of issues they deal with is very narrow, and excludes broader 
considerations, such as the functioning of the hospital as an ethical enterprise (2001, p.459). 
3.3 Differences between CECs and RECs
Research ethics, like clinical ethics, is an emerging field, whose roots can be traced back 
to the early 1970s. However, although both research ethics committees (RECs) and clinical 
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ethical governance of research differs in a number of ways from clinical ethics governance. 
Most significantly, while the operation of RECs is mandated by law in the US and Europe, 
CECs have no legal standing. Second, whereas CECs perform a purely advisory function, RECs 
make decisions about whether or not to approve a given research protocol, and they are held 
to account for these decisions. The ethical governance of research will be discussed below  
at 3.7.
3.4 CECs: Constitution and Terms of Reference
3.4.1 Clinical Ethics
Clinical ethics emerged in the late 1980s as a response to the increasingly abstract 
orientation of medical ethics. Less an academic sub-discipline within bioethics than a form of 
practice in its own right, the aim of clinical ethics is to make the concepts and principles  
of medical ethics more clinically relevant by bridging the gap between ethical theory and  
the concrete reality of clinical practice. As a practice oriented towards the resolution of 
concrete clinical problems, clinical ethics ‘takes place’ in the healthcare setting, not in the 
university environment, and what is most distinctive about it is its fusion of clinical and 
ethical perspectives and skills. Clinical ethics is reducible neither to theoretical disciplines 
such as philosophy or ethics, nor to clinical knowledge and expertise; rather, it must 
genuinely integrate both. The legitimacy of clinical or hospital ethics committees rests on 
their ability to provide a genuinely multidisciplinary approach to the analysis and resolution 
of ethical problems. 
Although the HEC has now become a fixture of the US hospital system and is gaining ground 
in the UK, such committees are still in the process of defining themselves, their role and 
their mandate. In the US – as in the UK – the general idea of a HEC must in each case to be 
adapted to the structure, mission and size of the institution to which the committee belongs, 
and to the resources available to it (Hackler and Hester, 2008, p.18). The Joint Commission 
for the Accreditation of Healthcare Organisations (JCAHO) makes no recommendations 
for the constitution or development of a ‘mechanism’ for addressing ethical concerns, nor 
does it specify the role it should play (Hackler and Hester, 2008, p.12). Since HECs have no 
legal standing, they have no fixed terms of reference, nor have set rules been established to 
regulate membership or composition. For this reason, a number of different approaches to 
clinical ethics consultation and a variety of models of consultation have developed over the 
course of the past twenty years.
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Where such committees have been effective, however, multidisciplinary and diverse 
membership has been regarded as a key factor in their success (Schick and Moore, 1998, 
p.78), with members drawn from a number of different areas of specialisation, including 
medicine, nursing, psychology, law, theology, ethics, social work and hospital administration. 
While not a requirement, the inclusion of community and patient representatives is 
recommended as a means of achieving a more balanced composition. Patient and 
community perspectives are often seen as providing a valuable external viewpoint and 
a check on the institutional interests of the committee (Hackler and Hester, 2008, p.14). 
The multidisciplinary composition of the HEC or CEC reflects the shift in the culture of 
healthcare delivery which has taken place over the course of the past twenty years, from 
an authoritarian approach to decision-making to a more inclusive and participatory model. 
Central to the efficacy of such a committee is professional respect for the contribution 
of each individual member (van der Kloot Meijburg and ter Meulen, 2001, p.i39) and 
a willingness to disregard differences in status within the organisation. Ultimately, the 
functioning of the committee rests on the variety of expertise and the range of professional 
perspectives on clinical care – and on the broader social context of healthcare provision – 
brought to bear by its members on the issues under consideration (Hackler and Hester, 2008, 
p.14). Ethical issues in healthcare are multifactorial and stem from a variety of sources, and a 
wide range of expertise is required to address them. However, while the combined expertise 
of each CEC is unique to that committee, strong leadership, clarity of purpose, the support of 
management and some level of formal training in ethics are indispensable to its effectiveness 
within the institution in which it functions (Schick and Moore, 1998). 
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4. The Role of Ethics Committees: What do they do?
Broadly speaking, the function of the hospital or clinical ethics committee is threefold 
(Fletcher and Siegler, 1996; Slowther et. al., 2001): 
1. it provides ethics education to health professionals and administrative staff, 
2. it provides institution-wide guidance on matters of policy development and revision, and 
3. it provides support to individual health professionals in the form of a clinical ethics 
consultation service, which may take a number of forms. 
While the first two functions are relatively uncontroversial, the third is more contentious and 
has given rise to considerable debate (Fletcher and Siegler, 1996). What is clear, however, is 
that virtually all hospital or clinical ethics committees understand their role as advisory, not 
as authoritative: even in cases in which hospital or ethics committees intervene, the making 
of the clinical decision is the responsibility of the health professionals involved, and the 
committee’s primary role is to provide support during the decision-making process. 
During the course of the past twenty years, the evolution of clinical ethics has been marked 
by a ‘shift in emphasis from issues of content to issues of process: from what the ethicist [or 
CEC] does to what the ethicist enables’ (Walker, 1993, p.33). Slowther et. al. (2002) emphasise 
that a central role played by the CEC is to bring into being a fair and reasonable process 
for the resolution of ethical issues, and argue that the existence of a CEC testifies to the 
seriousness which the organisation attaches to the discussion of ethical issues arising in 
the course of the delivery of care (2002, p.6). Rather than perceiving themselves as ethics 
‘experts’, ethics committees and individual ethicists are ‘architects of the moral space within 
the healthcare setting as well as mediators of the conversations which take place within that 
space’ (Walker, 1993, p.33). 
In other words, in addition to meeting health professionals’ need for decision-making 
support in difficult cases, these committees also perform the more general role of raising 
– and maintaining – awareness of ethical issues in the institution (Slowther et. al., 2004a, 
p.6). Part of their mandate is to provide a ‘reflective space’ within the institution where 
healthcare providers feel comfortable discussing ethical issues (Walker, 1993). Similarly, 
Gillon argues that, despite the lack of agreement in the US concerning the function of HECs, 
such committees represent the values and practices that ‘define the healthcare institution as 
a “moral community” and reinforce its moral mandate’ (Gillon, 1997, p.204). 
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4.1 Education
Some commentators view the educational function of the hospital or clinical ethics 
committee as its most fundamental function, and as indispensable to the performance of its 
other functions (Kinlaw, 2008, p.204). Hospital or clinical ethics committees have an explicit 
mandate to educate health professionals and administrative staff with regard to ethical and 
legal principles and guidelines, but they also have a responsibility to identify areas in which 
they themselves may require further education (Hackler and Hester, 2008, p.7). 
Because not every member of a clinical ethics committee will have formal training in ethics, 
the education of the staff of the organisation is necessarily intertwined with the education 
of the members of the committee themselves (Kinlaw, 2008, p.203). Every HEC or CEC should 
include members with ethics expertise or should have an ethics resource readily available 
to it. It should also be able to identify effective mechanisms for self-education, which would 
provide its members with a basic knowledge of the field of bioethics and furnish them with 
the competencies required to carry out ethics consultation and policy formulation, such as 
the competencies specified by the American Society for Bioethics and Humanities (ASBH) 
task force report of 1998. An effective HEC or CEC will use every consultation and every policy 
review as an opportunity to educate its own members, health professionals and hospital 
staff, and patients. 
One of the first tasks of any HEC or CEC as educator is to recognise the potential suspicion 
with which it may be viewed in the organisation, and to address this proactively.  
The willingness of members of the committee to participate in educational sessions on the 
various hospital units provides an opportunity to ‘demythologise’ the role of the HEC or CEC 
and emphasise the relevance of ethics to the everyday life of staff, patients and families 
(Kinlaw, 2008, p.210). In addition to existing weekly divisional or unit meetings, clinical staff 
meetings or Grand Rounds may also provide collaborative opportunities for institution- 
wide education.
4.2 Policy Guidance and Revision
While there is general agreement about the moral and legal principles associated with 
the duty of care, there is often serious disagreement about how these principles are to be 
implemented in practice (Doyal, 2001, p.i45). The formulation of each aspect of the duty of 
care contains variables which are open-ended and subject to interpretation. When health 
professionals interpret the same duties of care in different ways or cannot agree about the 
resolution of conflict between such duties, they are thrown into a state of moral and legal 
indeterminacy (Doyal, 2001, p.i46). 
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One of the functions of the HEC or CEC is to provide a practical resolution of this 
indeterminacy. Good clinical practice requires a procedural means of generating the 
most rational course of action in such circumstances. An effective HEC or CEC can resolve 
indeterminacy and optimise opportunities for rational deliberation by facilitating wider 
debate and discussion about the formation of clinical policies, in which contesting parties 
have an equal opportunity to put forward their views. The proactive involvement of a HEC 
or CEC in formulating policies concerning good clinical practice also creates a feeling of 
‘institutional ownership of moral and legal principles which have been agreed nationally’ 
(Doyal, 2001, p.i46).
In addition to the formulation of clinical policy, HECs or CECs are also responsible for the 
review of existing policies. Providing an effective policy review service entails getting policies 
which could benefit from an ethics review to the committee (Ells, 2006, p.268). In some 
institutions in the US, a process is in place which requires that certain policies be submitted 
to the HEC for review. Another option is to recommend the policy review service to policy-
makers themselves, and encourage voluntary referral. An ethics review of an existing policy 
may be triggered by a number of factors, including the negative impact of that policy on 
patient autonomy, privacy or well-being, or an inconsistency between the policy and the 
institution’s stated mission or values (Ells, 2006, p.271). In the US and Canada, accreditation 
standards may serve as a checklist of items to be addressed by the institution in a particular 
policy, for example, the elements to be included in a policy on informed consent. Finally, 
in reviewing a policy, the HEC or CEC should try to anticipate the moral significance of its 
implementation and its impact on patient care and organisational systems (Ells, 2006, p.272).
4.3 Clinical Ethics Consultation
In the US and Canada, clinical ethics consultation has become a standard way for hospitals to 
meet the accreditation requirement that they address the ethical issues arising in healthcare 
provision (American Society for Bioethics and the Humanities [ASBH], 2009). In the UK and 
in Europe, ethics consultation is increasingly becoming an accepted part of the landscape 
of healthcare provision. However, while there has been much talk about the provision of a 
consultation service, little guidance has been provided as to how to design such a service 
and what its responsibilities might be (Fletcher and Siegler, 1996, p.122). As clinical ethics 
consultation becomes more widespread, a number of commentators have drawn attention 
to the need for greater clarity in defining its nature and goals. Tulsky and Fox define ethics 
consultation as 
‘a service provided by a committee, team or individual to address the ethical issues involved in a 
specific, active clinical case’ (1996, p.112). 
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The task force report produced by the American Society for Bioethics and the Humanities 
(ASBH) defines ethics consultation as 
‘a service provided by an individual or group to help patients, families, surrogates, health care 
providers or other involved parties to address uncertainty or conflict regarding value-laden issues 
that emerge in health care’ (1998, p.3). 
Elsewhere, the report defines the goal of clinical ethics consultation as that of ‘assist[ing]  
the interested parties in addressing an ethical issue in patient care’ (ASBH, 2009, p.15).  
This assistance may take the form of helping the parties involved to understand the moral 
problem and the relevant facts at issue, and to reflect on alternative courses of action and 
their probable consequences, or it may serve to enable more effective communication 
between the parties involved. 
Fletcher and Siegler summarise the objectives of ethics consultation as the clarification of 
ethical issues, the facilitation of discussion of particular cases and the resolution of ethical 
disputes (1996, p.122). Hester suggests that the common goals of ethics consultations are 
‘clarification, conflict resolution or mediation, and treatment recommendation’ (Hester, 
2008, p.10). Conversely, Zaner argues that the job of an ethics consultation service is not to 
recommend a course of action, but 
‘to help individuals whose situation it is think through their circumstances as thoroughly as 
possible, then help them understand what must be decided and what aftermath can be expected’ 
(Zaner, 2007, p.29). 
While there is considerable debate concerning the legitimacy of any treatment 
recommendations which might be made by CECs, what is uncontroversial is that the ultimate 
goal of all clinical ethics services is to improve the outcome of healthcare provision and the 
quality of patient care (ASBH, 1998, p.8). In their 2009 report, the ASBH task force points out 
the importance of differentiating clinical ethics consultation from other practices carried out 
in the hospital context with which it might be confused, such as medical consultation, risk 
management, compliance and organisational ethics consultation. The goals of these various 
practices are different:
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‘[W]hile the objective of clinical ethics consultation is to provide defensible solutions to clinical 
moral problems, medical consultations provide medical information, risk management protects 
the institution from liability, compliance programmes promote institutional adherence to legal 
standards and organisational ethics consultations offer guidance on moral issues arising in the 
management of health care institutions.’ (ASBH, 2009, p.12-3)
4.4 Value Clarification in a Pluralistic Society
In their summary of the 1998 ASBH Task Force report, Aulisio et al. point out that 
contemporary Western healthcare provision takes place in a pluralistic society, governed by 
the idea that each individual has the right to pursue her own conception of the good life, 
and to live by her own values, provided that this does not prevent others from doing the 
same. In this context, the delivery of clinical care is fraught with ethical difficulty, much of it 
generated by inadequate communication and the confrontation between conflicting value-
systems. Yet, while the differences between the value-systems of the parties involved in an 
ethics consultation may be irreducible, good communication, inclusiveness and attention to 
process often help to reduce or resolve conflict (Harrison, 2008). 
Essential to all three of its functions, but particularly to its consultative function, is the pivotal 
role played by the HEC or CEC in clarifying the value-differences which underpin most 
conflicts arising from medical decisions. Resolution of value-conflict in the clinical setting 
requires not only attention to societal and cultural differences, but also sensitivity to the 
communication needs of the various parties involved, as well as awareness of the barriers 
to communication which may thwart the process. In order to achieve this aim, the HEC 
or CEC must have in place a transparent process for the systematic review and analysis of 
information relevant to the decision at hand. 
One of the most important contributions made by ethics committees or consultants is to 
ensure that decision-making process is 
‘inclusive, educational, respectful of cultural values and supportive of institutional efforts at 
quality improvement and appropriate resource utilisation’ (Schneiderman, 2005, p.601). 
Although in fraught clinical environments it may not always be possible to meet all of these 
requirements, health professionals and practitioners must acknowledge them as a goal to 
aim for in the process of improving the quality of care.
Clinical ethics consultation can be structured in a variety of different ways, and can involve 
the use of a number of different procedures and tools (ASBH, 2009, p.16). Consultations can 
be provided by individuals, by small teams, or by entire ethics committees (Shelton and 
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h Bjarnadottir, 2008, p.72). The dominant model in the UK and Europe is the multidisciplinary 
committee, whereas individual consultants with specialist training are more common 
in the larger hospitals in the US and Canada, which have more frequent need for ethics 
consultations, often on an urgent basis. 
Multidisciplinary collaboration and the ability to accommodate a plurality of perspectives are 
essential to the effective functioning of any ethics service, regardless of whether the service 
is provided by an individual or by a team. Although to date no one method for conducting 
ethics consultation has been universally adopted, there is widespread agreement that ethics 
facilitation is the most appropriate general approach for ethics consultation (Sheldon and 
Bjarnadottir, 2008, p.56; Zaner, 2007). 
The two goals of ethics facilitation are:
1. the identification and analysis of the nature of value uncertainty and
2. the facilitation of consensus between the parties involved 
(Aulisio, Arnold and Younger, 2000, p.60-61). 
In contrast to a more authoritarian form of decision-making by ethical ‘experts’, ethics 
facilitation rests on an open-ended approach which requires that the building of consensus 
be an inclusive process, in which all parties have a voice. This approach is based on the 
recognition that societal values, law and institutional policy all have a bearing on what can 
count as a morally-acceptable consensus (Aulisio et al., 2000, p.61).
The American Society for Bioethics and Humanities describe the tasks associated with ethics 
consultation as (2009, p.77-8):
•	 Effective navigation of the clinical setting in order to perform the various tasks demanded by  
ethics consultation
•	 Collection of information (a multi-part task utilizing the medical records and carrying out 
appropriate interviews) and assessing the appropriateness of the case for ethics consultation 
•	 Determination of whether the case falls within the scope of the ethics consultation service (the case 
must be referred to an appropriate resource if deemed outside the scope of ethics consultation.) 
•	 Evaluation, interpretation and analysis of the information. 
•	 Fostering communication between the parties to the consultation or facilitating a meeting of 
the principal parties and an understanding of each perspective; assessing options for moral 
acceptability; and assisting the parties to identify and think through ethically acceptable options. 
•	 Promoting implementation of an ethically acceptable plan of action by identifying responsibilities, 
documenting agreements and points of consensus the principals achieve in the meeting and/or 
documenting recommendations or ethically acceptable options. 
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4.5 Competencies for Clinical Ethics Consultation 
The principal goal of the American Society for Bioethics and Humanities task force report 
of 1998 was the improvement of the quality of clinical ethics resources in the US. The 
report documented the minimum training requirements and skills for those providing 
clinical ethics advice, drawing a distinction between the knowledge required for ethics 
consultation and the skills needed to conduct ethics consultation. The knowledge required 
for ethics consultation includes a broad familiarity with the concepts and issues of bioethics 
as a discipline, familiarity with the clinical context as it relates to ethics consultation, 
familiarity with the systems, policies and practices of the healthcare institution in which the 
consultation takes place, knowledge of relevant codes of ethics and professional practice 
guidelines and, finally, familiarity with local health law (1998, p.20).
The report lists three categories of skill needed for ethics consultation, ‘ethical assessment 
skills’, ‘process skills’ and ‘interpersonal skills’, and distinguishes between ‘basic’ and ‘advanced’ 
skills in each of these categories. 
•	 Ethical assessment skills form the basis for identifying the value uncertainty or conflict 
which underlies the request for consultation. These skills include the ability to distinguish 
the properly ethical aspects of the situation from other aspects (legal, medical, 
psychiatric), the ability to identify the assumptions underlying the positions of the 
various parties involved (e.g., assumptions about value or quality of life), and the ability 
to clarify concepts and issues relevant to the case discussion (ASBH, 1998, p. 13). 
•	 Process skills are needed in order to resolve the value uncertainty or conflict, and these 
include the ability to identify key decision-makers and include them in discussions, to 
create an atmosphere of trust in which participants feel free to express their concerns, to 
help individuals analyse the values underling their positions, and to negotiate between 
competing moral perspectives (ASBH, 1998, p.14). 
•	 Interpersonal skills are crucial for every aspect of ethics consultation, and include the 
ability to listen well, and to communicate interest, respect, support and empathy to the 
involved parties, the ability to elicit the moral views of the respective parties, the ability 
to enable the involved parties to communicate effectively and be heard by other parties, 
and the ability to recognise and transcend barriers to communication.
Individuals from a variety of academic and health-related backgrounds can be trained 
to develop the competencies necessary to become ethics consultants (Sheldon and 
Bjarnadottir, 2008, p.55). What primarily differentiates the approach of a qualified ethics 
consultant from that of an untrained layperson is the understanding and use of a method 
or framework for the systematic collection and analysis of information in the resolution of 
difficult ethical cases (Sheldon and Bjarnadottir, 2008, p.56). 
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4.6 Tools for Collection and Analysis
Examples of such frameworks include the following Case Analysis Tool developed by 
Christine Harrison, Clinical Bioethics Service, Hospital for Sick Children, Toronto: 
4.6.1 Harrison’s Case Analysis Tool
1. Clearly articulate what the problem is.
2. Gather and consider all relevant information, both medical and non-medical (see ‘Four-
box’ method below)
3. Identify the various courses of action possible, collaborating with colleagues where 
possible.
4. Identify the appropriate decision-makers and those who should participate in the 
decision-making process
5. Identify the various values and ethical principles associated with each alternative. 
Remember that individuals’ value-systems may vary radically.
6. Consider the consequences of each alternative – including probable harms and benefits 
and who will be affected. 
7. Select the best – or the ‘least bad’ – course of action.
8. Implement the action, and review the outcome.
4.6.2 Dubler and Liebman’s Guidelines
have formulated a related set of guidelines for ethics mediation in the clinical setting  
(Shelton and Bjarnadottir, 2008, p.72):
1. Understand the stated and latent interests of the participants
2. Level the playing field to minimise disparities in power, knowledge, skill and experience
3. Help the parties define their interests, search for common ground and maximise options 
for conflict resolution
4. Ensure that the consensus is justifiable as a principled resolution compatible with ethical 
principles and legal rights.
4.6.3 Jonson, Siegler and Winsdale’s ‘Four-Box’ method
Jonson, Siegler and Winsdale (2006), the ‘pioneers’ of clinical ethics, have developed a 
comprehensive method for gathering information prior to conducting clinical ethics 
consultation. These four categories of question have become known as the ‘four-box’ 
method:
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Medical Indications (principles of beneficence 
and nonmaleficence)
Patient Preferences (principle of autonomy)
•	 What is the patient’s medical problem? History? 
Diagnosis? Prognosis?
•	 Is the problem acute? Chronic? Critical? Emergent? 
Reversible?
•	 What are the goals of treatment?
•	 What are the probabilities of success?
•	 What are the plans in case of therapeutic failure?
•	 In sum, how can this patient benefit from medical/ 
nursing/ psychiatric care, and how can harms be 
avoided?
•	 Is the patient mentally capable and legally competent? 
Is there evidence of incapacity?
•	 [If competent,] what treatment preferences is the 
patient stating?
•	 Has the patient been informed of benefits, risks, 
understood this information, and given consent?
•	 If incapacitated, who is the appropriate surrogate? Is 
the approved surrogate using appropriate standards 
for decision-making?
•	 Has the patient expressed prior preferences (e.g., an 
advance directive?)
•	 Is the patient unwilling or unable to cooperate with 
medical treatment and care? If so, why?
•	 In sum, is the patient’s ethical and legal right to 
autonomous choice being respected to the fullest 
possible extent?
Quality of life (principles of beneficence, 
nonmaleficence, respect for autonomy)
Contextual features (principles of justice/
fairness)
•	 What degree of functional impairment is the patient 
experiencing? 
•	 What are the prospects, with or without treatment, 
for a return to a normal life?
•	 What physical, mental and social deficits are likely to 
result if treatment succeeds?
•	 Are there biases which might prejudice the 
provider’s evaluation of the patient’s quality  
of life?
•	 Is the patient’s present or future condition such 
that his or her continued life could be considered 
undesirable?
•	 Is there any plan or rationale to forego treatment?
•	 Are there any plans for palliative or comfort care?
•	 Are there family issues which might influence the 
patient’s treatment decisions?
•	 Are there provider issues – e.g., disagreement between 
doctors and nurses – which might influence treatment 
decisions?
•	 Are there financial and economic factors involved?
•	 Are there religious or cultural factors involved?
•	 Are there limits to confidentiality?
•	 Are there problems of resource allocation?
•	 How does the law influence treatment decisions?
•	 Is clinical research or teaching involved?
•	 Is there any conflict of interest on the part of providers 
or the institution?
411
Mo
du
le 
8 
Et
hic
al 
Go
ve
rn
an
ce
 in
 C
lin
ica
l C
ar
e a
nd
 R
es
ea
rc
h
4.7 Reasons for Consultation
Healthcare provision is fraught with ethical difficulty and requests for ethics consultations 
are ‘triggered’ by a wide variety of situations. In the course of meeting the day-to-day needs 
of patients, health professionals encounter numerous situations which may prove ethically 
challenging or troubling, and which, if unacknowledged, may result in moral distress, 
burnout or compassion fatigue on the part of the individual health professional. The need for 
formal clinical ethics support may express itself in a number of different ways, including the 
following:
1. It may emerge as a result of conflict between the healthcare team and the patient or 
member of the patient’s family during the course of the routine provision of care.
2. It may arise from disagreements between members of the healthcare team concerning 
the nature of the treatment provided or the manner in which it is provided.
3. It may issue indirectly from flawed or short-sighted management strategies, which 
can leave individual health professionals feeling unsupported or unheard, resulting in 
symptoms associated with moral distress, burnout and compassion fatigue.
4. It may arise as a response to the culture of the organisation, in the form of unease with 
decisions taken at the executive level and their implications for the quality of  
patient care.
4.7.1 Kinds of Issues
Historically, hospital or clinical ethics committees were consulted primarily in relation to 
issues such as the withholding or withdrawing of treatment, competent refusal of treatment, 
advance directives and DNR (Do Not Attempt Resuscitation) orders, in addition to problems 
involving capacity, consent and confidentiality. In recent years, however, the focus of these 
committees has shifted to issues of communication, negotiation and mediation. 
A number of recent surveys have examined the need for ethics support in the clinical 
context and the kinds of situation in which ethics consultations are requested. In 2001, a 
survey of 344 physicians across the US found that the most common factors underlying 
physician requests for ethics consultation were: the need for help in resolving conflicts, the 
need for assistance in dealing with difficult family members, the need for support in making 
treatment decisions and, finally, ‘emotional triggers’ (Du Val, Sartorius, Clarridge, Gensler, and 
Danis, 2001, p.i28). 
To the ‘traditional’ list of skills expected of an ethics consultant – the ability to identify and 
analyse ethical problems, the use of reasonable clinical judgement, communication and 
educational skills and the ability to facilitate negotiation – Du Val and colleagues added the 
skill of conflict ‘or even crisis’ resolution in emotionally-charged situations (Du Val et al., 2001, 
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(2001), they must also be ‘adept’ at identifying the particular needs of the individual health 
professional.
 ‘The ethicist must do more than grasp the clinical situation and analyse it from an ethical 
standpoint. The factors that trigger a consultation request must be clearly identified so that they 
can be properly addressed.’ (Du Val et al., 2001, p.i29)
Du Val et al. concluded that the increasing frequency with which physicians appeal to ethics 
consultants to mediate conflict suggests that the earlier intervention of ethicists in difficult 
situations might serve to reduce conflict (2001, p.i29). Similarly, Arnold and Wilson Silver 
argue that an understanding of the process by which conflicts arise and are resolved – basic 
knowledge about group process, mediation and conflict resolution – should form part of the 
training of every ethics consultant (2003, p.73).
Goals of Ethics Consultation
In the first major study to explore how ethics consultation is conducted in hospitals across 
the US, the following were ranked in order of prevalence as the primary goals of ethics 
consultation (Fox, Myers and Pearlman, 2007, p.16).
•	 Intervening to protect patient rights
•	 Resolving real or imagined conflicts
•	 Changing patient care to improve quality
•	 Increasing patient or family satisfaction
•	 Educating staff about ethical issues
•	 Preventing ethical problems in the future
•	 Meeting a perceived need of a staff member
•	 Providing moral support to a staff member
•	 Suspending unwanted or wasteful treatments
•	 Reducing the risk of legal liability
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4.8 Evaluation of Ethics Consultation
The ASBH Task Force report emphasises the need for evaluation of ethics consultation 
at three levels: the competencies of those who conduct consultations, the process of 
consultation itself and the outcomes of consultation (ASBH, 1998, p.27). The report 
acknowledges that a major impediment to the evaluation of the outcome of ethics 
consultation has been the lack of specification of the goals of consultation, but suggests that 
the success of the consultation can be determined by answering the following questions:
•	 Was there a consensus?
•	 Was the consensus within the boundaries set by societal values, law and  
institutional policy?
•	 Was the consensus implemented?
•	 What was the level of satisfaction among participants?
4.9 Ethics Committees: Concerns and Challenges
As clinical ethics services become more prominent in healthcare provision, the role played by 
HECs or CECs has come under increasing scrutiny. 
Concerns include:
•	 Concerns about the legitimacy of the recommendations made by clinical ethics 
consultation services
•	 Concerns about the qualifications and expertise which give the CEC authority to issue 
recommendations (Fiester, 2007, p.31)
•	 Concerns about a lack of standardisation in relation to the objectives and terms of 
reference of HECs and CECs
•	 Concerns about the need for ethics education and further training of CEC members
•	 Need for more information about the efficacy of the CEC in improving the moral quality 
of decision-making within healthcare institutions (van der Kloot Meijburg and ter 
Meulen, 2001, p.i39)
•	 Concerns about the lack of regulation and the need for accreditation of CECs
•	 Concerns about committee liability
•	 Demand for patient representation on HECs and CECs
While empirical research observing or measuring the efficacy of clinical ethics committees’ 
discussion of difficult cases is rare (Pedersen, Akre and Forde, 2009, p.147), a series of recent 
studies conducted by Schneiderman and colleagues claim to show that clinical ethics 
consultation is effective in reducing hospital days, hospital costs and ventilator days in the 
ICU (Schneiderman, Gilmer and Teetzel, 2000; Schneiderman, Gilmer, Teetzel et. al., 2003; 
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of the effectiveness of HECs in changing behaviour in the North American context (Slowther, 
Hill and McMillan, 2002). Fletcher and Hoffmann (1994) argue that, before granting ethics 
committees additional authority, 
‘there is a need for more research on their performance and a period of experimentation with 
quality standards governing their membership and operations’ (p.335). 
In their 2002 study, Slowther et al note a concern amongst health professionals that an 
interest in ethics on the part of its members does not provide the HEC with sufficient 
qualification to wield the ethical authority it has within the institution in which it functions, 
despite a perceived need for some form of clinical ethics support (2002, p.5). This is linked to 
a doubt that committee members who themselves lack formal training in ethics can provide 
a credible education for health professionals. However, Slowther et al. point out that the 
existence of a HEC within a healthcare institution does not imply that health professionals 
themselves lack the expertise to make ethical decisions, but rather, that the principal 
function of a HEC is to provide a forum to assist health professionals in thinking through and 
reflecting upon the decisions they make (2002, p.5). 
What health professionals lack is not ethical expertise, but decision-making support. Any 
moral credibility or authority wielded by a HEC within a healthcare institution would be 
derived from its balanced consideration of a variety of points of view and the fairness and 
transparency of its processes (2002, p.6). Similarly, Williamson et al. concur that the results of 
studies designed to determine the ‘success’ of ethics consultation are ‘mostly moot’, but point 
out that the use of resources by healthcare organisations to address ethical conflicts within 
the institution 
‘plays an important role in increasing public and institutional confidence in clinical decisions’ 
(Williamson et al., 2007, p.3). 
Further, even though the question of the effectiveness of HECs in the US has not been 
definitively answered, the establishment of a HEC can lead to a reduction in the acute stress 
often experienced by health professionals involved in difficult treatment decisions, by giving 
them the opportunity to share the load (Slowther et. al., 2002, p.7). 
Repeated again and again in the literature on ethics committees is the necessity of the 
support of institutional leadership for the work of the committees (van der Kloot Meijburg 
and ter Meulen, 2001, p.i38-39; Pearson, Sabin and Emanuel, 2003; Gibson, 2007, p.33). Given 
its lack of legal standing, 
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become firmly grounded in the organisation’  
(van der Kloot Meijburg and ter Meulen, 2001, p.i38-39). 
Similarly, Moreno argues that mechanisms must be put in place to define and promote the 
moral climate of the healthcare organisation, with the ethics committee as ‘one action arm’; 
‘[I]f the organisation as a whole isn’t committed to this effort, no ethics entity can rise above 
benign neglect.’ (Moreno, 2006, p.369)
Management helps to legitimise the role of ethical consultation and awareness-building 
within the hospital by providing for it and integrating it with hospital policy and services, and 
this support from management should be made visible by its providing the committee with 
training programmes and promoting the continuing education of its members (van der Kloot 
Meijburg and ter Meulen, 2001, p.i39). 
Slowther et al point out that if an ethics committee is to change practice within an 
institution, it needs to be seen as having authority within that institution, yet if it is seen as 
too close to the management structure of the institution, health professionals may see it as 
a regulatory or monitoring body and be reluctant to approach it. For this reason, a ‘delicate 
balance’ needs to be struck between being aligned closely enough with management to be 
respected, and being distant enough from management to remain autonomous within the 
institution (Slowther et. al., 2002, p.9). 
In some cases, the complexity of the role played by the ethics committee may result in the 
allegiance of the committee becoming divided: confusion may arise as to whether its primary 
objective is to facilitate and promote high quality moral standards in the delivery of care, or 
to provide policy advice which will minimise the risk of litigation or adverse publicity to the 
institution (2002, p.8). What is crucial is that the organisational climate must be such that the 
committee can perform its work with authority in an environment free of concerns about job 
security, reprisals and undue political pressure. 
Senior administrative personnel should anticipate that ethics consultation is inherently a 
controversial, potentially divisive and sometimes personally uncomfortable activity, and 
should ensure that the ethics committee can function without comprising its integrity (Miles 
and Purtillo, 2003, p.125). To demonstrate this support, the ethics service should be written 
into the institution’s governance documents, and the chair of the committee should be 
accountable in that role to a senior-ranking administrator, such as a vice-president or director 
of nursing or medical staff (Miles and Purtilo, 2003, p.122).
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commentators that institutional support is central to the success of ethics consultation 
services points to a further aspect of the concept of ethical governance: the internal ethical 
climate of the healthcare organisation itself. The attempt to create organisations which are 
ethical in character is known as organisational ethics (see Further Discussion section).
4.10 CECs in Ireland: The Current Situation
At the time of writing, there are at least ten functioning CECs in the Republic of Ireland. 
In Dublin, Beaumont Hospital has a clinical ethics forum and Our Lady’s Hospital for Sick 
Children, Crumlin, and the Mater Hospital have clinical ethics committees. The Bon Secours 
Hospital, the Daughters of Charity and the Sisters of Charity of Jesus and Mary all have 
clinical ethics committees. Wexford General Hospital has a newly-established ethics advisory 
committee, while the Mid-Western Regional Hospital in Limerick has an ethics committee 
which provides both research ethics and clinical ethics oversight. In Cork, the Mercy 
Hospital has an ethics committee and the University Hospital has an ethics forum. Most of 
these committees meet on a quarterly basis and have an average membership of between 
nine and thirteen members from a range of backgrounds. Most committees have been 
in existence for approximately four years, although the establishment of the Bon Secours 
clinical ethics committee dates back to 1989. 
The composition and terms of reference of these clinical ethics committees vary from 
institution to institution, although they have much in common. Generally speaking, these 
committees see their role as advisory. The Cork University Ethics Forum was established in 
2002 to provide support, consultation and clarification in relation to ethical issues arising 
from healthcare practice. It also provides education on issues in healthcare and guidance 
in the development of protocols and procedures. Likewise, the ethics committee of the 
Daughters of Charity, founded in 2006, provides education, policy advice and guidance on 
ethical issues arising in the course of providing patient care. The clinical ethics committee 
of the Mercy University Hospital, founded in 2006, serves as a referral facility and an ethics 
information resource for hospital staff. Its members facilitate ethics education within the 
hospital, assist in the development of ethical guidelines and provide a consultation service 
where appropriate. Established in 2006, the Beaumont Clinical Ethics Forum functions as an 
advisory body in relation to ethical issues arising in the course of providing care, and it also 
produces educational pamphlets dealing with ethical matters
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5. Research Ethics Committees (RECs)
5.1 Aims of Research Ethics
The initial purpose of identifying ethical principles to govern the conduct of biomedical 
research was to ensure that research participants or subjects are protected from exploitation. 
One of the earliest sets of guidelines for the ethical conduct of research was the Nuremberg 
Code of 1947, developed to prevent the reoccurrence of atrocities committed in the name 
of medical research by Nazi physicians during the Second World War (Anon., 1996). Like 
the Nuremberg Code, the Declaration of Helsinki (World Medical Association, 1964, 1975, 
1883, 1989, 1996, 2000, 2002, 2004, 2008) emphasised the protection of subjects and 
the importance of obtaining informed consent for research. The Council for International 
Organizations of Medical Sciences (CIOMS) guidelines (1982) and later revisions of the 
Declaration of Helsinki (World Medical Association, 1964, 1975, 1883, 1989, 1996, 2000, 
2002, 2004, 2008), stressed the need to extend this protection to research participants in 
developing countries. 
Biomedical Research on Human Subjects Requires Ethical Regulation 
•	 because of its inherent potential for the exploitation of vulnerable persons
•	 because the frequency of past abuses necessitates the ongoing oversight of research 
involving human subjects
•	 because conducting research with human participants is a privilege grounded in trust, 
and for this reason investigators have ethical obligations to research participants, 
however low-risk the research study may seem
•	 because the increasing prominence of, and expenditure on, research in the biosciences 
imposes stricter demands for responsibility and transparency in the conduct of research
•	 because advances in the field of new biotechnologies such as stem cell research, human 
germline genetic modification and nanotechnology have generated novel ethical 
challenges which must be addressed.
5.1.1 Belmont Report (1979)
The publication of the Belmont Report in 1979 by the National Commission for the Protection 
of Human Subjects of Biomedical and Behavioural Research drew attention to the need for 
the regulation of research involving human participants, and listed three principles which 
should for the basis for all such research: 
1. respect for persons 
2. beneficence 
3. justice 
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The Belmont Report called for the creation of local oversight bodies charged with reviewing 
the ethical issues arising in research involving human subjects. In the US, Institutional 
Research Boards (IRBs) came into existence to satisfy federal sponsors that human beings 
were not inappropriately subjected to harm or exploited during the course of their 
involvement in research (Murphy, 2008, p. 217). 
The fact that guidelines such as the Belmont Report and the Declaration of Helsinki lacked 
legal authority, although they possessed significant moral authority, led to the creation of 
legislation designed to protect subjects participating in clinical trials, such as 
1. Title 45 of the US Department of Health and Human Services’ Code of Federal Regulations 
(United States Department of Health and Human Services, 2005) and,
2. The EC Clinical Trials Directive (2001)
Both pieces of legislation mandate the independent review of all clinical research protocols 
by committees whose members have no affiliation with the research. This legislation also 
reflects an awareness at both national and international levels of the need for regulation to 
keep pace with advances in biomedical and biotechnological research. 
5.1.2 Clinical Trials Directive (2001)
The main aim of the Clinical Trials Directive (2001) is to standardise and streamline the 
research ethics application process, while enshrining in law the subject protections codified 
in the Declaration of Helsinki and the Belmont Report. The Directive has recently been 
transposed into law in all EC member states, including Ireland. Under European law, each 
member state must have in place a system of research ethics committees (RECs) charged 
with ensuring that any clinical research carried out in that state meets the requirements 
set out in the Clinical Trials Directive. The primary purpose of RECs is to review research 
protocols in order to determine their ethical acceptability. In its Operational Guidelines for 
Ethics Committees, the World Health Organisation (WHO) defines the role of research ethics 
committees as contributing to 
‘safeguarding the dignity, rights, safety, and well-being of all actual or potential research 
participants (WHO, 2000, p.1). 
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5.2 Research Ethics in the UK
RECs were set up across the UK to review the ethical issues arising from research conducted 
within the National Health Service. The Department of Health has mandated that all research 
involving NHS patients or NHS resources must receive REC approval prior to commencement 
of the research. The role and conduct of RECs in the UK is closely regulated, and is the 
responsibility of the relevant Strategic Health Authority. A central co-ordinating office 
for RECs was established to issue guidance and facilitate the provision of training for REC 
members (Slowther et. al., 2004a, p.9). 
5.3 Research Ethics in Ireland
Approximately 72 RECs have been identified in the Republic of Ireland. There is considerable 
variation in the size, function and level of activity of the different RECs. According to a recent 
study of research ethics committees in Ireland commissioned by the Health Service Executive 
(HSE), the number of submissions received in 2006 by the committees surveyed ranged from 
0 to 278, with a median of 36.5 applications (HSE, 2008, p.42). Most RECs reviewed between 
11 and 50 applications in 2006, with an average time period of 21.7 days between protocol 
submission and committee response (HSE, 2008, p.48). Only 60% of RECs had drawn up 
standard operating procedures for the review of research protocols, and only 13.3% had a 
dedicated budget for the education and training of members (HSE, 2008, p.42).
According to the Irish Council for Bioethics; RECs should comprise of members who are 
drawn from a broad range of disciplinary backgrounds in order to maximise the breath of 
their expertise. They advise that REC membership should include (2004, p.10):
•	 Member(s) with knowledge of and current experience in the areas of research which are 
regularly considered by the REC (e.g., scientist).
•	 Members with knowledge of and current experience in the professional care, counselling 
or treatment of people (e.g., nurse, medical practitioner, clinical psychologist, as 
appropriate)
•	 Member(s) with training in ethics (e.g., ethicist, philosopher, theologian)
•	 Member(s) with training in law
•	 Member(s) with training in statistics
•	 Lay member(s)
However, the HSE study found that, whereas the vast majority of RECs in Ireland have a legal 
representative, a medical doctor, a nurse and a lay person on the committee, few committees 
have a statistician or an ethicist available to them (HSE, 2008, p.38). 
Activities requiring REC review include the following (Irish Council for Bioethics, 2004, p.8):
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2. Trials of new treatment or interventions
3. Research involving human remains, cadavers, tissues, discarded tissue (e.g. placenta) or 
biological fluids
4. Physiological studies
5. Comparison of an established procedure – whether therapeutic, non-therapeutic or 
diagnostic – with other procedures which are not recognised as established
6. Innovative practices in health and disability services
7. Research conducted by students, including all activities which meet the definition of 
research with human participants
8. Observational clinical research
9. Research requiring access to personal information by means of questionnaires, 
interviews or other techniques of information gathering
10. Research involving the secondary use of data (use of data not collected for that research 
purpose), if any form of identifier is involved and/or if health information pertaining to 
individuals is involved
11. Case studies, when a series of subject observations ‘allow possible extrapolation or 
generalisation of the results from the reported cases and when there is an intent to 
publish or disseminate the data’.
The HSE report concluded that (2008, p.49):
•	 Overall, there is great commitment to, and participation in, RECs in Ireland
•	 What was found to work well, where they existed, were standardised application 
forms, standard operating procedures (SOPs), reliance on available expertise, feedback 
mechanisms and adequate resources
•	 Those areas in need of improvement include the development of standardised national 
application forms and SOPs
•	 There is a need for a resource of expert opinion which can be accessed by RECs when the 
need arises
•	 Training and administrative resources are inadequate
•	 There is a need for improved communication on several levels
•	 There is a need for the development of a knowledge network for research ethics
•	 Participants strongly suggested the need for a central national resource to coordinate 
and support some of the suggested improvements. 
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5.4 Principles for the Ethical Conduct of Research
While the Clinical Trials Directive provides general guidance in relation to the constitution, 
role and function of RECs, it provides little detail in relation to the complex ethical concerns 
generated by clinical research. Emanuel, Wendler and Grady (2000) have proposed a  
checklist of seven requirements which all clinical research must meet if it is to be considered 
ethically sound:
1. Social or scientific value. The proposed research must have social, scientific or clinical 
value, i.e., the intervention or study must have the potential to lead to improvements 
in human health or well-being or to increase knowledge through the dissemination of 
results (2000, p.2703).
2. Scientific validity. In order to avoid exploiting subjects and wasting resources, the 
research must be carried out in a methodologically rigourous manner; the study must 
be soundly designed, feasible and unbiased, with a valid hypothesis, a clear scientific 
objective and a plausible data analysis plan (2000, p.2704). In clinical research which 
compares different therapies, there must be at the outset a genuine lack of consensus 
within the scientific community as to whether or not the new intervention is more 
effective than the standard therapy. This is known as ‘clinical equipoise’ (2000, p.2704). 
3. Fair subject selection. The determination of inclusion and exclusion criteria and 
recruitment strategies for the study must be based on the scientific goals of the study, 
not on arbitrary factors such as social status (vulnerability or privilege) or convenience. 
•	 Subjects should be selected in a way which minimizes risk and enhances benefit both to 
individual subjects and to society (2000, p.2704). 
•	 Participants who are at greater risk of harm through participating in the study should be 
excluded, although no groups or individuals who could benefit from participation should 
be excluded without good scientific reason. 
•	 Those who accept the risks and burdens of research should be in a position to avail 
of its benefits, and subjects who will not benefit should not assume the burdens of 
participation so that others may avail of the benefits.
•	 Both the benefits and the burdens generated by participation in the study should be 
distributed as fairly as possible.  
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only limited knowledge is available, there is often great uncertainty about the degree of 
risk or benefit associated with participation. In these circumstances, clinical research is 
justifiable only if, 
•	 the potential risks to individual participants are minimized; 
•	 the potential health-related benefits to individual participants are maximised; and, 
•	 the potential benefits to both individual subjects and to society outweigh the risks. 
•	 The probability and severity of the risk must be proportionate to the benefit involved. 
•	 Assessments of risk and benefit should rely on explicit standards based on existing data.  
Where there is little probability of the individual subject receiving any direct benefit 
from the research, an evaluation of whether the benefit to society justifies the risk to the 
subject must be carried out (2000, p.2706).  
Research in which the risks outweigh the benefits cannot be justified because it contravenes 
the principles of nonmaleficence and beneficence by imposing harm on the subject.  
5. Independent review. Independent review of research protocols by persons unaffiliated 
with the research (generally research ethics committees or research ethics boards) helps 
to ensure the quality of the study and to rule out any potential conflicts of interest which 
could arise in the course of carrying out the study. Independent review promotes social 
accountability and assures members of the public that research participants will be 
treated ethically (2000, p.2706).
6. Informed consent. The purpose of the requirement that investigators obtain informed 
consent from subjects prior to enrolment in a study is to give the subject control over the 
decision to become involved in the research. Informed consent is closely linked to the 
idea of autonomy and indicates respect for the subject’s capacity to determine his or her 
own values, interests and preferences and to act on the basis of these values  
and interests.  
Informed consent presupposes that the subject has received accurate and adequate 
information about the nature, purpose and methods of the study and its risks, benefits 
and alternatives, has understood the relevance of this information and has made 
a voluntary and uncoerced decision to participate in the research (2000, p.2706). 
Persons with diminished decisional capacity have interests of their own and should not 
automatically be excluded from research which may benefit them directly or indirectly. 
Where a person is unable to provide informed consent, a proxy or surrogate may agree or 
refuse to participate in the research on the subject’s behalf, by trying to determine what 
the subject would have wanted had he or she not lacked capacity to decide. 
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investigator, but are owed respect as persons in their own right. Respecting participants 
involves a number of activities: 
•	 the subject’s personal health information must be kept confidential; 
•	 subjects must be permitted to change their minds and withdraw from the study at  
any point; 
•	 subjects should be provided with any additional information about the intervention or its 
effects which comes to light during the course of the study, and, 
•	 subjects should be continuously monitored for adverse reactions or changes in clinical 
status (2000, p.2707).
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6. Cases: CECs, RECs and Ethical Decision Making
6.1 Case 1: Ethics Consultation – Premature Neonate
 
Premature Neonate
A child lies in the neonatal intensive care unit of a local hospital, having been born twelve weeks 
premature. During delivery, the child suffered severe respiratory distress and had to be intubated 
and ventilated. An ultrasound scan performed shortly afterwards showed massive bilateral 
intracranial haemorrhage, with cortical extension. For three weeks, she has been on a ventilator, 
assisted by pulmonologists, cardiologists, neurologists and other specialists. She has dedicated 
nursing care, and her neonatologist visits the bedside daily. 
The doctors agree that there is no realistic hope that the child will survive intensive care. While 
avoiding absolute pronouncements, they try to explain to her parents that their daughter is 
not responding to treatment, that in all likelihood she will not live to leave the hospital, and 
that the treatment she is receiving involves considerable discomfort and pain. Her parents are 
young and distraught, and, believing that their child will recover, request that staff continue all 
aggressive treatment. 
Some of the nurses find this difficult, because they consider that the treatment is medically futile 
and simply prolongs the child’s suffering. When they ask their supervisor about the hospital 
policy on this issue, they are informed that there is no such policy. The doctors are confused 
about what ‘futility’ might mean in this situation, and are unsure whether or not they are legally 
and ethically bound to provide the treatment the parents demand. When they approach the 
parents about shifting to ‘comfort care’, the parents become confused and angry and accuse the 
clinical team of abandoning their child’s only means of survival. They insist that all aggressive 
measures continue. A team meeting is called and the hospital’s recently-appointed in-house 
ethicist is asked to provide an opinion about how to proceed.  
(Adapted from Hackler and Hester, 2008, p.1).
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6.1.1 Discussion 8
A case like this one, although not uncommon, is extremely difficult to resolve satisfactorily, 
and great care must be taken to be as inclusive as possible in the process of determining 
what should be done. A delicate balancing act is required if the ethicist is to ensure that 
all parties to the conflict are heard and validated. In clinical contexts, there is often a great 
variance of opinion about what constitutes ‘futile’ treatment: patients and families may often 
disagree strongly with health professionals on this issue. The bottom line is that there is no 
consensus in our society on this question, and intense negotiation is often the only way to 
resolve situations of this kind. Negotiation is not possible, however, if the confidence and 
trust of the parents are lost, or if the health professionals caring for the child end up feeling 
alienated. There should also be an awareness that concepts such as ‘value of life’ and ‘best 
interests’ may be defined in a number of different ways. 
To prepare for the meeting, the ethicist needs to study the patient’s chart and gather as 
much information as possible about the child’s medical condition and about her family from 
the doctors and nurses who have been looking after her for the past three weeks. She then 
needs to assess this information systematically, and recommend a process for arriving at a 
decision, for example, the process for decision-making identified at 4.6.1 above: 
Harrison’s Case Analysis Tool:
1. Clearly articulate what the problem is.
2. Gather and consider all relevant information (both medical facts and non-medical factors)
3. Identify the various courses of action possible, collaborating with colleagues where 
possible.
4. Identify the appropriate decision-makers and those who should participate in the 
decision-making process
5. Identify the various values and ethical principles associated with each alternative. 
Remember that individuals’ value-systems may vary radically.
6. Consider the consequences of each alternative – including probable harms and benefits 
and who will be affected. 
7. Select the best – or the ‘least bad’ – course of action.
8. Implement the action, and review the outcome, including the effects of the decision on 
the decision-makers.
1. Articulate the problem. What is the issue which needs to be resolved? What decision has 
to be made? Where is the conflict?
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h 2. Gather all relevant information: ‘Relevant information’ refers to any information which is 
needed to inform or enrich the decision-making process, including both medical and non-
medical facts. Medical facts include diagnosis, prognosis (and the estimated certainty of 
outcomes), health professionals’ past experience with the condition, and information about 
the organisation, such as relevant institutional policies, and relevant professional guidelines. 
Non-medical facts include information about the parents, family relationships, language 
barriers, cultural and religious beliefs, and the family’s past experiences with the health care 
system. In gathering information, it is vital to ascertain the parents’ understanding of the 
facts, their expectations of the technology involved, and the nature of the communication 
between the parents themselves.
3. Explore the available courses of action: This entails an explicit discussion of the range of 
treatment options available for the infant. This range of options is limited in two ways: 
a. parents may not refuse life sustaining measures which would be beneficial for their child, 
and 
b. health professionals are not obliged to provide medical interventions that would be non-
beneficial and harmful for the child. 
4. Identify decision-makers and participants: The decision lies primarily with the clinician 
but the opinion of parents should be included in all medical decisions. The lead clinician is 
responsible for surveying the available treatment options and proposing the options that 
are appropriate for that infant in her specific circumstances, for explaining the options to 
the parents, and for supporting the parents in a shared decision-making process. Those 
who should participate in the process are those who bear the greatest burden of care and 
conscience (the parents), those with special knowledge (the responsible clinician, relevant 
sub-specialists), and those with the most continuous, committed and trusting relationship 
with the patient and parents (members of the health care team directly involved in the care 
of the infant, extended family, religious leaders identified by the parents). 
5. Identify the values and principles associated with each alternative: 
All participants in the decision-making process need to take into account the professional 
and personal beliefs, values, and preferences of the decision-makers. 
Because the neonate’s perspective on the treatment she is receiving is unascertainable, 
the concept of her ‘best interests’ comes into play. Best interests are usually decided by 
considering the balance of burdens and benefits of treatment, within the context of the 
longer-range goals for the child. 
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the child is receiving and their obligation to promote the welfare of the child, while 
minimising harmful effects. This discomfort is significant in light of the fact that many health 
professionals who care for seriously-ill patients over a protracted period of time are prone to 
developing burnout or compassion fatigue. 
As her surrogate or proxy decision-makers, the child’s parents may not in this instance be 
impartial judges of what her best interests might be. However, what the parents are hoping 
for needs to be established and explicitly acknowledged by the health professionals caring 
for their child. 
The attending doctors must accept that no prognosis, however ‘certain’, is infallible, and 
that circumstances can influence the way patients or family members interpret the medical 
information they are given. As long as a patient can be seen to be breathing, family members 
can often remain in denial about the true nature of the patient’s condition. 
In situations of this kind, it is often the case that the parents are simply not ready, emotionally 
or psychologically, to accept the truth about their child’s condition. In this particular case, 
understandably, the distraught parents are unwilling to believe that there is ‘no hope’ for 
their daughter, and the reasons for this must be explored. If the basis for their belief that she 
will survive – or their unwillingness to discuss discontinuing treatment – is rooted in religion 
or in a religious interpretation of the principle of the sanctity of life, a chaplain should be 
invited to attend the case conference. If the basis for their belief is not religious, then the 
child’s medical condition and prognosis must again be discussed with them in a gentle and 
sensitive manner. 
Ensuring full parental comprehension may require a formal interdisciplinary case conference 
in order to identify and clarify what information has been and needs to be provided to the 
parents. This is best achieved without the parents present, but they should be aware of the 
meeting taking place and appraised of its conclusions. It should be made clear to the parents 
that, when guided by the best interests of the baby, withholding or withdrawing treatment 
does not mean to withhold or withdraw care; rather, it is to substitute another form of care 
for one which is judged not to benefit the child (Nuffield Council on Bioethics, 2006,  
[2.33], p.18). 
6. Identify the consequences: This requires a projection of the known and potential short- 
and long-term benefits and harms for each treatment option, including not just the medical 
consequences for the child, but also the psychological and emotional implications of each 
course of action for the principal decision-makers. 
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7. Select the best course of action. Once the values and perspectives of the various parties 
have been explored in a respectful and sensitive manner, and the available options and their 
implications investigated, the ‘least bad’ course of action should emerge from the decision-
making process. If the process has resulted in a consensus, this option may be implemented. 
(For discussion of a similar case, see Module 6, 6.4 Case 4: Withholding LPT in a Neonatal Unit 
– A Low Birth Weight Baby)
6.1.2 Suggested Professional Responsibilities 8
•	 A consensual decision-making process must be employed throughout. All participants 
should be invited to contribute to this process, with the common objective of achieving 
what is in the child’s best interests. A decision which respects parental authority and 
honours the clinicians’ commitment to promoting the child’s best interests can usually 
be achieved through a process of explanation, dialogue, and negotiation between the 
participants. Ultimately, all decision-makers must be in agreement with the plan of 
action proposed at the time, even though on occasion the agreement may be  
only temporary.
•	 The creation of an environment in which ethical issues and values can be thoroughly 
explored requires not only finding the appropriate physical environment for a formal 
meeting with the parents and whomever else they may choose to have present, but 
also an environment in which the responsible clinician creates an opportunity for 
open discussion. Additional, more private conversations between parents and the 
responsible clinician should be accommodated whenever possible. It is important not 
to overwhelm parents and family with the size of the group. 
•	 The participation and views of decision-makers should be documented. 
Documentation should also include who was present at the discussion, what was 
discussed, what was decided, which issues remain outstanding, and any plans for  
future meetings. 
•	 If, even after this process has taken place, consensus has still not been achieved, 
time should be allocated for further clinical observation, provided the child is not in 
discernible pain or otherwise compromised by the continuation of current treatment. 
The process should move as fast as the slowest participant in the decision-making 
group.
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•	 Health professionals should continue to discuss and explore with parents the 
underlying reasons for their disagreement. Early expressions of preference by parents, 
such as ‘do everything possible’ or ‘stop everything,’ need to be carefully and sensitively 
re-examined over time. 
•	 The cultural complexity of the decision-making process should be further explored. 
Practitioners must recognize that ethnic and cultural traditions, customs, and 
institutions inform parents’ beliefs and values, and that these influences may diverge 
•	 from the practitioners’ own value-systems. 
•	 Efforts to negotiate towards consensus should continue. The consensual nature of the 
decision-making process and the shared ‘burden’ of the decision must be reinforced. 
•	 The attention of senior management should be drawn to the need for a comprehensive 
institutional policy to provide guidance on end-of-life care in the NICU.
(Drawn from Clinical Bioethics Service, Hospital for Sick Children, Toronto [Harrison, 2008]):
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6.2 Case 2: Respecting the Dead – The Lost Baby
This is an unusual case, in which ethical concerns arise at a number of different levels. At 
issue is not harm done to a living being, but, rather, the question of the respect owed to a 
deceased neonate; given that no harm was done to the neonate while alive, what exactly is 
the responsibility of the hospital in this situation? In addition to the question of respect for 
the neonate, there is the more pragmatic question of how to disclose the error to the fragile 
and already distraught mother, and a further ethical concern relating to the DNA test, which 
was conducted without obtaining maternal consent. 
 
The Lost Baby
A neonate of 37 weeks’ gestation was delivered stillborn at a large community hospital, with 
an APGAR score of 0. An autopsy was scheduled to determine the cause of death. Customary 
practices in such situations included shrouding and tagging the neonate’s body. The distraught 
mother, who had had two previous miscarriages, requested that the neonate be dressed in the 
clothes she had provided for the cremation once the autopsy had been completed. Admissions 
were notified of the death and the neonate’s body was transported to the morgue in a bag by 
a porter, accompanied by security, again customary practise. Given that an autopsy was to 
take place, the neonate was not dressed and his clothes were sent to the morgue in a separate 
tagged bag. After the autopsy had taken place, the bags containing the neonate and his clothes 
were returned to the morgue, in identical bags of the same size, both bearing the same name 
and date. 
When the transport company contracted by the crematorium later came to collect the 
neonate’s body, they picked up the first bag bearing the correct name and date. The bag 
containing the neonate’s clothes was logged out and brought to the crematorium, where it 
was cremated, on the assumption that it contained the body. The bag containing the neonate’s 
body remained in the morgue for a further four weeks, until somebody finally noticed it during 
an inventory audit. When staff checked the name on the tag and consulted the records, it 
turned out that a body under that name had been logged out four weeks previously. A complete 
check of records had then to take place, to determine what had happened. 
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performed, and the results were matched against a snip of the neonate’s hair, which was 
covered in fluid from the mother’s birth canal. The lab analysis yielded a ‘highly probable’ 
match between the two samples. The crematorium was then contacted by the hospital and 
the director became livid when the mistake was explained. Instead of waiting for the hospital to 
approach the family, the  crematorium director disclosed the error directly to the mother’s sister, 
who had made the cremation arrangements. The sister insisted that the mother, a single parent 
with no local family support, be shielded from this new information. The memorial service for 
the neonate had not yet taken place and was scheduled for the following week. Nursing staff 
from the neonatal unit felt strongly that the mother deserved to be told the truth about what 
had happened to her child. 
The hospital CEO approaches the in-house ethicist and wonders how the hospital should 
respond to the situation
6.2.1 Discussion 8
The situation is a difficult one to classify, since the usual categories pertaining to disclosure of 
unanticipated outcomes – adverse event, medication error, system error, ‘patient protection 
event’, ‘environmental event’ – fail to capture what happened. The event is probably best 
defined simply as an error – the ‘failure of a planned action to be completed as intended’ 
(College of Nurses of Ontario, 2006).
Professional guidelines stipulate that, in all of the above kinds of situation, the patient 
or family must be informed of harm caused by negligence or human error. In this case, 
however, there was no ‘subject’ to whom harm was caused. Rather, expectations developed 
and articulated in the context of a highly sensitive and distressing situation were not met 
and procedures for the respectful disposal of human remains were not properly followed. 
The neonate’s remains ‘slipped through the net’ and there was no system of checks in place 
to ensure that the body was actually cremated. Neither the hospital nor the crematorium 
showed sufficient respect for either the neonate or the mother, and neither followed through 
on their obligations to ensure that the neonate was properly prepared for cremation. There 
was no continuity of care. The harm in this instance was symbolic, involving a violation of 
convention and a distortion of what we feel is the ‘right’ way to dispose of the dead. What 
complicates this case further is the fragility of the mother and the risk of adding to her 
distress by disclosing the error.
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Prior to arranging a meeting between the neonate’s family and representatives of the 
hospital, the ethicist must consider ethical issues that arise in relation to the patient and 
family as well as the organisation. 
Ethical issues that arise in relation to the patient and family include respect, fidelity, 
truthfulness, nonmaleficence and consent
Respect for persons: how should we think about the way in which persons are dealt with 
after death? Does the hospital owe anything to the neonate? What are its obligations towards 
the neonate’s mother? How desensitized do persons dealing with the dead become in their 
work environments? 
Fidelity (promise-keeping) and the ideal of patient-centred care: the mother was promised 
that the neonate would be dressed in his own clothes prior to cremation. She relied on the 
hospital to fulfil this promise and to ensure that the neonate’s body would be delivered intact 
to the crematorium. In a situation as sensitive as this, the failure to meet these expectations 
could cause enormous distress. Why were the mother’s wishes not respected?
Truthfulness: are we obligated to be truthful even in cases where the truth may be more 
harmful than continuing to maintain the illusion that nothing out of the ordinary has 
happened? From what does this obligation arise? Truth-telling is tied to the need to respect 
people as autonomous beings and observe their right not to be manipulated (this issue has 
been extensively discussed in Module 2).
Nonmaleficence: Can it be claimed that the hospital is obligated to respect the aunt’s 
request and shield the mother from further suffering? How will the news that her child lay in 
a plastic bag on the morgue floor for four weeks affect the mother? Is this desire to protect 
the mother motivated by paternalism or by a genuine concern for her well-being – or simply 
by an interest in defending the reputation of the hospital?
DNA testing without consent: Can the DNA test be justified, even though prior maternal 
consent was not obtained? Should any unexpected results have come to light in the 
course of conducting the analysis – e.g., information about a genetic disorder – was there a 
mechanism in place to disclose these new results to the mother, or to provide her  
with counselling? 
Ethical issues that arise in relation to the organisation can be considered in terms of the the 
benefits versus the risks of disclosure:
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Benefits: 
•	 From an organisational perspective, public confidence and trust in healthcare 
organisations is enormously important. It is widely acknowledged that transparency 
strengthens this covenant of trust between the healthcare organisation and the public, 
whereas the relationship would be seriously undermined if the organisation were seen to 
be acting in secret or attempting to cover up an error.
•	 Surveys have shown that handling disclosure properly minimizes damage to the patient-
provider relationship.
•	 Patients are often more disappointed that an error has been concealed from them than 
they are angry about the initial error.
•	 Cases involving disclosure are less likely to involve litigation than cases involving non-
disclosure.
•	 Disclosure provides an opportunity to re-examine practices and processes which may 
not have been recently reviewed, and to implement policies which may lead to an overall 
improvement in care. 
•	 An emphasis on transparency and disclosure can lead to a more open institutional 
culture and away from a culture of blame.
Risks: 
•	 Even greater distress and grief will be caused to the mother and family.
•	 Disclosure might lead to bad publicity, which in turn might lead to a loss of public 
confidence in the institution.
•	 The hospital might be sued.
Organisation’s Responsibilities:
•	 To strive for transparency in all aspects of its operation.
•	 To comply with the duty to disclose errors and unanticipated outcomes, since this is a key 
element of the patient safety movement. 
•	 To ensure that the organisation as a whole has a progressive attitude towards disclosure, 
and that senior leaders take responsibility for ensuring that health professionals and staff 
receive education in relation to disclosure.
•	 To improve processes and procedures by creating a policy, or revising an existing policy, 
with the aim of preventing the recurrence of such incidents. 
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What Should be Done?
The ethicist needs to set up a meeting between the crematorium director and 
representatives from hospital governance, nursing staff, the hospital morgue, risk 
management, patient safety and ethics services. It is important that the meeting does 
not turn into a finger-pointing exercise and that the morgue staff are not made to feel 
responsible for the incident: equal responsibility should be accepted by both institutions. 
The central question to resolve is the issue of whether and how to approach the neonate’s 
mother, and what mechanisms would need to be put in place to counter the damaging 
effect that the disclosure may have. Ultimately, if the hospital decides to disclose the incident 
to the mother, the necessity of providing support and counselling for her is as pressing as 
the question of whether or not to disclose (Ouellet, 2009). In addition to the organisational 
benefits of disclosure, in this case disclosing the truth to the mother might allow her to make 
alternative arrangements for the disposal of the neonate’s remains, and to hold a funeral 
service rather than a memorial service, which might provide her with closure.
What this and other cases of disclosure of unintended outcomes have in common is that 
truthfulness, respect and compassion must play a role in the way the situation is managed. 
More important than trying to explain the event itself, ascribe blame or defend the hospital’s 
position is empathising with the mother and enabling her to understand and come to terms 
with what happened. 
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6.2.2 Suggested Professional Responsibilities 8
•	 In organising the initial meeting, a great effort should be made to create an appropriate 
environment for discussion, and all perspectives must be explored in an open-ended, 
non-confrontational way, avoiding the impulse to ascribe blame and employing 
mediation techniques if necessary.
•	 It is important that the clinical ethics component in this case does not disappear 
behind the organisational ethics component. The ethicist should point out in 
unambiguous terms that, aside from its responsibility to society to pursue transparency 
(organisational ethics), the hospital has a responsibility to the mother – rooted in the 
duty of care (clinical ethics) – to disclose both the error itself and the fact that a DNA 
test has been performed without her consent. What remains to be determined is the 
timing and manner of the disclosure, and this requires a detailed discussion about 
the benefits and risks of disclosing information of this nature to someone in such a 
vulnerable condition.
•	 The neonate’s mother, or her sister, should receive a genuine apology from the hospital 
and a guarantee that every effort will be made to prevent a similar incident from 
happening in the future.
•	 Counselling should be offered to the mother to provide support in the aftermath of the 
disclosure.
•	 The hospital should commit itself to establishing a policy describing and clarifying 
procedures for the transferral of the bodies of patients who have died while in hospital.
Postscript:
In this complex case, the hospital decided to respect the wishes of the mother’s sister and 
did not disclose the incident to the mother. Hospital management made a commitment to 
creating a policy specifying procedures for care of the dead in the hospital and in the hospital 
morgue. The mother’s sister promised to disclose the event to the mother when she was 
strong enough to accept the news, and requested that the new policy be named after the 
neonate (‘____’s Policy’). The hospital agreed to this, and, during the course of ratifying the 
policy, the neonate’s story was retold several times. Each occasion was poignant and it was 
felt that the incident, although regrettable, had provided an opportunity for the hospital to 
review and improve the quality of care it provided. 
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6.3 Case 3: Research with Young People – Risking Suicide
Since many members of research ethics committees (RECs) receive little or no formal ethics 
education, they are increasingly turning to ethics consultants to help them to think about 
difficult ethical issues. Just as clinical ethics consultation fuses the expertise of the ethicist 
with that of the medical team, research ethics consultation requires a collaboration which 
unites the experience of the ethicist with the various kinds of medical or scientific expertise 
represented by the members of the research ethics committee. This collaboration is 
illustrated in the analysis of the following case:
.
 
Risking Suicide
Suicide among youths is a growing problem, with suicide the third leading cause of death 
among 10 to 24-year olds in the US (National Institutes of Health (NIH), 2009). Ireland has the 
highest youth suicide rate in the EU. Depression is a major risk factor for suicide in both youth 
and the general population. Standard clinical practice has been to treat depressed teens with 
antidepressants, even though most antidepressants on the market have not been approved 
for use in populations under 18. Whether the use of antidepressants in teens is associated with 
increased or decreased risk of suicide continues to be a matter of debate.
A clinical trial is now being proposed to determine the safety of a commonly-prescribed 
antidepressant in children and young people aged 12-17. Because there has been controversy 
regarding the relationship between the use of antidepressants and the risk of suicide, the 
investigators will treat suicidality as an outcome measure. The investigators define suicidality to 
include suicidal ideation, attempted suicide or death by suicide. Whereas most pharmaceutical 
clinical trials exclude patients who are at high risk for suicidality from participation, this trial 
proposes to include them. Investigators will randomize participants to one of four treatment 
arms: the drug under investigation (approved for adult use only), cognitive-behavioural therapy 
(CBT), the experimental drug combined with CBT, and a competitor drug – also approved for 
use in adults only which is widely used but has greater side-effects.
The hospital REC is uncertain about whether to recommend that the study be undertaken. Its 
members approach the hospital ethicist to help them resolve the issue. Should the study be 
approved with suicide as an outcome measure? If not, why not? If it is to be approved, what 
additional special protections should be put in place? (Adapted from James Dubois, 
2008, p.115-6)
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6.3.1 Discussion 8
In this case, given that the hospital has an in-house ethicist (as do many Canadian and some 
major US hospitals), she would also be a member of the hospital REC. As such, she would be 
in a position to educate the other members of the REC about the principles for the ethical 
conduct of research (5.4 above) and to supply information about the current legislative 
context, while the scientific and medical members of the REC would be responsible for 
interrogating the scientific evidence in favour of the study. It is then up to the committee as 
a whole to work together to think through the question of whether the proposed study is 
ethically acceptable, or whether it runs the risk of exploiting a doubly vulnerable  
patient population. 
The committee should devote special attention to the following ethical issues:
1. Social and Scientific Validity: 
A research study is valid if the research hypothesis has value for members of a particular 
group or for society at large, provided that the risks imposed on the participants 
are proportionate and do not outweigh the benefits of participation. It is an ethical 
requirement that those who bear the burdens and inconveniences of a given research 
study should be in a position to benefit from the research. It has also been argued that 
persons whose decision-making capacity may be impaired should not be summarily 
excluded from participation in research. Subject to certain restrictions, then, persons 
suffering from psychiatric disorders or lacking decisional capacity due to age or illness 
may be enrolled in research studies, provided that the risks are proportionate and that 
there is no other way of answering the research question than by studying the particular 
group in question.
Despite the public health and personal burdens associated with suicide, 
‘the empirically-validated knowledge base is limited and clinical wisdom and empirical evidence 
have minimal overlap when it comes to interventions with persons at high risk for suicidality’ 
(Pearson, Stanley, King and Fisher, 2001). 
This is because, among other factors, suicidal behaviours are relatively rare and often difficult 
to predict, making it difficult to conduct studies with statistically significant samples. Further, 
persons at high risk for suicide are frequently excluded from participation in clinical trials, 
and few trials are specifically designed to target people at high risk for suicide (Dubois, 
2008, p.116). Because pharmaceutical companies tend to be reluctant to fund ‘risky’ studies 
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this ultimately means that a group which could benefit greatly from research of this nature is 
being denied this benefit. 
 
Relationship of Risk to Benefit:
The EC Clinical Trials Directive permits research involving minors, provided that a certain ‘risk 
threshold’ is not exceeded (Article 4). However, the US Code of Federal Regulations (United 
States Department of Health and Human Services, 2005: Title 45, Part 46, Subpart D) is more 
stringent, distinguishing between four categories of risk in research involving minors:
i. research involving minimal risk, 
ii. research involving risk which is greater than minimal risk but offers the prospect of direct 
benefit to the subject, 
iii. research involving risk which is greater than minimal and has no prospect of benefiting 
the individual subject, but is likely to yield generalizable knowledge about the subject’s 
condition, 
iv. research not otherwise approvable but which provides an opportunity to ‘understand, 
alleviate or prevent a serious medical problem affecting the health or welfare of children’. 
(The same system of risk classification also protects prisoners and foetuses  
from exploitation). 
In the absence of a further set of conditions, parents may not consent to the enrolment of 
their children in research which promises no direct benefit to the child, unless the research 
is classified as presenting a ‘minor increase over minimal risk’. These standards are highly 
protective, and many commentators regard them as overprotective, serving ultimately to 
deny many children with chronic conditions, particularly psychiatric illnesses – the fruits of 
much-needed research. 
The reluctance on the part of pharmaceutical companies to conduct clinical trials involving 
minors with chronic illnesses has led to a practice known as ‘off-label’ prescribing: the 
prescribing for children of medicinal products licensed only for use on adult populations, 
since children were excluded from the clinical trials which tested the product. There are 
serious concerns about the safety and legitimacy of this practice. Tan and Koelch argue 
that the need to protect vulnerable participants from exploitation in research ‘has had the 
consequence of generating a lower standard of routine care for those very patients’, and 
they point to the need for research and clinical studies to reduce the high rate of ‘off-label’ 
medication use in minors (Tan and Koelch, 2008, p.2). 
In light of this, and given that the population involved in the above study are 
underrepresented in research, the trial in question is justified, provided that the risk-benefit 
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vulnerability of the study group as a whole. In this study, no-one is being denied a known 
effective treatment, and everyone is receiving some form of treatment. The experimental 
drug is already being prescribed off-label for children. If the research proved the drug safer 
than its competitor, or established the efficacy of the drug when combined with CBT, the 
benefits of the study would be significant. If the study has the support of the participants’ 
families, and if participants are carefully monitored, the risk of participation should not 
outweigh the benefits. This attempt to obtain the necessary knowledge while minimising the 
risk to participants is known as the principle of least infringement.
3. The Informed Consent Process:
Great care needs to be taken when designing the informed consent form. Under the 
Mental Health Act (2001), young people suffering from psychiatric illnesses are regarded 
as minors until they reach 18 years of age. Although their decisional capacity may well be 
fully developed, these young people – like younger children who are not yet capable of 
making mature decisions for themselves – require written parental consent if they are to 
participate in research. 
In order to make the decision-making process as inclusive as possible, a separate assent form 
should be designed for these young people, which explains in clear and non-patronising 
language the nature, purpose and potential risks and benefits of the study, and stresses 
the participants’ freedom to withdraw from the study at any time. Ideally, the decision to 
participate should be a joint decision made by the young person in conjunction with his 
or her parents. To ensure medication adherence, the consent form should emphasise the 
importance of parental support for the young person participating in the study. The need for 
close monitoring for indications of increased risk during the course of the study should also 
be emphasised. Participants should be supplied with contact numbers and encouraged to 
contact the investigators if they have further questions.
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6.3.2 Suggested Professional Responsibilities 8 
•	 The study should be allowed to proceed, subject to the implementation of the 
following safeguards, which are based on the principle of least infringement 
(Dubois, 2008, p.118-9). 
•	 All participants should be monitored closely for signs of increased suicidal ideation.
•	 Clear criteria – such as the experience of severe side-effects – should be established for 
the withdrawal of participants from the trial.
•	 Criteria should be established for ‘rescue treatment’, including the provision of 
emergency coverage and a protocol for hospitalization.
•	 Family involvement should be sought in monitoring for suicidality and in  
promoting compliance.
•	 The informed consent process should be modified to include additional efforts to foster 
decision-making capacity amongst participants, including younger participants.
•	 ‘Cross-over’ and stopping rules should be established (provision should be made for 
participants to switch from one treatment arm to another, depending on their response 
to the intervention). 
•	 Appropriate community consultation should shape the development and review of  
the protocol.
•	 Suicidality should replace suicide as an outcome measure. 
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7. Module 8 Further Discussion
7.1 Organisational Ethics and the Governance of Healthcare Organisations
During the course of the past decade, increased attention has been paid to the 
organisational or institutional backdrop against which ethical issues arise in healthcare. 
Ethical issues do not arise within a ‘vacuum’, yet hospital ethics programmes – where they 
exist – often tend to focus exclusively on specific decisions and behaviours, while the 
underlying ‘root cause organisational factors’ which influence these actions are frequently 
overlooked. Given that individual behaviours are particularly influenced by an organisation’s 
systems, processes, environment and culture, these larger contextual factors must also be 
taken into consideration (MacRae, Fox and Slowther, 2008, p.319). 
As Chen, Werhane and Mills (2007) observe, it is the healthcare organisation and its various 
subunits which provide the environment in which the interactions between patients, 
healthcare staff and family members take place. It is also the healthcare organisation which 
supports – or does not support – the values and beliefs of those interacting within it (Chen 
et al, 2007, p.S11). If there is no shared agreement about the purpose of a given system 
and the values it embodies, or if there is incompatibility between the beliefs and values of 
the individuals who make up the system, then ‘interactions within the system may become 
confused, counterproductive or even hostile’ (Chen et al, 2007, p.S12). For this reason, it is 
essential that both individuals and organisations respond effectively to ethical concerns 
(Veterans Health Administration, 2009, p.1). 
Rooted in an understanding of organisations as ‘systems’ and emerging from the field of 
business ethics, organisational ethics is a relatively new discipline concerned with the way 
in which the values which define an organisation are articulated, applied and evaluated by 
and within that organisation. Spencer, Mills, Rorty and Werhane (2000), describe this in terms 
of a focus on the ethical dimensions of organisations: their motives, the nature and quality 
of their actions and the effects of these actions (p.21). Organisational ethics is generally 
understood in terms of an organisation’s efforts to 
‘define its core values and mission, identify areas in which important values come into conflict, 
seek the best possible resolution of those conflicts, and manage its own performance to ensure 
that it acts in accordance with espoused values’ (Pearson, Sabin and Emanuel, 2003, p.32). 
As it applies to the healthcare industry, organisational ethics addresses the ethical issues 
arising from the intersection of the business, financial and management interests of 
healthcare provision (Spencer et al, 2000, p.5). Otherwise put, organisational ethics in 
healthcare is concerned with the ethical issues faced by managers and governors of 
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practices on patients, staff and the community  
(Gibson, Sibbald, Connolly and Singer, 2008b, p.243). 
With the emergence of a ‘more explicit market approach to medicine’, the ethical dimension 
of organisational behaviour in healthcare has become more visible in recent years (ASBH, 
1998, p.24), and the growing importance of hospital accreditation has made this more 
pronounced. Scrutiny of the way in which ethical issues are dealt with at both clinical and 
organisational levels is playing an increasingly prominent role in the accreditation process. 
Traditionally, conflicts arising from decision-making at the organisational level would have 
been addressed by healthcare organisations using the tools provided by business ethics; 
more recently, it has been recognised that a more nuanced approach is needed. With the 
increasing centralisation of the delivery and financing of health care and the emergence 
of cost containment as a national concern in many jurisdictions, ‘the intersection between 
bedside, community and boardroom has become inescapable’ (ASBH, 1998, p.24).
7.1.1 Organisational Ethics Issues
The kinds of issues which may be called organisational ethics issues include the following 
(Gibson, 2007, p.32-33):
•	 Resource allocation: in an era of increasing costs, limited resources, rising consumer 
expectations and demands for accountability, a fair process is needed to reach publicly 
defensible decisions about how resources are allocated, and to maintain trust among 
managers, staff, patients and the community at large. 
•	 Business development: healthcare organisations obtain funding from a number of 
sources, including business development, yet there is a concern that some business 
development opportunities may run counter to the organisation’s patient care mission, 
either directly or indirectly (renting floor space to fast-food outlets; increasing parking 
fees).  
•	 Fundraising and relationships with donors: the source of funding for healthcare 
organisations is coming under increased scrutiny; should charitable donations be 
accepted from tobacco or alcohol companies? Should individuals who have made 
large donations or their families receive preferential treatment or expedited access to 
treatment? 
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attitudes, turnover rates and absenteeism, and on the prevalence of moral distress and 
burnout among health professionals; in organisations in which staff feel respected and 
fairly treated by colleagues, they report higher quality of care ratings, increased job 
satisfaction and greater trust in management.  
•	 Institutional policy development: institution-wide policies governing controversial issues 
such as end-of-life care are needed to ensure consistency and continuity of care across 
the organisation, and to support health professionals and patients or families faced with  
difficult decisions. 
•	 Disclosure of error, risk and unanticipated outcomes: disclosure of error or risk is seen  
as an important part of the fiduciary (or trust-based) relationship between the  
healthcare organisation and its patients, and additional guidance and support are often 
required to enable health professionals to implement disclosure policies in ethically-
challenging situations.
7.1.2 Conflicts
Just as individuals can be held morally accountable for their actions, so too can organisations; 
the society to which the healthcare organisation belongs has justified expectations about 
how it should function, and these may be tacit or explicit, morally sanctioned or legally 
enforced (Spencer et al., 2000, p.20-1). 
Like individuals, organisations too can face conflicts of interest and commitment, particularly 
in situations in which organisational demands conflict with the organisation’s mission 
(Spencer et. al., 2000, p.143). This is particularly the case in the current market-driven 
climate, in which the provision of health care is now perceived as an industry, rather than 
as the meeting of a social need. Even a not-for-profit healthcare organisation needs to have 
sufficient capital to meet its operating costs and must be able to obtain funds to invest in 
new technology. A healthcare organisation committed to providing health care for a certain 
population is placed in a near-perpetual situation of conflict of commitment, because its 
resources will always be limited and therefore it will not be able to provide every kind of 
health care to each of its patients. A healthcare organisation which claims to serve patients 
first but prioritises profitability places itself, its managers, and often the professionals 
employed by it in a conflict of commitment (Spencer et al., 2000, p.143). 
These are conflicts of commitment rather than conflicts of interest because healthcare 
organisations are complex entities with multiple responsibilities, and tensions between 
these responsibilities are not uncommon (Winkler and Gruen, 2005, p.110). Every healthcare 
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invariably clash with the commitment to provide quality health care, even in organisations 
which explicitly prioritise patient care. Yet adequate health care is an intrinsic social good 
which human beings need in order to be able to flourish, and a prerequisite for normal 
societal functioning (Winkler and Gruen, 2005, p.114). 
Given this, businesses which provide health care bear special social responsibilities, 
irrespective of their profit-making status (Daniels and Sabin, 2002, cited in Winkler and 
Gruen, 2005, p.114). Although a commitment to core values is not incompatible with 
competitiveness in business (Spencer et. al., 2000, p.145), what ultimately defines the ethical 
nature of the organisation are the principles according to which it sets its priorities and 
allocates its resources.
 
7.2 Ethical Leadership 
Ethical values or standards adapted by organisations are generally articulated in mission 
statements, vision statements or codes of ethics. These statements of core organisational 
values represent the organisation’s perception of itself as an ethical entity, the central 
purpose it intends to accomplish and where it wants to be at a certain point in the future.  
The values mentioned in the mission statement can be philosophical – for example, 
compassion, care, accountability, respect, trust – or ‘operational’ – for example, a focus on 
skill and knowledge, or a commitment to the provision of certain kinds of services. They also 
serve to distinguish that organisation from similar organisations, and influence both the 
structure of the organisation and the roles and behaviour of ‘stakeholders’ within it  
(Spencer et. al., 2000, p.142). 
7.2.1 Positive Ethical Climate
An effective organisational ethics approach involves developing and maintaining a positive 
ethical climate within the healthcare organisation. According to Spencer et al, the creation of 
a positive ethical climate involves balancing two sets of expectations; 
1. it involves ensuring that the organisation’s expectations for professional and managerial 
performance are consistent with its stated mission and goals, as they are actually 
implemented. 
2. the organisation must embrace a set of values which reflect societal norms and 
expectations concerning how such organisations should operate and what goals they 
should prioritise (Spencer et. al., 2000, p.6). 
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within any organisation committed to the development of an ethical climate, a central 
responsibility of leadership is to ‘ensure that the organisation makes it easy for employees to 
‘do the right thing’’ (Veterans Health Administration, 2009, p.iii). According to Spencer et al, 
an organisation can ‘impair or enhance the moral agency of the individuals employed by it’ 
(2000, p.23). Thus, the challenge for the healthcare organisation is to create an ethical culture 
which enables ethical conduct, rather than a culture of compliance which enforces it 
(Gibson, 2007, p.33). 
Organisations can be said to promote ethical conduct if leaders 
•	 encourage and model ethical behaviour, 
•	 reward ethical conduct and 
•	 discipline unethical conduct, 
•	 provide forums for discussing ethical issues and 
•	 emphasise fair treatment of employees (Winkler and Gruen, 2005, p.111). 
In order to create a positive ethical climate in which all employees feel comfortable 
discussing ethical concerns, senior management must demonstrate that ethics is a priority, 
communicate clear expectations for ethical practice, and support and promote their 
institution’s ethics programme (Veterans Health Administration, 2009) 
Gibson lists five factors which are essential for the development of a positive ethical climate 
within a healthcare organisation (Gibson, 2007; Veterans Health Administration, 2009, p.33-4):
•	 Senior management must play an essential role in setting the ethical tone of the 
organisation.
•	 The organisation’s statement of its mission, vision and values should provide a ‘moral 
compass’ which is used in decision-making within the organisation.
•	 Ethical guidelines and policies are essential for translating the organisation’s mission, 
vision and values into practice and these play an important role in guiding conduct and 
minimising conflict.
•	 Processes and mechanisms for ethical decision-making must be put in place and should 
be used in attempts to resolve value-based disagreements about how policies and 
guidelines are interpreted.
•	 Ongoing evaluation is required to ensure that organisational ethics issues are accurately 
identified and constructively resolved, and that the organisation’s mission, vision and 
values are implemented, both by the organisation and at the level of individual action.
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7.3 The Relationship between Clinical and Organisational Ethics
In their 1998 task force report, the American Society for Bioethics and Humanities (ASBH) 
stated that a definitive separation of the spheres of clinical ethics and organisational ethics 
was not possible, given that many clinical ethics issues or conflicts have an organisational 
ethics dimension, and many organisational ethics issues have implications for clinical 
practice (ASBH, 1998, p.24). 
To take a controversial example, discussions of conflicts arising from the routine resuscitation 
of critically-ill patients often make reference to a shortage of ICU beds and specialist staff 
– clearly an organisational ethics issue which accompanies clinical ethics concerns about 
patient autonomy and dignity. 
Yet there are clear differences between clinical ethics and organisational ethics. The former 
straddles the boundary between clinical practice and ethical analysis, while the latter 
involves the ethical analysis of the business and management practices of healthcare 
organisations, as well as their stewardship of public funds and the manner in which they 
discharge their societal and public health obligations. 
Organisational ethics consultation requires additional knowledge about the business and 
cost-containment elements of health care provision and managed care, and about billing 
practices, marketing, resource allocation, definitions of standard or experimental care, and 
conflicts of interest (ASBH, 1998, p.26). Given the emerging nature of organisational ethics 
and the rapidly-changing structure and financing of health care, the ‘technical content’ to be 
mastered in order to conduct such consultations often has to be learnt within the context of 
the consultation itself. 
Consultation in relation to organisational ethics issues is usually requested by senior leaders 
within the organisation, and the impact of any resolution of organisational ethics issues 
is often much more extensive than the impact of clinical ethics consultation (ASBH, 1998, 
p.25). Organisational ethics is by nature much broader in scope than clinical ethics, involving 
as it does everyone within the healthcare organisation – payers, purchasers, visitors, the 
community, employees, patients and their families (Schyve, 2003, p.135). 
Because the practice of organisational ethics consultation is much less well-established 
than clinical ethics consultation, many healthcare organisations in the US have set up 
organisational ethics programmes or committees, in an attempt to create a process for the 
resolution of organisational ethics issues and to promote the development of a positive 
ethical climate. These initiatives are driven by the belief that, as organisational ethics 
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organisational ethics services may become necessary. In their 2009 report, the ASBH task 
force draws an explicit distinction between clinical and organisational ethics consultation, 
claiming that, while the task of clinical ethics consultation services is to ‘achieve defensible 
solutions to clinical ethics problems’, the task of organisational ethics consultation services is 
to achieve defensible solutions to organisational ethics problems (ASBH, 2009, p.12-3). 
During the course of the past decade, the principal area of overlap between clinical and 
organisational ethics has been the sphere of policy formulation and revision. Although 
this continues to be part of the remit of clinical ethics committees, as organisational ethics 
becomes better defined, it seems likely that policy work will increasingly be carried out by 
organisational ethics committees or consultants. Despite differences between clinical ethics 
and organisational ethics, however, decision-making at both clinical and organisational 
levels is framed against the same context of societal, institutional, communal, professional 
and individual values. The goal of both clinical ethics consultation and organisational ethics 
consultation is the same: ‘to help people resolve uncertainty or conflict regarding value-
laden issues’ (ASBH, 1998, p.25). 
Organisational ethics as a discipline has been slower to gain a foothold in the landscape 
of European and Irish healthcare provision than in the US and Canada. However, it seems 
likely that the increasing complexity of the relationship between healthcare organisations, 
insurance providers, healthcare systems – both public and private – and the market will 
sooner or later drive the creation of organisational ethics programmes in Europe, as it has 
done across the Atlantic. Irish healthcare organisations concerned about organisational 
ethics issues face a significant challenge: the difficulty of separating the spheres of clinical 
ethics and organisational ethics in a context in which, to date, neither is well-delineated or 
properly defined. 
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8. Module 8 Summary Learning Guides
8.1 Why the Need for Clinical Ethics?
•	 The provision of health-care involves achieving a balance between promoting the well-
being and best interests of patients and their right to be partners in decisions made 
about their treatment. This balance requires accommodating a number of different 
value-systems, some of which may be in conflict with one another. Clinical ethics 
support contributes to the clarification and resolution of these value-conflicts.
•	 Excellence in the delivery of care requires ongoing education of staff in relation to 
patient rights, issues of consent and confidentiality, communication methods and 
mediation techniques.
•	 Mechanisms and frameworks for ethical decision-making are needed to assist health 
professionals in making difficult decisions. 
•	 There is a need for a fair and reasonable process for the resolution of conflicts arising in 
the context of the provision of care.
•	 There is a need for past mistakes to be acknowledged and skilfully converted into 
learning opportunities for health professionals and staff, in order to prevent  
re-occurrence.
•	 There is a need for advocacy on behalf of those who do not have a voice because they 
lack power in the medical hierarchy (patients, members of minority populations, staff in 
vulnerable positions, low-paid contract employees).
 
8.2 Case Analysis Tool for Clinical Ethics Consultation: 
•	 Clearly articulate the problem.
•	 Gather and consider all relevant information (medical and non-medical)
•	 Identify the various courses of action possible.
•	 Identify the appropriate decision-makers and those who should participate in the 
decision-making process
•	 Identify the various values and ethical principles associated with each alternative. 
•	 Consider the consequences of each alternative – including probable harms and 
benefits and who will be affected. 
•	 Select the best – or the ‘least bad’ – course of action. 
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8.3 Principles of Research Ethics
•	 The research must have social or scientific value.
•	 The research must be scientifically and methodologically valid.
•	 Methods of subject selection and recruitment must be fair.
•	 The relationship of risk to benefit must be proportionate.
•	 Mechanisms for independent review of the research must be observed.
•	 Informed consent must be obtained
•	 Subjects must be respected
8.4 Factors Essential to a Positive Ethical Climate 
•	 Senior management play an essential role in setting the ethical tone of the organisation
•	 The organisation’s statement of its mission, vision and values provides a ‘moral compass’ 
for decision-making within the organisation.
•	 Ethical guidelines and policies which operationalise or embody the organisation’s 
mission, vision and values play an important role in guiding conduct and minimising 
conflict.
•	 Processes and mechanisms for ethical decision-making help to resolve value-based 
disagreements about how policies and guidelines are interpreted.
•	 Ongoing evaluation is required to ensure that organisational ethics issues are 
accurately identified and constructively resolved, and that the organisation’s mission, 
vision and values are implemented, both by the organisation and at the level of 
individual action
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9. Module 8 Activities 
9. 1 Reflect back on the particulars of Case 1.
a. In your opinion, does it make sense to say that concepts such as ‘value of life’ and ‘futility’ 
are relative concepts? Document the reasons why you agree or disagree with this 
statement.
b. Can you think of situations in which health professionals make value judgements about 
patients’ quality of life and these judgements may influence the treatment they receive? 
Can we say with certainty that existence in a persistent vegetative state – or even in 
intensive or long-term care – is not worth living? 
c. Can you think of any (morally significant) differences between a case such as this one and 
a case in which health professionals are discussing discontinuing treatment for an adult 
in a persistent vegetative state or coma? Re-read Module 3, Case 2 in relation to the Irish 
Ward of Court Case (1995).
9.2 Reflect back on the particulars of Case 2. 
a. In your own opinion, should the hospital have acted differently? Should the error have 
been disclosed to the mother, and if so, why? Would your answer be different if the 
neonate’s body had lain undiscovered in the morgue for a longer period, say, a year  
or more?
b. Can you think of any other exceptions to the general principle that errors should always 
be disclosed?
c. What do your professional guidelines have to say about the disclosure of medical errors 
or adverse or sentinel events?
d. Imagine that you are the clinical ethicist in this scenario and that you have to apply 
Harrison’s framework for decision-making (4.6.1 above) to the situation. Describe how 
this would structure your approach to the case. What information would you need? How 
would you weigh the demand for disclosure against the need not to harm the mother?
e. Imagine it is your task to draft the policy named after the neonate. What would be the 
main elements of the policy?
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9.3 Reflect back on the particulars of Case 3.
a. It could be argued that, as minors suffering from a psychiatric illness, the participants 
in this proposed study are doubly vulnerable. Does the right to participate in research 
outweigh the risk posed to these participants? 
b. Do you think there is a good case to be made for excluding such populations altogether 
from participation in research? Could it be argued that this is paternalistic or over-
protective? 
c. In your opinion, is there a danger that classifying a particular group as ‘vulnerable’ 
involves a form of stereotyping? 
d. Is there anything missing from the list of additional protections for participants provided 
at the end of Case 3 above? 
e. Take a look at the Article 4 of the Clinical Trials Directive, ‘Clinical Trials on Minors’. In 
your view, is it adequate to protect this vulnerable group of minors from exploitation? 
Compare this with the discussion of categories of risk presented in the US Department 
of Health and Human Services’ Code of Federal Regulations Title 45, Part 46, and Subpart 
D: ‘Additional Protections for Children Involved as Subjects in Research’. Which, in your 
opinion, offers greater protection to minors? (United States Department of Health and 
Human Services, 2005)
f. Can you think of any other principles which might be added to the list of principles for 
the ethical conduct of research provided by Emanuel et. al (2000). Are these principles 
adequate to protect participants who are vulnerable in other ways, e.g., participants in 
developing world research?
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